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ABSTRACT: Biological membranes are tricky to investigate. They are complex in terms
of molecular composition and structure, functional over a wide range of time scales, and
characterized by nonequilibrium conditions. Because of all of these features, simulations are
a great technique to study biomembrane behavior. A significant part of the functional
processes in biological membranes takes place at the molecular level; thus computer
simulations are the method of choice to explore how their properties emerge from specific
molecular features and how the interplay among the numerous molecules gives rise to
function over spatial and time scales larger than the molecular ones. In this review, we focus
on this broad theme. We discuss the current state-of-the-art of biomembrane simulations
that, until now, have largely focused on a rather narrow picture of the complexity of the
membranes. Given this, we also discuss the challenges that we should unravel in the
foreseeable future. Numerous features such as the actin-cytoskeleton network, the
glycocalyx network, and nonequilibrium transport under ATP-driven conditions have so far
received very little attention; however, the potential of simulations to solve them would be exceptionally high. A major
milestone for this research would be that one day we could say that computer simulations genuinely research biological
membranes, not just lipid bilayers.
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1. INTRODUCTION
Biological membranes are everywhere. All our cells are
surrounded by a biological membrane. So also are the tiny
organelles such as the nucleus that contains our genetic code
and the endoplasmic reticulum that synthesizes most of our
proteins. Biological membranes keep us alive when they
transfer oxygen from our lungs to our bloodstream.
Biomembranes also control our mood, because they host the
receptors of signaling molecules such as dopamine in our brain.
It is quite intriguing that membranes can play such crucial
roles in maintaining life, yet these membranes are basically just
soft, few nanometers thick lipid interfaces. However, the more
closely one looks at them, the more complex they turn out to
be. It is quite justified to note that despite about 100 years of
research, we still do not understand exactly what biological
membranes really look like.
We know that they are made up of thousands of different
lipids. We know that they host numerous proteins that carry
out many of the cellular functions. And we know that all the
communication between the outside and the inside of cells is
controlled by biomembranes. However, we also know that
biological membranes are constantly being modified as their
content and heterogeneous structure change constantly during
our life. In essence, biomembranes are characterized by a series
of transient structures that evolve under nonequilibrium
conditions. To fully understand what is going on in
biomembranes, one should be able to unravel all the possible
processes, starting from reactions on a scale of angstroms to
large-scale events taking place on a scale of micrometers.
One of the methods of choice to accomplish this aim is
computer simulation. By carrying out simulations on well-
defined model systems and using experimental data as input,
one can generate new information by predicting novel
phenomena and by helping to interpret experimental
observations. By bridging different simulation techniques to
each other, one can also investigate multiscale phenomena,
such as how a single chemical reaction in a protein leads to
macroscopic motion of a cell.
At present, the field of biomolecular simulations is
undergoing a paradigm shift. The quality of atomistic
simulation models has reached a level where computer
simulations are a major complement to experimental research.
At the same time, increased computing resources have made
millisecond atomistic simulations possible; this is a crucial
point given that the activation of many membrane receptors
takes place on a millisecond time scale. Furthermore, both
quantum mechanics/molecular mechanics (QM/MM; see
Table 1 for a complete list of abbreviations) and coarse-
grained molecular simulation models have developed so
dramatically that there are now a number of reliable ways to
explore multiscale phenomena by means of multiscale
simulations.
In this review, we describe the challenge that we must face.
The question is, when we want to understand how biological
membranes function, then what exactly should we be able to
simulate?
In this spirit, we here discuss the recent progress in
computer simulations of biomembranes. It is worth clarifying
that when we talk about biomembranes, then we mean the real
biological membrane in our living cells. So, no one has
simulated it yet, although many would like to.
We discuss how the quite extreme diversity of different lipids
govern membrane behavior, cellular signaling, mass transport,
formation of functional membrane domains, storage of energy,
and metabolism. We discuss several themes that have so far
received little attention but that are of exceptionally central
importance for understanding the functioning of biomem-
branes, such as glycosylation and other post-translational
modifications and the machinery associated with, for example,
the actin cytoskeleton and the glycocalyx. We close the review
by introducing some of the future challenges and goals. The
aim is that, someday, we will be able to simulate the
functioning of biomembranes and cells in a multiscale manner,
using simulation models that match reality.
2. HISTORICAL OVERVIEW
It is always fascinating to see retrospectively how science has
uncovered the secrets of nature. Let us here briefly discuss two
themes that are central to this review: the understanding of
biological membranes in terms of theoretical models proposed
over the years and the history of computer simulations as the
basis for simulating lipid systems together with other
biomolecules.
2.1. Brief History of Cell Membrane Models
Several models have been suggested during the previous 95
years to explain the structural and dynamical aspects of
biological membranes. Already in 1925, Gorter and Grendel1
suggested that lipids form biomolecular layers. Then in the
1950s, Robertson2 proposed a three-layer structure, where two
layers of proteins were attached to a lipid layer in the middle. A
few years later Lenard and Singer suggested a revised model,3
where the proteins were now allowed to span a lipid bilayer
structure. This picture was yet considered incomplete, and in
1972 Singer and Nicolson proposed the famous “fluid mosaic”
model4 that is nowadays generally known also as the Singer−
Nicolson model.
The fluid mosaic model depicts reality, as we understand it
today, already in a quite convincing manner. It suggests that
lipids form a fluid two-dimensional matrix that hosts proteins
to carry out their functions. In the fluid mosaic model, lipids as
well as proteins are assumed to be more or less randomly
distributed in the plane of a lipid bilayer structure, thereby
providing a considerable degree of freedom for lateral and
rotational diffusion. Meanwhile, this assumption also implies
that the model does not account for lateral heterogeneity
despite the fact that the idea of lateral heterogeneities and
membrane domains in model membranes was suggested
already in 1970.5−7 After the fluid mosaic model was proposed,
more and more data were published in favor of membrane
heterogeneity and lateral lipid composition fluctuations,
leading to the ideas of lateral segregation, domain formation,
and lipid−protein interactions driving the formation of
functional membrane regions (see discussion in refs 8 and 9,
for example). Further, while a number of additional models to
account for aspects such as hydrophobic matching, and the
role of the cytoskeleton and the glycocalyx network were
further proposed in the 1980s and 1990s (for a comprehensive
discussion on this theme, see the reviews by Ole Mouritsen
and Luis Bagatolli10,11), it is fair to say that the next major
paradigm was suggested by Simons and Ikonen in 1997 in
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terms of the raft hypothesis.12 In the raft model, based on
observations reported some years earlier,13 one assumes
membranes to be comprised of cholesterol- and sphingolipid-
rich domains functionally associated with specific proteins
involved in cellular functions, in particular cell signaling. The
idea of domains rich in cholesterol was not new, and it had
been explored theoretically prior to the suggestion of the raft
hypothesis. In particular, the theoretical work by Hjort Ipsen et
al. had predicted that under certain thermodynamic conditions
cholesterol generates the coexistence of cholesterol-rich liquid-
ordered (Lo) and cholesterol-poor liquid-disordered (Ld)
phases.14 This picture has largely been the basis of the idea
that lipid rafts are highly ordered cholesterol-rich membrane
domains or even membrane phases. Yet, this picture is not
complete.
Is it justified to consider ordered protein-free membranes or
membrane domains as lipid rafts? If one can show that protein-
free membrane domains have a biological function and if
ordered protein-free membrane phases (compare with nano-
scale membrane regions) exist in real cell membranes, then
Table 1. List of Abbreviations and Their Full Forms Used in This Article Given in Alphabetical Order
abbreviation full form
ABC ATP binding cassette
AH amphipathic helix
ANTH AP180 N-terminal homology
APP amyloid precursor protein
AQP0 Aquaporin-0
BAR bin/amphiphysin/RVS domain
BK big potassium channels
BMP bis(monoacylglycero)phosphate
CEs cholesteryl esters
CL cardiolipin
CETP cholesteryl ester transfer protein
Ci-VSP PD voltage sensitive phosphatase PTEN domain
CO cholesteryl oleate
COMT catechol O-methyl transferase
CP actin-capping protein
cPLA2 PLA2 cytosolic
Cpx complexin
CRAC cholesterol recognition amino acid consensus motif
cryoEM cryogenic electron microscopy
CTB cholera toxin
CYP cytochrome P450
dDAT Drosophila dopamine transporter
DHA docosahexaenoic acid
EGFR epidermal growth factor receptor
EM electron microscopy
ENTH epsin N-terminal homology domain
EPR electron paramagnetic resonance
Exo70 exocyst complex component 7
FRET Förster resonance energy transfer
GABA(A) γ-aminobutyric acid receptor type A
GABAAR pentameric ligand gated ion-channel
GIVA PLA2 family in human group IVA
GltPH orthologous bacterial aspartate transporter
GPCR G protein-coupled receptors
GPMVs Giant plasma membrane-derived vesicles
GRP1 general receptor of phosphoinositides 1
GVIA PLA2 calcium-independent group VIA
hDAT human dopamine transporter
HDL high-density lipoprotein
Tm temperature of the main phase transition
HMMM highly mobile membrane mimetic
HOPS protein sorting complex
Hsc70 70 kDa heat shock protein
hSERT human serotonin transporter
HVR hypervariable region
IF inward-facing
KV voltage-gated potassium channels
LAT linker of activation of T cells
LC3 microtubule-associated protein light chain 3
abbreviation full form
Ld liquid-disordered
LDL low-density lipoprotein
LDs lipid droplets
LeuT bacterial leucine transporter
Lo liquid-ordered
MATs monoamine transporters
MB-COMT membrane-bound COMT
MD molecular dynamics
MD/MC molecular dynamics/Monte Carlo
MOA monoamine oxidase
MscL conductance mechanosensitive ion channel
Munc18a mammalian uncoordinated-18 protein
nAChR nicotinic acetylcholine receptor
NhaA Na+/H+ antiporter
nHDL nascent HDL
NMR nuclear magnetic resonance
NPC1 Niemann−Pick C protein 1
NPC2 Niemann−Pick C protein 2
NSF N-ethylmaleimide sensitive factor
NSS neurotransmitter-sodium-symporter
OF outward-facing
Osh oxysterol binding protein
PH pleckstrin homology
PKCα protein kinase C-α
PLA2 phospholipase A2
PMF potential of mean force
PTEN-like phosphatase tensin-type domain
QM/MM quantum-mechanics/molecular mechanics
S1P1 sphingosine 1-phosphate receptor 1
SANS small angle neutron scattering
SAXS small angle x-ray scattering
SC stratum corneum
S-COMT water-soluble COMT
Sec3 exocyst complex component 1
SNARE soluble N-ethylmaleimide-sensitive factor attachment protein
receptor
STED stimulated emission depletion microscopy
STxB Shiga toxin
Syt1 synaptotagmin-1
TAGs triacylglycerols
TAP antigen translocation complex
TGs triglycerides
TO triolein
TRPV1 transient receptor potential vanilloid subtype 1
t-SNARE membrane-attached SNARE
v-SNARE vesicle-attached SNARE
WALP tryptophan (W)-alanine (A)-leucine (L) peptide
α-TTP α-tocopherol transfer protein
β2AR β2-adrenergic receptor
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perhaps yes. Otherwise, quite likely not. The core of the matter
lies in that lipid rafts are considered, after two decades of
research, as fluctuating and functional nanoscale assemblies of
proteins and lipids.15 This picture would also intuitively make
sense, since a lipid raft would then correspond to a concept of
a protein that together with specified lipids would form a
protein−lipid complex, that is, a functional protein−lipid unit.
Given that individual (integral) membrane proteins are about
3−6 nm in size, and the dynamical lipid pool bound to the
protein increases the lateral size of this complex by ∼5 nm,16
then the minimal size of a lipid raft would be on the order of
10 nm. Experimental data are not incompatible with this
assessment: there was a quite long period when the resolution
of super-resolution microscopy increased steadily, and every
time the spatial resolution was improved, the size estimates for
rafts also decreased. Currently, when the spatial resolution of,
for example, stimulated emission depletion microscopy
(STED) is in the range of 10−20 nm,17 the raft size is also
predicted to be in the same range.
There will be more refined models for cell membranes, but
the lipid raft model serves currently as a quite reasonable
paradigm to understand the conditions where cell functions
take place in biological membranes. In the following sections,
we discuss many of these processes quite in detail.
2.2. History of Computer Simulations with Applications to
Lipids
The era of computer simulations can be traced back to the
dates when the first computers were deployed. The develop-
ment of the first electronic computer (ENIAC; Electronic
Numerical Integrator and Computer) that operated from 1945
to 1952 changed the world quite completely. The second
computer known as MANIAC (Mathematical Analyzer,
Numerical Integrator, and Computer) operated between
1952 and 1958 and was followed by, surprisingly, MANIAC
2 and MANIAC 3.
The people who pioneered this process can also be
considered as the pioneers of the computer simulation field.
For instance, Nicholas Metropolis, who was one of the figures
developing and using ENIAC,18 originally suggested19 an
obvious name for the Monte Carlo simulation method.20,21 A
very essential detail at this point is that the first molecular
dynamics (MD) simulations were reported not earlier than in
1957. Therefore, the computational science between 1945 and
1957 was based on Monte Carlo simulations that rely on
stochastic sampling, and therefore on the use of random
numbers to solve problems in a stochastic manner.
Unfortunately, the quality of random numbers is typically
considered to be self-evident, and is often not appreciated, so
let us make an exception here and discuss this important topic
briefly before we move on to focus on lipid simulations.
Together with John von Neumann, Nicholas Metropolis also
studied randomness of the decimals of π and e,22 and
developed the first algorithm for generating pseudorandom
numbers that are needed in all stochastic simulation techniques
we use these days: the so-called midsquare method.23,24 In this
method, an arbitrary n-digit integer is squared, creating a 2n-
digit product. A new integer is formed by extracting the middle
n digits from the product. We do not encourage using the
Figure 1. Naming convention for common lipids (upper panel) and names with abbreviations of the lipids discussed in the manuscript (lower
panel).
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midsquare technique, however, since the properties of the
pseudorandom number sequences generated with the method
are bad24 (consider a seed of 50 with n = 2, for example), but it
was the first step in the right direction to find efficient and
practical means to generate huge numbers of pseudorandom
numbers for stochastic computer simulation applications. This
pioneering work has evolved to a research field of its own,25
with an objective to develop deterministic algorithms that
generate pseudorandom number sequences that mimic truly
random behavior as closely as possible, but with extreme
efficiency. Importantly, these sequences are used not only in
Monte Carlo sampling methods but also in MD simulations
that often are based on using stochastic noise to model the
effect of a thermodynamic heat bath, that is, temperature.
Given this, the quality of the pseudorandom number
generators used in simulation packages is critical to the
reliability of the simulation results. The essence of the matter is
that if the quality of pseudorandom number sequences used in
any stochastic simulation method, including MD, is low, then
the validity of the results may be compromised. As a matter of
fact, when articles of simulation studies using stochastic noise
are reported, it is truly peculiar how seldom the name of the
pseudorandom number generator used in the stochastic
simulations is mentioned at all.
The footsteps of the above work by Metropolis and von
Neumann also generated the first MD simulations, which were
conducted on hard-sphere models and reported in 1957.26 The
first MD simulation of argon as a representative of a real liquid
was published in 1964.27 It took a few years more until the first
simulations on biological molecules were reported. In 1977,
MacCammon et al. studied a small protein (bovine pancreatic
trypsin inhibitor) for 8.8 ps.28 The simulation time was quite
limited but so was also the environment, since the simulation
was conducted in vacuum. Due to progress in the design of
faster computers, the simulation time scales have increased
rapidly, and the first 1 μs simulation on protein folding was
performed already in 1998.29
Meanwhile, the era of lipid simulations started in 1980 as has
been reviewed by Rich Pastor.30 The first MD simulations
were based on simplified models of monolayers,31 lipid bilayers
without solvent (water),32 and small micelles immersed in the
water phase.33 A few years later, Larry Scott and his co-workers
started combining Monte Carlo and MD for simulations of
lipid membranes.34−36 Using Monte Carlo can sometimes be a
clever and efficient trick, since it allows the use of unphysical
moves that may foster the sampling of the phase space.
Yet, it is a fact that the most common method used today for
simulations of complex membranes is MD. Further, while this
is a matter of taste, it may be fair to say that the field of lipid
simulations as we understand it today started in early 1990s,
when a number of exciting articles of hydrated lipid bilayers
were published in a row.37−40 At the same time, the experts
started to pay significant attention to the accuracy of the
simulation models. Let us consider one of these trends in more
detail here.
In 1994, Egberts et al.41 designed a model for DPPC (for the
naming convention of lipids, see Figure 1) based on the
GROMOS-87 force field. However, since their initial choice of
the force field parameters resulted in the gel phase, they
reduced the partial charges of the lipids by a factor of 2,
adjusted the van der Waals parameters for the CH2/CH3
groups, and modified the dihedral potential of the acyl chains
into the Ryckaert−Belleman representation to reproduce the
structure of the acyl chains. The changes corrected the
problem and resulted in a model that generated a lipid bilayer
in the liquid-disordered phase. Then, three years later Berger et
al. published a lipid simulation model that is still in common
use and known as the “minimal standard” in lipid
simulations.42 As is well-known, the tough part in the
development of classical simulation models is the derivation
of Lennard-Jones interaction parameters. To this end, Berger
et al. systematically reparametrized the nonbonded interactions
used in the Egberts paper by applying OPLS (optimized
potential for liquid simulations) parameters that were earlier
used in a model for DMPC.43 They systematically adjusted the
Lennard-Jones parameters for CH2/CH3 groups by simulating
bulk pentadecane and then fitted the Lennard-Jones
parameters to find a match with experimental data for volume
and heat of vaporization.
In a way, the “Berger lipids” have become a classic. This
model is not bad, rather it is surprisingly good given that it was
developed with minor resources about 20 years ago. It was
essentially the most accurate force field from 1997 until about
2010, when CHARMM36 lipids were published. Many senior
scientists working today on lipid simulations recall nostalgically
the times when they used the Berger model in 1 ns (or may be
even 100 ns) simulations and then used the data of a single
simulation to publish a solid paper.
Starting from about 2000, the progress in lipid membrane
simulations has been rapid. For recent reviews, see, for
instance, the one in ref 44 and the review describing the
progress in lipid force field development by Lyubartsev and
Rabinovich.45 In other reviews, some methodological topics
are discussed including MD simulations and modeling tools,46
free energy calculations,47 artifacts frequently encountered in
simulations,48 and problems about validating MD results.49−51
2.3. What is Currently Feasible by Computer Simulations?
The answer to this question depends on the quality and the
nature of the simulation models, the amount of computer
resources available for simulations, and also how efficiently the
simulation software is integrated to the hardware.
As to classical atomistic simulations, protein folding has
been explored over millisecond time scales.52 Nanoscale
domain formation in lipid membranes has been investigated
in systems of ∼1000 lipids over ∼1 μs per system, the total
simulation time being ∼10 μs.53 The dynamics of membrane
proteins and their allosteric interactions with cholesterol have
been investigated over simulation times of >100 μs.54 Since the
activation process of membrane proteins usually takes place in
time scales of milliseconds, it is expected that in a few years the
consideration of these events in full atomic detail becomes
feasible.
In coarse-grained simulations, the scales depend very much
on the extent of coarse graining. In the MARTINI model,
using an explicit solvent, large highly protein-crowded
membranes have been explored over multi-millisecond time
scales.55 In related simulations of lipid membranes with
integral membrane proteins, several papers have reported data
for large membranes over times from ∼10 μs56 to milli-
seconds.57 In implicit solvent simulations, the scales would
obviously be much longer.
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3. BIOMEMBRANES AS THE TARGET OF
SIMULATIONS: NATIVE MEMBRANES WHOSE
BEHAVIOR WE WOULD LIKE TO UNDERSTAND
Biological membranes are highly complex systems composed
of various types of macromolecules, in particular lipids,
proteins, and carbohydrates. Even the smallest membrane-
bound intracellular organelle with a diameter of ∼100 nm is
huge compared to atomic size scales. This makes them almost
impossible to model and simulate as a whole. Considering that
a real cell is approximately 10 μm in size, the challenge faced
by computer simulations is indeed enormous.
Due to these unfortunate facts, biological membranes are
explored via simulations by focusing on smaller fragments
Figure 2. Glycerol-based lipids. Upper panels show the glycerol backbone with possible modifications, the middle panel shows the most common
headgroups, and the bottom panel shows phosphatidylinositol headgroups.
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instead of being examined as a whole. This divide-and-conquer
approach allows capturing of the entire complexity of real cell
membranes and the processes that take place in their vicinity.
Here we provide the background for sections 4−10. We
present the most important molecular components of which
the biomembranes are formed, lipids, proteins, and glyco-
conjugates. Of these components, glucoconjugates have
received the least attention in membrane simulations. We
further discuss post-translational modifications such as
glycosylation and their roles in membrane function. Again, it
turns out that these structural modifications have received very
little attention in membrane simulations until now. Finally, we
draw the reader’s attention to the themes where the
biomembrane structure is really challenging, such as the
glycocalyx and the cell wall. Understanding how these complex
structures function would be extremely important, but
currently the simulation research done to explore these
systems has been very modest.
The reader is requested to keep in mind that we focus on
providing a concise overview of the complexity of biomem-
branes in this section. Simulations to explore these themes are
discussed in later sections.
3.1. Lipids
3.1.1. Diversity of Lipids. Lipids, which are the main
building blocks of, for example, membranes, lipid droplets, and
lipoproteins, constitute a large and diverse group of biological
compounds. The physical and chemical properties charac-
terized by lipids are very diverse; thus there are also very
distinct molecules all known as lipids. For instance, various
lipids are intermediate metabolites on synthetic pathways, such
as 17 different sterols acting as precursors of cholesterol;
signaling molecules, such as steroid hormones; and cofactors of
enzymatic proteins such as retinol; as well as products of
pathological oxidation processes. In practice, lipids are
essentially surface-active (amphiphilic) fatty molecules that
have a biological function. Here for the definition of lipids we
emphasize the importance of biological function. While soaps
and detergents are also surface-active molecules, they lack the
biological function and thus are not lipids.
The Lipid Maps Structure Database (LMSD) (http://
lipidmaps.org/data/structure/) of biological lipids contains
structures of nearly 21 000 known and 22 000 predicted lipids.
Not all of these lipids are abundant in biological membranes.
Nonetheless, they are found in trace amounts in biological
membrane samples. The number of typical lipid types found in
cells is ∼1000, though there are significant differences between
different organs or clades. For a recent review of lipid diversity,
please read refs 58−61. In spite of this variety, artificial lipids
are actively developed for pharmaceutical applications62−69 or
as research tools.70−72 For reviews, see refs 73−75.
Importantly, lipids play diverse roles not only in membrane
structures but also in physiological processes in whole
organisms. For example, cholesterol-derived bile acids
participate in the digestion of fats76 and steroid-glycosides
such as saponins act as protective elements in plants.
In this section, we discuss the lipids and the lipid groups that
are the main building blocks of biological membranes. We
introduce the key building blocks needed to construct
simulation models for lipid membrane structures. To
demonstrate the diversity of lipids in a real setting, we also
discuss recent lipidomics studies that highlight the variety of
lipids that the simulation models should include, if the aim
would be to simulate membranes whose content would match
reality.
3.1.2. Main Lipid Classes. Glycerol-Based Lipids. Back-
bone. Glycerol-based lipids are the most common lipids in
both prokaryotes and eukaryotes. Glycerol-based lipids are
predominantly esters of the glycerol group, which is the
backbone of the lipid. The glycerol group is linked to fatty acid
chains and a polar headgroup (Figure 2). Typical membrane
lipids in this class have two chains attached to the sn-1 and sn-2
positions, while the headgroup is connected to the sn-3
position. There are also lipids known as lyso-lipids with a single
chain, such as lyso-phosphatidylcholine (lyso-PC), which acts
as a modulator of membrane curvature. Lipids with three
hydrophobic chains (triglycerides) are the storage form of
lipids found, for example, in lipid droplets and lipoproteins. If
the ester linkage to the glycerol group is replaced with an ether
link (Figure 2), one ends up with ether lipids such as
plasminogens, where the ether bond is a part of the vinyl group
(Figure 2).77
Headgroups. The simplest headgroup of glycerol-based
lipids is the unesterified hydroxyl group. Lipids with this group
are called diacylglycerols (DAGs) (Figure 2). DAGs are a
minor component of cell membranes, but they play a central
role in lipid synthesis. Further, they also play an essential role
in signaling as second messengers.78,79 As the headgroup of
DAGs is smaller than their hydrophobic part, they induce
spontaneous negative curvature. Due to this quite unique
property, DAGs are involved in membrane fusion and fission.79
Another simple headgroup is the phosphate group present in
phosphatidic acid (PA), which is perhaps the simplest
phospholipid (Figure 2) but also the one with the most
complex biophysical properties.80,81 PA, similarly to DAG, is
only a minor component in cell membranes, their concen-
tration in intracellular membranes being ∼1 mol %. Never-
theless, it is a crucial metabolite in the synthesis of other
phospholipids and a second messenger in cellular signal-
ing.82−85 PA is also vital for mitochondrial function due to its
role in mitochondrial fusion and fission.86 Due to the relatively
small headgroup of PA, diacyl-PA has a conical shape
promoting spontaneous negative membrane curvature, but its
monoacyl form, the lyso-PA, has a cylindrical shape, which
promotes a flat membrane topology.87 Specific lipases
interconvert these two forms during membrane fusion and
fission. PA is also characterized by complex protonation
behavior, since at physiological pH there are two possible
protonation states with a charge of −1 and −2. The
equilibrium between these states is likely influenced by
membrane lipid composition, proteins, divalent cations, and
modifications to the chemical structure of the molecule (e.g.,
the lyso form).88,89
Phosphatidylcholines (PCs) are the main structural lipids in
animals and fungi, while in plants and bacteria, they are less
common. Most biophysical studies of lipid bilayers have been
based on PC membranes that are commonly used as a control.
The headgroup of PC is relatively large and zwitterionic,
containing a positively charged tetramethylammonium moiety
along with a negatively charged phosphate group. Like in all
naturally occurring phospholipids including PA and phospho-
lipid groups discussed below, the headgroup is linked to a
glycerol backbone via an ester bond with a phosphate group.
Nevertheless, lipids with reverse order of charge, where the
tetramethylammonium group attaches the headgroup to the
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glycerol backbone, were synthesized providing a better
understanding of PC’s electrostatic properties.90
Another common zwitterionic lipid is phosphatidylethanol-
amine (PE), which is not only the second most common lipid
in animals but also commonly found in bacteria. The
headgroup of PE is composed of a positively charged amine
group and a negatively charged phosphate group. PE is a
precursor of PC, which is synthesized by substitution of
hydrogen atoms of the amine group with methyl groups.
Interestingly, in some bacteria intermediates between PE and
PC with one or two methyl groups act as structural lipids.91
Figure 3. Most common headgroups of plants and bacteria in glycerol-based glycolipid headgroups (see ref 101). The dotted line indicates the
attachment point for DAG.
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Phosphatidylserine (PS) is the main negatively charged lipid
in animals, accounting for 8−15 mol % of all phospholipids in
cells.92,93 The headgroup consists of a negatively charged
phosphate group esterified with serine, thus having another
negatively charged group, a carboxylic group, and a positively
charged amine group. PS is located mostly in the inner leaflet
of the cell membrane, and its translocation to the outer leaflet
signals apoptosis.94,95 PS directly interacts with and regulates
the functions of numerous proteins, such as protein kinase C,
Raf-1, a serine-threonine kinase, AMPA, a glutamate receptor,
and proteins related to exocytosis.92
Another important negatively charged lipid is phosphatidyl-
glycerol (PG). The PG headgroup consists of a negatively
charged phosphate group esterified with a neutral glycerol
molecule. While PG is a minor component of animal
membranes,96 its concentration is high in plants and
bacteria.91,97
Figure 4.Most common free fatty acids from human serum (see ref 103): (A) saturated fatty acids, (B) unsaturated 22 carbon long fatty acids, (C)
unsaturated 20 carbon long fatty acids, (D) unsaturated 18 carbon long fatty acids, and (E) remaining unsaturated fatty acids. Arrows in panel A
show the last carbon atoms; those in panels B, C, and D show the positions of unsaturated bonds. In panel E, the left arrow shows the position of a
double bond, while the right arrow shows the last carbon atom.
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Phosphatidylinositols (PIPs) constitute a group of lipids
found in small quantities in cells but having significant
functions related to cellular signaling, membrane trafficking,
cell division and migration, and endo- and exocytosis.98−100
The headgroup of PIPs is based on inositol, a hexane ring
substituted with hydroxyl groups attached to each carbon,
which can be esterified by phosphatidic acid. In biological
PIPs, there are up to three phosphates. Phosphate groups in
water solution may be singly or doubly deprotonated; thus,
PIP molecules may adopt various protonation states.
Glycerol-based glycolipids are common components of plant
membranes. They are especially enriched in photosynthetic
thylakoid membranes (Figure 3).101 They may comprise up to
50 mol % of lipids in higher plants. In Prochlorococcus, the main
phytoplankton organism, they may comprise even 94−99 mol
% of all lipids. Further, they are also components of
cyanobacterial membranes. The headgroup of this class of
glycolipids is a carbohydrate moiety directly linked to the
glycerol backbone. Most common glycerol-based glycolipid
species are monogalactosyldiacylglycerol (MGDG) and
digalactosyldiacylglycerol (DGDG).101 Other sugars, such as
glucose, mannose, glucuronosyl, and sulfoquinovosyldiacylgly-
cerol are also present in bacterial glycolipids. MGDGs that are
not membrane-forming lipids are believed to play a role similar
to that of cardiolipin in mitochondria.102
Carboxylic Acids: Lipid Chains. Biological samples contain
diverse types of not only lipid headgroups but also hydro-
carbon chains. For instance, analysis of free fatty acids in
human plasma has identified 31 different species (Figure 4).103
The most common ones are oleic acid (18:1, O, 37 mol %),
palmitic acid (16:0, P, 30 mol %), stearic acid (18:0, S, 10 mol
%), linoleic acid (18:2, Li, 7 mol %), palmitoleic acid (16:1, 7
mol %), myristic acid (14:0, M, 3 mol %), and arachidonic acid
(20:4, A, 1 mol %).103 The shortest fatty acid that has been
observed is lauric acid (12:0, L), and the longest one is cerotic
acid (26:0). All of the identified fatty acids have an even
number of carbons with four exceptions: pentadecanoic acid
(15:0), margaric acid (17:0), heptadecenoic acid (17:1 ω-7),
and tricosanoic acid (23:0). The number of unsaturated bonds
has been found to range from zero (10 cases) to six
(docosahexaenoic acid (22:6 ω-3, D or DHA). The
polyunsaturated fatty acid content covers about 3.5 mol % of
all fatty acids.
Combinations of 31 different free fatty acids in lipids with
two chains leads to 496 possible pairs of chains, thus 961 lipid
species for each possible headgroup. In reality, though, the
relevant number of different chain pairs is much smaller, since
some combinations are much more frequent than the others.
For instance, usually lipids contain 16−18 carbon-long
saturated or moderately unsaturated chains. These “standard”
plasma fatty acid compositions are, however, not universal, as
they depend on many factors such as diet. Moreover, in
different tissues and cells, there are different fatty acid profiles.
For instance, in the brain tissue, the chain composition in PCs
mirrors the standard fatty acid profile, while PE and PS are
highly enriched in polyunsaturated fatty acids.104
Fatty acid profiles in fungus also have similar features: the
predominant chain types are C16 and moderately unsaturated
(1−3 double bonds) C18 chains.105 A comparison of the fatty
acid profiles of 43 fungus species has shown that nearly 90% of
all chains belong to the above-mentioned dominant cases, but
their proportions vary significantly.106 For example, palmitic,
oleic, and linoleic acid contents range from 15% to 28%, 16%
to 41%, and 9% to 27%, respectively.106 In different groups of
fungi up to 45% of fatty acids are polyunsaturated fatty acids
(PUFAs).106 Differences in the main fatty acid profiles were
also observed in different spore types of the same fungal
species.107 A more detailed analysis of fatty acid profiles from
the edible fungus Laetiporus sulphurous revealed the presence
of 30 different fatty acids with the chain length ranging from 10
to 24; it also showed that the fatty acid with the highest degree
of unsaturation has six double bonds (22:6).108 Further, fungi
have a high concentration of unusual fatty acids. For example,
the fraction of branched fatty acid chains may reach 50% in the
Conidiobolus species,105 and a relatively large fraction of
branched chains has been found in samples of soil microbes.109
An analysis of the fatty acid composition in diverse
organisms (including animals, plants, algae, insects, and
fungus) has suggested a general feature that 16 and 18 carbon
chains (palmitic, palmitoleic, stearic, oleic, and linoleic acid)
with some amount of myristic acid are overall the most
abundant ones.110
In nature, the double bond in the unsaturated fatty acids
mainly adopts a cis conformation. On the other hand, trans
unsaturated fatty acids are also found in bacterial membranes
in small amounts, as they are produced in response to
Figure 5. Sphingolipid structures.
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environmental stress. Trans unsaturated fatty acids also occur
in human food as a result of industrial oil treatment (see refs
111 and 112 and references therein).
Unsaturated fatty acids are targets for oxidation by free
radicals, resulting in numerous oxidized moieties including
hyperoxide, hydroxyl, carboxylic, aldehyde, or ketone groups.
Oxidized lipids have significantly different properties than the
native (unmodified) ones,113−118 and are involved in
pathological mechanisms of numerous illnesses.119−121
Cardiolipin. Cardiolipin has to be discussed as a special case
since it is truly unique. It is highly branched and charged. Its
glycerol moiety connects two phosphatidic acid moieties
together (Figure 2). Due to the two phosphate groups, there
are two protonation states at the physiological pH, due to
which the molecule assumes a charge of either −1 or −2. The
older literature suggests that cardiolipin is mostly singly
charged.122−124 However, the latest studies have shown
definitively that both phosphate groups are deprotonated;
therefore cardiolipin is doubly charged in a lipid bilayer
environment.125−127
Cardiolipin has typically four acyl chains. Thus, considering
the 32 different fatty acid types, one expects theoretically up to
∼106 possible molecular species.128 When oxidation products
are also taken into account, this number grows to ∼107. Yet the
actual number of observed species is much lower. The most
common cardiolipin in mammals is tetra-linoleoyl-cardiolipin,
which accounts for 80% of all cardiolipins in heart and skeletal
muscle tissues. Meanwhile, neural tissues exhibit a larger
diversity of cardiolipin species. For instance, about 100
different cardiolipin species have been identified in the rat
brain;129 however this number ranges between 20 and 40 in
other organs.130
Sphingolipids. Sphingolipids constitute a class of lipids with
a sphingosine backbone (Figure 5). Typically, sphingosine acyl
chains are 16−18 carbons long and have a trans unsaturated
bond between carbons 4 and 5. A common modified form,
sphinganine, lacks the double bond and may have additional
hydroxyl groups attached to carbons 4 and 5.131 An acyl chain
attached to the amide group in the sphingosine backbone has
usually a length of 16 to 24 carbons.132 The acyl chains are
typically saturated; the only unsaturated species is nervonic
acid 24:1.132
Sphingolipids differ from other lipids also in terms of their
headgroup diversity. While sphingomyelin has phosphatidyl-
choline as a headgroup, ceramide’s headgroup is only a
hydroxyl group (for review of sphingolipid structure and
biophysical properties, see refs 132−134). This makes
ceramide an analogue of DA, a glycerol-based lipid discussed
above. Ceramide actually acts as a precursor for a large group
of glycolipids.
Further, sphingolipids known as glycosphingolipids have a
headgroup that is comprised of carbohydrates. They are
present in the extracellular leaflet in small quantities amounting
to a few mol %, but they are quite enriched in specific tissues
and cell types such as neural tissues, where they can constitute
up to 30 mol % of all lipids. Gangliosides, which in turn are
derived from glycosphingolipids, have a headgroup of complex
carbohydrates with at least one sialic acid residue. These lipids
act as receptors for various extracellular proteins including
bacterial toxins, and they also regulate transmembrane protein
function by interacting with their extracellular domains.
Sphingolipids are present in all eukaryotes but rarely in
prokaryotes.135 Although the cellular concentration of
sphingolipids is small (on the order of a few mol %), they
accumulate in the plasma membrane, predominately in the
Figure 6. Structures of the most common sterols in animals, plants, and fungi. The structure of the steroid core is comprised of four rings (labeled
ABCD in the cholesterol molecule) that are fused to one another. The carbon atoms of cholesterol are numbered.
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extracellular leaflet. Sphingolipids together with cholesterol
form nanoscale dynamical ordered domains (raf ts), which are
thought to play vital functions in cellular processes including
signaling, cell adhesion, intercellular communication, and
apoptosis.15,133,136,137 Unsurprisingly, specific species of
sphingolipids, for example, sphingosine 1-phosphate, are
involved in numerous illnesses, particularly in the central
nervous system.138
Sterols. Sterols constitute a group of lipids with a steroid
ring, which is a group of biological compounds with a core
made up of 17 carbon atoms arranged in a specific four fused
ring configuration. Some common sterols are shown in Figure
6 with the steroid core and atom numbering indicated on the
chemical structure of cholesterol. Typical sterols have a
hydroxyl group attached to carbon 3 (Figure 6); however
other hydrophilic groups such as ketone are also found in
certain sterols. The remaining part of the molecule is typically
hydrophobic and characterized by considerable structural
diversity in terms of groups attached to the steroid ring,
number and positions of double bonds, and the structure of the
short chain at the end of the molecule. The Lipid Maps
database currently lists 2828 compounds belonging to the
steroid family, but only a small fraction of these compounds
function as structural elements in biological membranes. The
majority of these compounds are signaling molecules,
surfactants (bile acids and saponins), or metabolites or are of
unknown function.
Cholesterol is perhaps the most widely known sterol due to
its ubiquity and vital functions in vertebrate membranes.
Membranes in the eye lens, where the concentration of
cholesterol can be as large as 70 mol %,139,140 represent the
extreme cases of cholesterol enrichment in biomembranes.
Despite this, crystals of cholesterol-rich membranes have not
been captured. Unusually high levels of cholesterol have also
been observed in neural tissues and in the skin.141−143
In cells, the highest level of cholesterol is observed in the
plasma membrane, where it constitutes 10−50 mol % of the
lipid content.144 However, its distribution between the
cytosolic and extracellular leaflets has remained controver-
sial.145 In intracellular membranes, the cholesterol content is
much lower. For instance, in mitochondrial membranes, the
cholesterol concentration is essentially negligible.
Cholesterol affects numerous physicochemical properties of
lipid bilayers by, for example, increasing their mechanical
strength and decreasing their permeability.146−150 In artificial
membranes, cholesterol has been observed to modulate
membrane phase behavior by leading to the formation of the
Lo phase, which is liquid-like due to its fluidity (lack of
translational order) but also highly ordered due to conforma-
tional order in the lipid acyl chain region strengthened by
cholesterol. Membranes in the liquid-disordered (Ld) phase
lack the conformational order that is therefore the fingerprint
of cholesterol. Depending on cholesterol concentration and
temperature, Lo domains can separate from the Ld ones in
model membranes. By analogy, separation of the phases is also
assumed to occur in biological membranes, but the cases where
this has been shown to take place have been rare.151,152
These cholesterol-rich ordered domains, assuming that they
exist in biomembranes, are often considered as the basis for a
concept of raf ts.12,15,153−155 In this context, it is important to
stress that there is considerable evidence in favor of the idea
that cell membranes are signaling platforms for numerous
cellular processes17,156,157 and that there are nanoscale
membrane regions where proteins and lipids function together
to realize signaling processes.158−161 However, what exactly is a
raft is still unclear. The current understanding of rafts
highlights the importance of their functionality,15 so in this
spirit we consider that lipid membranes or lipid domains
without proteins should not be called rafts, unless one can
show that these lipid regions have a biological function.
Cholesterol can get oxidized due to both normal metabolism
and pathological states (for a review, see ref 162). In both
cases, behavior of the oxidized sterol and its effect on the
physicochemical properties of the membrane are significantly
different from those of cholesterol.163,164
Moving on, the majority of invertebrates lost the ability to
synthesize sterols during the evolution.165−167 Therefore, they
depend on dietary uptake of sterols, which are then
enzymatically modified to suit their needs.168
In plants, more than 200 sterols (phytosterols) have been
identified until now. While no single sterol species seems to
dominate the plant sterol profile, sitosterol, campesterol, and
stigmasterol are the most common ones followed by
brassicasterol, gramisterol, obtusifoliol, cycloartenol, amyrin,
stigmastanol, and sitostanol.169 Sitosterol and campesterol are
also noteworthy, as they constitute 90 mass % of phytosterols
(plant sterols) in the human diet.170 In Arabidopsis thaliana, of
all sterols, 64 mol % are sitosterols, 11 mol % are campesterols,
6 mol % are stigmasterols, 3 mol % are isofucosterols, and 2
mol % are brassicasterols.171 Despite the commonly held belief
that plants do not contain cholesterol, the remaining 14% of
sterols in Arabidopsis thaliana are, actually, cholesterols.171
Phytosterols are of medical interest because even though they
are as abundant as cholesterol in the human diet, their plasma
concentration does not contribute to cardiovascular dis-
eases.172 On the contrary, they are likely cholesterol-lowering
agents.173 Nevertheless, the inability to expel sitosterol leads to
its accumulation in a rare genetic syndrome called sitoster-
olemia.174 Finally, phytosterols are also of interest to the food
industry and actively studied due to their potential in
improving food quality.175
Ergosterol is the principal fungal sterol, typically constituting
80% of fungal membrane sterols.176 However, it does not
dominate the fungal sterol profiles in the manner of cholesterol
for the vertebrates. In fact, other sterols like cholesterol, 4-
methyl cholesterol, 24-ethyl cholesterol, brassicasterol, and
some precursors of these sterols are frequently found in
fungi.177 The current knowledge of fungal sterols is limited, as
only 175 species have been examined.177 This is surprising
given that many antifungal drugs target ergosterol synthesis.178
The synthesis of ergosterol is intriguing also from the
evolutionary perspective. Fungi developed an ergosterol
biosynthetic pathway, although a cholesterol biosynthesis
pathway already had existed. This happened even though
synthesis of ergosterol is energetically more expensive and at
the same time ergosterol is a less potent modifier of lipid
bilayer properties, such as ordering and condensing effects.
Prokaryotes, leaving aside a few exceptions, are traditionally
thought not to utilize sterols. An exception to this is
mycoplasma, a parasitic bacterium with a minimalistic genome
that takes all its lipids from the host organism.179 Recent
studies showed that at least 34 bacterial species can synthesize
and use sterols,180 but their functions remain unknown.
Bacteria also often feature another group of lipids with sterol-
like structures called hopanoids.91,181 In bacteria, hopanoids
seem to serve the same function that sterols serve in other
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organisms by inducing the formation of ordered phases and
rafts.182,183
While most sterols are natural and serve biological functions,
there exist few synthetic sterols predominately synthesized to
be used as research tools. Since only a few natural sterols are
intrinsically fluorescent (e.g., dehydroergosterol and choles-
tenone),184,185 sterols with attached fluorescent labels, for
example, BODIPY,186 or photoreactive groups (so-called click
groups)187 were developed. A second group of synthetic
cholesterol analogues is derived by modifying the functional
groups of cholesterol, with the purpose of investigating the
important functions of cholesterol structure. These cholesterol
derivatives include enantiomeric cholesterol,188 epicholester-
ol,189 sterols without methyl groups on the rings,190−193 and
sterols with a modified side chain.194
Other Lipid Classes. Lipopolysaccharides are bacterial lipids
present in the outer membrane of Gram-negative bacteria,
protecting them from harmful environmental factors. Lip-
opolysaccharides have three functional units: lipid A, core
polysaccharide, and O-antigen polysaccharide (see Figure
7).195 The lipid A backbone is a β(1−6) linked glucosamine
disaccharide phosphorylated at positions 1 and 4. A typical
lipid A moiety has six hydrocarbon chains, mostly 14 carbons
long, although some lipid A moieties have four chains with
different lengths. The core polysaccharide is composed of up
to 15 sugar units and is connected to the sugar moiety of lipid
A via a bacteria-specific sugar, 3-deoxy-D-manno-octulosonic
acid (Kdo).
Isoprenoids are lipids based on isoprene units with every
second bond in the chain unsaturated, which makes them rigid
(Figure 7). Examples of isoprenoids include carotenoids,
pigments of plants, and photosynthetic bacteria. Polyprenyls,
on the other hand, have unsaturated bonds spaced with two
saturated bonds, which makes them very flexible (Figure 7).
Polyprenyls act as ubiquinone substrates for redox reactions in
respiration and photosynthesis. Polyprenyl chains are also
present in glycosylphosphatidylinositol (GPI) lipids used to
anchor peripheral membrane proteins.
Archaea is a phyla not belonging to either bacteria or
eukaryotes, but having many unusual molecular mechanisms
(Figure 7).195−197 They have glycerol-based lipids with ether
links. Typically, archaeal lipid chains are branched or
polyprenyls. A common archaea-specific lipid type that can
be considered as an example is bola-amphiphile. These lipids
contain chains connected to two headgroups located in the
opposite bilayer leaflets, implying that these lipids span the
lipid bilayer. Sometimes, bola-amphiphiles contain five carbon
rings in their chains.
3.1.3. Lipids in Cells. Distribution of Lipids between
Cellular Compartments. Eukaryotic cells are complex
structures with membrane-bound subcellular compartments
and organelles. Each cell is surrounded by the cell membrane.
Two close and connected membranes surround the nucleus.
Each mitochondria is surrounded by a double membrane with
the inner membrane forming stack-like folded structures, called
the cristae. Other organelles like the Golgi apparatus, the
endoplasmic reticulum, endosomes, and exosomes are stack-
like structures or vesicles wrapped by membranes. To serve the
different functions that each of these membranes have, their
lipid composition differs significantly (Figure 8). Extensive
discussion of subcellular distribution of lipids can be found in
refs 144 and 198 and in the special issue of Biochimica et
Biophysica Acta - Molecular and Cell Biology of Lipids (2016).199
Here, we discuss only the most important features of the
subcellular distribution of lipids.
Figure 7. Structures of lipid A, carotenoid (zeaxanthin), quinone, and bolaamphiphile (caldarchaeol).
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Cholesterol is the main component of the cell membrane.
Here, the molar ratio of cholesterol to phospholipids may be as
large as one. On the other hand, in the intracellular
membranes, like those that enclose mitochondria, endoplasmic
reticulum, or endosomes, this molar ratio is only 0.1. The only
organelles with a higher amount of cholesterol are the Golgi
apparatus and exosomes, which are formed in the Golgi
apparatus. Sphingomyelins, known as the partner of cholesterol
in the formation of raft domains, are present in high
concentrations in the cell membrane, and in lower concen-
trations in exosomes and the Golgi apparatus. That is, the
spatial distribution of sphingomyelin overlaps with that of
cholesterol. PCs are the main phospholipids in all types of
animal cell membranes, amounting to 30−60 mol % of all
phospholipids. The second most common lipid in the
intracellular membranes is PE, amounting to 15−30 mol %
of all phospholipids. The second most common phospholipid
in the cell membrane is sphingomyelin. PIPs and PSs are
present in most cellular membranes with a concentration of 5−
15 mol %, except in the mitochondrial membrane, where PS
concentration is very small. In contrast, cardiolipins and PGs
are predominately found in mitochondria.
Asymmetry of the Cell Membrane. Cell membranes have
an asymmetric distribution of lipids between the intracellular
and extracellular leaflets.200,201 Sphingomyelins, PCs, and
gangliosides are present mainly in the extracellular leaflet,
while PE, PS, PG, PIP, and PA lipids are almost exclusively
located in the intracellular leaflet. Certain transmembrane
enzymes actively maintain this asymmetry by translocating
lipids from the extracellular to the intracellular leaflet
(flippases) and vice versa (floppases).200,202−204 Scramblases,
on the other hand, facilitate the passive mixing of the leaflets
without directionality and substrate specificity.204
While cholesterol is present in both leaflets of the plasma
membrane, its transmembrane distribution is still a con-
troversial subject, since experiments have not been able to
measure it directly. To understand the background of this
issue, one has to consider how the asymmetric distribution of
lipids is typically measured. To avoid causing artifacts, an
approach that has been found useful and reliable is to employ
enzymes that break lipids apart. For instance, to measure the
distribution of PCs, one can expose the extracellular leaflet of a
plasma membrane to phosholipases that break PCs to lyso-PCs
and fatty acids. Right after the exposure, the plasma membrane
content can be resolved through mass spectrometry. By
Figure 8. Cellular distribution of phospholipids. Composition is given in mol %. Reproduced with permission from ref 198. Copyright 2018
American Society for Biochemistry and Molecular Biology.
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00538
Chem. Rev. XXXX, XXX, XXX−XXX
O
repeating the same experiment separately on the cytosolic
leaflet, one can resolve how PCs are distributed between the
two leaflets. In a similar way, one can measure the distribution
of other lipids by using, for instance, sphingomyelinases for
SM.
The problem is that for cholesterol there is no enzyme of
this kind. What is used instead is, for example, techniques that
depend on indirect analyses that largely use membrane-
perturbing probes, non-natural cholesterol derivatives, or
detergents at low temperatures to extract cholesterol. Since
these treatments alter the membrane structure quite severely, it
is not clear how well the resulting data for cholesterol’s
asymmetric distribution really matches reality. The results
found for cholesterol distribution are therefore quite
perplexing. Mondal et al. found in studies of the CHO cell
line that 60−70% of the plasma membrane sterol is in the
cytoplasmic leaflet.205 Meanwhile, in a recent work Liu et al.
used a new imaging method using tunable orthogonal
cholesterol sensors and found that the concentration of plasma
membrane cholesterol in the inner plasma membrane leaflet
was ∼12-fold lower than that in the outer leaflet.206 For
comparison, for ergosterol Solanko et al. used a technique
where they quantitatively replaced endogenous ergosterol by
(fluorescent) dehydroergosterol and found that the majority
(∼80%) of ergosterols in the yeast plasma membrane are
located in the cytoplasmic leaflet.207 If the reader considers
these results to be confusing, he/she is not the only one. At the
moment, it would be too daring to make strong and generic
conclusions about the distribution of cholesterol in the plasma
membrane.
It is quite certain that the cholesterol distribution depends
on cell type, membrane curvature, the proteins in the
membrane (as many of them act as sensors of cholesterol)
and the activity of flippases and floppases translocating
cholesterol. The cholesterol transporter ABC1 transfers
cholesterol from the cell membrane to the high density
lipoprotein particle.208,209 The lack of known enzymes that
actively transport cholesterol between the leaflets suggests that
the cholesterol distribution solely depends on the distribution
of other membrane components. Besides, due to the fast flip−
flop rate of cholesterol, metastable distributions resulting from
kinetic barriers are unlikely. Cholesterol has a high affinity for
sphingomyelin, which is mainly located in the extracellular
leaflet. Recent studies showed that the length of the acyl chain
modulates the affinity of cholesterol for sphingomyelin.210,210
Long chains interdigitating into the opposite leaflet promote
localization of cholesterol into the opposite leaflet. However, to
make the situation more complicated, cholesterol has high
affinity also for PS,211−213 which is mainly located in the
intracellular leaflet. The interplay of these factors can in part
explain the conflicting results about the transmembrane
cholesterol distribution.
The asymmetry of the plasma membrane is well established.
However, there are also other biomembranes that are
characterized by an asymmetric lipid distribution, too, such
as the membranes of the synaptic vesicles,214 and cellular
organelles including the endoplasmic reticulum,215 and the
Golgi apparatus.216,217
Example of Lipidomics 1: Cells and Exosomes Derived
from Them. Although the combinations of different head-
groups and acyl chains yield a vast number of possible lipid
species, cells incorporate only a small subset of them. This is
demonstrated by a lipidomics study of PC3-prostate cancer
cells and exosomes. A total of 277 different lipid species were
found, of which 60 were found only in cells, 190 in both cells
and exosomes, and 27 only in exosomes.96 In cells, 72% were
phospholipids, 19% were cholesterol, 7% were sphingomyelins,
and the remaining 2% were DAG, ceramide, and glycolipids.
For comparison, exosomes were enriched in cholesterol (44%)
and sphingomyelin (16%), while they were depleted in
phospholipids (38%). Exosomes contained also more PS and
more lipids with longer acyl chains (20-carbon-long instead of
the most frequent 18-carbon-long) and sphingomyelin with
22- and 24-carbon-long chains. Subsequent studies showed
that long sphingomyelin chains penetrate deeply into the
opposite leaflet, modifying its structure.218,219
Example of Lipidomics 2: Remodeling of the Postsynaptic
Cell Membrane During Neural Development. There are
known examples of membranes whose compositions change
during their lifetime; this is particularly well understood for the
membranes of eye lenses.220 These changes are observed over
a period of many years and result from aging. What is even
more exciting, lipid composition can be modulated during the
cellular development. For the first 60 postnatal days,
postsynaptic membranes isolated from rat brains were shown
to change in their lipid composition.221 During this period, the
amount of cholesterol, sphingolipids, and PE plasmalogens
increased and the amount of PC decreased. Moreover,
unsaturation and acyl chain length were observed to increase
for glycerol phospholipids. In particular, the amount of
polyunsaturated ω-3 chains increased, while the amount of
saturated and monounsaturated chains decreased over a period
of 60 days. The changes in the lipid composition may lead to
ordered domain formation and stabilization as shown in
biophysical experiments.
Example of Lipidomics 3: Effect of Obesity on Lipid
Profile. Obesity is characterized by the accumulation of an
excessive amount of fat in the adipose tissue. Obesity
frequently leads to cardiovascular illnesses and metabolic
complications, such as insulin resistance. In order to
understand the effects of excessive fat accumulation in the
adipose tissue, lipidomics analysis of adipose tissue samples
was performed.222 Samples originated from identical twins
chosen such that one of the twins was morbidly obese, while
the second one had normal weight. The results of lipidomics
studies showed substantial remodeling of the lipid profile in
adipose tissues in response to the excessive fat accumulation.
In particular, concentration of palmitoleic and arachidonic fatty
acids was elevated. Other lipid types with increased
concentration were PEs and plasmalogens. In particular, PE
plasmalogen species with arachidonic acid chains were
accumulated. Surprisingly, the physicochemical properties of
lipid bilayers designed to mimic the observed lipid profiles of
the normal and obese individuals were found to be very similar.
3.2. Membrane Proteins
3.2.1. Membrane Proteins in Numbers. Proteins are the
second main component of biological membranes. They
contribute up to 25−75% of the membrane mass223 with
high variability among the membrane types. For example, in
synaptic vesicles, it has been estimated that proteins constitute
25 mol % of the inner and 18 mol % of the outer leaflet224 and
that there are 20 lipids per transmembrane helix. Membrane
proteins are traditionally divided into 8 classes: single-pass
membrane proteins, which have a single transmembrane helix
(4 classes), multipass transmembrane proteins, GPI-anchored
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proteins, lipid-anchored proteins, and peripheral membrane
proteins.223 Most transmembrane proteins have α-helical
transmembrane segments, but some are also of the β-barrel
type.
In the human genome, about 26% of genes encode
membrane proteins.225 In HeLa cells (the oldest stable
human cell line, derived from epithelial cancer),226 30% of
the expressed proteins are membrane proteins, contributing to
only 7−8% of the total protein mass.227 Genomic analysis of
29 prokaryotic and eukaryotic species showed that 15−30% of
genes encode α-helical membrane proteins;228 for humans, this
number is 25−30%.229 Interestingly, no correlation between
the number of transmembrane proteins and the complexity of
the organism has been found except for 7-helix transmembrane
proteins, which are more frequent in eukaryotes, and 6- and
12-helix proteins, which are more frequent in prokaryotes. β-
barrel transmembrane proteins are less frequent than the
helical ones with less than 3% of the prokaryotic genome
coding them.230 (For a review of the function and evolution of
β-barrel transmembrane proteins, see Chaturvedi and
Mahalakshmi.231)
Further analysis of the human genome has indicated that
there are at least 3399 helical membrane protein species
classified into 230 families.232 Among these proteins, the
largest group is comprised of membrane receptors coded by
1352 genes. The largest group of receptors is the G protein-
coupled receptor (GPCR) family encoded by 901 genes,
followed by receptors of the immunoglobulin superfamily
encoded by 149 genes, and tyrosine kinase type receptors
encoded by 72 genes. More than 60% of existing drugs target
membrane proteins, mainly GPCRs, highlighting their
pharmacological importance.233,234 The second most abundant
group of membrane proteins are transporters and channels,
which are coded by 817 genes.232 These two major groups are
followed by membrane enzymes with 533 members, adhesion
proteins with 187 members, and 181 members with unknown
functions.232
The number of transmembrane helices in membrane
proteins ranges from 1 to 14.235 Constituting 43−45% of
helical membrane proteins, the single pass or bitopic
membrane proteins, which have a single transmembrane
helix, are the most numerous. The recently created Membrane
Database lists about 6000 members of bitopic membrane
proteins from various organisms.236 Interestingly, the number
of bitopic proteins and their functional diversity have increased
during evolution with increasing organismal complexity.237
Human cell membranes encompass more bitopic proteins than
those of lower organisms, particularly those that function as
receptors. Indeed, the majority of human bitopic membrane
proteins are receptors, enzymes, and adhesion proteins.
Interestingly, bitopic membrane proteins are more often
associated with the cell membrane than the subcellular
membranes. Bitopic membrane proteins frequently form
homodimers (for an extensive review, see ref 238) Recently,
a number of bioinformatics tools for dimer structure prediction
and databases for storing experimentally and theoretically
predicted structures were created.239−241 Analysis of interfaces
between two transmembrane helices revealed the existence of a
few conserved dimerization motifs, with the most frequent
being the GXXXG motif.242,243
The second most frequent transmembrane proteins are
those with seven transmembrane helices constituting 10−15%
of all membrane proteins.235 The most prominent members of
this group are the GPCRs. Finally, proteins with 2, 4, and 12
transmembrane helices each represent 5−10% of membrane
proteins.235
3.2.2. Insight into Structure of Integral Membrane
Proteins. Despite the abundance and medical importance of
membrane proteins, information on their three-dimensional
structures is somewhat limited. In the PDB database only
about 2% of the entries include membrane proteins. We note
Figure 9. An example of membrane protein (β2AR) engineering toward successful crystallization. Removal of stabilizing point mutations (PDB
3D4S):256 (A) mutation E1223.41W stabilizing the structure, (B) mutation N187E introduced to avoid glycosylation. The altered proteins are
shown on the left panels and the native protein on the right. The spheres colored according to the atom type represent the native and mutated
residues. The neighboring residues are shown in stick representation. A water molecule is shown as a ball-and-stick representation. Reproduced
with permission from ref 255. Copyright 2015 American Chemical Society.
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Table 2. Membrane Proteins the Structures of Which Have Been Solved Together with Lipids
protein lipids PDB ID year ref
(1) Light-Harvesting Complex 1
Blastochloris viridis cardiolipin 5Y5S 2018 1378
PG
PE
spirilloxanthin
ubiquinone-8
menaquinone-8
Thermochromatium tepidum dihydroneurosporene 6ET5 2018 1379
menaquinone-9
ubiquinone-9
Thermochromatium tepidum PE 4V8K, 3WMM 2014 1380
PG
spirilloxanthin
ubiquinone-8
menaquinone-8
(2) Photosynthetic Reaction Center
Heliobacterium modesticaldum PG 5V8K 2017 1381
diaponeurosporene
Thermochromatium tepidum PE 1EYS 2000 1382
spirilloxanthin
menaquinone-8
Rhodobacter sphaeroides cardiolipin 4N7K 2014 1383
PC
GLU-GAL-DG
spheroidene
Rhodobacter sphaeroides cardiolipin 2J8C, 2UXM, 2UXL, 2UXK, 2UXJ, 2UX5, 2UX4, 2UX3, 2UWW, 2UWV,
2UWU, 2UWT, 2UWS, 2J8D
2007 1384
PC
GLU-GAL-DG
spheroidene
ubiquinone-10
Rhodobacter sphaeroides cardiolipin 1OGV 2003 1385
ubiquinone-10
Rhodobacter sphaeroides ubiquinone-10 1AIJ, 1AIG 1997 1386
Rhodobacter sphaeroides spirilloxanthin 1PSS, 1PST 1994 1387
ubiquinone-10
Rhodobacter sphaeroides ubiquinone-10 2RCR 1991 1388
Blastochloris viridis DAG 4CAS 2013 1389
octaprenyl-
pyrophosphate
dihydroneurosporene
menaquinone-7
Blastochloris viridis dihydroneurosporene 2WJN, 2WJM 2009 1390
menaquinone-7
Rhodopseudomonas viridis diaponeurosporene 1PRC, 2JBL, 1DXR 1995 1391
menaquinone-7
ubiquinone-1
(3) Light-Harvesting Complex of Photosystem II
Pisum sativum (Pea) PG 2BHW 2005 1392
DGDG
violaxanthin
lutein
neoxanthin
Spinacia oleracea (spinach) complex
CP29
violaxanthin 3PL9 2011 1393
lutein
neoxanthin
Spinacia oleracea (spinach) PG 1RWT 2004 1394
DGDG
violaxanthin
lutein
neoxanthin
Rhodospirillum molischianum lycopene 1LGH 1996 1395
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Table 2. continued
protein lipids PDB ID year ref
(3) Light-Harvesting Complex of Photosystem II
Rhodopseudomonas acidophila rhodopin b-D-glucoside 1NKZ, 1KZU 2003 1396,1397
1997
(4) Supercomplex of Light-Harvesting Complex of Photosystem II of C2S2M2-type
Pisum sativum (Pea) PG 5XNL, 5XNO, 5XNN, 5XNM 2017 279
MGDG
DGDG
sulfoquinovosyl-DG
violaxanthin
lutein
neoxanthin
β-carotene
plastoquinone-9
(5) Photosystem II
Cyanidium caldariu (red alga) PG 4YUU 2016 1398
MGDG
DGDG
sulfoquinovosyl-DG
β-carotene
plastoquinone-9
Thermosynechococcus vulcanus PG 5WS5, 5WS6, 5GTI, 5GTH 2017 1399
MGDG
DGDG
sulfoquinovosyl-DG
β-carotene
plastoquinone-9
Thermosynechococcus vulcanus PG 4UB6, 4UB8 2015 1400
MGDG
DGDG
sulfoquinovosyl-DG
β-carotene
plastoquinone-9
Thermosynechococcus vulcanus,
Thermosynechococcus elongatus
(strain BP-1)
PG 4IL6 2013 1401
MGDG
DGDG
sulfoquinovosyl-DG
β-carotene
plastoquinone-9
Thermosynechococcus vulcanus PG 3WU2, 3ARC 2011 1402
MGDG 5V2C 2017 1403
DGDG
sulfoquinovosyl-DG
β-carotene
plastoquinone-9
Thermosynechococcus elongatus
(strain BP-1)
PG 4RVY, 4PBU 2014 1404
MGDG
DGDG
sulfoquinovosyl-DG
β-carotene
plastoquinone-9
Thermosynechococcus vulcanus PG 3A0B, 3A0H 2009 1405
MGDG
DGDG
β-carotene
plastoquinone-6
Thermosynechococcus vulcanus,
Thermosynechococcus elongatus
(strain BP-1)
β-carotene 1IZL 2003 1406
Thermosynechococcus elongatus
(strain BP-1)
PG 5KAF, 5TIS, 5KAI 2016 1407
MGDG
DGDG
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Table 2. continued
protein lipids PDB ID year ref
(5) Photosystem II
sulfoquinovosyl-DG
β-carotene
plastoquinone-9
Thermosynechococcus elongatus
(strain BP-1)
PG 5E7C, 5E79 2016 1408
MGDG
DGDG
sulfoquinovosyl-DG
β-carotene
plastoquinone-9
Thermosynechococcus elongatus
(strain BP-1)
PG 4V62, 3BZ2, 3BZ1 2009 1409
MGDG
DGDG
sulfoquinovosyl-DG
β-carotene
plastoquinone-9
Thermosynechococcus elongatus
(strain BP-1)
PG 2AXT 2005 1410
MGDG
DGDG
sulfoquinovosyl-DG
β-carotene
plastoquinone-9
Thermosynechococcus elongatus
(strain BP-1)
β-carotene 1S5L 2004 1411
plastoquinone-9
(6) Supercomplex of Photosystem I with Light-Harvesting Complex I
Pisum sativum (pea) PG 4XK8 2015 1412
MGDG
DGDG
β-carotene
violaxanthin
lutein
phylloquinone
(7) Photosystem I
Pisum sativum (pea) MGDG 2WSC, LW5, 2WSF, 2WSE 2010 1413
β-carotene
phylloquinone
Thermosynechococcus elongatus
(strain BP-1)
MGDG 1JB0 2001 1414
β-carotene 2012
phylloquinone 2011
MGDG 4FE1 2012 1415
β-carotene
phylloquinone
PG
MGDG 3PCQ 2011 1416
β-carotene
phylloquinone
diaponeurosporene
(8) Photosystem I Supercomplex with Light-Harvesting Complexes I and II
Zea mays PG 5ZJI 2018 1417
MGDG
DGDG
violaxanthin
β-carotene
phylloquinone
Cyanidioschyzon merolae PG 5ZGB 2018 1418
DGDG 5ZGH
β-carotene
phylloquinone
(9) Mammalian Respiratory Supercomplex
Sus scrofa PC 5GUP 2016 278
PE
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Table 2. continued
protein lipids PDB ID year ref
(9) Mammalian Respiratory Supercomplex
cardiolipin
(10) Cytochrome Oxidase
Thermus thermophilus DAG 2YEV 2012 1419
native Thermus lipid
(5PL)
(10) Cytochrome c Oxidase
Paracoccus denitrif icans PC 1QLE 1997 1420
Bos taurus PC 5W97, 5WAU 2017 1421
PE
PG
cardiolipin
triacylglycerol
cholic acid
Bos taurus PC 5XDQ 2018 1422
PE
PG
cardiolipin
triacylglycerol
cholic acid
Bos taurus PC 5Z84, 5ZCQ, 5ZCP, 5ZCO, 5Z86, 5Z85 2018 1423
PE
PG
cardiolipin
tristearoylglycerol
cholic acid
Bos taurus PC 1V54, 1V55 2003 1424
PE
PG
cardiolipin
triacylglycerol
cholic acid
(11) Cytochrome b6 f
Nostoc sp. PC 4H44, 4H13, 4H0L 2013 1425
PA
sulfoquinovosyl-DG
β-carotene
Chlamydomonas reinhardtii MGDG 1Q90 2003 1426
sulfoquinovosyl-DG
β-carotene
Mastigocladus laminosus MGDG 2E74, 2E76, 2E75 2007 1427
sulfoquinovosyl-DG
β-carotene
Mastigocladus laminosus PC 2D2C 2006 1428
β-carotene
Mastigocladus laminosus PC 1VF5 2003 1429
β-carotene
plastoquinone-9
(12) Cytochrome bc1 Complex
Rhodobacter sphaeroides PE 2FYN, 2FYU 2006 1430
Saccharomyces cerevisiae PG 3CX5, 3CXH 2008 1431
PA
cardiolipin
Saccharomyces cerevisiae PC 1KB9 2001 1286
PE
PG
PIP
cardiolipin
ubiquinone-6
Gallus gallus PE 1BCC, 3BCC, 3H1J, 3H1I, 3H1H, 2BCC 1998 1432
ubiquinone-10
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Table 2. continued
protein lipids PDB ID year ref
(12) Cytochrome bc1 Complex
PE 3CWB 2008 1433
ubiquinone-10
cardiolipin
Bos taurus PE 1PPJ, 2A06, 1PP9 2005 1434
cardiolipin
(13) Complex II
Gallus gallus PE 2FBW, 1YQ4, 1YQ3 2006 1435
2H89, 2H88 1436
Sus scrofa PE 1ZOY, 1ZP0 2005 1437
Escherichia coli (strain K12) cardiolipin 2ACZ, 2AD0 2006 1438
Escherichia coli PE 1NEK, 1NEN 2003 1439
cardiolipin
(14) Formate Dehydrogenase
Escherichia coli cardiolipin 1KQF, 1KQG 2002 1440
(15) Complex I
Ovis aries PC 5LNK 2016 277
PE
cardiolipin
Mus musculus PC 6G2J 2018 1441
PG
cardiolipin
lipid fragment
Yarrowia lipolytica PE 6GCS 2018 1442
cardiolipin
lipid fragment
(17) Nitrate Reductase
Escherichia coli PG 1Y4Z, 1Y5N, 1Y5L, 1Y5I 2005 1438
Escherichia coli PA 1SIW 2004 1443
Escherichia coli PG 1Q16 2003 1444
PA
(18) Gastric Proton Pump
Sus scrofa PC 5YLU, 5YLV 2018 1445
(19) Copper-Transporting PIB-ATPase
Legionella pneumophila PC (headgroup only) 4BBJ 2014 1446
(20) Na+,K+-ATPase
Squalus acanthias cholesterol 5AVQ, 5AW9, 5AW8, 5AW7, 5AW6, 5AW5, 5AW4, 5AW3, 5AW2, 5AW1,
5AW0, 5AVZ, 5AVY, 5AVX, 5AVW, 5AVV, 5AVU, 5AVT, 5AVS, 5AVR
2015 1447
Squalus acanthias cholesterol 3A3Y 2009 1448
Squalus acanthias cholesterol 2ZXE 2009 1449
Sus scrofa cholesterol 4RES 2015 1450
Sus scrofa PC 3WGU 2013 1451
cholesterol
Sus scrofa cholesterol 4HQJ 2013 1452
Sus scrofa PS 4HYT 2013 1453
cholesterol
Sus scrofa PC 3B8E, 3KDP 2007 1454
(21) Ca2+-ATPase
Oryctolagus cuniculus PC 5XA7, 5XAB, 5XAA, 5XA9, 5XA8 2017 1455
Oryctolagus cuniculus PC 4NAB 2013 1456
Oryctolagus cuniculus PE 3W5A, 3W5D, 3W5C, 3W5B 2013 1457
Oryctolagus cuniculus PE 2AGV, 2ZBG, 2ZBF, 2ZBE, 2ZBD, 2Z9R, 2EAU, 2EAT, 2EAS, 2EAR, 2DQS 2005 1458
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Table 2. continued
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(22) Chloroplast ATP Synthase c-Ring
Pisum sativum DGDG 3V3C 2012 1459
(22) Rotor of the V-type ATPase
Enterococcus hirae PG 2BL2 2005 1460
(23) Potassium-Importing KdpFABC Membrane Complex
Escherichia coli PC 5MRW 2017 1461
(24) Niemann−Pick C1 Protein
Homo sapiens cholesterol 3JD8 2018 857
(25) Multidrug Resistance Protein 1
Bos taurus cholesterol 6BHU 2018 1462
(26) ABC Transporter
Homo sapiens cardiolipin 4AYT, 4AYX, 4AYW, 3ZDQ 2013 1463
(27) ABC Maltose Transporter
Escherichia coli PG 4KHZ, 4KI0 2013 1464
Escherichia coli PG 4JBW 2013 1465
Escherichia coli PG 3RLF, 3PUX, 3PUW, 3PUV 2011 1466
(28) ABC Core-Lipopolysaccharide Transporter MsbA
Escherichia coli PE 6BPL, 6BPP 2018 1467
lauric acid
myristic acid
(29) Bile Acid Transporter Homolog
Neisseria meningitidis PE 3ZUY, 3ZUX 2011 1468
(30) Mitochondrial ADP/ATP Carrier
Saccharomyces cerevisiae cardiolipin 4C9G, 4C9Q, 4C9J, 4C9H 2014 1469
Bos taurus cardiolipin 2C3E 2005 1470
Bos taurus cardiolipin 1OKC, 1YMJ, 1YM6 2003 1471
(31) Sodium/Proton Antiporters
Pyrococcus abyssi PE 4CZ8, 4CZA, 4CZ9 2014 1472
(32) Mitochondrial Calcium Uniporter MCU
Cyphellophora europaea PG 6DNF 2018 1473
(33) Betaine Transporter BetP
Escherichia coli PG 4C7R 2013 1474
Corynebacterium glutamicum PG 4DOJ, 4AIN 2012 1475
(34) Translocator Protein (TSPO)
Rhodobacter sphaeroides PA 4UC1, 4UC3, 4UC2 2015 1476
(35) Sodium-Dependent Citrate Symporter
Salmonella enterica PE 5A1S 2015 1477
(36) Serotonin Transporter
Homo sapiens cholesterol 6AWN, 6AWQ, 6AWP, 6AWO 2018 1478
Homo sapiens cholesterol 5I6X, 5I75, 5I74, 5I73, 5I71, 5I6Z, 5I66 2016 820
(37) Cationic Amino Acid Transporter
Geobacillus kaustophilus cholesterol 5OQT, 6F34 2018 1479
(38) Dopamine Transporter
Drosophila melanogaster cholesterol 4XNU, 4XNX 2015 1480
Drosophila melanogaster cholesterol 4XP1, 4XPT, 4XPH, 4XPG, 4XPF, 4XPB, 4XPA, 4XP9, 4XP6, 4XP5, 4XP4 2015 819
Drosophila melanogaster cholesterol 4M48 2013 818
(39) Multidrug Transporter MdfA
Escherichia coli deoxycholic acid 4ZP0, 4ZP2, 4ZOW 2015 1481
(40) Multidrug Efflux Transporter AcrB
Escherichia coli PE 5JMN 2016 1482
(41) γ-Secretase
Homo sapiens PC 5A63 2015 1483
(42) Zinc Metalloprotease
Homo sapiens PC 4AW6, 2YPT 2013 1484
(43) Rhomboid Protease GlpG
Escherichia coli PC 2XTV, 2XTU 2011 1485
Escherichia coli PG 2IRV 2007 1486
(44) Bacterial Vitamin C Transporter UlaA/SgaT
Escherichia coli triglyceride 4RP9, 4RP8 2015 1487
(45) Methyltransferase Icmt
Escherichia coli cardiolipin 4A2N 2011 1488
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(45) Methyltransferase Icmt
palmitic acid
Escherichia coli PG 5AZC, 5AZB 2016 1489
Tribolium castaneum undecane 5V7P 2018 1490
lipid fragment
(46) 4-Amino-4-deoxy-L-arabinose Transferase
Cupriavidus metallidurans PC (headgroup only) 5EZM, 5F15 2016 1491
decaprenyl-phosphate
(47) Oligosaccharyltransferase
Saccharomyces cerevisiae PC 6C26 2018 1492
Saccharomyces cerevisiae PC 6EZN 2018 1493
PE
(48) Serotonin Receptor
Mus musculus PC 6BE1 2018 1494
(49) Synaptic GABAA Receptor
Homo sapiens cholesteryl
hemisuccinate
6D6U, 6D6T 2018 1495
(50) GluN1/GluN2B δ-ATD NMDA Receptor
Xenopus laevis cholesteryl
hemisuccinate
5UN1 2018 1496
(51) α4β2 Nicotinic Receptor
Homo sapiens cholesteryl
hemisuccinate
6CNJ, 6CNK 2018 1497
(52) Ligand-Gated Ion Channel GLIC
Gloeobacter violaceus PC 4F8H 2012 1498
Gloeobacter violaceus PC 3P50, 3P4W 2011 1128
Gloeobacter violaceus PC 4HFI, 4ILC, 4ILB, 4ILA 4IL9, 4IL4 2013 1499
Gloeobacter violaceus PC 3EAM 2009 1041
(53) Lipid-Gated Cation Channel TRPC3
Homo sapiens DAG 6CUD 2018 1500
PE
(54) Ammonia Channel (AmtB)
Escherichia coli PG 4NH2 2014 271
(55) Proton-Gated Urea Channel
Helicobacter pylori PA 3UX4 2012 1501
(56) Urea Transporter B
Bos taurus ceramide 4EZC, 4EZD 2012 1502
(57) Aquaporin Z
Escherichia coli PE 2ABM 2008 1503
PG
(58) Aquaporin 5
Homo sapiens PS 3D9S 2008 1003
(59) Aquaporin 4
Rattus norvegicus PE 2ZZ9 2009 1504
(60) Aquaporin 0
Ovis aries PE 3M9I 2010 1505
Ovis aries PC 2B6O, 2B6P 2005 1506
(61) Mechanotransduction Ion Channel
Drosophila melanogaster PC 5VKQ 2017 1507
(62) Calcium-Activated Cation TRP Channel
Homo sapiens PA 5MKE, 5MKF 2017 1508
palmitic acid
(63) Lysosomal Calcium-Permeable Channel TRPML3
Callithrix jacchus PE 5W3S 2017 1509
cholesteryl succinate
(64) Transient Receptor Potential Melastatin 4 (TRPM4)
Homo sapiens cholesteryl succinate 6BQR, 6BQV 2018 267
(65) nvTRPM2 Channel in Complex with Ca2+
Nematostella vectensis POPC 6CO7 2018 1510
cholesterol
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(66) TRPC4 Ion Channel
Mus musculus PA 5Z96 2018 1511
cholesteryl
hemisuccinate
Danio rerio PA 6G1K 2018 1512
cholesteryl
hemisuccinate
(67) Voltage-Gated Calcium Channel CavAb
Arcobacter butzleri PC 5KLB, 5KMH, 5KMF, 5KMD, 5KLS, 5KLG 2016 1513
(68) Voltage-Gated Calcium Channel CavAb
Arcobacter butzleri PC 4MS2, 4MW8, 4MW3, 4MVZ, 4MVU, 4MVS, 4MVR, 4MVQ, 4MVO,
4MVM, 4MTO, 4MTG, 4MTF
2013 1514
(69) Trimeric Intracellular Cation Channel TRIC-B1 and TRIC-B2
Caenorhabditis elegans PIP2 5EGI 2016 1515
(70) Voltage-Gated Sodium Channel
Homo sapiens PC 5EK0 2015 1516
Homo sapiens PG 6AGF 2018 1517
alpha proteobacterium HIMB114 PC 4DXW 2012 1518
Arcobacter butzleri PC 5VB2, 5VB8 2017 1519
Arcobacter butzleri PC 4EKW 2012 1520
Arcobacter butzleri PC 3RVY, 3RW0, 3RVZ 2011 1521
Arcobacter butzleri PC 6C1E, 6C1P, 6C1M, 6C1K 2018 1522
(71) Magnesium Channel TRPM7
Mus musculus cholesteryl
hemisuccinate
5ZX5, 6BWF, 6BWD 2018 1523
(72) G Protein-Gated Inward Rectifier K1 (GIRK) Channel 2
Mus musculus PIP2 4KFM 2013 1524
(73) Inward Rectifier Kir2.2 Channel
Gallus gallus PIP2 3SPI, 3SPJ, 3SPH, 3SPG, 3SPC 2011 1525
(74) High-Conductance Ca2+-Activated K+ Channel
Aplysia californica PG 5TJI 2017 1526
Aplysia californica PG 5TJ6 2017 1527
(75) Voltage-Gated K+ Channel Eag1
Homo sapiens cholesteryl succinate 5K7L 2016 1528
(76) Voltage-Gated K+ Channel Kv1.2-2.1 Chimera
Rattus norvegicus PG 5WIE 2017 1529
(77) Voltage-Gated K+ Channel
Rattus norvegicus PG 3LNM 2010 1530
(78) Voltage Dependent Potassium Channel (Kv1.2−Kv2.1 Chimera)
Rattus norvegicus PG 2R9R 2007 1531
(79) SthK Cyclic Nucleotide-Gated Potassium Channel
Spirochaeta thermophila PG 6CJQ 2018 1532
(80) Organellar Two-Pore Channel
Mus musculus PIP2 6C9A, 6C96 2018 1533
(81) Two Pore Domain Potassium Ion Channel TREK2
Homo sapiens PC 4BW5, 4XDL, 4XDK, 4XDJ 2015 1534
(82) Two-Pore Channel TPC1
Arabidopsis thaliana PA 6E1M, 6E1P, 6E1N, 6E1K, 6CX0 2018 1535
oleic acid
(83) Potassium Channel KcsA
Streptomyces lividans DAG 5VK6, 5VKH, 5VKE 2017 1536
Streptomyces lividans DAG 5EC1, 5EC2, 5EBW, 5EBM, 5EBL 2016 1537
Streptomyces lividans DAG 2JK5, 4UUJ, 2W0F 2014 1538
Streptomyces lividans DAG 4MSW 2013 1539
Streptomyces lividans DAG 3IGA, 3GB7 2009 1540
Streptomyces lividans DAG 1K4C, 1K4D 2001 1541
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Table 2. continued
protein lipids PDB ID year ref
(84) KcsA Potassium Channel
Streptomyces coelicolor DAG 6BY2, 6BY3 2018 1542
(85) Patched 1 Receptor
Homo sapiens cholesteryl
hemisuccinate
6DMB, 6DMY, 6DMO 2018 1543
(86) Metabotropic Glutamate Receptor 1 (GPCR)
Homo sapiens cholesterol 4OR2 2014 1544
oleic acid
(87) Corticotropin-Releasing Factor Receptor (GPCR)
Homo sapiens PG 4K5Y 2013 1545
(88) P2Y1 Receptor 1 (GPCR)
Homo sapiens cholesterol 4XNV, 4XNW 2015 1546
cholesteryl succinate
(89) P2Y1 Receptor 1 (GPCR)
Homo sapiens cholesterol 4PXZ, 4PY0 2014 1547
Homo sapiens cholesterol 4NTJ 2014 1548
(90) Serotonin Receptor 5-HT2B (GPCR)
Homo sapiens cholesterol 5TVN 2017 1549
Homo sapiens DAG 4NC3 2013 1550
cholesterol
palmitic acid
oleic acid
(91) Chimeric Protein of Serotonin Receptor 5-HT2B−BRIL (GPCR)
Homo sapiens, Escherichia coli cholesterol 4IB4 2013 1551
palmitic acid
oleic acid
(92) Cannabinoid Receptor CB1 (GPCR)
Homo sapiens cholesterol 5XRA, 5XR8 2017 1552
oleic acid
(93) μ-Opioid Receptor (GPCR)
Mus musculus cholesterol 5C1M 2015 1553
Mus musculus cholesterol 4DKL 2012 1554
(94) κ-Opioid Receptor (GPCR)
Homo sapiens cholesterol 6B73 2018 1555
(95) M1 and M4 Muscarinic Acetylcholine Receptor (GPCR)
Homo sapiens cholesteryl hemi-
succinate
5CXV, 5DSG 2016 1556
(96) Endothelin Receptor Type-B (GPCR)
Homo sapiens cholesterol 5X93, 5XPR 2017 1557
(97) Viral Chemokine Receptor (GPCR)
human cytomegalovirus cholesterol 4XT1, 4XT3 2015 1558
(98) CC Chemokine Receptor 9 (CCR9)
Homo sapiens cholesterol 5LWE 2016 1559
oleic acid
(99) A1 and A2A Adenosine Receptors
Homo sapiens cholesterol 5MZJ, 5N2S, 5N2R, 5MZP 2017 1560
Homo sapiens cholesterol 4EIY 2012 1034
oleic acid
(100) β2 Adrenoceptor
Homo sapiens cholesterol 5X7D 2017 1561
Homo sapiens cholesterol 3PDS 2011 1562
Homo sapiens cholesterol 3NY8, 3NYA, 3NY9 2010 1563
Homo sapiens cholesterol 3D4S 2008 256
Homo sapiens cholesterol 2RH1 2007 1004
Meleagris gallopavo cholesterol 2Y00, 2Y03, 2Y02, 2Y01 2011 1564
(101) Isorhodopsin
Todarodes pacif icus PC 3AYN, 3AYM 2011 1565
palmitic acid
retinal
Todarodes pacif icus PC 2Z73 2008 1566
palmitic acid
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00538
Chem. Rev. XXXX, XXX, XXX−XXX
Z
Table 2. continued
protein lipids PDB ID year ref
(101) Isorhodopsin
retinal
(102) Rhodopsin
Bos taurus oleic acid 6FK6, 6FKD, 6FKC, 6FKB, 6FKA, 6FK9, 6FK8, 6FK7 2018 1567
Bos taurus PE 2X72 2011 1568
PA
palmitic acid
retinal
Bos taurus PE 3C9L, 3C9M 2008 1569
palmitic acid
retinal
Bos taurus PE 1GZM, 3C9L 2004 1002
palmitic acid
retinal
(103) Tetraspanin CD81
Homo sapiens cholesterol 5TCX 2016 1570
(104) STRA6 Receptor for Retinol Uptake in Complex with Calmodulin
Danio rerio cholesterol 5SY1, 5K8Q 2016 1571
(105) Cruxrhodopsin-3
Haloarcula vallismortis bacterioruberin 4L35, 4JR8 2014 1572
(106) Blue Light-Absorbing Proteorhodopsin
uncultured bacterium DAG 4JQ6, 4KNF, 4KLY 2013 1573
retinol
(107) Proton Pumping Rhodopsin AR2
Acetabularia acetabulum cholesterol 3AM6 2011 1574
retinal
(108) Xanthorhodopsin
Salinibacter ruber PC 3DDL 2008 1575
salinixanthin
(109) Archaerhodopsin-2
Halobacterium sp. PC 3WQJ 2014 1576
PG
DAG
bacterioruberin
squalene
(110) Sensory Rhodopsin II
Natronomonas pharaonis DAG 3QDC, 3QAP 2011 1577
retinal
eicosane (lipid
fragment)
(111) Sensory Rhodopsin
Nostoc sp. PE 1XIO 2004 1578
retinal
(112) Light-Driven Chloride Pump Halorhodopsin
Natronomonas pharaonis PC 3A7K 2010 1579
PA
DAG
bacterioruberin
retinal
(113) Bacteriorodopsin
Halobacterium salinarum DAG 6G7H, 6G7L, 6G7K, 6G7J, 6G7I 2018 1580
retinal
Halobacterium salinarum DAG 5B6V, 5H2P, 5H2O, 5H2N, 5H2M, 5H2L, 5H2K, 5H2J, 5H2I, 5H2H,
5B6Z, 5B6Y, 5B6W, 5B6X
2016 1581
retinal
Halobacterium salinarum oxysterol 5B35, 5B34 2016 1582
retinal
Halobacterium salinarum DAG 4X31, 4X32 5J7A 2015 1583
retinal
Halobacterium salinarum DAG 4FPD 2013 1584
retinal
Halobacterium salinarum DAG 3T45 2012 1585
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Table 2. continued
protein lipids PDB ID year ref
(113) Bacteriorodopsin
retinal
Halobacterium salinarum DAG 3NS0, 3NSB 2011 1586
retinal
Halobacterium salinarum DAG 1C8R, 1C8S 1999 1587
retinal
trimethyl-tetracosane
(lipid fragment)
Halobacterium salinarum DAG 1C3W 1999 1588
retinal
trimethyl-tetracosane
(lipid fragment)
Halobacterium salinarum retinal 1QHJ, 1QKP, 1QKO 1999 1589
trimethyl-tetracosane
(lipid fragment)
Halobacterium salinarum DAG 5B6V, 5H2P, 5H2O, 5H2N, 5H2M, 5H2L, 5H2K, 5H2J, 5H2I, 5H2H,
5B6Z, 5B6Y, 5B6W, 5B6X
2016 1581
retinal
Halobacterium salinarum oxysterol 5B35, 5B34 2016 1582
retinal
Halobacterium salinarum DAG 4X31, 4X32 5J7A 2015 1583
retinal
Halobacterium salinarum DAG 4FPD 2013 1584
retinal
Halobacterium salinarum DAG 3T45 2012 1585
retinal
Halobacterium salinarum DAG 3NS0, 3NSB 2011 1586
retinal
Halobacterium salinarum DAG 1C8R, 1C8S 1999 1587
retinal
trimethyl-tetracosane
(lipid fragment)
Halobacterium salinarum DAG 1C3W 1999 1588
retinal
trimethyl-tetracosane
(lipid fragment)
Halobacterium salinarum retinal 1QHJ, 1QKP, 1QKO 1999 1589
trimethyl-tetracosane
(lipid fragment)
Halobacterium salinarum DAG 1KG8, 1KGB, 1KG9 2001 1590
retinal
Halobacterium salinarum DAG 1M0K, 1M0L 2002 1591
retinal
trimethyl-tetracosane
(lipid fragment)
Halobacterium salinarum PA-phosphate 2BRD 1996 270
retinal
(114) Xanthorhodopsin
Salinibacter ruber PC 3DDL 2008 1575
Salinixanthin
(115) Archaerhodopsin-2
Halobacterium sp. PC 3WQJ 2014 1576
PG
DAG
bacterioruberin
squalene
(116) Sensory Rhodopsin II
Natronomonas pharaonis DAG 3QDC, 3QAP 2011 1577
retinal
eicosane (lipid
fragment)
(117) Sensory Rhodopsin
Nostoc sp. PE 1XIO 2004 1578
retinal
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that this number also includes extramembrane domains of
bitopic proteins or structures of single transmembrane helices.
As of 18 April 2018, the database of three-dimensional
membrane protein structures maintained by Stephan White
(UC Irvin) included 2506 entries of PDB records and 772
unique proteins (http://blanco.biomol.uci.edu/mpstruc/). In-
formation concerning membrane protein structures is collected
in a few independent databases. An extensive comparison of
these can be found in Shimizu et al.244
The primary method for resolving the protein structure is X-
ray crystallography.245,246 Determining the structure of
proteins is already difficult in itself, but determining the
structure of membrane proteins with crystallography is all the
more difficult. Since the first protein structure was solved in
1955 for myoglobin,247 it took 27 years to solve the first
membrane protein structure−the photosynthetic reaction
center.248 Prior to crystallization, membrane proteins have to
be extracted from the membrane, purified, expressed, and
embedded in lipid structures such as micelles. Finally, the
challenge is crystallization. Alternatively, proteins may be
embedded into cubic phases, which have repetitive crystal-like
structures. Membrane protein crystallography typically em-
ploys about ten different detergents249 to embed proteins into
micelles, and monoolein to form cubic phases.250 Recently,
lipids such as cholesterol or its more soluble derivative,
cholesteryl hemisuccinate, have frequently been used as
cosolvents.163,251,252 To make proteins to form crystals, the
proteins are usually heavily modified, including removal of
glycosylation, introduction of stabilizing point mutations,
inclusion of scaffolding proteins such as antibodies, and
removal of flexible loops (Figure 9).253 These modifications
can alter the native structure, causing, for example, the
arrangement of protein domains to change or the protein
structure to partially unfold. Insulin receptor structures
strikingly exemplify such crystallographic artifacts. While the
heavily modified crystal structure captured a U-shaped
arrangement of the dimer,254 electron microscopy of the
unmodified protein contested that by revealing a T-shaped
arrangement.254 Recent simulations of Manna et al. provide
another illustrative example of this issue.255 They used the
crystal structure of β2AR (one member of the GPCR protein
family) as the basis of their atomistic simulations and studied
what happens when the structural modifications made to the
protein structure for crystallization were reversed one at a time.
It turned out that the final protein structure without structural
modifications was clearly different from the underlying protein
structure that included the modifications.
The second most common method to solve protein
structure is nuclear magnetic resonance (NMR) spectrosco-
py.257 Currently, there are about 100 structures of membrane
proteins or their fragments in the PDB database that have been
determined by NMR. The majority of these are small proteins
with one or two transmembrane helices. A few larger proteins,
such as the GPCR chemokine receptor,258 could also be
structurally characterized with NMR. Electron paramagnetic
resonance (EPR) spectroscopy combined with site-directed
spin labeling is capable of providing information about
intramolecular distances allowing the determination of protein
structure. However, it is rarely used, since it requires many site-
directed mutations to resolve the whole structure. (For a
review, see Bordignon and Bleicken.259)
In recent years, cryo-electron microscopy (CryoEM) has
emerged as an important method in structural biology.260−263
As CryoEM does not require crystals, the proteins do not need
to be modified. Besides, sample preparation is less complicated
in comparison to X-ray crystallography. Recent developments
Table 2. continued
protein lipids PDB ID year ref
(118) Light-Driven Chloride Pump Halorhodopsin
Natronomonas pharaonis PC 3A7K 2010 1579
PA
DAG
bacterioruberin
retinal
(119) Fragaceatoxin C
Actinia f ragacea PC 4TSY, 4TSQ, 4TSP, 4TSO, 4TSN, 4TSL, 3W9P, 3VWI 2015 1592
(120) Murine Voltage-Dependent Anion Channel 1 (mVDAC1)
Mus musculus PC 4C69 2014 1593
Mus musculus PC 3EMN 2008 1594
(121) Omp85
Escherichia coli PC 4C00, 4BZA 2013 1595
(122) CmeC Outer Membrane Channel
Campylobacter jejuni lipid fragment 4MT4 2014 1596
(123) Outer Membrane Carboxylate Channels OccK2
Pseudomonas aeruginosa PE 3SZD, 3T24, 3T20, 3T0S, 3SZV, 3SYS, 3SYB, 3SY9, 3SY7 2012 1597
(124) Lanosterol 14-α-Demethylase
Saccharomyces cerevisiae lanosterol 4LXJ, 5EQB, 4K0F 5V5Z, 5JLC, 5HS1, 5ESN, 5ESM, 5ESL, 5ESK, 5ESJ,
5ESI, 5ESH, 5ESG, 5ESF, 5ESE, 4ZE3, 4ZE2, 4ZE1, 4ZE0, 4ZDZ, 4ZDY,
4WMZ
2014 1598
(125) N-Acylphosphatidyl-ethanolamine-Hydrolyzing Phospholipase D
Homo sapiens PE 4QN9 2015 1599
(126) Phosphoglycosyl Transferase
Campylobacter concisus PE 5W7L 2018 1600
(127) Gasdermin
Mus musculus cardiolipin 6CB8 2018 1601
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that allow the use of nanodiscs have given CryoEM yet another
advantage, as nanodiscs are better membrane mimetics than
micelles.264−267 The main drawback of CryoEM is its low
resolution. Nevertheless, at least 124 membrane protein
structures have been solved with this method (based on the
database “Membrane proteins of known 3D structure”268).
Computational methods such as MD or machine learning have
also been used to predict the structures of membrane proteins;
however, this task is still challenging. (For a review, see
Almeida et al.269)
3.2.3. Lipids as a Structural Element of Trans-
membrane Proteins. Lipids are often tightly bound to
membrane proteins. Therefore, they are extracted from
membranes together with proteins and appear in crystal
structures. In early studies of bacteriorhodopsin, it was
estimated that the protein might be cocrystallized with at
least ten lipids, and electron density was observed for six of
these.270 More recent mass spectroscopy studies showed that
the stabilizing effect of protein−lipid binding on the protein
structure depended on both the number and the type of bound
lipids.271 For instance, the binding of a single cardiolipin to
Aquaporin Z appears to stabilize the protein to a similar degree
as the binding of three PC molecules.271 Lipids not only
stabilize membrane proteins but also regulate their function in
various ways (for reviews, see refs 272 and 273).
Table 2 lists the PDB data bank entries of membrane
proteins that contain lipids resolved as a part of the protein
structure. While more than 245 reports of such cases exist in
the PDB data bank, the number of distinct proteins is slightly
over 100 (May 2018). A previous report from 2014 listed 100
entries with noncovalently bound lipids in protein struc-
tures,274 highlighting the accumulating evidence for tight
lipid−protein association. Such structures predominantly
belong to helical proteins with only two single helices and
five β-barrel proteins.
Most frequent lipids among the membrane protein
structures are PCs appearing in 59 entries for 36 distinct
proteins (Table 2), followed by zwitterionic PE found in 42
entries for 28 distinct proteins. As to charged lipids, PG is the
most frequent with 41 entries for 28 distinct proteins. Inositol
and PIP2 are present in six structures and PS in only two. DAG
appears in 35 structures, PA in 12, and oleic or palmitic acids
in 15. DAG, PA, and oleic and palmitic acids occur in small
quantities in biological membranes; thus, in most cases they
are fragments of larger lipids, where the remaining part of a
molecule is not resolved.
Cardiolipin is a unique lipid due to its role in the formation
of respiratory supercomplexes in mitochondria.275 Planas-
Iglesias et al. built up a database of proteins known to bind
cardiolipin. Out of the total 62 proteins, 21 were cocrystallized
with cardiolipin and seven were not membrane proteins.276
The database revealed distinct contributions from the
cardiolipin headgroup and acyl chains to its protein-binding
mechanism. Acyl chains appear to bind the helical regions of
the proteins, while the headgroups show a preference for
unstructured flexible regions. Positively charged amino acids
are essential for binding the negatively charged cardiolipin
headgroup. After the report by Planas-Iglesias et al. was
published, cardiolipin has also been found in respiratory
complex 1277 and in mammalian respiratory supercomplex
structures.278
Cholesterol is the most common sterol observed in the
crystal structures of membrane proteins. In this context, Table
2 lists 53 entries belonging to 33 distinct proteins. However,
the reader is advised to realize that actually in some of the
cases it is not cholesterol that is in the structure but cholesteryl
hemisuccinate. Cellular experiments with reactive cholesterol
analogues (so-called clickable cholesterols) reveal 250
cholesterol binding proteins, including various enzymes,
channels, and receptors.187
Some less common lipids have also been cocrystallized with
membrane proteins. Mono- and digalactosyl-diacyl-glycerol
(MGDG and DGDG) are common lipids in plants and the
predominant lipids in chloroplasts. These lipids are therefore
present in structures of photosynthetic proteins.279 Carote-
noids constitute a group of isoprenoid lipids also involved in
photosynthesis. They have also been cocrystallized with
photosynthetic complexes, reaction centers, and antennas.
The cocrystallized carotenoids are not limited to the most
common one, β-carotene, but also include others, such as
violaxanthin, neoxanthin, and lutein. Retinol is a short
carotenoid found in complex with rhodopsins and bacterio-
rhodopsins. Moreover, polyprenyl lipids such as ubiquinone
are present in the structures of photosynthetic and respiratory
chain proteins.
3.2.4. Peripheral Membrane Proteins. Peripheral
membrane proteins do not have transmembrane segments
but are attached to the membrane surface via polar interactions
with lipids or transmembrane proteins or via an anchor that
links the protein to the lipid membrane.
Peripheral membrane proteins are hard to identify, since
membrane protein binding and recognition employ several
mechanisms. Usually, two such mechanisms are necessary to
establish stable docking of the protein to the membrane
surface. The most common membrane docking mechanisms
involve specific interactions with certain lipids, hydrophobic
patches on the protein surface, recognition of physical
properties of the bilayer, and protein lipidation. Protein−
membrane binding may also require conformational changes in
the structure of the protein as it approaches the membrane
surface. Additionally, numerous intracellular proteins with a
net positive charge form some interaction with the intracellular
membranes rich in anionic lipids such as PS, PG, cardiolipin,
and PIPs. Given these reasons, it is not very surprising that the
perception of many proteins has changed over time. For
instance, L-DOPA decarboxylase, which for a long time was
considered to be water-soluble, was later discovered to be
membrane-associated.280 For the same reasons, the number of
peripheral membrane proteins is hard to estimate.
A few protein domains involved in membrane recognition
and binding have been characterized.281 The C1 domain was
first recognized in protein kinase C as a diacyl-glycerol binding
protein.282 This small domain composed of 50 residues
appears in about 66 human proteins. It interacts with the
membrane via nonspecific electrostatic interactions with
anionic lipids, and by means of several hydrophobic residues
that insert themselves into the membrane core.
There are about 14 known protein domains that bind PIPs
(For a recent review, see refs 281 and 283). Among them, the
100−150 residue-long PH domain is the most common one,
existing in ∼250 proteins. The PH domain can likely bind
different PIP species; however binding is inhibited by Ca2+ and
Mg2+ due to changes induced on the PIP headgroup.284 FYVE
domains are only 70−80 amino acids long, recognizing PIP3.
Membrane docking of these two domains is stabilized by
hydrophobic residues that insert themselves into the
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membrane core located around lysine or arginine residues,
which interact electrostatically with PIP phosphate groups.
Additionally, dimerization can stabilize docking of the protein.
The PX domain has a docking mechanism similar to that of
FYVE, but it binds various PIPs. The ENTH (epsin N-terminal
homology domain) and ANTH domains are also PIP-binding
domains. During the docking process, a conformational
rearrangement leads to the formation of an amphipathic
helix, which stabilizes interactions with lipids. On the other
hand, the C2 domain requires Ca2+ cations to anchor to the
membrane. While it has no specific lipid-binding pocket, it
interacts with various PIP species. The BAR domain is another
compelling case in that it requires both PIP and bilayer
curvature in order to be able to bind to a membrane with high
affinity. Other domains known to dock to lipid bilayers are
FERM, GOLPH3, PDZ, PROPPINS, PTB, and Tubby.
Glycolipids, in particular gangliosides, are a group of lipids
that participate in signaling and recognition. Although the
majority of their binding partners are transmembrane proteins,
including protein kinase receptors, some water-soluble proteins
also recognize and bind them. Galectins are such small proteins
that have a carbohydrate recognition domain with affinity for
β-galactoside-containing oligosaccharides.285 Dimers or
oligomers of galectins connected via flexible linkers allow
them to bind several targets simultaneously. Gangliosides also
act as receptors for bacterial toxins such as cholera toxin.286
Also, HIV entry into the host cell is mediated by interactions of
gangliosides with the virus protein gp120.287
PA is another intriguing signaling lipid involved in many
cellular processes. Despite the large number of proteins
interacting with PA, no common binding motif or domain
has been found.288 Several 3−4 residue long sequences rich in
arginines and lysines were found in certain proteins. Direct
interaction of PA with arginine and lysine lowers the pKa of the
headgroup further leading to its deprotonation. The small
headgroup with a charge of −2 further strengthens PA
electrostatic interactions.88,289 This mechanism, called the
electrostatic-hydrogen bonding switch, has been documented for
several proteins.290 Moreover, sequences composed of hydro-
phobic residues were also found to participate in PA binding.
Interestingly, membrane binding of PA-binding proteins also
depends on membrane curvature.291
Cardiolipin, as an anionic lipid, has important functions in
mitochondria.275,276 Due to its double negative charge,
cardiolipin is also expected to attract peripheral proteins.
Examples of such proteins are mitochondrial creatine kinase,
Figure 10. Dimer interactions in the chemokine receptor 4 (CXCR4) crystal structure. The structures include a small molecule antagonist (A, B)
or a cyclic peptide CVX15 (C, D). (A, C) The surface representation of the CXCR4 dimer and (B, D) the dimer interface. The surface involved in
dimerization is highlighted in dark blue and yellow, respectively. Reproduced with permission from ref 316. Copyright 2010 American Association
for the Advancement of Science.
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nucleoside diphosphate kinase,292 and cytochrome c.293
Further, microtubule-associated protein is involved in recog-
nition of cardiolipin on damaged mitochondria.294 Phospha-
tidylglycerols might play a role akin to that of cardiolipin in
mitochondria. Similarly, some peripheral proteins recognize
phosphatidylglycerols selectively.295
PE has a zwitterionic headgroup, which can be recognized
by proteins in the phosphatidylethanolamine-binding protein
family,296 which has 400 known members. Nevertheless,
anchoring of these proteins to the membrane also requires
negatively charged lipids.297
Figure 11. Membrane-associated protein complexes. (A1) The V-shaped dimer of the mitochondrial ATP synthase. Protomer fitted with atomistic
details is taken from PDB 2WSS338 (α-subunits, cyan; β-subunits, blue; γδε subunits, gray; OSCP, green) and PDB 3U2Y339 (yellow, c10-ring).
Reproduced with permission from ref 333. Copyright 2015 Kühlbrandt. (A2) Organization of mitochondrial cristae. Reproduced with permission
from ref 340. Copyright 2015 Davies et al. (A3, left) Cryo-EM structure of the respiratory chain supercomplex composed of NADH dehydrogenase
(complex 1, blue), a cytochrome bc1 dimer (complex 3, pink), and cytochrome c oxidase (complex 4, green). (A3, right) The ubiquinol binding
sites of complexes 1 and 3. Arrows indicate the electron path through the supercomplex.341 Reproduced with permission from ref 332. Copyright
2011 John Wiley and Sons. (B) Translocon complex. (B1) The pretranslocation state of the ribosome with an A-site tRNA (red) and a P-site tRNA
(green). An arrow shows the direction of tRNA’s traversal motion.342 (B2) Insertion of a nascent protein by the ribosome into a nanodisc
membrane working with the SecYE translocon. The protein and P-site tRNA are shown in green. An arrow shows the direction of the protein’s
movement.343 (B3) Bacterial ribosome with erythromycin (in red circle) at its binding site.344 Reproduced with permission from ref 345. Copyright
2015 Elsevier. (C) Formation of COPII carrier formation. Sar1 is GTPase, Sec23 and Sec24 proteins are the inner-layer coat components, and
Sec13 and Sec31 are the outer-layer coat components. Reproduced with permission from ref 346. Copyright 2013 Elsevier. (D) Nuclear pore
complex. The tomographic structure (EMD-3105)347 embedded into double membrane of nucleus envelope; cytoplasmic filaments and nuclear
basket, which are not part of the experimental structure, are shown in cartoon representation. Reproduced with permission from ref 348. Copyright
2016 Elsevier.
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00538
Chem. Rev. XXXX, XXX, XXX−XXX
AF
Membrane curvature is a property of lipid bilayers, which
may be recognized or induced by peripheral membrane
proteins. (For a review, see ref 298). In addition to the
above-mentioned BAR domain proteins, various amphipathic
helices recognize curved bilayer regions.
A frequent mechanism for protein anchoring to the
membrane surface involves post-transcriptional modifications,
for example, lipidation, which we discuss in more detail below
in the section on post-translational protein modifications.
As with transmembrane proteins, lipids are also present in
crystal structures of peripheral membrane proteins. For
example, the glycan of ganglioside GM1 is present in the
crystal structures of cholera toxin,299 capsid protein VP1 of
Simian virus 40300 and polyomaviruses,301,302 AB5 toxin,303
complement factor H,304 galectin 3 CRD domain,305 Agrocybe
aegerita lectin AAL,306 and endoglycoceramidases.307 Interest-
ingly, distinct conformations of glycans are observed in
complement factor H and cholera toxin. PIP2 is another
good example. PIP2 is present in crystal structures of focal
adhesion protein vinculin,308 clathrin membrane adapter
protein epsin, which has an ENTH domain, and Sla2, which
has an ANTH domain.309 Furthermore, PIP2 is present also in
rabphilin, which has a C2 domain and is involved in vesicular
transport,310 multifunctional scaffold protein Kibra, which also
has a C2 domain,311 Arf GTPase-activating protein ASAP1,
which has a PH domain, HIV-1 Gag protein responsible for
virus assembly,312 alpha-tocopherol transfer protein,313 cytos-
keleton regulating protein neurofibromin 2,314 and phospha-
tidylinositol 3-kinase α.315 GM1 and PIP2 exemplify the
importance of lipids for the functions of peripheral proteins
and reveal the amazing range of cellular processes, where
protein−lipid interactions are crucial.
3.2.5. Protein Oligomerization and Large Membrane-
Associated Protein Complexes. Membrane proteins are
known to form dimers, oligomers, or larger complexes
incorporating multiple different proteins. The simplest case is
the above-discussed dimerization of bitopic receptors, where
multiple possible arrangements of transmembrane helices are
possible. Other well-documented cases are known from the
available crystal structures. For example, cytochrome bc1
(respiratory complex 3) is a functional dimer of three proteins,
namely, cytochrome b, cytochrome c, and Riske protein.
Here we discuss examples of protein complex formation
ranging from small-scale dimerization or oligomerization to
formation of large supercomplexes composed of hundreds of
proteins and lipids (see Figure 10).
GPCRs, the largest class of transmembrane receptors, form
functional oligomers (for recent reviews, see refs 317−319). In
some cases, oligomerization has been established to be
obligatory for their function, such as among class-C GPCRs.
For instance, metabotropic glutamate (mGlu) receptors form
covalently bound dimers. When extracted and reconstituted in
nanodiscs as monomers, they fail to activate G protein.320
Another receptor of this family, γ-aminobutyric acid receptor
(GABAB), exists as a heterodimer of GABAB-R1 and GABAB-
R2. Contrary to family C, family-A GPCR receptors can
activate G protein when reconstituted as monomers.321
However, there is some evidence that they form homo- and
hetero-oligomers in the cellular environment.319 Homodimers
of the dopamine D2 receptor were shown to behave as a single
signaling unit and simultaneously bind a single G protein.322
Other studies showed that one-third of the muscarinic M1
receptors organize into dimers in the cell membrane.323 While
β1-adrenergic receptors form transient dimers, β2-adrenergic
receptors form stable dimers.324 Dimerization of β2-adrenergic
receptors seems to be necessary for their export from the
reticulum to the plasma membrane.325 Moreover, β1-
adrenergic326 and CXCR4316 receptors were crystallized as
dimers revealing their dimerization interfaces. Another layer of
complexity arises from the formation of hetero-oligomers,
which leads to cross-talk between different signaling pathways.
An example of such hetero-oligomers is the dopamine D2
receptor oligomerizing with the adenosine A2A receptor.
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Mechanisms underlying GPCR oligomerization are not well
understood. However, the involvement of lipids has been
discussed in the literature. These lipid-mediated mechanisms
include nonspecific ones driven by a tendency to minimize the
hydrophobic mismatch between the proteins and the
membrane, as well as those that involve specific lipid
interactions mainly with cholesterol and polyunsaturated
lipids.328 Dimerization or oligomerization is not limited to
GPCRs and has been shown also for other classes of
transmembrane proteins, for example, bile acid transporter
ASBT329 and receptor tyrosine kinase.330,331
Mitochondrial proteins are organized into complexes of
various sizes. The mitochondrial respiratory chain consists of
five complexes located in mitochondrial cristae, which are
elongated tubes or sheets on the inner mitochondrial
membrane protruding into the mitochondrial matrix (see
Figure 11). Complexes 1, 3, and 4 have been shown to be
organized into a supercomplex, which keeps the orientation
and the position of each protein unit optimal for an efficient
flow of substrates.332,333 The supercomplex also includes 200−
400 lipids, including cardiolipin.35 ATP synthase (complex 5)
is organized into dimers forming rows at the tip of the cristae,
where the membrane curvature is maximal. This supra-
organization ensures that ATP synthase uses the proton
gradient generated by the supercomplex with utmost efficiency.
The elongation of the cristae is controlled by other
macromolecular structures connecting the inner and the
outer mitochondrial membranes at the contact sites.334,335
Transmembrane protein synthesis is coupled to the insertion
into the lipid bilayer. To accomplish this coupling, ribosomes
associate with the reticular membrane−protein complex, the
translocon. Translocon is composed of several units, the most
crucial of which is the protein-conducting channel, Sec61.336
This highly conserved channel facilitates the translocation of
the protein through the lipid bilayer as ribosome synthesizes
the protein. Other important units of translocon are the signal
peptidase complex, which cleaves the signal peptides,
oligosaccharyltransferase complex, which catalyzes the cotrans-
lational N-glycosylation, and two other complexes with
unknown functions: the translocating chain-associated mem-
brane protein and the translocon-associated protein complex.
The overall structure of the ribosome-translocon complex is
known (see Figure 11); however, not all parts of the complex
are resolved in atomistic detail.337
Coat protein complex II (COPII) vesicle is responsible for
the delivery of the secretory proteins from the endoplasmic
reticulum to the cell membrane via the Golgi apparatus and for
the transport of membrane proteins synthesized in the
endoplasmic reticulum to other cellular compartments.346,349
Three different proteins responsible for inducing the
membrane curvature and closing and coating the vesicle
organize the formation and the disassembly of COPII vesicles,
which have a size of ∼60−90 nm (Figure 11). Cargo proteins
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are thought to participate in vesicle formation, and additional
proteins are involved in the initiation of the vesicle formation.
Another interesting lipid−protein ensemble is the nuclear
pore complex, which controls the transport of proteins and
RNA between the cytosol and the nucleus (Figure 11). The
mass of the complex formed by ∼30 different protein species
and 50−100 individual proteins is about 50−112 MDa.348,350
The complex has an 8-fold symmetry and is assembled of many
preformed supercomplexes. The nucleus is surrounded by two
membranes, which are connected at the nuclear pore via a
highly curved bilayer. The central part of the pore is filled by
flexible, unstructured proteins, which form a hydrogel
responsible for the pore selectivity. The pore is permeable to
small molecules. Proteins larger than 40 kDa need to associate
with the transport protein responsible for the pore selectivity
before they enter or exit the nucleus. This translocation
mechanism is not well understood.351
3.2.6. Post-translational Modifications of Membrane
Proteins. Membrane proteins are subject to post-translational
modifications. The number of possible modifications is
immense. Over 200 different types of post-translational
amino acid modifications are known, and new ones are still
systematically discovered.352 Analysis of data in Swiss-Port
(2011_7) revealed 87,308 post-translational modifications
detected experimentally, and 234,938 predicted on 530,264
proteins.353 The most frequent modifications are phosphor-
ylation, acetylation, N-linked glycosylation, amidation, hydrox-
ylation, methylation, O-linked glycosylation, and ubiquityla-
tion.353 Two out of three proteins in the cell are estimated to
be phosphorylated.354 Post-translational modifications are
challenging for analytical chemistry methods, as only a small
fraction of the given protein might be modified.355 Moreover,
many modifications are reversible (e.g., phosphorylation,
acetylation, methylation, palmitoylation, and GlcNAcylation).
Experimental identifications of these modifications are made
even more challenging and error prone by complicated
modifications such as lysine methylation, which can lead to
three different products.356 The main experimental method
used for identification of protein modifications is mass
spectroscopy,355 but bioinformatics-based prediction tools are
also quite successful and commonly used.357 Most of the post-
translational modifications are observed in all types of proteins
in all cellular compartments; however, tyrosine sulfation occurs
only in the transmembrane and secretory proteins.358 Multiple
types of post-translational modifications may take place on a
given protein during various stages of its activity (a review
summarizing the post-translational modifications in class-C
GPCRs is given in ref 359, see Figure 12). Also, multiple post-
translational modifications regulate biological function at the
organismal level (e.g., biological rhythm, see ref 360).
Glycosylation occurs in half of the eukaryotic proteins.362 It
affects, for example, the intracellular transport of membrane
proteins, receptor interactions with their ligands and galectins
as well as gangliosides, and dimerization and signaling of the
tyrosine kinase receptor.363 Mass of the attached carbohydrates
is often substantial; for example, the mass of glycans decorating
the epidermal growth factor receptor, a protein composed of
1180 amino acids, is about 40 kDa for ∼220 hexose units in 15
N-glycan arms.364 Abnormal glycosylation is a regular feature
of cell membrane proteins in numerous cancers. Particularly,
increased sialylation, core fucosylation, branching, O-glycan
truncation, and high mannose N-glycosylation are common in
cancers.365 Disturbed glycosylation of Notch proteins is known
to induce developmental disorders as well as cancer and other
diseases.366 Similarly, glycosylation of voltage-gated calcium
channels was implicated in numerous pathologies.367
O-GlcNAcylation is an O-type glycosylation, where
acetylglucosamine (GlcNAc) is attached to a serine or a
threonine. As observed in most of the cellular compartments
and also on transmembrane proteins, O-GlcNAcylation has
Figure 12. (A) Post-translational modifications of GPCRs. The figure shows a cellular compartment where modifications are performed.
Reproduced with permission from ref 359. Copyright 2015 Elsevier. (B) Structure and process of formation of a GPI anchor. Abbreviations:
GlucN, glucosylamine; GalNac, N-acetyl galactose; EtNP, phosphatidylethanolamine; ± indicates nonmandatory fragments. Reproduced with
permission from ref 361. Copyright 2012 Elsevier.
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numerous functions (For a review, see refs 368 and 369).
However, pathological O-GlcNAcylation occurs in diabetes,370
cancer,371 and neurodegeneration.372 Nuclear pore complex is
extensively O-GlcNAcylated with nearly half of the proteins
modified.373 In particular, intrinsically disordered nucleoporins
are heavily O-GlcNAcylated, which is considered to be a
mechanism for preventing aggregation and degradation of
these proteins. The roles and effects of O-GlcNAcylation are
not well understood. For example, it may induce both
protective and pathological effects during cardiac hypertrophy
development.374
Ubiquitination is a post-translational modification, in which
a small protein, ubiquitin (8.5 kDa), is attached to the protein.
The main function of ubiquitination is the control of protein
degradation. Examples of membrane proteins for which
ubiquitination has recently been shown to control degradation
include the epithelial Na+ channel and arginine transporter,
Can1.375,376 Ubiquitination also controls protein trafficking
and DNA repair.377,378 While the most frequent sites of
modification are the lysine side chains, alternative attachment
points exist: the N-terminal amine group, the hydroxyl groups
of serine and threonine residues, and the thiol groups of
cysteine residues.378
Lipidation is particularly important for peripheral membrane
proteins as it is involved in membrane binding, but it also
occurs in transmembrane proteins. There are many possible
lipids used in lipidation, including acyl chains, isoprenoids,
sterols, phospholipids, and glycosylphosphatidylinositol (GPI).
The most common acyl chains attached to proteins are the
myristoyl and the palmitoyl chains (For extensive reviews, see
refs 379 and 380). N-myristoylation is an attachment of the
myristoyl chain to the N-terminus, which contains the
consensus sequence Met-Gly-X-X-X-Ser/Thr.379 First, the
methionine is removed, and then myristoyl is attached via
the amide group to the glycine. Myristoylation has been
identified in about 150 mammalian proteins.379 Myristoylation
is not likely to drive protein docking to the membrane surface
on its own,379 as it contributes only 8 kcal/mol to the
membrane binding free energy.381 For this reason, a second
contribution is also needed, which might be the presence of
hydrophobic or basic amino acids, favorable interactions with
other membrane proteins, or a second lipidation.379
S-Palmitoylation is the attachment of a palmitoyl chain to
the cysteine residues. While there seems to be no consensus
sequence for S-palmitoylation, bioinformatics tools can predict
S-palmitoylation sites.382 It is estimated that 10% of human
proteins are palmitoylated.383 Palmitoylation, unlike myristoy-
lation, can drive protein docking to the membrane on its
own.379 N-Palmitoylation occurring at the N-terminus of the
protein is a rare type of palmitoylation. Cholesterolylation, also
uncommon, is known as a second lipidation after N-
palmitoylation of the hedgehog signaling protein.384,385
Other fatty chains used to lipidate proteins are octanoyl,
palmitoleic, stearoyl, and arachidonic acids.379
Prenylation is an attachment of the isoprenoid chain to the
C-terminus of proteins favoring their membrane association.
The two types of prenylation are farnesylation and
geranylgeranylyzation. Farnesyl is a 15-carbon and geranyl−
geranyl a 20-carbon isoprenoid. In prenylation, isoprenoids are
attached to a cysteine side chain at the C-terminus, which has
the consensus sequence of C-a-a-X, where C is cysteine and “a”
is an aliphatic amino acid.386−388 Before prenylation, the last
three residues are removed, and the C-terminal carboxylic
group of cysteine is methylated making the C-terminus
hydrophobic. In mammals, there are about 50 known
farnesylated and about 170 known geranylgeranylated proteins,
among which are Ras and Rab proteins involved in cellular
signaling.389 For this reason, prenylation is targeted in cancer
therapies.389,390
Approximately 150 proteins are GPI-anchored. GPI is a
glycosylated phosphatidylinositol molecule with a glycosyl
moiety composed of a glucosamine and three subsequent
mannose units.361,391 At the first and the third mannose,
ethanolamine-phosphate groups are attached (Figure 12). The
ethanolamine-phosphate moiety located at the third mannose
acts as the connection point for the protein C-terminus. Polar
parts of GPI may differ between organisms or even between
cells, having additional carbohydrates, ethanolamine-phosphate
groups, or palmitoyl.391 GPI anchor is essential for protein
trafficking and sorting.392 The synthesis of GPI is complex and
requires substantial remodeling of the molecule, including, for
instance, the replacement of the polyunsaturated chain of PI
(the stem of the GPI anchor) with a saturated one.391 In
humans, 26 genes are involved in the synthesis and maturation
of the GPI anchor.393 Thirteen known mutations of these
genes lead to inherited genetic disorders, which manifests with
various syndromes. These genes are also associated with
cancers and prion diseases.393
Lipidation of proteins with phospholipids has been shown
only for yeast Apg8 protein located in the autophagosome and
for its mammalian analog LC3. The attached lipid was
phosphatidylethanolamine.394,395 Interestingly, this modifica-
tion occurs only for membranes with large defects, such as in
highly curved bilayers.396
Finally, oxidation is another protein modification, which can
be enzymatically catalyzed as a part of a healthy cellular
function. But, oxidation can also result from pathological
oxidative stress due to free radicals, metal-catalyzed reactions,
or ozone.397−400 Indeed, ozone or nitrogen dioxide inhalation
may lead to protein oxidation in lungs.401 A possible
consequence of oxidation is protein backbone cleavage or
side chain modifications to many amino acids (see Table
3).399,400,402 Oxidized proteins are effectively repaired or
degraded; however, they can accumulate in pathological
states,403−405 such as in cardiovascular diseases,406 Alzheimer
disease,407 and aging.408
3.3. Cell Membranes at the Border of Cytoplasm and the
Extracellular Environment
3.3.1. Integrins. Integrins are heterodimeric, bitopic
membrane proteins located in the cell membrane of animal
cells. Integrin heterodimers are composed of subunits α and β.
There are 18 α subunits and 8 β subunits, which combine to
form 24 distinct known dimers.411 Integrins mainly facilitate
the cell−extracellular matrix adhesion (see Figure 13). They
are also receptors that pass signals in and out of the cell.
Integrin activation is a complex process regulated by numerous
proteins. The key proteins involved in integrin activation are
talin and kindlin, which directly interact with the β subunit.
The inactivating proteins are sharpin, nisharin, and MDG1,
which interact directly with the α subunit.412 Other proteins
interacting with integrins are signaling and recycling proteins.
Integrins are indirectly connected to the cytoskeleton, to actin
filaments. The mechanisms of integrin regulation are far from
understood. The complexity of the process is highlighted by a
proteomics analysis, which indicated that over 300 proteins are
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involved in integrin adhesion.413 Integrins act also as receptors
for extracellular matrix components, including collagen fibers
in the interstitial matrices and laminins in pericellular
matrices.414 We note that the extracellular matrix is another
complex structure that is not understood, and its nonun-
iformity in the body aggravates this.414
3.3.2. Glycocalyx. Glycocalyx is an extracellular structure
formed by carbohydrate polymers, glycoproteins, and glyco-
lipids (Figure 14). Glycocalyx is most frequently discussed in
the context of vessel endothelial cells, where it extends 150−
400 nm away from the membrane and is organized in 100 nm-
wide units along the membrane plane. Glycocalyx and its
components are also found in many other organs and cells,
including intestinal epithelium, mucus, smooth muscle cells,
osteocytes, and cancer cells.416 The main function of
glycocalyx is to act as a barrier between a cell and its
environment, but it is also involved in mechanosensing.417−419
Glycocalyx is of great medical interest due to its involvement in
numerous diseases, for example, atherosclerosis, stroke, sepsis,
diabetes and related renal diseases, hypertension, pulmonary
edema, and cancer.416,420,421
The main components of glycocalyx are the proteoglycan
proteins that anchor long carbohydrate polymers (Figure 14).
Carbohydrate polymers forming the glycocalyx are heparin
sulfate, chondroitin sulfate, hyaluronic acid, dermatan sulfate,
and keratan sulfate.419,422,423 The major carbohydrate polymer,
heparin sulfate contributes up to 50−90% of proteoglycans in
the glycocalyx. Heparin sulfate and chondroitin sulfate are
anchored to the cell membrane by a transmembrane protein
called syndecan, which can accommodate five polymer
chains.422 The syndecan, which has four subtypes, is also
important for the above-mentioned mechanosensing function
of glycocalyx, as it is connected to the cytoskeleton.422,424
Especially heparin sulfate is expected to participate in
mechanosensing via interactions with the extracellular
matrix.416 Currently the structure of syndecans is not known;
only the structure of a 28-residue-long intracellular domain of
syndecan-4 was solved in solution in the dimeric form (PDB
1EJP).425
The second group of proteins anchoring heparin sulfate and
chondroitin sulfate to a membrane are GPI-anchored proteins,
called glypicans, which have six subtypes.422 Only the structure
of human glypican 1 is known (PDB 4ACR,426 4AD7,426
4BWE,427 and 4YWT428). However, not all proteoglycan
proteins that are attached to heparin or chondroitin sulfate are
membrane-associated, such as perlecan, versican, decorin,
biglycan, and mimecan.422 Hyaluronic acid is anchored to
the cell membrane by the CD44 receptor, but it may be also
loosely associated with the glycocalyx structure without specific
interactions.422,423 Currently, the structure of CD44 is not
known; only the structure of the human and murine
hyaluronan binding domain composed of about 180 residues
was solved (e.g., PDB 1UUH,429 2JPC430), while the structure
of the remaining ∼560 residues is not known.
Glycoproteins and glycolipids are also considered to be a
part of the glycocalyx, but their size is insignificant when
Table 3. Oxidation Products of Amino Acids
amino acid product
(1) Oxidative Modifications of Amino Acid Residue Side Chains399,400,409,410
arginine γ-glutamyl semialdehyde, glyco-oxidation adducts
cysteine disulfides, cysteic acid, glutathione cysteine, lipid
peroxidation adducts, amino acid oxidation adducts,
sulfenic acid, sulfinic acid, sulfonic acid, nitroso-cysteine
glutamic acid oxalic acid, pyruvate adducts, hydro-peroxides
histidine aspartate
asparagine
2-oxo-histidine
4-hydroxy-glutaminic acid
lipid peroxidation adducts
amino acid oxidation adducts
hydro-peroxides
isoleucine hydro-peroxides
leucine 3-hydroxy-leucine, 4-hydroxy-leucine
5-hydroxy-leucine, hydro-peroxides
lysine α-amino-adipic semialdehyde, chloramines, hydro-
peroxides
lipid peroxidation adducts, amino acid oxidation adducts
glyco-oxidation adducts
methionine methionine sulfoxide, methionine sulfone
phenylalanine 2-hydroxy-phenylalanine, 3-hydroxy-phenylalanine
4-hydroxy-phenylalanine, 3,4-dihydroxy-phenylalanine
proline glutamic semialdehyde, 4-hydroxyproline, 5-hydroxyproline
pyroglutamic acid, 2-pyrrolidone, hydro-peroxides
threonine 2-amino-3-ketobutyric acid
tryptophan 2-hydroxy-tryptophan, 4-hydroxy-tryptophan
5-hydroxy-tryptophan, 6-hydroxy-tryptophan
7-hydroxy-tryptophan, n-formyl-kynurenine
3-hydroxy-kynurenine, kynurenine
6-nitro-tryptophan, tryptophan-tryptophan cross-linkages
hydro-peroxides
tyrosine 3,4-dihydroxy-phenylalanine, 3-nitro-tyrosine, 3-chloro-
tyrosine
3,5-dichloro-tyrosine, tyrosine−tyrosine cross-linkages
tyrosine-oxygen-tyrosine, 2,3-dihydroxy-phenylalanine
hydro-peroxides
(2) Metal-Catalyzed Oxidation of Amino Acid Residues in Proteins400
histidine aspartate, asparagine, oxo-histidine
proline hydroxy-proline, glutamate, γ-glutamyl-semialdehyde
arginine γ-glutamyl-semialdehyde
lysine amino-adipic-semialdehyde
threonine amino-ketobutyrate
tyrosine Tyr−Tyr (dityrosine)
cysteine ESESE (disulfide cross-links)
Figure 13. Simplified cartoon representation of components of the
modular nascent cell-matrix adhesions. RGD, substrate for integrin
binding. Reproduced with permission from ref 415. Copyright 2016
Wiley Periodicals, Inc.
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compared to above-discussed carbohydrate polymers, as
glycolipids can contain one sugar monomers and each N- or
O-glycan linked to a glycoprotein has about ten sugar
monomers.
3.3.3. Cell−Cell Junctions. Cells are frequently directly
connected via different types of cell junctions: tight junctions,
adherens junctions, desmosome, and gap junctions (Figure
15). Each of these connections has a different function, but
they are dynamically coupled to each other and are located at
specific regions in the cell membrane.431,432
Tight junctions are cell−cell connections located at the
borders of the membrane compartments in polarized cells. The
most generic examples of tight junctions can be found in the
epithelial and endothelial cells, where the tight junctions
separate apical and basolateral membranes.433−435 Tight
junctions are formed by a few classes of proteins, among
which the most important are the transmembrane proteins
claudins and occludins (Figure 15).436 According to some tight
junction models, lipids also participate in the junction
structure.436 The junctions bring two cell membranes into
close contact, which is sometimes referred to as a kiss point.
Tight junctions control material flow into the paracellular
space, which is of particular importance for the blood−brain
barrier.437,438 Moreover, tight junctions act as fences
preventing the flow of lipids and proteins between distinct
membrane domains of polarized cells.435 Tight junctions are
also connected with the cytoskeleton and participate in
mechanotransduction.439
Adherens junctions are formed by the transmembrane
proteins cadherins and nectins, while desmosomes are formed
by specific desmosomal cadherins called desmogleins and are
considered by some authors as a separate type of junction
(Figure 15).438,439,450 In these junctions, the distance between
two connected membranes is longest among all junction types,
being ∼34 nm for desmosomes.451 In mature junctions,
multiple cadherins form clusters that, together with a strong
association with the cytoskeleton, provide mechanical strength
to the junctions.440 Adherence junctions are of primary
importance for tissue integrity and their mechanical proper-
ties.439,451 Desmosomes are the strongest cellular junctions;
thus, they are especially important for tissues like skin and
organs like heart, which are subject to mechanical stress.450,452
It is, therefore, not surprising that mutations of desmosomal
proteins cause myocardial, skin, and hair pathologies.453−455
The main components of the gap junctions are proteins that
belong to two groups: connexins and pannexins, both of which
Figure 14. Glycocalyx and its components. (A) Electron microscopy image of the endothelial glycocalyx in a coronary capillary. Reproduced with
permission from ref 420. Copyright 2005 Wolters Kluwer Health, Inc. (B) A cartoon representation of proteoglycans and glycoproteins on the
surface of endothelial cells. The red line represents the cytoskeleton. Reproduced with permission from ref 419. Copyright 2006 John Wiley and
Sons.
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are proteins with four-helical transmembrane domains (Figure
15).456,457 These proteins form channels connecting cyto-
plasms of two cells, whose opening and closure are controlled
by various mechanisms.458 The diameter of the channel in its
narrowest part is ∼1.4 nm, thus allowing the passage of water,
ions, and small solutes including second messengers.448,459
Membranes of the two cells connected via gap junctions are at
a distance of 2−4 nm.448,449 This distance results in a gap
Figure 15. Cell−cell junctions. (A) Overview of cell−cell junctions and main proteins involved in their formation. Reproduced with permission
from ref 439. Copyright 2017 John Wiley and Sons. (B, left) Tight junction location in the cell membrane providing a barrier between an apical
membrane and a basolateral membrane. PC is shown in red, sphingolipids and cholesterol are shown in green, and tight junction proteins are
shown in purple. Reproduced with permission from ref 433. Copyright 2008 Elsevier. (B, right) Molecular architecture of a tight junction formed
by two claudin molecules. Reproduced with permission from ref 436. Copyright 2016 Springer Nature. (C) Maturation of an adherens junction via
dimerization and aggregation. Reproduced with permission from ref 440. Copyright 2017 Cold Spring Harbor Laboratory Press. (D) Three-
dimensional model of the E-cadherin−catenin cell adhesion complex associated with F-actin based on the crystal structures: E-cadherin ectodomain
EC1−5 trans-dimer (purple or dark yellow) bound to calcium (yellow spheres) (PDB 3Q2 V),441 p120 catenin (blue) bound to E-cadherin (PDB:
3L6X),442 β-catenin (green) bound to E-cadherin (PDB 1I7W),443 αE-catenin (red) (PDB 1DOW,444 4IGG,445 and 4K1N),446 and F-actin (light
and dark gray) (PDB 3B63).447 Reproduced with permission from ref 440. Copyright 2017 Cold Spring Harbor Laboratory Press. (E) Schematic
representation of connexins and gap junction channels. Reproduced with permission from ref 448. Copyright 2007 The Society for Investigative
Dermatology. (F) Molecular architecture of a gap junction channel (PDB 2ZW3).449 Reproduced with permission from ref 449. Copyright 2009
Springer Nature.
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when compared to tight junctions, where the kiss point is
formed. Typically, in cells gap junctions form plaques gathering
a large number of individual channels together.460
Connexins and pannexins are present in vertebrates, while in
nonvertebrates gap junctions are formed by innexins, which are
related to pannexins.456 In humans, there are 21 known
connexin isoforms, and cells express many of them at the same
time. To form a pore, six connexin molecules are needed in
each membrane. They may be of different isoforms allowing
for very many combinations.448,461,462 Gap junctions are not
selective for ions, and thus they play a role in electrical
coupling between cells, which is of high importance in nerve
tissues and muscles.463 On the other hand, gap junctions are
selective for second messengers, which is likely achieved by the
huge number of combinations to form a channel due to
simultaneous expression of many connexin isoforms.459,463
This also explains why mutations of only one isoform can lead
to cancer or other disorders.463−469
Plant and fungal cells are surrounded by a cell wall, but
direct cell−cell communication analogous to gap junctions
exists. In plants, analogs of gap junctions are called
plasmodesmata, which are elongated patches of cytoplasm
passing through the cell wall;470,471 in fungi, they are called
septal pores.471 The molecular architecture of these con-
nections is not understood yet.
3.3.4. Cell Wall. The cell wall is a structure that surrounds
plant,472−476 bacterial,477−480 and fungal cells.481−484 That is,
the majority of cells on earth have cell walls. The main function
of the cell wall is to provide mechanical protection from
external forces. It is also involved in signaling and sensing the
external environment; however the exact mechanisms are not
known.
The cell wall is composed of carbohydrate polymers, which
are specific for each group of the organisms. In plants, the main
polymer is cellulose, while in fungi it is glucan and chitin, and
in bacteria, it is peptidoglycan. Synthesis and organization of
the cell wall is a complex process, which is still not clear.
However, cell walls are of pharmaceutical importance as targets
for antibiotics and antifungal drugs. The cell membrane plays
important roles in cell wall synthesis, anchoring, and
establishing its connection with the cytoskeleton.
In plants, the cell wall is composed of cellulose fibers, which
are connected with matrix carbohydrates like pectin, hemi-
cellulose, and a polyphenolic compound, lignin (Figure
16).472−475 Lignin and matrix carbohydrates are synthesized
in the intracellular compartment, after which they are actively
transported through the cell membrane to the cell wall.
Cellulose fibers, in turn, are synthesized by cellulose synthase,
which is a large enzymatic complex located on the cell
membrane. Cellulose synthase has a diameter of ∼30 nm in the
region spanning the cell membrane and is connected to the
cytoskeleton. The cell wall of plants is anchored to the cell
membrane by numerous GPI-anchored proteins, which bind
directly to either cellulose or other carbohydrates. Other
groups of proteins that anchor the cell wall to the cell
membrane are arabinogalactan proteins, wall-associated kinase
receptors, and analogs of integrin. The cell wall is connected to
the cytoskeleton via transmembrane proteins belonging to the
class-1 formin family.
The fungal cell wall is similar in complexity to the plant cell
wall, but its structure is even less understood.484−486 The main
carbohydrate polymers of fungal cell walls are α-1,3-, β-1,3-,
and β-1,6-glucans and chitin, which form a mesh-like structure.
Their synthesis takes place at the cell membrane.484 Additional
components of the mesh structure are melanin and phenolic
pigments, whose structures are not well characterized.484
Fungal cell wall is attached to the cell membrane
predominantly via GPI-anchored proteins.482
A bacterial cell wall structure in comparison to fungal and
plant cell walls is less complicated and better understood.
Figure 16. Cartoon representation of the complexity of the plant cell wall. The cell membrane is shown in brown; matrix polysaccharides are shown
as thin brown, blue, green, red, and black chains. The question mark represents an unknown bonding partner of integrin-like receptors. Adapted
with permission from ref 475. Copyright 2015 Oxford University Press.
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However, the entire envelope surrounding bacterial cells
(including their cell wall, the outer membrane in Gram-
negative bacteria, and glycocalyx) makes bacterial cell−
environment barrier the most complex among all groups of
organisms (Figure 17a,b). Due to the importance of bacteria in
human health, the bacterial cell envelope structure, the
synthesis of its structural units, and the assembly process are
of primary interest, as they are potential targets for antibiotics,
too.487,488
The main component of the bacterial cell wall is
peptidoglycan, a polymer whose basic unit is disaccharide−
pentapeptide N-acetyl-glucosaminyl-(β,1→4)-N-acetyl-mur-
amyl-L-alanyl-D-glutaminyl(γ)-L-(meso)diaminopimelyl-D-alan-
yl-D-alanine (Figure 17c). In peptidoglycans, carbohydrates
form linear structures, while pentapeptides are crossed-
connected via short peptides called bridges. Due to this,
peptidoglycan has mesh-like structure that is not as rigid as the
cell wall of plants but allows changes of cell shape necessary in
active movements of bacteria. The exact structure of the mesh
differs between bacterial species due to different lengths of the
bridge peptide and number of formed connections (See ref
489). The second component of the cell wall of Gram-positive
bacteria is teichoic acids, polymers of 3-phosphate glycerol or
5-phosphate ribitol or both, attached to a peptidoglycan
MurNac residue via two sugar units (sequence) (Figure
17e).490 Alternatively, teichoic acids remain connected with
lipids. Teichoic acids may comprise 50% of the cell wall mass.
Elements of the bacterial cell wall are recognized by innate
immune systems;491 thus, bacteria have developed numerous
modifications to the basic structure described here.492−494
Synthesis of the bacterial cell wall elements is an almost
entirely membrane-associated process, where Lipid I and II act
Figure 17. Cartoon representation of the bacterial cell wall structure. (A) Gram-negative bacteria and (B) Gram-positive bacteria. For the legend,
see panels C and D. (C) Chemical structure of the peptidoglycan unit. (D) Chemical structure of teichoic acid. (E) Synthesis of peptidoglycan.
Proteins are shown as gray ellipses.
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as platforms for the peptidoglycan unit formation (Figure
17e).495 The precursor of Lipid I is a polyprenol chain with a
single phosphate group and UDP-N-acetylmuramic acid
pentapeptide synthesized in the cytoplasm. The next step of
the synthesis produces Lipid II by attachment of GlucNac to
Lipid I and the peptide forming a bridge between them (Figure
17c). Synthesis of Lipid II takes place at the inner leaflet of the
membrane; thus, it has to translocate to the outer leaflet of the
cell membrane. However, it is not clear which proteins are
involved in this process. The leading candidate as a Lipid II
floppase is the MurJ protein, although it is possible that more
proteins are involved in the process.496 At the outer leaflet, a
peptidoglycan fragment is used to extend the cell wall, and a
phosphorylated polyprenol moiety translocates back to the
inner leaflet of the cell membrane. Synthesis of teichoic acids is
substantially similar to the synthesis of Lipid II, as it also takes
place at the inner leaflet of the cell membrane and uses
phosphorylated polyprenol as the base to which elements of
teichoic acids are gradually attached.490 The ABC transporters,
TagG or TarG, translocate the mature construct to the outer
leaflet of the cell membrane, where teichoic acid is attached to
the MurNAc residues of peptidoglycan. Interestingly, an
enzyme responsible for this final step of teichoic acid
integration into the cell wall has not been identified yet.
Current state of knowledge of the molecular architecture of
the cell wall and its connection with the cell membrane is not
impressive. This is particularly highlighted by the lack of
knowledge of the structures of the main proteins involved in
organization of the cell wall. This is surprising considering the
pharmacological importance of the cell wall as an antimicrobial
target. Current drugs typically target the synthesis of the cell
wall elements, which takes place inside cells. This allows the
bacteria to develop resistance using ABC transporters. Here,
one can imagine drugs that prevent the assembly of the cell
wall by acting outside the cell membrane. In this case,
development of resistance would be much more complicated.
3.4. Challenges
As discussed in this section, biological membranes are complex
structures made up of lipids, proteins, and carbohydrates. All of
these components have specific functions, but they also depend
on each other. The primary role of lipids is to form the
membrane matrix, which provides a 2-dimensional environ-
ment for various proteins to carry out their functions. Lipids
also specifically regulate protein activation through allosteric
interactions, and they act as primary receptors for peripheral
membrane proteins. Proteins, in turn, affect lipids. Enzymes
modulate lipids to, for example, induce membrane curvature.
Local lipid composition is modulated by flippases, floppases,
and scramblases, which establish and maintain asymmetric
lipid compositions across the bilayer leaflets. Carbohydrates
are also a part of these interactions as modifications in the
glycolipid headgroups or post-transcriptional modifications of
proteins.
The properties of lipid bilayers depend on where they are
located in a cell. For example, the cell membrane is thick and
rigid, while reticular membranes are thinner and more fluid. All
of the cellular membranes are connected together via a
complex interaction network, which is far from understood.
To construct realistic computational models of biological
membranes, we need to know their exact lipid, protein, and
carbohydrate composition as well as the structures of the
proteins. Recent studies have given us a growing number of
transmembrane protein structures thanks to the improvements
in protein crystallography and cryo-EM methods. Cryo-EM is
particularly promising, since its resolution is now close to the
atomistic level. Despite this progress, structures remain to be
characterized for most transmembrane proteins, and too little
is known of the structures of peripheral proteins, which are
likely different in water-soluble and membrane-bound forms.
Omics-type studies provide valuable information concerning
molecular composition. However, when performed on crude
tissue samples, these studies are not sufficient to build realistic
models of the biological membranes. Therefore, we need data
specifically collected for individual organelles, or membrane
types. The number of published studies is still quite modest
due to experimental difficulties to get sufficiently good samples
from specific organelles, which are not contaminated by other
cellular components. Post-transcriptional modifications of
proteins pose yet another difficulty for the construction of
realistic simulation models. For example, protein glycosylation
is a specific process, and for most proteins, the exact
glycosylation sequence is unknown. Besides, the glycosylation
sequence for each protein depends also on the cell type.
Finally, large-scale structures of systems where membranes
are involved, such as glycocalyx, cell wall, and the connection
of the membranes with the cytoskeleton and the extracellular
matrix are weakly understood. These structures are particularly
challenging to simulate due to their dynamic nature, multiple
partners interacting via weak and redundant interactions, and
the presence of unstructured carbohydrates. To characterize
these complex structures, support given by new experimental
methods is likely needed.
4. ARE BIOMEMBRANES COMPRISED OF TRANSIENT
FUNCTIONAL DOMAINS?
In this section, we discuss how computer simulations have
tackled a number of open questions regarding the laterally
heterogeneous structure of the plasma membrane, and
therefore how scientific computing has helped to bridge
together studies on model membranes and living cells. First,
however, we complement our previous discussion in sections 2
and 3 by briefly reviewing the current paradigm of plasma
membrane heterogeneity provided by the lipid raft model. We
briefly discuss the state-of-the-art experiments on living cells,
model membranes, and plasma membrane-derived vesicles, all
of which approach this topic from different perspectives.
Notably, we consider the convincing evidence suggesting that
the nanoscale heterogeneities in the plasma membrane are
associated with the phase behavior of model lipid membranes.
We close the outlook on experimental results by discussing
some open questions that might benefit from computer
simulation studies.
Next, we take a bottom-up approach and review recent
simulation studies by focusing on membrane heterogeneity.
Here, we first concentrate on studies on lipid phase behavior.
We start from single-component membranes and then move
on to recent studies on binary mixtures containing either two
kinds of phospholipids or a phospholipid with cholesterol.
Moving on to ternary mixtures, we consider studies of uniform
raft-like membranes, studies with preformed raft-like domains,
and studies that capture spontaneous phase separation into
ordered raft-like and disordered non-raft like phases. Next, we
consider heterogeneities in complex membranes whose
composition mimics the content found in plasma membranes.
Finally, we discuss simulation studies that suggest protein−
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lipid interactions to give rise to the formation of distinct
functional domains. We mainly focus on the development that
has taken place during the past decade, unless earlier studies
are of significant interest.
We close the section by discussing the limitations of the
current simulation studies and provide our opinion on how
these limitations could be overcome in the future by tightly
integrating experimental and simulation efforts.
4.1. Heterogeneity in the Plasma Membrane and Model
Membranes
As discussed in section 2, a reasonably accurate picture of the
structure of cellular membranes was provided by the fluid
mosaic model introduced by Singer and Nicholson back in
1972.4 This model remains mostly valid even today, although
the discoveries made during the last four decades have also
called for some updates.497 Namely, according to the current
paradigm, cellular membranes display both transmembrane
and lateral heterogeneity. While the former is discussed in
detail in our description of the target membrane in section 3,
the latter is captured in the raft concept,12 which states that
specific lipids and proteins cluster to form nanoscopic ordered
domains. More precisely, the Keystone Symposium on Lipid
Raf ts and Cell Function held in 2006 defined rafts to be
heterogeneous and dynamic entities containing sphingomyelin
and cholesterol.498 More recent interpretations15 have stressed
that rafts are functional, which emphasizes the importance of
accounting for proteins, too. The diameter of rafts has often
been estimated to be 10−200 nm, yet rafts have been
considered to be able to coalesce via protein−lipid and
protein−protein interactions. A schematic picture of a lipid raft
based on current understanding is shown in Figure 18.
Multiple roles have been assigned to rafts during the last two
decades since their introduction in 1997. Most importantly,
they provide membrane proteins with specific cholesterol-rich
environments, where they can perform their functions
associated with, for example, signaling and trafficking.15 During
the last two decades, our picture of rafts has evolved due to a
significant amount of experimental and theoretical work. The
modern view considers rafts as transient and fairly ordered
functional domains, whose formation is driven mainly by
lipid−lipid interactions.17 These favorable lipid−lipid inter-
actions include, in addition to cholesterol and sphingomyelin,
also interactions of cholesterol with other saturated lipids and
gangliosides.17 Additionally, the roles of hydrophobic mis-
match, cortical actin, and the possibility of protein-induced
domain formation have been highlighted.17
Curiously, even though the resolution of experimental
techniques has steadily improved since the introduction of
the raft concept, there are still no direct observations of their
existence in the membranes of living cells. This controversy has
also sparked alternative explanations for the numerous indirect
findings.499 Perhaps, the most convincing pieces of evidence
come from super-resolution fluorescence correlation spectros-
copy (FCS) measurements. Independent studies by two
groups employing different experimental setups suggest that
sphingomyelin and GPI-anchored proteins are transiently
trapped in small (∼10 nm) domains in the plasma membranes
of living cells and that this phenomenon is cholesterol-
dependent.500,501
There is a plethora of evidence showing that cholesterol is a
crucial player in promoting lateral heterogeneity in the plasma
membrane. It can induce the Lo phase
14 when mixed with
lipids whose chains are adequately saturated, such as
sphingomyelin (SM). Since cholesterol and sphingomyelin
are also the main components of rafts, their association with
the Lo phase is imminent, and membranes are assumed to
resemble the coexistence of Lo-like raft domains with Ld-like
regions, although with the two phases being less distinct than
in model membranes. However, the plasma membrane is an
incredibly complex entity502 with the combinations of the
various types of acyl chains and headgroups adding up to
thousands of distinct lipid moieties. This picture is further
complicated by the presence of numerous kinds of membrane
proteins, the interactions between the membrane and the actin
cytoskeleton, membrane asymmetry, and the interplay of the
two membrane leaflets with their distinct solvent environ-
ments. It is clear that understanding the phase behavior and
nanodomain-forming properties of biomembranes requires the
use of simplified model membranes with a much more limited
number of lipid types.
The phase behavior of a lipid membrane is captured in a
phase diagram, which usually maps lipid composition and
temperature to either a single phase or coexistence of two or
more phases. Constructing such a diagram requires that
Figure 18. Schematic drawing of the organization of the plasma membrane. Saturated lipids, shown in reddish colors, segregate with cholesterol to
form a domain that structurally resembles the liquid-ordered phase. Glycolipids, GPI-anchored proteins, and lipidated proteins partition preferably
into this domain, while many other membrane proteins reside in the regions outside the rafts, resembling a liquid-disordered phase. Reproduced
with permission from ref 17. Copyright 2017 Springer Nature.
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numerous points in the phase space are sampled, that is, that a
model system is set up and experimentally characterized at
each point. Therefore, realistic mixtures of thousands of lipids
are way beyond the reach of this approach. Instead, phase
diagrams have been mainly measured for synthetic liposomes
formed by two or three lipid components, one of them usually
being cholesterol (see the thorough reviews of the available
phase diagrams by Marsh,503,504 Veatch and Keller,505 and
Feigenson.506 Importantly, some cholesterol-containing lipid
mixtures show Lo/Ld phase coexistence under specific
compositions and temperatures. The domain structure can
be readily visualized using fluorescence microscopy by tagging
two molecules with distinct partitioning preference (Lo or Ld)
with different probes and locating these probes by illumination.
This leads to beautiful pictures that show micrometer-sized
domains in mixtures of either (1) two phospholipids with
different chain lengths mixed with cholesterol,507,508 (2) two
phospholipids with differing degrees of chain unsaturation
combined with cholesterol,509,510 or (3) a phospholipid with
unsaturated chains and sphingomyelin with a saturated chain
mixed with cholesterol.511,512 The common factor in these
mixtures is that one of the two types of noncholesterol lipids
has a high temperature of the main phase transition (high-Tm),
while the other has a low temperature of the main phase
transition (low-Tm). Interestingly, the demixing to two distinct
phases occurs usually at up to the ambient temperature, which
is somewhat lower than the body temperature and falls
between the values of high-Tm and low-Tm. This behavior
strongly indicates that in Lo/Ld coexistence, the role of
cholesterol is to melt the gel phase into the Lo phase, as in its
absence the mixture would exhibit gel/Ld coexistence.
However, it is still unclear how the picture of nanoscopic Lo-
like rafts in an otherwise Ld-like membrane is related to the
microscopic phase separation observed in model membranes.
Curiously, in addition to large-scale phase separation seen in
ternary lipid mixtures, some binary mixtures of cholesterol and
a lipid with saturated chains reveal heterogeneous behavior
with a resemblance to both Lo and Ld phases.
513,514 However,
no micrometer-sized phase separation is observed in such
systems using fluorescence microscopy. These observations
have recently been explained by the presence of ordered
cholesterol-rich nanodomains, whose size is below the
diffraction limit.514 These nanodomains with a size similar to
that postulated for lipid rafts could arise through multiple
physical mechanisms.515 However, the coupling of macro-
scopic phase separation and nanodomain formation is still
somewhat controversial, and this picture is further complicated
by two very recent independent reports of nanoscopic
substructures within the Lo phase of phase-separated model
membranes.516,517
One promising approach to study the phase behavior of the
plasma membrane is to induce the budding of vesicles out from
the plasma membrane of a living cell. These giant plasma
membrane-derived vesicles (GPMVs) provide a quasi-model
system: they are well fit for biophysical characterization
techniques, and their composition is assumed to be a faithful
representation of the real plasma membrane. However, they
are free of the many complexities present in vivo, such as the
actin cytoskeleton or the involvement of active processes.
Interestingly, GPMVs undergo phase separation at below
ambient temperature, while they are microscopically homoge-
neous at body temperature.518 This behavior is consistent with
that of ternary model membranes, suggesting that the latter
indeed capture the essential features of the plasma membrane.
It is unclear how well the GPMVs capture the heterogeneity
present in a plasma membrane of a living cell, notably the
absence of active processes and the actin cytoskeleton. Very
recently, a landmark study demonstrated reversible phase
separation in the vacuole of live yeast152 suggesting that these
factors cannot suppress the formation of domains. However,
contrasting results were reported on live rat basophilic
leukemia cells, which did not exhibit the miscibility phase
transition, that is, the demixing of lipids into two liquid phases
when cooled down.152
The observation that both GPMVs and synthetic liposomes
undergo phase separation only slightly below the body
temperature suggests that transient heterogeneities in the size
range postulated for lipid rafts might result from critical
fluctuations, that is, compositional fluctuations near a critical
point.519 Indeed, such phenomena have been observed for
both GPMVs520 and synthetic liposomes,521 further supporting
the use of model systems to understand the heterogeneity in
the plasma membrane.
Unfortunately, the used model systems are often composi-
tionally symmetric, which is not the case in the plasma
membrane, as discussed in section 3. Notably, while the
extracellular leaflet, rich in cholesterol, sphingomyelin, and
phosphatidylcholines with somewhat unsaturated chains, is
assumed to display heterogeneities, the intracellular leaflet, rich
in phosphatidylethanolamine, phosphatidylserine, and other
anionic lipids, all with similarly unsaturated chains, is not
expected to do so. Currently, relatively little is known about
the coupling between membrane leaflets, and it is unclear
whether domain formation in the extracellular leaflet can
induce structural heterogeneity in the intracellular one.522
Before moving on, the extensive theoretical work should also
be highlighted. Phase diagrams calculated using different
approaches reveal the physical parameters necessary for
determining whether a system undergoes phase separation,
forms nanoscopic domains, and ends up as a microemulsion or
as a modulated phase.515,523 However, these studies are not
discussed further in this review.
Concluding, recent evidence strongly supports the presence
of cholesterol- and sphingomyelin-rich nanoscopic domains in
the plasma membrane. These domains likely arise due to
critical composition fluctuations near a phase coexistence
region, which can lead to transient domain formation in a
system that is homogeneous in equilibrium. Due to this
analogy, we shamelessly refer to ordered nanodomains as being
“Lo” in the following sections, even though such structures do
not correspond to an equilibrium phase.
The limited ability of experiments to directly probe
nanoscale phenomena in soft matter has left a plethora of
questions open: What is the mechanism behind phase
separation or raft formation? How are the structures of the
two distinct plasma membrane leaflets correlated? How do the
details in lipid structures regulate the tendency to phase
separate or to form nanodomains? How do additional
molecules, such as drugs, affect the lateral heterogeneities of
the membrane? Can membrane proteins induce heterogeneity
in their environment, hence providing themselves with a
functional domain? As discussed below in detail, all these
questions have recently been subject to examination by
biomolecular computer simulations.
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4.2. Gel Phases and Transition Temperatures
To understand the complete phase behavior of mixed lipid
membranes, one has to know how single-component
membranes act under different conditions. Such membranes
already display surprisingly complex phase behavior as a
function of temperature. Our understanding of the phase
transitions between the various gel and ripple phases is largely
based on differential scanning calorimetry, while structural
information on the phases comes mainly from scattering
experiments. Contrastingly, above Tm, the liquid-disordered
phase is characterized by a plethora of experimental techniques
including NMR. Scattering techniques require a model that
estimates the lipid densities based on the measured electron
density profiles. For heterogeneous systems, such as the ripple
phase, details of the structure remain unknown. Computer
simulations are therefore highly desired to provide an atomistic
picture of membrane structure and the phase transitions in
such systems. While the various gel phases have little
importance in living cells, it is crucial that a simulation
model provides a reasonably accurate estimate for the main
transition temperature. Otherwise the model is unlikely to
correctly reproduce the phase behavior of more complex lipid
mixtures, whereas discussed abovethe Lo phase forms
when cholesterol melts the gel phase. Unfortunately, many
simulation force fields rest on a weak foundation, since they are
parametrized only to reproduce liquid phase properties.
4.2.1. Phase Behavior of Single-Component Bilayers.
Perhaps due to the difficulties in sampling the essentially
immobile gel phase, very few MD studies have probed phase
transitions involving the gel phase. Yet, these studies have
revealed how the current models struggle in capturing the
phase behavior accurately.
United-atom simulations of the melting of DPPC and DPPE
bilayers were unable to capture the formation of the ripple
phase,524 and even the gel phase structure provided by the
Berger model was partially incorrect.525 However, in another
study on DPPC bilayers using a similar model yet a larger
system size, the formation of the ripple phase was observed.526
Moreover, its structure agreed well with experimental data.
Marrink et al. studied the formation of the gel phase in
DPPC bilayers using the coarse-grained MARTINI model.527
They observed the establishment of an untilted gel phase at
temperatures below 295 K, some 20 degrees lower than the
experimentally resolved Tm of DPPC. Moreover, the lipid
chains were expected to adopt a tilted conformation, which
could be induced by adjusting the sizes of the beads therein.
However, considering the level of detail in this model, this
agreement is already quite impressive.
Rodgers et al. systematically studied the phase behavior of
phosphatidylcholine lipids with different acyl chain lengths.528
They performed temperature scans similar to those in
experimental calorimetric studies. The MARTINI model only
captured a single transition between gel and fluid phases, while
a dissipative particle dynamics model was able to reproduce all
expected phases. Notably, the melting points of lipids were
again found to be somewhat lower than in reality.
4.2.2. Phase Transitions in the Presence of Choles-
terol. Arnarez et al. performed temperature scans of DPPC
membranes with increasing concentrations of cholesterol using
the MARTINI model.529 They found that the hysteresis in the
temperature-dependence of the enthalpy vanished with
increasing content of cholesterol. This behavior is in excellent
agreement with the experimental observation that at sufficient
concentration cholesterol induces the Lo phase both below and
above Tm.
513
In contrast, a study by Waheed et al., also using the coarse-
grained MARTINI model, did not report disappearance of
hysteresis during the phase transition of DPPC even at high
cholesterol concentrations.530 While the reason for this
discrepancy is unclear, it might result from the different
cholesterol model employed in these two studies.
We note that in addition to coarse-grained models, also
modern atomistic lipid models derived to reproduce the
properties of the liquid phases struggle in describing the main
transition temperatures of lipid bilayers.531,532
Concluding, the conventional force fields have been derived
to describe the liquid phases of lipid membranes. However,
they severely struggle to capture the behavior below Tm, and
also the value of Tm itself. This limitation is of concern since
cholesterol can melt the gel phase into the Lo phase, which is
crucial for the formation of Lo/Ld phase coexistence in ternary
mixtures. This issue, including other model-related ones, is
discussed in more detail below.
4.3. Binary Mixtures of Non-cholesterol Lipids
Mixtures of two lipid moieties with different transition
temperatures due to varying levels of chain unsaturation,
different chain lengths, or different headgroups all have
relatively similar phase diagrams. At temperatures approx-
imately between the two transition temperatures, the systems
undergo a separation into gel and liquid phases with
compositions defined by the tie line. This region is of interest
since therein the inclusion of cholesterol can lead to the
separation into the Lo and Ld phases. To our best knowledge,
all bilayer-forming binary mixtures of phospholipids with a
different Tm display this somewhat ideal behavior, which leaves
very few open questions for computer simulations. However,
for the realistic Lo/Ld phase separation in ternary mixtures, it is
crucial that the properties of the gel/Ld coexistence region are
correctly captured in the same system in the absence of
cholesterol. Unfortunately, this coexistence in binary mixtures
has been studied relatively little using simulations.
Faller and Marrink studied mixtures of DLPC and DSPC in
the coarse-grained scheme.533 In a narrow temperature and
composition window, they observed the formation of Ld-like
domains in an otherwise gel phase membrane.
Pyrkova et al. studied atomistic membranes containing
different ratios of DOPC and DPPC in the Ld phase.
534 They
observed nonideal mixing in the nanoscale and postulated that
the heterogeneities might serve as seeds for the formation of
larger domains by external stimuli. Although this study did not
consider temperatures between the Tm values of DPPC and
DOPC and hence the gel/Ld coexistence, the observed
heterogeneity is likely the two-component equivalent of critical
fluctuations, where small transient domains arise near phase
coexistence.
Similar nonidealities were also observed in two coarse-
grained simulations of Ld phase membranes consisting of
DPPC and a lipid with two unsaturated chains of different
lengths.535,536
Baoukina et al. studied membranes formed by POPG,
DOPC, and DPPC, mimicking the composition of the
cholesterol-free pulmonary surfactant.537 At temperatures
below Tm of DPPC, the system displayed coexistence of
DPPC-rich gel domains in an Ld-like membrane rich in DOPC
and POPG. The former formed by a nucleation mechanism,
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and the gel domains coalesced into large ones. We see no
reason not to expect similar behavior also in a binary DPPC/
DOPC mixture below the Tm of DPPC.
Concluding, only a few studies exist to our knowledge of
binary systems with a low-Tm and a high-Tm lipid. Moreover,
these mixtures were studied at a temperature above the Tm
values of both lipid components, and therefore only transient
heterogeneities, with likely resemblance to critical fluctuations,
were observed. This observation calls for a systematic study of
the gel/Ld coexistence in a binary mixture, and the effects of
introducing cholesterol in this mixture as the third component.
4.4. Binary Mixtures with Cholesterol
The presence of cholesterol substantially complicates the phase
behavior of lipid membranes. It induces the ordering of lipid
chains with most potent effects on saturated chains.538 At large
enough concentrations in such systems, it induces the Lo
phase, both above and below the Tm of the other lipid moiety,
as long as the chains of this other lipid are saturated enough.513
Since the literature on the ordering effects of cholesterol up to
2008 has been reviewed carefully by Roǵ et al.,149 we focus
here on more recent studies. We also omit reports of
cholesterol effects on the bulk properties of the membrane.
Still, due to their systematic and extensive nature, there is
reason to mention the recent studies probing the effects of
cholesterol in binary mixtures with phospholipids with
different headgroups and acyl chains,539 and in mixtures of
sphingomyelin and cholesterol.540
4.4.1. Phospholipid−Cholesterol Interactions Arising
from Details in Cholesterol Structure. Using atomistic
(united atom) simulations, Martinez-Seara et al. discovered
that the unique ordering effects of cholesterol result from a
very distinct spatial and orientational structure that it forms
with phospholipids.541 The presence of the two out-of-plane
methyl groups in the ring structure of cholesterol was found to
be crucial for these effects. Even more importantly, a smoother
cholesterol analog was unable to induce similar ordering
patterns as cholesterol. This highlights the importance to
understand the effects arising from chemical details in sterol
structure, since based on this study it is clear that the order
induced by a sterol around it depends on the details of the
sterol structure. After all, there are ∼20 sterols, and the phase
diagrams they give rise to are sterol dependent, and also the
allosteric binding of sterols to membrane receptor proteins
depends on the details of the sterol structure.54
Garg et al. studied the solubility limits of cholesterol in
POPC and POPS bilayers in the coarse-grained MARTINI
scheme and found a good match between simulations and
scattering experiments.542
Using a set of free energy calculations combined with
theoretical predictions, Diáz-Tejada et al. evaluated the
preference of cholesterol to interact with phospholipids of
different levels of chain unsaturation.543 To this end, they
simulated binary lipid mixtures using the coarse-grained
MARTINI model. Their analyses revealed that, despite
cholesterol preferring saturated environments, the interactions
among cholesterol molecules are repulsive despite the level of
saturation of the chains of the surrounding phospholipids. This
results in a homogeneous distribution of cholesterol molecules
in the membrane plane, independent of the degree of
saturation of the phospholipid chains. Furthermore, the
spontaneous demixing resulting in a cholesterol-depleted
domain is very unlikely, as the free energy of creating such
domain was found to be high and surprisingly similar for
DPPC and DOPC lipids, yet larger for DLiPC. At low
cholesterol concentrations, entropy is behind this unfavorable
demixing, while at higher cholesterol concentrations enthalpic
effects become dominant.
4.4.2. Phase Behavior of Phospholipid−Cholesterol
Mixtures. Before moving to macroscopically phase-separating
mixtures in the next subsection, we note that simulations have
thoroughly probed the suggested heterogeneous behavior with
a resemblance to Lo and Ld phases
513 in the binary mixture of
DPPC and cholesterol.
Waheed et al. performed united atom and coarse-grained
temperature scans in a DPPC bilayer with various cholesterol
concentrations and observed no signs of domain formation
resembling neither the Lo/Ld coexistence nor the gel/Lo
coexistence.530
More recently, Zhang et al. performed a very similar study
on DPPC/cholesterol mixtures, but they sampled the phase
diagram at fixed temperatures.544 Again, no spontaneous
demixing of lipids occurred. However, in simulations starting
from cholesterol-poor and cholesterol-rich regions, no mixing
was observed at low temperatures indicating a coexistence of
gel and Lo regions, which might also result from the slow
dynamics of the gel phase. At higher temperatures, no Lo/Ld-
like heterogeneity was observed.
The third and most recent coarse-grained study of the phase
behavior of the DPPC/cholesterol mixtures was performed by
Wang et al.545 They focused more carefully on low cholesterol
concentrations and witnessed nonideal behavior in the
condensation effect in the region where experiments reported
Lo/Ld-like heterogeneity. However, no visible domains were
observed in the system, except in the gel/Lo coexistence region.
To our best knowledge, the only atomistic simulation that
has probed the phase space of the DPPC/cholesterol system
was performed by Javanainen et al.53 Within the single-phase
regions of the phase diagram, the system showed expected
behavior in line with experiments. However, within the phase
diagram region initially associated with Lo/Ld coexistence,
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the spontaneous formation of a nanodomain was observed.
The nanodomain contained a cholesterol-free hexagonally
packed core. The formation of such small domains could
explain why some experiments report Lo/Ld phase coexistence
for this system under some conditions, while fluorescence
microscopy does not detect macroscopic phases.53 Some
recent experimental and simulation studies are also in favor of
this view.514
Concluding, many simulations, mostly using coarse-grained
models, have been used to probe the phase behavior of
phospholipid−cholesterol systems extensively. However, only
one atomistic study reported heterogeneities in the form of
visible nanodomains. As such domains have been reported in
many experiments, it is worth questioning whether the
interactions between phospholipids and cholesterol are
described in sufficient detail in the coarse-grained scale.
Given that the details in sterol structure can be critically
decisive for membrane structure541 and these tiny details
cannot be easily included in coarse-grained sterol models, the
importance to validate predictions based on coarse-grained
models with atomistic simulation data is more than justified.
Yet, it is positive that the solubility of cholesterol can be
reproduced in the coarse-grained level, and the recent
cholesterol parametrization546 seems to capture the specific
asymmetry-induced effects on lateral membrane packing
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observed at the atomistic level. These details in cholesterol
structure are likely important for correctly capturing the phase
behavior of both binary and ternary mixtures.
4.5. Ternary Lipid Mixtures
As discussed above, the picture where ordered rafts float in an
otherwise disordered membrane is often associated with the
macroscopic Lo/Ld phase separation. This separation is
observed in model membranes, plasma-membrane derived
vesicles, and the vacuole of living yeast152 at temperatures
lower than the body temperature, yet not in live rat basophilic
leukemia cells.547 While higher temperatures suppress macro-
scopic separation, critical fluctuations can give rise to transient
nanoscopic domains. Moreover, the interactions with the
cytoskeleton or the nonequilibrium conditions induced by
active processes might further affect the phase and favor the
formation of nanoscopic domains instead of microscopic ones,
as demonstrated by the differences between live cells and
GPMVs.518,547 Molecular dynamics simulations have been
extensively employed to probe the factors that affect the phase
behavior of ternary mixtures. Here, we first describe studies of
homogeneous membranes with a raft-like composition. Next,
we consider studies on preformed raft-like domains, and finally
move on to simulations where spontaneous phase separation
into Lo/Ld coexistence is observed.
4.5.1. Simulations of Raft-Like Mixtures. Based on
experimental studies on both the plasma membrane and model
membranes, raft models in simulation studies usually contain
sphingomyelin, cholesterol, and a phosphatidylcholine lipid
such as POPC.548 Alternatively, sphingomyelin is often
replaced by DPPC that is more commonly employed in
model membranes, yet is scarce in the plasma membrane. The
structural and dynamic properties of raft-like ternary mixtures
have been characterized computationally in numerous
studies.549−551 Overall, these studies report tight yet
heterogeneous at nanoscale lateral structure resulting from
the favorable packing of cholesterol and sphingomyelin.
Yang et al. carefully analyzed the interactions among DPPC,
POPC, and cholesterol using atomistic simulations.552 They
considered compositions corresponding to the two phases in a
phase-separated system. In this mixture, the saturated chains
interacted most favorably with each other, whereas the
interactions between saturated and unsaturated chains were
least favored. Cholesterol was found to interact with saturated
chains favorably. These observations are in line with the
experimentally observed push−pull mechanism of lipid raft
formation.553
Using a bright approach of mixed MD/MC (Molecular
Dynamics/Monte Carlo) simulations, de Joannis et al. resolved
the relative affinities of DOPC and DPPC to interact with
cholesterol.554 They simulated the ternary mixture at different
cholesterol concentrations with a fixed chemical potential
difference between DOPC and DPPC, which demonstrated
the expected preference of DPPC toward cholesterol. More-
over, probing the DPPC/DOPC ratios at different cholesterol
concentrations and comparing the observed compositions with
experimental tie lines allowed the evaluation of the difference
in the chemical potentials of DPPC and DOPC. Here, the tie
lines were not well reproduced, which might result from the
limitations of the united atom simulation model. Moreover, no
separation into fluid and gel phases was observed in the
absence of cholesterol, even though simulations were
performed below the Tm of DPPC. This behavior likely results
from the limitations in the system size and the inability of the
used model to accurately capture the transition to the gel
phase.525
Sodt et al. simulated in atomistic detail raft-like Lo phase
membranes with compositions corresponding to the Lo phase
in a phase-separated DOPC/DPPC/cholesterol mixture.555
They observed a hexagonal substructure of saturated chains
with interstitial cholesterols and unsaturated chains. Curiously,
this structure resembles the one found for nanodomains in
binary DPPC/cholesterol mixtures.53 The structure of the Lo
phase is shown in Figure 19.
In a follow-up study, Sodt et al. considered single-phase
systems corresponding to the Lo phase composition in phase-
separated DOPC/PSM/cholesterol and POPC/PSM/choles-
terol mixtures.556 As highlighted in Figure 19, the behavior of
DOPC/PSM/cholesterol resembled that of DOPC/DPPC/
cholesterol, yet there were a few notable differences. While the
Lo phase had a hexagonal substructure with cholesterol
perturbing hexagonal ordering and the formation of a gel
phase, the interactions between PSM and cholesterol differed
from those between DPPC and cholesterol. PSM favored the
rough face of cholesterol, and their mutual association due to
hydrogen bonding broke the hexagonal ordering of lipid
chains. DPPC, however, preferred the smooth cholesterol face
instead, and the hexagonal order was perturbed by cholesterols
located at a favorable position between a saturated and an
unsaturated chain. Curiously, cholesterol favored interactions
with DOPC over PSM and DPPC in the Lo phase in DOPC/
PSM/cholesterol and DOPC/DPPC/cholesterol mixtures, yet
Figure 19. Lipid organization in the liquid-ordered phase (left
column) and in the liquid-ordered/liquid-disordered coexistence
(right column). The figure highlights the structural similarity of lipid
organization in PSM/DOPC/cholesterol (top) and DPPC/DOPC/
cholesterol (bottom) mixtures. Here, saturated lipid chains are shown
in red, unsaturated ones in blue, and cholesterol in yellow. The
hexagonal packing of the ordered regions and the partitioning of
cholesterol to domain boundaries are evident. Reprinted with
permission from ref 556. Copyright 2015 Elsevier.
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in POPC/PSM/cholesterol mixture cholesterol preferred to
interact with PSM.
Concluding, simulations of ternary lipid mixtures provide us
information on the structure of rafts and of the specific lipid−
lipid interactions underlying their formation. Such studies,
often performed at atomistic resolution where the essential
structural details are present, provide reasonable agreement
with experimental data. This finding also suggests that data
obtained from lower level models should be compared against
atomistic simulations in addition to experimental data.
4.5.2. Simulations Considering Preformed Domains.
Studying phase separation using MD simulations is currently
almost exclusive to coarse-grained simulations due to the
prolonged time and large size scales involved. However, the
behavior of preformed ordered domains in a disordered
membrane has also been studied in atomistic resolution.
Pandit et al. simulated a small Lo-like domain consisting of
SM and cholesterol and evaluated the effects of the domain
boundary on the properties of the surrounding Ld phase
formed by DOPC.557 They observed long-range perturbations
in membrane structure, yet the short simulation time due to
atomistic resolution did not allow for a proper relaxation of the
compositions of the domain and its surroundings, which leads
to an overestimation of boundary effects. In another study,
Pandit et al. studied the phase separation process in the same
ternary mixture.558 While the atomistic simulation was too
short to track the whole separation process, the role of
cholesterol in promoting domain formation was found to be its
specific positioning and orientation between DOPC and SM
molecules.
More recently, in addition to the single-phase simulations
discussed in the previous section, Sodt et al. employed
atomistic models to study Ld phase membranes with an
embedded ordered domain.555 Their structures are shown in
Figure 19. Here, the compositions of the domain and its
surroundings were realistic, as they were adjusted based on the
tie lines measured for this DOPC/DPPC/cholesterol mix-
ture.521 During the simulations. spanning multiple micro-
seconds, lipids readily exchanged between the domain and its
surroundings, yet the domain remained distinguishable
through the simulation. The hexagonal structure, also observed
in the pure Lo phase, was also present in the phase-separated
system. In agreement with the simulations by Pandit et al.
mentioned above,558 they observed cholesterol positioning at
the boundary of the domain with the smooth face of the
cholesterol ring facing the ordered domain.
As discussed above, Sodt et al. also extended their study to
mixtures containing sphingomyelin instead of DPPC and
POPC instead of DOPC.556 In the system with a preformed
ordered domain, cholesterol favored interactions with
sphingomyelin, as expected. The hexagonal structure, observed
in the pure Lo phase system was also readily visible in the
phase-separated system, even though there were also differ-
ences as discussed earlier. A snapshot of this system, shown in
Figure 19, allows for a direct comparison of the molecular level
organization in PSM/DOPC/cholesterol and DPPC/DOPC/
cholesterol membranes.
Apajalahti et al. studied the dynamics of lipids in phase-
separated DLiPC/DPPC/cholesterol and DAPC/DPPC/cho-
lesterol membranes in the coarse-grained scheme.559 As
expected, they observed the lateral diffusion to be distinctly
different in the Lo and Ld phases. However, the lifetimes of the
correlated lipid motion as lipids migrated in a concerted
manner as lipid clusters (see section 5) were quite alike in both
phases. In general, this correlation had a spatial range of about
10 nm and a lifetime of the order of a microsecond, indicating
that prolonged and extended simulations are required to study
phase-separated membranes in proper equilibrium conditions.
Concluding, atomistic studies on preformed domains can
provide information on the structure of the domain and its
boundaries as well as the lipid exchange between the domain
and its surroundings. Notably, when the composition of the
domain and its environment are in proper equilibrium, a feat
only recently achieved in atomistic resolution, the simulation
can provide insight into these questions and hence help explain
experimental findings. Indeed, we consider that the two studies
by Sodt et al.,555,556 also discussed in the caption of Figure 19,
currently provide the most detailed description of phase
coexistence available from molecular dynamics simulations.
4.5.3. Simulations That Have Captured Spontaneous
Phase Separation. The coarse-grained MARTINI model has
been commonly employed to study the phase behavior of
ternary lipid mixtures, as reviewed recently.560,561 While the
model has its limitations in describing such mixtures, discussed
in this section, it has also provided substantial insight on how
external conditions, proteins, or other molecules affect the
phase behavior and related kinetics and energetics. The
discussion below mainly considers coarse-grained studies, yet
when atomistic data exist for comparison, it is also reviewed.
Requirements for Phase Separation and Related Issues.
The seminal study by Risselada et al. a decade ago
demonstrated the spontaneous Lo/Ld phase separation of a
mixture containing DLiPC, a low-Tm lipid with two
diunsaturated chains and hence containing two kinks; DPPC,
a high-Tm lipid with two saturated chains; and cholesterol.
562
The phenomenon was reproduced in both planar bilayers and
vesicles. The two phases and their boundary region were
carefully characterized, and phase registration across the
leaflets was observed.
While this work has sparked numerous central follow-up
studies discussed extensively in this section, too, some related
methodological issues are also worth noting right away. First of
all, the use of DLiPC/DPPC/cholesterol instead of DOPC/
DPPC/cholesterol complicates comparison to experiments
since, to the best of our knowledge, the former has not been
characterized. Without the experimental phase diagram and the
tie lines, it is hard to predict the compositions of the Lo and Ld
phases in the coexistence phase. However, the phases are likely
not as exclusive as MARTINI predicts: essentially all DPPC
was observed to be in the Lo phase, whereas the Ld phase
consisted almost solely of DLiPC. As an example, experiments
in turn suggest that in DOPC/DPPC/cholesterol mixtures the
ratio of DPPC in the Lo and Ld phases is approximately two.
563
The seemingly odd choice of using DLiPC/DPPC/cholesterol
mixtures instead of DOPC/DPPC/cholesterol systems in
MARTINI simulations is discussed further in the next
subsection.
It is also worth noting that the Lo phase in many of the early
MARTINI studies on phase coexistence was extremely
ordered, almost to the level of the gel phase.546 While the
new cholesterol parameters improve the situation signifi-
cantly,546 plenty of the studies reviewed below were performed
using the original model, which hardly allows any molecules to
partition to the Lo phase.
Experiments only report Lo/Ld phase coexistence at
temperatures where the cholesterol-free mixture would exhibit
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gel/Ld coexistence, that is, below the Tm of the high-Tm lipid.
In the MARTINI model, however, the coexistence in the
DLiPC/DPPC/cholesterol mixture also takes place at
simulation temperatures above the Tm of DPPC in the
MARTINI model,528 as mentioned earlier. This discrepancy,
together with the almost exclusive partitioning of cholesterol to
the Lo phase, suggests that the phospholipid−cholesterol
interactions are somewhat imbalanced compared to reality. As
discussed earlier in this section, this error might be rooted
already in the incorrect phase behavior of single-component
membranes.
Recently, Pantelopulos et al. studied the minimum size of a
membrane required for the phase separation process.564 They
simulated DLiPC/DPPC/cholesterol membranes of different
sizes and observed that only systems with over ∼1500 lipids
showed phase separation with well-defined phase boundaries,
while many structural properties (possibly) likely converge
only in systems composed of over 10000 lipids. Interestingly,
in large enough systems, nanoscopic domains were found to
exist in a mostly phase-separated membrane.
Baoukina et al. simulated a mixture of DOPC/DPPC/
cholesterol at different temperatures.537 Notably, the DOPC
model was modified and the used model actually resembled
that of DLiPC, hence resulting in the spontaneous separation
into Lo and Ld phases. Moreover, at higher temperatures,
nanoscale heterogeneities were observed. As the temperature
was lowered, larger yet transient clusters started to form, likely
similar in nature to critical fluctuations. These clusters were
coupled between the leaflets.
Despite the limitations, however, the MARTINI model can
provide qualitative information on phase coexistence. More-
over, this information quite often seems to have predictive
value and to agree well with experiment. Therefore, even with
its shortcomings, it is currently the best model to describe
spontaneous phase separation and factors affecting it in
complex lipid mixtures at sufficiently large time and size scales.
Effect of Lipid Chain Length, Unsaturation, and
Cholesterol Content. The coarse-grained MARTINI approach
has been used to study the effects of composition on phase
behavior thoroughly. Here, we describe studies on symmetric
lipids with different chain lengths and saturation levels,
whereas the next subsection focuses on studies on the effects
of lipid chain asymmetry.
As a first striking observation on the effects of lipid
saturation on phase separation, many teams have reported
that the DOPC/DPPC/cholesterol mixture, a standard model
system in laboratory experiments, does not undergo sponta-
neous phase separation in simulations using the MARTINI
model.565−569 This finding raises the question of whether
phase separation in MARTINI occurs for the right physical
reason.
Davis et al. studied the effect of lipid chain bead types on
phase behavior and noticed that phase separation was driven
by the different Lennard-Jones interactions between saturated
and unsaturated segments of the lipid chains.565 Therefore,
phase separation in the DOPC/DPPC/cholesterol system
could be induced by changing the bead types corresponding to
the double bond region in the DOPC chains to the same types
as in DLiPC chains. Notably, another kink in the chains, due to
the second double bond in linoleic acid of DLiPC, was not
required. These findings suggest that phase separation in
MARTINI is not driven by entropy, as expected, but instead by
enthalpy.
This study was extended by Hakobyan and Heuer, who
studied the effect of chain kinks and Lennard-Jones parameters
on the phase behavior of the DLiPC/DPPC/cholesterol
mixture further.569 Interestingly, while the kinks in the
DLiPC chains were found to be less relevant for phase
separation, introducing them in the DPPC chains resulted in
random lipid mixing. Removing the kinks from the DLiPC
chains, however, resulted in its gelation and hence in the
system showing gel/Lo phase coexistence. Curiously, unlike in
the Lo/Ld coexistence of DLiPC/DPPC/cholesterol mixture,
the leaflet registration vanished in the gel/Lo coexistence.
Very recently, Carpenter et al. refined the MARTINI model
to capture the phase separation in the DOPC/DPPC/
cholesterol mixture.570 By adjusting the bonded parameters
of the CG models to match those observed in all-atom
simulations, they were able to fine-tune the phase behavior of
the pure lipid membranes, which resulted in an agreement
between the simulations and the experiments on the ternary
system. Unfortunately, this comes with a cost: the bond
lengths and the related force constants in the refined model
vary from bond to bond, hence suggesting that each lipid
should be carefully parametrized based on atomistic data,
instead of relying on universal parameters for such bonds, one
of the key strengths of the MARTINI model.
Domanśki et al. studied the effect of lipid chain length on
phase behavior using the MARTINI model.567 They
hypothesized that the shortening of the acyl chains of the
saturated DPPC lipid would lead to weaker phase separation
due to lower hydrophobic mismatch. Indeed, replacing 4-bead
chains of DPPC by 3-bead chains of DMPC, they observed the
reduction in line tension of the phase boundary. Further
shortening of the chains of the saturated lipid to two beads
resulted in the disappearance of phase coexistence and the
emergence of smaller-scale heterogeneities with a characteristic
size scale of a couple of nanometers. The effect of cholesterol
concentration on phase behavior was also studied, and
lowering of cholesterol concentration was found to result in
a systematic decrease in line tension. However, despite getting
less stable upon a reduction of the amount of cholesterol
present, phase separation was still observed even at a
cholesterol concentration of 6 mol %.
Lin et al. also studied the effect of chain unsaturation on
phase separation using lipids with symmetric chains.568 In
agreement with other studies listed above, they also observed
that DOPC/DPPC/cholesterol mixtures do not phase
separate. Replacing DOPC by either DLiPC, DAPC, or
DDPC stabilizes phase separation, and the effect is stronger
the higher the degree of chain unsaturation is. Moreover, lipids
with a higher unsaturation level interacted less with
cholesterol. This difference in behavior led to a larger order
parameter difference and height mismatch between the phases
and therefore also to an increase in line tension. The effect of
height mismatch was further studied in the DPPC/DLiPC/
cholesterol system. Replacing DPPC by DMPC with two
saturated chains, comparable in length to those of DLiPC, had
essentially no effect on phase separation indicating that it is
driven mainly by differences in lipid order instead of
membrane thickness. This finding was supported by the
absence of phase separation in a mixture of DPPC/DMPC/
cholesterol, where both phospholipids have similar affinities for
cholesterol but different chain lengths. These observations are
in disagreement with the findings of Fowler et al., who
reported stricter phase boundaries in systems with higher
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thickness mismatch of the two phases,571 as well as the findings
of Domanśki et al., who reported the decrease of line tension
upon the shortening of the DPPC chains.567 Finally, Lin et al.
also considered DDPC/DLiPC/DPPC/cholesterol mixtures at
increasing DPPC-to-DLiPC ratios.568 The Ld phase formed by
DDPC and DLiPC had a substructure where DLiPC resided at
the Lo/Ld interface, while DDPC formed the core of the Ld
phase. This peculiar organization was likely driven by the less
favorable interaction of cholesterol with DDPC than with
DLiPC. The key observations were complemented by
experiments, which showed higher mixing temperatures for a
DDPC/DPPC/cholesterol system as compared to the DOPC/
DPPC/cholesterol mixture, favoring the view that a higher
level of unsaturation of the low-Tm lipid stabilizes phase
separation.
Concluding, the effects of lipid structure and model
parameters on the stability of phase separation have been
thoroughly investigated using the MARTINI model. While the
model has its limitations, we see no reason to question the
observed trends resolved from the systematic probing of
structural features. These trends provide us with at least
qualitative information on how the plasma membrane lipidome
and changes therein could modulate domain formation.
Notably, the studies that have resolved factors dictating
whether a membrane forms nanodomains or undergoes phase
separation are of interest in the light of the raft concept. More
such studies are discussed in the next subsection.
4.5.4. Macroscopic Separation or Nanodomain For-
mation? Different Behavior of Lipids with Symmetric and
Asymmetric Chains. Experimental work suggests that when
mixed with a phospholipid with saturated chains, such as
DPPC, and cholesterol, DOPC with two unsaturated chains
induces macroscopic phase separation, whereas POPC with
one unsaturated and one saturated chain induces nanodomain
formation.506,572 Moreover, between these microscopically
separating “Type 2” and nanodomain forming “Type 1”
mixtures, quaternary mixtures with varying amounts of both
DOPC and POPC can also induce a modulated phase. This
peculiar behavior and the role of lipid chain saturation
symmetry have been extensively studied using MARTINI
simulations.
Figure 20. Factors affecting the nature of phase separation in coarse-grained simulations. (A) Morphologies of domains in DLiPC/PLiPC/DPPC/
cholesterol mixtures as a function of DLiPC/(DLiPC + PLiPC) ratio (ρ). The mixtures shown here are those with ρ = (i) 0, (ii) 0.5, and (iii) 1.
The membrane is tessellated with areas assigned to cholesterol shown in yellow, DPPC in blue, PLiPC in green, and DLiPC in red. The domain
boundaries are shown as black lines. The phase separation becomes stronger with increasing ρ. Adapted with permission from ref 573. Copyright
2015 American Chemical Society. (B) The partitioning of POPC (orange) at the Lo/Ld phase boundary. The liquid-ordered phase is formed
mainly by DPPC (cyan) and cholesterol (gray), whereas the liquid-disordered phase consists mainly of DLiPC (red). Adapted with permission
from ref 574. Copyright 2010 Elsevier. (C) The effect of transmembrane peptides on the alignment of Lo and Ld phases across leaflets in the
DPPC/PLiPC/DLiPC/cholesterol mixture. Aligned Lo phases are shown in white, aligned Ld phases in black, and nonaligned regions in gray. Here,
ρ = 0.6 (see panel A). Data are shown for (i) the peptide-free system and (ii) a system with 4 mol % WALP-23. Adapted with permission from ref
575. Copyright 2016 American Chemical Society. (D) Alignment of Lo and Ld phases across leaflets is modulated by lipid chain length. The lipid
with two saturated chains is shown in blue, cholesterol in yellow, and the lipid with two unsaturated chains in red. Here, the saturated chains were
either (i) 4 beads (corresponding to 16−18 carbons) or (ii) 5 beads (corresponding to 20−22 carbons) long. Adapted from with permission from
ref 576. Copyright 2011 American Chemical Society. (E) The alignment of Lo and Ld phases is modulated by chain interdigitation. The Lo phase is
mainly formed by DPPC (orange) and cholesterol (white), whereas the Ld phase consists of mainly DLiPC (green). The GM1 lipids (blue)
partition to the Lo phase. With a long saturated chain, GM1 perturbs the phase alignment (panel i), whereas with a shorter chains this effect
vanishes (panel ii). Adapted with permission from ref 219. Copyright 2017 Elsevier. (F) Mechanism of phase separation depends on hydrophobic
mismatch. Dark blue and red highlight regions with alignment of the lipids with two unsaturated and two saturated chains, respectively, whereas in
regions colored in light blue and red, this alignment is not present. The time evolution of the alignment is demonstrated by data measured at 0, 2, 4,
and 10 μs of simulation time. Here, DLiPC serves as the lipid with two unsaturated chains, whereas the lipid with saturated chains is either (i)
DLPC (3 beads per chain, corresponding to 12−14 carbons) or (ii) DAPC (5 beads per chain, corresponding to 20−22 carbons). Adapted with
permission from ref 571. Copyright 2016 American Chemical Society.
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The group of Gerald Feigenson employed coarse-grained
simulations to provide a detailed view of experimental findings
regarding Type 1 and Type 2 mixtures. They studied the effect
of replacing DLiPC by PLiPC on the phase behavior of the
standard DPPC/DLiPC/cholesterol mixture.573 In line with
experiments, membranes with the lipid with two unsaturated
chains (DLiPC in simulations and DOPC in experiments)
phase-separated into Ld and Lo regions, while membranes with
the lipid with one saturated and one unsaturated lipid (PLiPC
in simulations and POPC in experiments) formed transient
nanodomains. However, no modulated phases were detected in
simulations at intermediate compositions, likely due to the
limitations imposed by the flat geometry and the size of the
simulated membrane. The united-atom simulations performed
on fine-grained structures revealed fairly long-ranged perturba-
tions of membrane properties at the edge of a domain or phase.
They also carefully probed quaternary mixtures with an
increasing ratio of DLiPC to PLiPC and provided insight
into the transition from the Type 1 to the Type 2 mixture.
Interestingly, this transition was fairly sharp, and membrane
registration also rapidly increased during the transition.573 The
membrane morphologies at selected PLiPC/DLiPC ratios are
shown Figure 20A.
In a follow-up paper, combining experiments on various
quaternary mixtures with coarse-grained simulations, this
transition was concluded to take place at a fixed line tension
value.577 Here, the simulations performed at intermediate
mixtures with both DLiPC and PLiPC present revealed
complex and dynamic morphologies for the domains that did
not coalesce.
Rosetti and Pastorino evaluated the roles of lipid chain
symmetry and saturation level on phase separation using the
MARTINI model.566 They again observed that a DOPC/
DPPC/cholesterol membrane showed uniform lipid mixing,
while DLiPC/DPPC/cholesterol and DAPC/DPPC/choles-
terol mixtures spontaneously phase-separated. The phase
boundary in the latter was stricter, as was also reflected by a
2-fold increase in line tension. Mixtures with DPPC,
cholesterol, and a lipid with one unsaturated and one saturated
chain were also studied. In both PLiPC/DPPC/cholesterol
and PAPC/DPPC/cholesterol membranes, only short-scale
heterogeneity was observed. This behavior, associated with
nanodomains506,572 (see also below), was stronger in the
PAPC/DPPC/cholesterol with a higher level of unsaturation,
as expected, and it could be further strengthened by lowering
the simulation temperature.566 Curiously, in line with other
simulation studies discussed below,573 membrane registration
was only observed in phase-separated membranes.566
Domanski et al. studied the effect of lipid composition on
phase behavior in the coarse-grained MARTINI scheme.567
They observed that mixtures of PLiPC, DPPC, and cholesterol
only form transient heterogeneities with a characteristic size of
2.5 nm.
Curiously, the study by Pantelopulos et al. discussed earlier
demonstrated the possibility for the presence of small
nanodomains in a membrane under large-scale phase
separation.564 This behavior seems to somewhat disagree
with the concept of exclusively Type 1 and Type 2 mixtures.
Concluding, in line with experiments, replacing the low-Tm
lipid with two unsaturated chains by one with only one
unsaturated chain seems to favor nanodomain formation
instead of phase separation, which might have importance for
the formation of rafts with similar structural features. The
mechanism behind this behavior is discussed in more detail in
the next section.
Linactant-Induced Nanodomains. One possible mecha-
nism through which “hybrid” lipids with one unsaturated and
one saturated chain might promote nanodomain formation is
that they can partition to phase boundaries and act as a
linactant. Linactant is a two-dimensional analogy to surfactant
and is hence a molecule that reduces the line tension of an
interface, thus disfavoring the coalescence of small domains
into larger ones and all the way to microscopic phases. Hybrid
lipids reduce the line tension of phase boundaries by
partitioning efficiently into both phases and reducing their
structural dissimilarity.578 However, this picture has also been
challenged by experiments.579
This concept was studied by Schaf̈er and Marrink, who
included POPC, PLiPC, and a single-tailed lyso-PC into the
ternary phase-separating mixture of DLiPC, DPPC, and
cholesterol.574 They observed that POPC indeed preferred
the phase boundary, where it decreased the line tension,
whereas PLiPC partitioned to the Ld phase and had no effect
on the phase stability. Lyso-PC was found at the interface, yet
with its one tail, it had no significant impact on line tension. A
snapshot of the membrane with POPC present and
partitioning at the phase boundary is shown in Figure 20B.
The concept of hybrid lipids acting as linactants was studied
further by Rosetti et al.580 They simulated a mixture of DAPC,
DPPC, and cholesterol with increasing amounts of DAPC
replaced by PAPC. The DAPC/DPPC/cholesterol system
phase separated spontaneously, and PAPC was observed to
partition to the boundary, where it systematically decreased
line tension. With the thickness of PAPC being intermediate
between DPPC and DAPC, it relieved the stress resulting from
the hydrophobic mismatch.
Concluding, lipids with asymmetric chains can destabilize
phase coexistence and hence promote the formation of
transient nanoscopic ordered domains. While the plasma
membrane is exceptionally complex in composition, it is
evident that lipid chains with different saturation levels can
regulate the lifetimes and sizes of raft-like ordered domains.
Phase Behavior Affected by Proteins. The plasma
membrane is crowded with proteins,581 which has implications
on both membrane dynamics and structure. Moreover, recent
observations from single-molecule tracking experiments
suggest that cellular membranes are partitioned by actin-linked
pickets and fences, which prevents the free diffusion of lipids
and proteins.582 In this model, pickets are proteins
immobilized by their interaction with the actin cytoskeleton.
Fischer et al. simulated the DLiPC/DPPC/cholesterol
mixture in the coarse-grained scheme and examined the role
of immobile obstacles on phase separation.583 To this end,
they restrained individual DPPC lipids either in the plane of
the membrane in both leaflets or in all dimensions but only in
one leaflet. Hence, the first setup allowed undulations
perpendicular to the membrane, while they were suppressed
in the second one. Immobilized lipids prevented full phase
separation, which was otherwise observed. When fluctuations
were present, multiple domains formed in the membrane, and
they did not coalesce. Suppressing the fluctuations and
inducing immobilized lipids only in one leaflet resulted in
intermediate behavior between macroscopic phase separation
and nanodomain formation.
Domanśki et al. studied the effect of multiple tryptophan
(W)−alanine (A)−leucine (L) peptides (WALP) or one
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00538
Chem. Rev. XXXX, XXX, XXX−XXX
AX
GPCR bacteriorhodopsin on the phase behavior of ternary
lipid mixtures.567 The phase separation of the DLiPC/DPPC/
cholesterol system was not substantially affected by the
presence of a small concentration of WALP peptides or a
single bacteriorhodopsin. However, WALP peptides somewhat
stabilized the separation by increasing the line tension of the
phase boundaries, whereas a single bacteriorhodopsin did not
have such an effect. Interestingly, the presence of a large
number of WALP peptides in the PLiPC/DPPC/cholesterol
increased the size of heterogeneities from a couple of
nanometers to 6 nm, indicating critical behavior between
nanodomain formation and phase separation. This effect was
strongly concentration-dependent, as a smaller amount of
WALP peptides did not result in an impact of similar
magnitude, even though the size scale of heterogeneities was
somewhat increased.
Ackerman and Feigenson studied the effect of the presence
of WALP peptides of different lengths on the tendency of
quaternary lipid mixtures to phase-separate or to form
nanodomains.575 Here, they used the DLiPC/PLiPC/DPPC/
cholesterol mixtures from their earlier studies. They found that
shorter peptides stabilized phase separation at all DLiPC/
PLiPC ratios by partitioning to the Ld phase. However, all
peptides, regardless of their length, promoted membrane
registration. Both effects were found to be stronger for shorter
peptides and larger peptide concentrations. The differences in
phase alignment with different PLiPC/DLiPC ratios in the
presence and absence of WALP peptides are demonstrated in
Figure 20C.
Concluding, immobile objects, such as pickets, seem to
strongly destabilize phase separation, while freely diffusing
membrane-spanning objects such as peptides can promote
phase separation via the hydrophobic matching mechanism.
These two phenomena highlight the importance of considering
the effects of proteins on membrane phase behavior.
4.5.5. Interleaflet Coupling and Phase Separation
Mechanism. It is still debated whether the putative domain
formation in the extracellular leaflet of the plasma membrane
induces heterogeneity also in the cytosolic leaflet, which by
itself does not form domains or phase-separate.522 Another
critical question is whether the positioning of such domains is
coupled across the membrane leaflets, that is, whether the
membrane shows registration.522 Model membranes and
theoretical work584 have been employed to resolve these
questions, yet MD simulations can again prove to be helpful in
providing a more detailed picture of these effects.
Coupling of Membrane Properties across Leaflets.
Perlmutter and Sachs simulated an extensive set of coarse-
grained membranes based on the DLiPC/DPPC/cholesterol
mixture.576 In one of their setups, one leaflet had this phase-
separating composition, whereas the other leaflet consisted
solely of DLiPC. Curiously, phase separation in one leaflet
induced heterogeneity in the opposing leaflet, as the regions
facing the Lo phase showed increasing lipid order. When
DPPC was replaced by lipids with longer chains in the phase-
separating leaflet, this effect was strengthened due to the
further disordering of the DLiPC lipids facing the Ld regions in
the non-phase-separating leaflet. Symmetric phase-separating
membranes were also studied either with DPPC (4 coarse-
grained beads per fatty acid, corresponding to 16−18 carbons)
or with saturated lipids with longer chains (5 or 6 coarse-
grained beads per fatty acid, corresponding to 20−22 or 24−26
carbons, respectively). Surprisingly, while the most commonly
employed DLiPC/DPPC/cholesterol mixture showed strong
registration between the leaflets, strong antiregistration was
observed for other tested lipids with longer saturated chains.
This effect was also dependent on the ratios of the lipids
present in the mixtures. Snapshots of the registered and
antiregistered membranes are shown in Figure 20D. This study
highlights the role of curvature stress in membrane registration
and demonstrates that hydrophobic mismatch might have a
more significant role in interleaflet coupling instead of in
intraleaflet separation.
Tian et al. simulated asymmetric bilayers using an all-atom
model.585 The leaflets reflected the typical compositions of the
Lo and Ld phases in a phase-separating POPC/DSPC/
cholesterol mixture and were first equilibrated as parts of
symmetric bilayers. Interestingly, the leaflets retained their
properties in the asymmetric bilayer, suggesting that their
structural parameters are not mutually coupled. However, the
removal of lipids from one leaflet induced stress in the
membrane, which also affected the results in the opposing
leaflet.
Manna et al. studied the effect of long-chained GM1 lipids,
located in one of the leaflets, on the phase behavior of the
DLiPC/SM/cholesterol mixture.219 Based on lipidomics data,
such long-chained GM1 is present in the plasma membrane,586
whereas the acyl chains of other lipid types are much shorter.
The coarse-grained simulations revealed that a relatively
modest concentration of GM1 with a 30-carbon long chain
was able to perturb both the degree of phase separation and its
rate in the opposing leaflet, as well as to decrease membrane
registration. Snapshots demonstrating the effect of long-
chained GM1 on domain registration are shown in Figure
20E. These observations were suggested to have possible
implications for signaling across the plasma membrane.
Two very recent studies employing the MARTINI model
have revealed the crucial role of cholesterol for domain
registration. Weiner and Feigenson observed that the amount
of midplane cholesterol in the membrane correlates with the
tendency for domain antiregistration.587 Increasing the length
of the chains of the lipid with saturated chains resulted in the
antiregistration, in line with the results of Perlmutter and
Sachs,576 and this was coupled with an increased cholesterol
concentration in the membrane core. Moreover, similar effects
were recovered when the concentration of cholesterol was
increased. A possible explanation for the observed effect is that
the midplane cholesterol compromises the coupling between
lipid chains and hence favors antiregistration. Curiously,
midplane cholesterol most prefers to locate itself in domain
boundary regions.
Along the same lines, Thallmair et al. observed that
restricting cholesterol flip−flops in quaternary lipid mixtures
and more complex plasma membrane models resulted in a
decrease in the level of nanodomain registration.588 However,
no such effects were observed for mixtures undergoing larger
scale phase separation. The suppression of cholesterol flip−
flop had no effects on average membrane properties. Moreover,
the level of registration only decreased when cholesterol was
not allowed to partition to the membrane midplane, whereas
preventing complete flip−flops had no such effect. This finding
is in line with those by Weiner and Feigenson,587 suggesting
that the cholesterol molecules residing in the membrane
midplane are crucial for the decrease in membrane registration.
Mechanism of Phase Separation. The effect of hydro-
phobic mismatch between the lipid phases on the phase
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separation mechanism and domain registration was studied by
Fowler et al.571 They observed that in the case of a high
mismatch, phase separation and registration proceeded via an
antiregistered intermediate, which was absent in the case of a
low mismatch. These two mechanisms are highlighted in
Figure 20F. However, large membranes in all studied cases
eventually relaxed to a registered conformation, yet smaller
membranes were found to favor antiregistration. Interestingly,
the threshold for this effect lies at the putative size range of
lipid rafts.
As discussed above, phase separation in the coarse-grained
MARTINI model is driven by enthalpy.565,569 Before this
observation, Hakobyan and Heuer compared the phase
separation process of the DLiPC/DPPC/cholesterol mixture
using coarse-grained and united-atom models.589 The coarse-
grained membranes readily phase-separated during the 12 μs
simulation time, whereas the united-atom membrane displayed
only partial demixing during the 9 μs simulation. To fill this
gap, a united-atom simulation of a preformed DPPC/
cholesterol domain in a DLiPC membrane served as a model
for complete phase separation. Interestingly, when the number
of DPPC−DPPC neighbors, characterizing the degree of phase
separation, was plotted against simulation time that was scaled
based on the differences in lateral diffusion coefficients, the
phase separation kinetics seemed strikingly similar. This
finding suggests that the underlying phase separation
mechanisms are alike in both models. Indeed, the structural
parameters extracted from the united-atom system with a
preassembled domain agree reasonably well with those of the
phase-separated coarse-grained system. Even though the
mechanism seems similar, it is unclear whether the right
factors drive it. In the united-atom model, cholesterol has
special arrangements around saturated and unsaturated lipid
chains, which provides an entropic contribution to the
separation process. However, no such tendencies were
observed in the coarse-grained model supporting the idea
that phase separation is driven by enthalpy therein.
Concluding, coarse-grained simulations have demonstrated
that structural details can affect membrane registration, which
can result from at least the mechanical properties of the leaflets
or direct interactions by interdigitating lipid chains. Moreover,
the antiregistered membrane might serve as an intermediate
step on the way to registration. Most importantly, simulations
have demonstrated that the formation of a domain in one
leaflet can induce heterogeneity in the other leaflet that does
not phase separate by itself. Since the model used to
demonstrate this feature captures the essential elements of
the plasma membrane structure, this finding has significant
implications for our understanding of the structure of lipid
rafts.
4.5.6. Membrane-Partitioning Solutes Affecting
Phase Separation. The ability of specific molecules to
strengthen or weaken the phase separation has been examined
using simulations. These simulations have revealed many
possible mechanisms that are summarized in Figure 21.
Rossi et al. studied the effect of polystyrene on lipid
membranes and observed that it partitions to the Ld phase and
stabilizes phase separation.593 This study was extended to
other plastics with very different effects, either stabilizing or
destabilizing phase coexistence, based on their chemical
nature.594 The authors later continued to study some
hydrocarbon compounds and observed different behaviors
for aliphatic and aromatic molecules.590 While the former
partitioned at the phase boundary and destabilized the
separation, the latter partitioned exclusively to the Ld phase
and stabilized it. These mechanisms are highlighted in Figure
21A.
Reigada et al. studied the effects of chloroform on mixtures
of DSPC, DLiPC, and cholesterol.591 They observed that it
promotes phase registration across the leaflets via an entropic
effect, while it does not affect the phase separation kinetics or
the degree of separation within individual leaflets. This
mechanism is highlighted in Figure 21B.
In addition to partitioning into the bilayer, certain molecules
can affect membrane phase behavior by phase-dependent
attachment to the membrane surface. Moiset et al. studied the
effect of mono- and disaccharides on the phase behavior of
DPPC/DLiPC/cholesterol mixture in the coarse-grained
scheme.592 They observed that nonreducing disaccharides,
but not reducing disaccharides or monosaccharides, destabi-
lized phase separation. Interestingly, this behavior, confirmed
Figure 21. Mechanisms that stabilize or destabilize phase separation
in ternary bilayers. (A) Aromatic and aliphatic compounds have
different effects on phase separated membranes. Cholesterol is shown
in yellow, DPPC headgroups in blue, DLiPC headgroups in red, and
hydrophobic compounds in gray. Aromatic benzene partitions to the
Ld phase and stabilizes separation (panel ii), whereas aliphatic
hexadecane partitions at the phase boundary and destabilizes
separation (panel iii). Note that in panel iii, cholesterol is not fully
shown to reveal the presence of hexadecane in the Lo phase. Adapted
with permission from ref 590. Copyright 2014 Barnoud et al.
(https://creativecommons.org/licenses/by/4.0/legalcode). (B) Effect
of chloroform on domain registration. DSPC is shown in red, DLiPC
in blue, cholesterol in orange, and chloroform in green. In the absence
of chloroform (panel i), the phases are unaligned, whereas in the
presence of chloroform (panel ii), the alignment is present. Adapted
with permission from ref 591. Copyright 2015 Reigada et al. published
by the Royal Society. (C) Mechanism of disruption of phase
separation induced by surface-bound molecules. Sucrose has fewer
sufficiently large defects as biding sites in the Lo phase (panel i) than
in the Ld phase (panel ii). Therefore, the presence of sucrose favors
lipid mixing. A similar effect is not observed for smaller glucose, which
binds the Lo and Ld phases with equal magnitudes. Adapted from ref
592. Copyright 2014 American Chemical Society.
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by experiments, was explained by the differences in the surface
topology of the membrane: The membrane has more surface
defects able to accommodate nonreducing disaccharides when
no phase separation is present. Hence, in such conditions,
demixing of the phases is favored. This mechanism is
highlighted in Figure 21C.
Muddana et al. studied the phase behavior of the DLiPC/
DPPC system when cholesterol was replaced by a non-lipid
amphiphile.595 In line with experimental observations, vitamin
E destabilized phase separation, while benzyl alcohol and
Triton-X 100 stabilized it. Moreover, the MD simulations
provided an atomistic picture of the underlying mechanisms:
Vitamin E acted as a linactant, benzyl alcohol partitioned to the
DLiPC-rich phase and further decreased order therein, whereas
Triton-X showed nonspecific partitioning yet promoted
hydrophobic mismatch by thickening the DPPC-rich phase.
Concluding, the MARTINI model reveals numerous
mechanisms through which different molecules can disturb
phase separation and regulate membrane heterogeneity. The
information provided by these studies can be harnessed to
understand how the complex mixture of molecules present in
the cell membrane and its environment can affect raft
formation. Besides, these findings are essential for under-
standing how both undesired particles, such as plastic
nanoparticles, as well as desired ones, such as pharmaceuticals,
can affect membrane organization and thereby have also
implications on health.
4.5.7. More Complex Lipid Mixtures. Membranes with
a Realistic Lipid Composition. Some recent simulations have
considered even more complex membrane compositions,
mimicking the composition of real membranes. These
initiatives are partly driven by more and more lipidomics
data becoming available in the literature.
Ingoĺfsson et al. simulated a model for the plasma membrane
consisting of a total of 63 lipid moieties distributed
asymmetrically between the leaflets.596 They applied a soft
harmonic potential, modeling the interactions with the
cytoskeleton, to a fraction of the lipid headgroups. This trick
helped them keep the thickness of the water slab reasonably
thin and therefore the computational requirements reasonable.
The simulation reproduced many central phenomena
suggested by experiments. Transient nanoscopic domains,
coupled across the leaflets, were observed. While gangliosides
formed clusters in the extracellular leaflet, phosphatidylinositol
displayed similar behavior on the cytosolic side. However, the
former is likely enhanced by the artificially strong clustering
tendency of the ganglioside model.597 Finally, cholesterol
equilibrated by spontaneous flip−flops, which resulted in its
enrichment on the extracellular leaflet. Snapshots of this
complex membrane are shown in Figure 22A.
In a follow-up study, Ingo ́lfsson et al. adjusted the
composition of their plasma membrane model to match that
of brain plasma membranes,599 meaning that the levels of
polyunsaturated fatty acids (PUFAs) and cholesterol were
increased. An increase in cholesterol content orders the
membrane, while PUFAs have an opposing effect. These
effects partially cancel each other, and the behavior of the brain
plasma membrane model does not differ significantly from that
of the average plasma membrane model. However, the domain
sizes and their lifetimes were more significant in the averaged
plasma membrane. Similarly, domain registration was more
prominent therein. Interestingly, the domain size was found to
heavily depend on the undulations of the bilayer: while
suppressing undulations by harmonic restraints modeling the
interactions with a cytoskeleton resulted in a decrease in
domain size in the brain plasma membrane model, an opposite
effect was observed for the average plasma membrane model.
This finding highlights the importance of often overlooked
curvature on membrane heterogeneity. Indeed, local curvature
seems to be a crucial parameter in defining domain
registration.587,591 Moreover, the lipid sorting of the tethers
pulled from this membrane model and their subsequent
Figure 22. Small and transient domains in complex biomembranes.
(A) In a membrane with a total of 63 lipid types, GM1 (shown in red)
clusters at the outer leaflet (ii), while phosphoinositides, shown in
magenta, form small clusters in the inner leaflet (iii). Adapted with
permission from ref 596. Copyright 2014 American Chemical Society.
(B) Similar clustering of GM3 (shown in purple) in the outer leaflet
(iii) and to a lesser degree that of phosphoinositides (yellow) in the
inner leaflet (ii) in a 7-component membrane. Adapted with
permission from ref 598. Copyright 2014 Koldsø et al. (https://
creativecommons.org/licenses/by/4.0/legalcode).
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softening was observed by Baoukina et al.600 All in all, the
picture provided by these studies by Ingoĺfsson and co-workers
is currently the most comprehensive model of a protein-free
plasma membrane.
Other Complex Lipid Mixtures. The role of curvature on
lipid sorting was further evaluated by Koldsø et al., who
simulated asymmetric 7-component membranes in the coarse-
grained scheme.598 GM3 gangliosides and to a lesser degree
also phosphoinositides were found to assemble into nano-
domains, yet the former effect is again likely overestimated by
the exaggerated interactions between gangliosides in the used
model.597 The mechanism behind this clustering was found to
be dynamic curvature fluctuations, which sorted GM3 to
concave regions in the extracellular leaflet, whereas phosphoi-
nositides localized in the concave areas in the intracellular
leaflet together with cholesterol. In both leaflets, PE lipids also
partitioned to these concave regions. A snapshot of this
membrane, highlighting the clustered lipids, is shown in Figure
22B. The model of Koldsø and co-workers contained lipids
with one saturated and one monounsaturated chain, yet the
effect of the presence of lipids with two monounsaturated
chains was also evaluated. In line with the inability of such
lipids to induce phase separation within the MARTINI
model,565 no signs of large-scale lateral heterogeneity were
observed.
Guixa-̀Gonzaĺez et al. studied brain cortex tissue membranes
with compositions characteristic for healthy individuals and
individuals with neurodegenerative or mental disorders.57
These membranes contained a total of seven lipid components,
including phosphatidylcholines with saturated and monounsa-
turated chains, sphingomyelin, and cholesterol. Additionally,
SDPC with a PUFA chain, whose membrane levels are affected
by the diseases mentioned above, was present in the mixture.
In the absence of any proteins, only transient heterogeneities
were observed, as the polyunsaturated chains formed clusters
of irregular shape but were unable to undergo separation on a
larger scale.
Flinner and Schleiff considered membranes mimicking the
composition of the red blood cell.601 These membranes
contained an asymmetric distribution made up of a total of 9
different lipids of four different families, PE, PC, PS, and SM,
and with different chains. This mixture was found to show
transient domain formation and dissociation, which was found
to be driven by fatty acids. Indeed, changing all headgroups to
PC had no significant effect on lateral heterogeneity. However,
in the absence of cholesterol, no domain formation was
observed, as expected.
Concluding, coarse-grained simulations have been used to
probe very complex lipid mixtures that aim to mimic the lipid
composition of the plasma membrane. These studies have
revealed the formation of small and transient lipid clusters,
which might bear a resemblance to rafts in the plasma
membrane. However, the current paradigm views rafts not as
lipid entities but instead as lipid−protein platforms. This role
of proteins in the formation of raft-like domains is discussed in
detail in section 4.5.8.
4.5.8. Membrane Proteins Induce the Formation of
Local Domains. Instead of being purely lipid assemblies,
heterogeneity also arises from specific protein−lipid inter-
actions that shape the composition in the immediate vicinity of
a membrane protein. Such interactions were recently reviewed
by Hedger and Sansom.602 In the following, we focus on
Figure 23. Protein-induced lateral heterogeneity. (A) Lateral heterogeneity induced by membrane proteins. The gp130 TMD (i), shown in red,
gets solvated by GM3 (light blue) and PIP2 (orange). The S1P1 (ii), shown in purple, interacts favorably with PIP2 and cholesterol (green).
Adapted with permission from ref 56. Copyright 2015 American Chemical Society. (B) Preferential solvation of dopamine D2 (blue) and adenosine
A2A (red) receptors by SDPC (yellow) with a polyunsaturated chain. The other four lipid types are shown in gray. Reproduced with permission
from ref 57. Copyright 2016 Guixa-̀Gonzaĺez et al. (https://creativecommons.org/licenses/by/4.0/legalcode). (C) The formation of a Lo domain
surrounded by the influenza hemagglutinin proteins due to sterical hindrance. DLiPC is shown in dark blue, DPPC in cyan. Adapted with
permission from ref 605. Copyright 2013 Parton et al. (https://creativecommons.org/licenses/by/4.0/legalcode).
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protein-induced domains in multicomponent plasma mem-
brane models. These can form in many ways: a single protein
can alter its neighborhood by favorable interactions with
certain lipid types. Additionally, charged lipids can glue
proteins together into aggregates. Moreover, these two
mechanisms together can result in the formation of large
aggregates with specific lipid and protein compositions.
Koldsø and Sansom simulated the transmembrane domain
of the cytokine receptor gp130 in POPC membranes where a
fraction of the lipids in the intracellular leaflet was replaced by
anionic POPS.603 They observed the heterogeneous distribu-
tion of the PC and PS lipids around the gp130 transmembrane
domain, which was further affected by the presence of extra
amino acids in the gp130 structure beyond the transmembrane
domain.
In a follow-up study, Koldsø et al. included a total of 16
gp130 transmembrane domains embedded into the asym-
metric 7-component system earlier described.598 Here, the
basic amino acids, located within the intracellular leaflet, again
clustered anionic lipids, this time the PIP2 present in the
model. On the extracellular leaflet, GM3 assembled around the
gp130 transmembrane domain. Interestingly, this localization
of the GM3 and PIP2 near the transmembrane domain did not
affect the size of the lipid clusters compared to the protein-free
membranes.
In yet another study, Koldsø and Sansom simulated larger
versions of the protein-free and the gp130 transmembrane
domain-containing plasma membrane models and comple-
mented the study with a large plasma membrane model
containing multiple copies of the GPCR sphingosine 1-
phosphate receptor 1 (S1P1).56 All these membranes consisted
of more than two million MARTINI beads, making them
currently the most extensive simulations of the plasma
membrane outside of studies focusing on long-time lipid
dynamics.604 Snapshots of the membranes containing gp130 or
S1P1 are shown in Figure 23A. The earlier results for gp130
transmembrane domain were reproduced, and favorable
interactions with S1P1 were observed for cholesterol and
PIP2. These changes in local lipid composition induced by the
presence of the proteins could result in more extensive
heterogeneities through protein aggregation.
The same group also studied the effect of membrane
composition on inwardly rectifying potassium (Kir) channel
clustering.606 These channels were found to interact favorably
with PIP2, PS, and GM3 lipids, inducing heterogeneity in their
environment. However, a more detailed exploration of these
environments was omitted.
As discussed earlier in this section, in the studies of
Ackerman and Feigenson575 and Domanski et al.,567 WALP
peptides were found to promote phase separation and
membrane registration via the hydrophobic mismatch
mechanism. Especially the increase in the size of hetero-
geneities in the PLiPC/DPPC/cholesterol membranes is a
reliable indicator of protein-induced domain formation, even
though the driving force is not based on specific lipid−protein
interactions as in most of the other studies discussed in this
section.
Sharma et al. simulated the self-assembly of membranes
mimicking the composition of synaptic vesicles.607 They biased
the self-assembly protocol to induce membrane asymmetry
corresponding to experimental data. Notably, PC and SM were
located in the intravesicular leaflet, whereas the cytoplasmic
leaflet consisted mainly of PE, PS, and PIP2. Cholesterol was
present in both leaflets at equal amounts due to rapid
equilibration via flip−flops. This self-assembly was demon-
strated in the presence of a 48-residue long segment of
syntaxin-1A, which was readily embedded into the forming
bilayer. Favorable interactions between syntaxin-1A and PIP2
were observed in the self-assembled structures leading to local
heterogeneity.
Several factors (lipid composition, protein structure,
mutations, and cations) affecting syntaxin-1A clustering were
resolved in a multidisciplinary study by van den Bogaart et
al.608 In addition to pure DOPC, they evaluated syntaxin-1A
clustering in membranes where one leaflet was enriched with
either PI(4,5)P2 or PI(3)P. Moreover, PIP2 was also included
in a mixture of DOPC and DOPS. The simulations showed, in
line with experiments, that the presence of PIP2 results in the
formation of syntaxin-1A clusters, and PIP2 acts as a bridge
between the monomers.
In the study by Guixa-̀Gonzaĺez et al., described in the
previous subsection,57 the inclusion of adenosine A2A and
dopamine D2 receptors in the brain cortex tissue membranes
induced the formation of SDPC- and cholesterol-rich coronas
in their immediate vicinity. These coronas were observed to
promote receptor oligomerization with implications for their
signaling. Moreover, this oligomerization led to the formation
of protein−lipid assemblies rich in SDPC and cholesterol.
These assemblies are evident in Figure 23B, which shows a
snapshot of the simulation of an SDPC-rich membrane.
Similar enrichment by polyunsaturated fatty acids was also
observed in the environment of glycophorin A, when it was
embedded in the complex mixture corresponding to the
composition of the red blood cell plasma membrane.601 While
glycophorin A had persistent interactions with sphingomyelin
and cholesterol, it still preferred to partition into the Ld phase
together with polyunsaturated fatty acids.
In all of the examples discussed, a single protein can induce
heterogeneity in its vicinity due to specific protein−lipid
interactions. However, proteins can also affect membrane
heterogeneity in other ways. Parton et al. studied clusters of
influenza hemagglutinin proteins in a phase-separating DLiPC/
DPPC/cholesterol membrane.605 They observed that the
proteins destabilized phase separation compared to the
protein-free case. Interestingly, protein clusters were able to
sterically cage slowly diffusing DPPC lipids as compared to the
faster moving DLiPC ones. This hindrance resulted in the
formation of a Lo domain surrounded by the transmembrane
segments of the protein. A snapshot of this domain is shown in
Figure 23C.
Finally, we must highlight the major effort of Corradi et al.
to build on the multicomponent systems by Ingoĺfsson et al.596
by including 10 distinct membrane proteins in the membrane
and observing their interactions with the over 60 lipid
components.609 They observed specific interactions deter-
mined by lipid charge and chain unsaturation. Moreover,
interactions with cholesterol varied substantially between the
proteins. All these effects led to both specific direct lipid−
protein contacts as well as longer-range changes in membrane
structure characterized by thickness and curvature.
Concluding, membrane proteins can induce heterogeneity
via different mechanisms. Direct protein−lipid interactions
reshape the neighborhoods of proteins, while the coalescence
of many such lipid shells leads to the formation of larger
functional domains, especially if protein aggregation has
functional implications. Proteins can also affect heterogeneity
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via physical mechanisms, such as promoting hydrophobic
mismatch between the phases thereby stabilizing the
separation. This field will undoubtedly grow as new protein
structures become available and will likely move on to employ
even more complex lipid mixtures to resolve favorable lipid−
protein interactions. We believe that the coarse-grained
framework, introduced by Corradi et al.,609 will provide a
useful approach for such attempts.
4.6. Challenges
Our somewhat limited understanding of heterogeneity in the
plasma membrane is primarily based on experiments carried
out in live cells, plasma membrane extracts, or model
membranes. Despite these efforts, numerous details in the
plasma membrane organization remain a mystery. Recently,
both theoretical efforts and computer simulations have been
extensively employed to understand how lipids arrange in
membranes under different conditions. The progress in the
simulation field has especially benefited from the rapid
development of simulation models and computer infra-
structure. Currently, atomistic models can probe the structure
of preformed domains and their boundaries in detail. The
coarse-grained MARTINI model captures the spontaneous
separation of membrane lipids into two liquid phases. On the
basis of these possibilities, different factors affecting phase
separation have been probed by numerous groups. The studies
have revealed different mechanisms that might regulate the size
scale of heterogeneities and favor small domains in the plasma
membrane environment. Moreover, they have provided insight
on the interleaflet coupling between membrane leaflets, a
feature that is extremely hard to tackle experimentally. Coarse-
grained simulations have also probed complex lipid mem-
branes, where, in line with experiments, small and transient
nanodomains are observed. Moreover, simulations have
demonstrated how lipid−protein interactions, driven by
different mechanisms, can result in the formation of membrane
heterogeneities in the protein’s immediate neighborhood and
lead to longer-range structural perturbations.
While all these efforts have advanced the field substantially,
many challenges still remain. So far, the spontaneous phase
separation or nanodomain formation in ternary or more
complex systems has not been demonstrated using atomistic
models. While the limitations in the force fields cannot be
ruled out, the biggest reason for this is the limited simulation
time scale, which is likely in the 10−100 μs regime. Moreover,
the system sizes need to be fairly big, too.
For coarse-grained models, these scales do not usually pose a
problem, yet simulations large enough to capture multiple
coexisting nanodomains that do not coalesce or long enough to
probe the formation of transient domains in complex mixtures
are still scarce. Unfortunately, for coarse-grained models, the
issues with methodology are more severe. The MARTINI
model predicts a very sharp separation that is readily seen
when a simulation trajectory is visualized. However, tie lines
measured experimentally suggest more subtle differences in the
compositions of the coexisting phases, down to a level where it
cannot be distinguished by the naked eye. This calls for
algorithms to detect the phase coexistence, and the models
could be improved based on experimental tie lines. Moreover,
the canonical mixture of DOPC, DPPC, and cholesterol used
in numerous experiments does not phase-separate in the
standard MARTINI model. Fortunately, attempts to improve
the situation have been proposed recently.
It is also worth highlighting that to provide correct phase
behavior of ternary and more complex mixtures, the phase
behavior of the underlying single-component and binary
mixtures should be correct. This means that the melting
points should be reproduced with reasonable accuracy.
Moreover, to provide liquid−liquid coexistence upon the
addition of cholesterol, the gel−fluid coexistence should be
captured in its absence. Unfortunately, many models do not
capture the main transition points of lipids, and for the
MARTINI model, the values of Tm of high-Tm phospholipids
are drastically underestimated. It seems that phase separation
and domain formation are driven by enthalpy rather than
entropy in MARTINI. Due to the decrease in degrees of
freedom, this behavior is likely common for all coarse-grained
models. Hence, the temperature-dependence is not captured
well with the models suggesting that they are used at the
temperature in which they were parametrized. Unfortunately,
below the Tm of a high-Tm phospholipid, this might no longer
be the case.
To conclude, there are many methodological issues that
need to be solved before simulations can be considered as an
equal counterpart to experimental work. The time scales of
atomistic simulations need to be extended significantly to
probe spontaneous phase separation. As long as this task
remains too challenging, coarse-grained models are a tempting
option, given that their parametrization is critically evaluated in
the light of their shortcomings. Still, the coarse-grained models
are an indispensable tool for providing qualitative information
on phase separation and to explain experimental observations.
5. LATERAL DIFFUSION IN THE MEMBRANE PLANE:
IS IT BIOLOGICALLY RELEVANT?
Systems without internal motion are frozen, that is, crystalline.
If a system is frozen, it cannot be alive, can it? And if a system
is not alive, it is likely not relevant in a biological sense.
The process maintaining a biological system in motion is
diffusion. In biological membranes, diffusion takes place as
lipids, proteins, and the other molecules hosted by the lipid
membrane move in two dimensions in the membrane plane.
This motion, as surprising as it may be, is largely based on a
very simple phenomenon: a random walk.
The first observations of random walk were made in 1828 by
the botanist Robert Brown,610 who explored the pollen of
plants and observed that, when placed in water, the pollen
particles conducted irregular “swarming” motion that we today
call Brownian motion. Theoretically, Brownian motion
describes the motion of a colloidal particle in a liquid, resulting
from numerous random molecular collisions with tiny liquid
molecules. Each of these collisions has only a marginal effect
on the colloid. However, when the collision rate is large and
since each of the collisions leads to an exchange of momentum
between the liquid molecules and the colloid particle, the
overall effect on the colloidal particle is perceptible as a
random movement.
In biological membranes, the size of membrane-associated
proteins is much greater than the size of the surrounding
solvent and lipid particles. One can then assume that the idea
of random walks is valid for membrane proteins, too. For lipids
in a membrane, the separation of mass scales is not so obvious,
meaning that lipids move in an environment of largely identical
particles−other lipids. Given this, there is reason to assume
that the motion of lipids at time scales where they collide with
one another is not a pure random walk, but the motions of the
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lipids next to one another are somehow correlated. At long
times, when the “memory” of these time-dependent
correlations has died out, the random walk picture is expected
to emerge again. Altogether, there is an analogy from colloidal
particles to biological molecules, thus providing us with some
grounds to use the random walk concept to describe diffusion
in biomembrane systems.
Lipids and proteins use thermal energy as a driving force to
move about until they find their partners in functional
complexes. As we discuss in section 7, lipids regulate the
function of many membrane proteins. Some of the modulation
mechanisms are based on specific lipid−protein interactions,
such as allosteric binding. The allosteric binding in turn is
possible if and only if the specific lipid in question finds the
binding pocket of its protein host, and this requires diffusion to
take place. In the same spirit, for membrane protein complexes
comprised of several proteins, the formation of the functional
complex requires the proteins to diffuse in the membrane plane
until they find their partners.
It is noteworthy that the typical length scales of the domain
structures in membranes are in the 10−1000 nm range, that is,
on scales where diffusional processes can be effective on the
time scales that are relevant in biology. This can be rationalized
by considering the time needed to diffuse over a distance L in a
time scale tD. Based on dimensional analysis and the definition
of diffusion, this time scale for diffusion in two dimensions is
on average tD = L
2/(4D). Given that a typical diffusion
coefficient D for a lipid in a cell membrane is about 10−7 cm2/
s,611 the time needed to diffuse over a domain of size 100 nm is
∼250 μs, or a distance of 1 μm in 25 ms. These times are
amazingly short given that the diffusion is not driven by any
external source of energy but is fully based on thermal
fluctuations. Meanwhile, the diffusion time scales as tD ≈ L2,
which is bad news for long-range transport.
For membrane proteins, one can perform the same analysis
but with certain reservations. The diffusion coefficient
describing membrane protein diffusion depends on the actin
cytoskeleton network, the cell type, and also the cell studied
(within the same cell type) due to heterogeneities between
different cells and then obviously also on thermodynamic
conditions.612 Anyhow, using a value of ∼10−9 cm2/s that is
quite often in the right ballpark,613 one finds the diffusion time
tD to be around 25 ms for L = 100 nm and 2.5 s for L = 1 μm.
In brief, diffusion based on thermal fluctuations without an
external energy source is an exceptionally efficient means to
transport molecules and molecular complexes along the
membrane surface, if the transport takes place over a relatively
short distance. For long-range transport, this conclusion is not
as evident.
Based on this picture, it is tempting to ask whether Nature
has over evolutionary times developed strategies to compart-
mentalize and structure biomembranes on scales from
nanometers to micrometers in order to take advantage of
thermally driven diffusion. Regardless of the answer, what is
clear is that diffusion is an exceptionally important dynamic
process that renders most biological processes possible.
Here, we do not discuss topics covered elsewhere, such as
how the diffusion coefficient depends on membrane lipid
content611,614 or how anomalous diffusion contributes to
membrane functions.615 Instead, we focus on selected
questions that aim to unravel how diffusion of lipids and
proteins takes place in biomembranes as their complexity is
increased systematically.
What is the mechanism of lipid diffusion at the molecular
level? How do lipids and proteins move together in the
membrane plane? How do cellular conditions such as protein
crowding influence the diffusion process? How do the protein
networks that are bound to membrane structures affect the
diffusion rates? Are there valid theories able to grasp the
essential physics of lateral diffusion and its dependence on the
relevant thermodynamic variables?
In this section, our aim is to discuss recent computational
research that has unraveled these questions. In part, they
represent examples of the groundbreaking knowledge needed
to understand the core of the diffusion process. Further, they
highlight the profound challenge to understand the underlying
physical bases of diffusion in more and more complex
membrane environments. We close this section by identifying
a few major questions where molecular simulations would be
very helpful to understand the physical laws underlying a
number of biologically relevant dynamical processes.
5.1. Mechanisms of Lipid and Protein Diffusion in Lipid
Membranes
5.1.1. Concerted Lipid Motion. As discussed in section
5.2.1, the picture that has been an established way to think of
how lipids diffuse in a membrane has been based on the
concept of free volume pockets. For a number of years, one has
assumed based on theories developed originally for hard-
sphere colloids that lipids move in the membrane plane by
“jumping” from one position to another. First, a lipid is
assumed to reside in its cage, surrounded by other lipids in a
quite tightly packed membrane. Then, if a thermally driven
density fluctuation causes the membrane to locally expand,
thus creating more space for the lipid in question in its vicinity,
or if another lipid moves to a new position next to the lipid in
question, then the lipid can “jump” to a new position over a
distance of about its own size, that is ∼1 nm. While this picture
is appealing, it is hard to find experimental evidence that would
prove its validity.
Atomistic simulations suggested a different picture. Falck et
al.616 carried out atomistic simulations on single-component
phospholipid bilayers and inspected the lateral trajectories of
all individual lipids. Examples of center of mass trajectories
covering the last 30 ns of one of the simulations are shown in
Figure 24. The relation L2 ≈ 4Dt for the distance L traveled by
the lipid during time t, with the observed diffusion coefficient
of D = 1.5 × 10−7 cm2/s and L = 0.7 nm for the linear size of a
lipid, suggests that each lipid should diffuse over L in about 8
ns. Therefore, if jump diffusion were the predominant diffusion
mechanism, Figure 24 should show several jumps for each of
the lipids. However, most trajectories do not contain such
jumps. The trajectory labeled A in Figure 24 contains one of
the fewer than 10 rapid jump-like events that were observed in
any of the simulations analyzed in the study.
However, a detailed analysis by Falck et al.616 demonstrated
that none of these jump-like events were a real “jump”, where
the lipid in question would have migrated over its own size
when the neighboring lipids would have stayed more or less
still. Therefore, the diffusion mechanism of lipids is not based
on jumps. It turned out to be more complicated and based on
concerted motion of various lipids. Figure 25 depicts this
motion for a representative case during a period of 1 ns. The
data show that the movement of the lipids undergoing jump-
like motion is actually highly correlated with the motion of
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their neighbors’ movement; one can observe several lipids to
move as loosely defined local clusters.
The above observations are consistent with related earlier
findings by Ayton and Voth who used a coarse-grained model
to study lateral diffusion on a mesoscopic level.617 More recent
coarse-grained simulation studies by Apajalahti et al.559 are also
in agreement with the above picture and suggest the sizes of
the dynamical lipid clusters that undergo concerted motion to
be larger than ∼10 nm. Experimentally, the predictions by
Falck et al.616 have been later tested by the Unruh group using
quasielastic neutron scattering, which is the method of choice
to explore membrane dynamics over time scales on the order
of 1 ns. Their data618,619 are consistent with the concerted lipid
diffusion mechanism predicted by Falck et al.616 Similar
observations have also been made in quasielastic neutron
scattering experiments by Armstrong et al.620 and in simulation
studies by Chavent et al.621 and Starr et al.622
The simulation results therefore provide a confirmed and
validated picture for the mechanism of lateral diffusion of lipids
in membranes. In essence, lateral diffusion is not dominated by
jumps. Instead, the mechanism is based on predominately
continuous, correlated, and concerted motion of neighboring
lipids. The correlations persist over tens of nanometers,
manifesting themselves as two-dimensional flow patterns
originating from thermal density fluctuations complemented
by local momentum conservation despite the dissipative nature
of the membrane embedded in a water bath. These flow
patterns are expected to play a role in the molecular
Figure 24. Examples of center of mass trajectories for selected lipids
in the plane of a DPPC bilayer, showing the last 30 ns of the
simulation. The red inset (top left) highlights an example of how a
trajectory is expected to look like if the diffusion were jump-
dominated. The diffusion of lipids marked with A−D are discussed
further in Figure 25. Adapted with permission from ref 616. Copyright
2008 American Chemical Society.
Figure 25. Trajectories of selected lipids and their immediate neighbors during 1 ns time intervals. The red trajectory in each panel is part of the
trajectory labeled A, B, C, or D in Figure 24. For each lipid, the 1 ns interval was chosen to be the one during which the lipid migrated the longest
distance during the simulation. The blue trajectories are those of the nearest neighbors, which in practice are the lipids whose centers of mass are
within 1 nm of that of lipid A, B, C, or D at any time during the 1 ns period. The black arrows indicate the total displacements during the 1 ns
period. Adapted with permission from ref 616. Copyright 2008 American Chemical Society.
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mechanisms of several key processes in membranes, such as in
the formation of lipid domain structures, allosteric binding of
lipids with their host proteins, and exposing membrane
proteins to lateral pressure.
5.1.2. Concerted Motion of Protein−Lipid Com-
plexes. It is now clear that lipids move in a concerted fashion
as loosely defined correlated transient clusters. Then, what
happens if an integral membrane protein is embedded in the
lipid membrane? How does the protein move, and how does
the presence of the protein interfere with the lateral dynamics
of the lipids in a membrane?
These questions were explored by Niemela ̈ et al.16 using
atomistic as well as coarse-grained simulation models. In
atomistic simulations, they focused on resolving the lateral
diffusion of a voltage-gated channel Kv1.2 in a one-component
POPC membrane. As Figure 26 depicts, they found that the
protein and the neighboring lipids form a transient complex:
about 100 lipids move laterally together with the protein. On
average, these lipids close to the protein move much more
slowly than the other lipids farther away from the protein.
The study revealed that the effects on the layer of lipids in
direct contact with Kv1.2 (annular lipids) were strongest, yet a
significant slowing-down effect was observed also for several
other layers of lipids up to a distance of ∼7 nm from the
protein center of mass (about 4 nm from the lipid−protein
interface). The annular lipids as the closest neighbors of the
protein were found to be largely immobile. As the lateral
distance from the protein increased, so did also the lipid
diffusion coefficient. However, only lipids that were as far as
∼7 nm from the protein center of mass were observed to have
a diffusion coefficient that was close to the value found in a
protein-free membrane (or very far from the protein surface).16
The implications of these observations are quite exciting.
For Kv1.2 studied in the above case,16 the number of lipids
whose lateral diffusion was slowed down significantly by the
protein was about 50−100. These lipids essentially diffuse
together with the protein as a dynamic protein−lipid complex.
Given that biological membranes are highly crowded with
proteins, a typical lipid−protein ratio being roughly 50:1−
100:1,581,623 the results by Niemela ̈ et al.16 highlight an
important conclusion that in native biological membranes
there are no free lipids but they are all subject to a significant
interplay with proteins. Moving on, since in biological
membranes the average distance from the surface of one
protein to the surface of its protein neighbor is just a few
nanometers, one can conclude that in protein-crowded
membranes the membrane-mediated protein−protein inter-
actions are significant and very likely the lateral diffusion of
membrane proteins is also correlated. Further, since for
colloids such as membrane proteins the diffusion coefficient
D and the system’s viscosity η are scaled through the relation D
≈ 1/η, it is apparent that a moving protein senses a viscosity
that differs quite substantially from the one in a protein-free
membrane.
The results of Niemela ̈ et al.16 have been confirmed in a
number of other simulation studies for other protein systems,
such as aquaporin-0624 and hemagglutinin.605 Experimental
verification of this phenomenon remains to be done, since it is
not clear which technique would be appropriate to do so.
Meanwhile, theoretically the physical basis is clear. Based on
fluid dynamics, particles close to a surface do not move along
with a flow when adhesion forces are stronger than cohesion
forces. Therefore, as long as the lipid−protein attraction at the
protein surface is greater than the lipid−lipid interaction, the
velocity of the lipids next to the protein surface goes down to
zero. The size of the dynamical lipid cluster bound to the
protein therefore also depends on the relative strengths of
lipid−protein and lipid−lipid interactions, and on the shape of
the protein as it may form regions that confine lipid motion.
The take-home message of these simulation predictions is
that in protein-crowded biological membranes, the dynamics of
lipids and proteins are not two separate issues but they have to
be considered together.
5.2. Theoretical Descriptions for Lateral Diffusion in Model
Membranes
5.2.1. Free Volume Theory for Diffusion of Lipids.
Theoretical understanding of lateral diffusion in protein-free
lipid membranes is not exceptionally strong. The only
theoretical description that has received considerable attention
is the free volume theory, which was originally presented in
1959 by Cohen and Turnbull625 to describe diffusion of hard
spheres (colloids) in a liquid environment. Later, it has been
extended to describe diffusion also in lipid membranes.626−630
The free volume theory is based on several assumptions. The
main assumption is that diffusion takes place as jumps, where
the diffusing particle moves rapidly over a distance close to its
own size. This obviously requires that there is a free volume
pocket available next to the diffusing particle. Since
consideration of this process is theoretically quite tough in
any interacting many-body system, the derivation in the free
volume theory is done in a mean-field fashion in terms of the
average free volume. The diffusion coefficient D is then
described by
Figure 26. Mean lateral displacements of lipids in one of the two
membrane leaflets over a time scale Δt = 50 ns. The protein is shown
in white, and its center of mass is centered. The scale bar on the right
indicates dark blue to be characterized by very slow diffusion, and
dark red to correspond to fast lateral diffusion. The blue region
around the protein highlights the slowed-down lipids that move
together with the protein in a concerted fashion. Adapted with
permission from ref 16. Copyright 2010 American Chemical Society.
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where vf is the free volume available and v* is called the critical
volume, which represents the minimum size of the free volume
pocket required for a jump. The parameter A is a constant, and
γ is a numerical factor accounting for possible overlap of free
volume (0.5 < γ < 1).625 This description was later extended by
Macedo and Litovitz631 to account for energetic barriers that
need to be overcome in a diffusion process, thereby
complementing the above equation by an activation term.
The same idea has been applied to describe diffusion in lipid
membranes626−630 in two dimensions, for which reason the
free volume theory in this context is often called the free area
theory. The most common description of the free area theory
applied to describe diffusion of lipids in membranes is the one
discussed by Almeida et al.,626 who considered lateral diffusion
as a two-dimensional process. Then the critical volume is
replaced with a critical area, a*, above which lateral diffusion
can take place. Following the results of MacCarthy and
Kozak,628 Almeida et al.626 considered that γa* = a0, where a0
is the cross-sectional close-packed area of the lipid. The
expression for the lipid diffusion coefficient then turns out to
be
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Here δ is the distance between the neighboring lipids (“cages”
surrounded by other lipids), kB is the Boltzmann constant,
a(T) is the area per lipid at temperature T, and Ea is the
activation energy of a diffusion jump. In practice, this equation
is fitted to diffusion data to yield values for the close-packed
cross-sectional area of a lipid a0 and the activation energy Ea.
The validity of the free area theory was tested by Javanainen
et al.632 in a lung surfactant mixture of DPPC, POPC, POPG,
and cholesterol. They studied lateral diffusion of lipids in
Langmuir monolayers, where the area per lipid can be varied
systematically. Since Javanainen et al.632 also computed the
membrane-spanning close-packed cross-sectional area profiles
of every lipid type in the membrane, they were able to resolve
the value that a0 should have to render diffusion possible in the
first place.
When the free area theory was fitted to diffusion data, one
found for all lipid types an area parameter of a0 = 40 Å
2.
Meanwhile, when a0 was determined from the close-packed
cross-sectional area profiles, one found values that were smaller
and also lipid-type dependent. For cholesterol, a0 was ∼25 Å2,
and for other lipids, the values ranged from 25 to 35 Å2, with
values increasing with increasing average area per lipid.
Altogether, one can conclude that there is no quantitative
agreement; therefore, the values found by fitting the free area
theory to actual diffusion data should not be taken literally.
However, the ballpark seems to be correct.632
Javanainen et al.632 also considered the activation energy by
repeating the diffusion simulations at several temperatures.
The activation energy was then determined from the Arrhenius
(activated) form,633 resulting in the Arrhenius diffusion barrier,
EA, that is assumed to describe the rate-limiting barrier in a
diffusion process. Alternatively, pragmatically speaking, EA
describes how significantly diffusion speeds up for increasing
temperature. The Arrhenius barriers that were found were
dependent on the lipid type and the average area per lipid. At
small areas, the Arrhenius diffusion barrier ranged between 24
(POPG) and 43 kJ/mol (cholesterol). At large areas, it varied
between 18 (POPC) and 31 kJ/mol (cholesterol). These
values are close to those measured in experiments.634
Meanwhile, the diffusion activation barrier, Ea, found by fitting
the diffusion data to the free area theory was about 14 kJ/mol.
The quantitative disagreement between EA and Ea is so obvious
that clearly the activation barrier Ea in the free area theory does
not correspond to the Arrhenius barrier EA.
We are not aware of other analyses where the validity of the
free area theory would have been tested. However, one can
discuss the validity of the assumptions that are its basis. The
main assumption is that diffusion of lipids takes place as jumps.
As discussed in section 5.1.1, this is not the case. There are no
jumps. Instead, lipids undergo concerted motions where many
lipids move as loosely defined lipid clusters, and this diffusion
mechanism has been confirmed by quasielastic neutron
scattering experiments.618,619 Moving on, in the free area
theory, one assumes that a diffusing lipid is a hard rod with a
well-defined close-packed area a0, which is independent of
temperature and composition of the membrane. The results by
Javanainen et al.632 and Falck et al.635 have shown that this
assumption is too simplified. Further, in the free area theory,
the diffusing lipid needs to break loose from the interactions
with its nearest neighbors by overcoming the activation energy
Ea. The above discussion shows, however, that the
interpretation of Ea is not a simple feat. It is not clear how
Ea should be interpreted in terms of the interactions between
the lipids, ions, and water.
Concluding, the free volume theory is an appropriate
theoretical framework to consider diffusion in hard-sphere
systems such as colloids; however there is quite a bit of
convincing evidence suggesting that it is not an appropriate
approach to describe the diffusion of lipids in membranes.
The take-home message is that there is clearly room for
developing a new theory to describe lipid diffusion, not an easy
task but certainly an appealing and rewarding challenge.
5.2.2. Saffman−Delbruck Theory for Diffusion of
Membrane Proteins. In section 5.1.2, we mentioned that
for colloids the diffusion coefficient is inversely proportional to
the viscosity of the solvent hosting the colloid, that is, D ∝ 1/η.
Would it be possible to use the same relation to describe the
lateral diffusion of integral membrane proteins in a lipid
membrane environment? To some extent yes, since intuitively
this inverse coupling has to be valid. However, based on the
seminal work by Saffman and Delbrück,636 there are also other
factors influencing the diffusion of these proteins.
Saffman and Delbrück636 considered the lateral diffusion of
an individual membrane protein in a protein-poor membrane.
Instead of describing lipids in any molecular detail, they used a
continuum-level approach, where the lipid membrane was
described as a thin layer of viscous fluid, surrounded by
another, less viscous liquid. As to the protein, the key variable
is its size R measured as its lateral radius.
The Saffman−Delbrück (SD) relation for the protein
diffusion coefficient then arises as636
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where μm and μf are the viscosities of the membrane and the
surrounding fluid (typically water), respectively, h is the
hydrophobic thickness of the membrane, and γ ≈ 0.5772 is the
Euler−Mascheroni constant.
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The SD relation is currently the widely accepted paradigm
for describing protein diffusion under dilute (protein-poor)
conditions, since a number of experiments on membrane
protein diffusion have shown agreement with the SD
prediction D ∝ ln(1/R).637−639 Results of computer
simulations on membrane protein diffusion have also been
reported to be in line with the SD relation.640−642 Despite this,
fits to experimental data measured in living cells by Oswald et
al. have revealed that the values found for several of the
physical observables in the SD relation are nonphysical.639 In
particular, Oswald et al.639 concluded that the membrane
viscosity they found by fitting the diffusion data to the SD
relation was 1−2 orders of magnitude larger than the
membrane viscosity found in vitro. The interpretation of the
parameters in the SD relation can therefore be more
challenging than one might assume.
However, this is surprising given that in section 5.1.2 we
found membrane proteins to diffuse as dynamical complexes
with ∼100 lipids. Would it be possible that the protein size R
in the SD relation is not the hard-core size of the protein but
rather the size of the dynamical protein−lipid complex?
Further, since the diffusion of lipids next to a membrane
protein is slowed down to a significant degree, the membrane
viscosity sensed by the protein (and the lipids in its vicinity) is
much higher compared to the viscosity sensed by lipids far
from the protein. Intuitively, this could be consistent with the
experimental observations by Oswald et al.
Javanainen et al.55 and Jeon et al.643 considered this
possibility in molecular-scale simulations (see Figure 27
(top)). By varying the proteins, and therefore their size, they
found the simulation data for protein diffusion to match the
SD relation D ∝ ln(1/R). For the protein size R, they observed
that the fit of the simulation data to the SD equation was better
when it was made with the concerted dynamical protein−lipid
cluster, compared to the bare protein without lipids. The
radius R was then ∼1−2 nm larger than the size of the bare
protein.
Simulation results therefore suggest that the protein size in
the SD equation is not the hard-core cross-sectional lateral size
of the protein. Rather, it describes the average radius of a
protein−lipid cluster that is dynamically constrained to move
in a concerted fashion (cf. section 5.1.2). In practice, in
addition to the protein, this is expected to include a lipid
corona that is at least a few shells of lipids thick.
The appealing view that arises here is that protein motion
taking place in soft membrane systems is not just about protein
motion. Rather what happens is that proteins move as quite
massive protein−lipid clusters whose size and inertia are larger
than those of the protein alone. Biologically, this makes sense
since exploiting this strategy fosters the stability of the protein
such that its membrane microenvironment comprised of lipids
around it changes very slowly, and once the protein has
reached circumstances where it has the lipids needed for its
correct membrane partitioning and activation, these conditions
will be maintained for sufficiently long times when the protein
is doing its job.
5.3. Beyond Saffman−Delbruck: Influence of Protein
Crowding
However, cases where cell membranes would be poor in
proteins are rare. Usually the situation is quite the opposite, as
cell membranes are typically very rich in proteins.581,623,644
Obviously the diffusion of proteins and lipids slows down for
increasing protein crowding due to blocking effects that
become more pronounced with increasing protein cover-
age.56,640,644−649 However, the exciting question is, how does
the size dependence D(R) for the membrane protein diffusion
coefficient change for increasing crowding with proteins? Is the
SD relation still valid?
Figure 27 (bottom) shows the results of extensive coarse-
grained simulations of Javanainen et al.55 Intriguingly, when
protein crowding increases, there is a crossover from the SD
relation, D ∝ ln(1/R), to behavior characterized by the Stokes
law D ∝ 1/R. The change in diffusion is profound in spite of
the fact that the distribution of membrane protein sizes is
limited, ranging from the size of individual proteins (∼1 nm)
to the size of the largest protein complexes (of the order of 10
nm). In essence, while in the dilute limit the protein size does
not matter much, in crowded settings the protein size plays a
decisive role in protein diffusion. The crossover between these
highly different behaviors takes place when the lipid−protein
ratio is around 200−300, that is, for significantly smaller
protein concentrations than in native cell membranes.
The simulation results provide compelling evidence that
protein diffusion under protein-poor and protein-rich con-
ditions is distinctly different. In the dilute limit, hydrodynamics
is important, and consequently proteins of all sizes diffuse
largely at the same speed. However, in membranes crowded
with proteins, there is no space or time for the formation of
hydrodynamic modes, thus diffusion is instead dominated by
protein−protein collisions, which cause large proteins or
protein complexes to be largely immobile, while small proteins
are able to move rapidly.
5.4. Confinement by the Actin Cytoskeleton Network
The actin cytoskeleton comprises a highly dynamic protein
network regulated by a myriad of binding proteins. It is
involved in numerous cellular functions, including motility,
programmed cell death, and cell division. Given that the
Figure 27. Diffusion coefficients of integral membrane proteins (D)
versus protein/inclusion size (R). Results are shown for a polydisperse
mixture of proteins based on simulations of a coarse-grained
(MARTINI) model (colored points) and a system comprised of
two-dimensional disks (gray). The results are shown in dimensionless
units. The lines are fits to the Saffman−Delbrück relation (full line)
and the Stokes law (dotted line). (top) In the dilute case, the data
fully agree with the SD model. (bottom) In the crowded case, the
Stokes-like 1/R dependence of the diffusivity is evident. Different
colors of the markers stand for different proteins. Adapted with
permission from ref 55. Copyright 2017 American Chemical Society.
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cytoskeleton is bridged to the plasma membrane, the
cytoskeleton underlying the membrane is likely to influence
the organization of membrane proteins and lipids and
therefore also influence their lateral diffusion. This is
particularly likely for membrane proteins and their complexes
that can be quite significant in size, extending deep into the
cytosolic side of a membrane and therefore interacting with the
cytoskeleton protein network.
Due to the complexity of the cytoskeleton network and its
size, it is not a simple feat to simulate its effects on lateral
diffusion. An excellent step in this direction was carried out by
Koldsø et al.,650 who used coarse-grained (MARTINI)
simulations to study the influence of compartmentalization
caused by cytoskeletal immobilization on lateral diffusion. It
was found that it leads to reduced and anomalous diffusion of
both proteins and lipids, and this in turn was observed to result
in a reduced rate of protein dimerization within the membrane
and of migration of membrane proteins between different
compartments. The study represents a promising molecular-
scale approach for future work to explore diffusion under
complex and realistic conditions that would include the effects
of the cytoskeleton.
Partly in the same context, it would be fascinating to
understand how peripheral proteins diffuse along the
membrane surface. The physical context is here very different
from the one with transmembrane proteins, since peripheral
proteins are bound to the lipid membrane or membrane
receptors via physical, often electrostatic, forces or via linkers
that anchor them to the membrane, and the viscosity of the
solvent surrounding them is much lower compared to that in a
membrane. Recently, not much has been done, however. A
nice exception is the work by Yamamoto et al.,651,652 who
elucidated the localization and dynamics of membrane-binding
lipid recognition proteins on the (cytosolic) surface of PIP-
containing lipid bilayers. They observed that the anomalous
diffusion and long-term correlated interaction of the protein
with the membrane may contribute to an enhanced probability
of encounter with target complexes on cell membrane surfaces
and that the dynamic and transient interactions between the
protein and membrane lipids can give rise to fluctuating
diffusivity.
The scales associated with cytoskeleton-induced compart-
mentalization are large; therefore also lateral diffusion should
be considered over time and spatial scales that are far beyond
the molecular scales. A question arises whether highly coarse-
grained simulation approaches would be more meaningful to
consider lateral diffusion under these conditions compared to
molecular simulation models. Recent work by Kalay et al.
supports this view.653 They modeled the membrane as a two-
dimensional fluid composed of hard particles simulated
through MD. They showed that the diffusion sharply slows
down with increasing fraction of immobile particles. Similar
physics-based and highly simplified two-dimensional simu-
lation models have been used recently in other contexts, too,55
and there is much literature published in the 1980s and 1990s,
where models of the same type have been exploited to study
surface diffusion problems, including the work by Saxton with
lattice models for membranes.654−656 It would be highly
justified to focus for a moment on the knowledge that was then
created and use it now to develop new and simple simulation
models for considerations of membrane dynamics over large
scales. If combined with state-of-the-art techniques for the
derivation of intermolecular free energy functionals for these
coarse-grained models (using atomistic/molecular simulation
models and experimental data with, for example, force
matching and inverse Monte Carlo techniques), one could
generate simple but realistic large-scale models with reasonable
effort.
5.5. Challenges
Without lateral diffusion, cells would not function. Given this,
it may be fair to say that diffusion is a biologically relevant
process.
Computer simulation studies on lateral diffusion started
from solving the easy problems, such as, how lipid unsaturation
or the amount of membrane cholesterol influences the
diffusion rate inside a membrane domain whose lipid content
is clearly specified. These are examples of clarifying nanoscale
conditions, where diffusion can play a significant role. Further
examples of exploring diffusion in the nanoscale include
elucidation of the effects of membrane-binding peripheral
proteins on the diffusion and reorganization of lipids in a
membrane, studies of diffusion of second messengers inside a
membrane in processes such as complex I activation that
requires ubiquinone binding to the protein inside the
membrane hydrophobic core, and computational research
needed to understand the links between short-time anomalous
diffusion and the biological functions. Unraveling these
questions will need some brains, but the resources and
simulation models to do the job we mainly have already.
Meanwhile, there are numerous extremely interesting and
important research topics that also call for clarification but are
so resource-intensive that the simulation models to be used to
unravel the underlying biological processes have to be
considered very carefully. These cases are challenging because
they take place on remarkably large, often macroscopic, scales.
For instance, interpretation of super-resolution microscopy
diffusion experiments sounds like an easy task, since the scales
studied even in experiments are small. Wrong. If the
experiments are done with living cells, the membrane
environment is such a mess that bridging molecular
simulations to super-resolution microscopy experiments
requires the simulations to be done under conditions that
mimic living matter as closely as possible. To sample the
process adequately, the simulation system overall has to
describe reality to a sufficient degree. This is the reason why in
this section we have discussed diffusion in membranes of
increasing complexity. Starting from diffusion in well-defined
membrane domains at short scales, moving on to multi-
component membranes with diffusion between domains of
varying sizes, moving further on to include the effects of
proteins under crowded conditions, seeing the formation of
functional membrane protein oligomers as a result of their
diffusion, accounting for the effects of the actin cytoskeleton
network, and then understanding all this complexity under
nonequilibrium conditions with mass transport into and out of
the cell membrane, that is a challenging task. The good news is
that it will be done. The bad news is that maybe not today.
At the same time, certain practical and methodological
problems remain to be solved. One encountered problem is
sampling that is often too modest. Here, one has to keep in
mind that diffusion is well-defined only in the long-time
hydrodynamic limit. This can be a major problem especially in
the determination of the diffusion coefficient of membrane
proteins, because their diffusion is so slow that achieving the
linear behavior of the mean-squared displacement is a
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challenge in atomistic as well as coarse-grained simulations.
With coarse-grained models, another persistent problem is the
adhesive nature of membrane proteins, meaning that in
membranes, proteins tend to stick to each other too tightly.657
If the interaction is too strong, it can lead to binding that looks
irreversible at simulation times. This would alter lateral
membrane dynamics. If at the same time the dimerization of
proteins takes place at a wrong interface, then the chances for
coarse-grained simulation models to describe the dynamics of
complex formation would be compromised. More work is
needed to overcome these issues. Moving on, a number of
recent studies have investigated the significance of finite-size
effects on lateral diffusion.604,658−660 This is an issue that
should be resolved in detail especially for diffusion problems
where the dynamics takes place over large scales in a
compartmentalized system. The work by Vögele et al.604 is
an exceptionally inspirational study that demonstrates the role
of hydrodynamic interactions in finite-size effects and
consequently stresses the need to establish and use simulation
thermostats such as dissipative particle dynamics that conserve
momentum. Finally, comparison of simulation and exper-
imental diffusion data is based on the assumption that
simulations are able to mimic the conditions used in
experimental measurements, and that one understands what
actually is measured in experiments. In this context, one of the
major issues is the use of fluorescent dyes or other markers,
which, without doubt, always interfere with the membrane
dynamics. Recent simulation studies have provided new
information on how experimental conditions can be optimized
to minimize the adverse effects of probes.70,661 This
information also helps to build simulation models that bridge
simulations to experiments in the most fruitful fashion.
What is needed are game changers: simple simulation
models that correctly account for the principles of physics that
dictate system behavior under nonequilibrium conditions on
large scales in space and time and are thus able to describe
biologically relevant conditions and processes in the meso- and
macroscale.
6. MASS TRANSPORT
An essential feature of cellular membranes is their “selective
permeability” in mass transport. This term refers to a vital
property of biological membranes that lets some solutes pass
though the membrane without much resistance but prevents
others from entering or leaving the cell. The selective
permeability realized through the synergy between all
components of the membranes, ranging from lipids to proteins,
is the main determinant of mass transport, which we discuss in
this section.
Two essential features determine the transport of a certain
solute through the membrane. The first one is the electro-
chemical gradient of the solute, which depends on two
components: the difference in (i) solute concentration and (ii)
charge between the inside and the outside of a cell. The solutes
move effectively under the influence of the thermodynamic
force imposed by their electrochemical gradients. Therefore,
the electrochemical gradient of the solute determines the
directionality of its diffusion and does not depend on the
properties of the membrane. On the other hand, the
permeability of the solute depends also on the membrane,
which poses a free energy barrier against the diffusion of the
solute depending on the physicochemical properties of the
solute and the membrane. These two features, namely, the
electrochemical gradient of the solute across the membrane
and the free energy barrier imposed by the membrane, are the
determinants of passive permeability through a membrane. We
note here that membranes not only are composed of lipids but
also contain various protein and carbohydrate compounds that
are collectively involved in determining the free energy barrier
against solutes. Some proteins, for instance, act as channels
that facilitate the permeation of specific solutes, for which the
lipid phase of the membrane constitutes a large free energy
barrier.662
While the aforementioned mode of mass transport may
sometimes be facilitated by proteins, it is a passive process, as
its direction is along the electrochemical gradient and does not
need external energy. However, living cells also need to
internalize certain molecules, such as nutrients, and get rid of
others, such as waste and toxic compounds produced in the
cell. These cellular processes essentially move the solutes
against their electrochemical gradients and, thus, require
external energy. Biological membranes are equipped with
machinery that couples various sources of energy stored in the
electrochemical gradients of some molecules and ions, or
chemical bonds of molecules such as ATP to facilitate and
derive these active mass transport processes.662
Overall, biological membranes regulate and facilitate mass
transport by an intricate interplay between their various
components that may or may not require harnessing energy
from external sources. In this section, we review recent
computational studies on the role of biomembranes in mass
transport in three major modes depending on the machinery
involved in it:
• Passive nonfacilitated permeation: This route refers to
the diffusion of molecules down their electrochemical
gradient across the membrane without the help of
membrane proteins. Particularly, small hydrophobic
molecules permeate the membrane primarily via this
route.
• Facilitated transport: Most molecules cannot efficiently
pass through the membrane due to their size or
electrochemical properties. Besides, some need to be
transported against their electrochemical gradients.
Specialized membrane-associated proteins facilitate the
permeation of such molecules.
• Channel proteins: Specialized channel proteins
facilitate selective permeation of various molecules
across the membrane, including ions and water.
The cells regulate many important cellular
processes, such as signaling, via the intricate
gating mechanisms of channel proteins. Gating
requires protein conformational changes, which
can be triggered by membrane potential, ligand
binding, light, and temperature depending on the
type of the channel. Regardless of the gating
mechanism, an open membrane channel forms a
selectively permeable but continuous pathway
between the two sides of the membrane.
• Carrier proteins: Larger and more complex
molecules and those that have to be transported
against their electrochemical gradient (active
transport) require another special class of
membrane proteins, called carriers. In contrast to
channels, carrier proteins are only open to one side
of the membrane at a given time. The carrier
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facilitated transport, therefore, requires a series of
conformational changes, in which the protein
visits many conformational states. This universal
transport mechanism of carriers is called the
alternating-access model. Carriers are classified
based on the energy-coupling mechanism required
by the transport process.
• Passive transport: Not all carriers facilitate
active transport. Some are, indeed, respon-
sible for downhill permeation of large polar
molecules. Most such carriers are uniporters,
as they bind and carry one substrate at a
time.
• Secondary active transport: Some carriers
use the energy stored in the electrochemical
gradients of one or more of their substrates
to transport the other(s) against their
gradient. These carriers are called secon-
dary-active transporters, and are referred to
as symporters or antiporters, depending on
whether the substrates move in the same or
opposite directions during the transport,
respectively.
• Primary active transport: Still some other
carriers catalyze ATP hydrolysis and couple
the released energy to transport of their
substrates against their electrochemical
gradients. Due to this direct coupling with
the primary energy source, ATP, they are
called primary active transporters.
• Lipid transport facilitated by membrane transport
proteins: Both channels and carriers are integral
membrane proteins. Here, we add to these
traditional categories a group of soluble and
peripheral membrane proteins that facilitate lipid
transport between discontinuous membranes.
These proteins bind to a donor membrane
superficially to capture hydrophobic molecules
dissolved in the membrane, usually lipids. They
dissociate and carry the hydrophobic molecule
through the aqueous phase to an acceptor
membrane.
• Vesicular (bulk) transport: This mode of mass transport
involves wrapping of molecules to be transported in
vesicles. The processes are called endocytosis or
exocytosis, depending on whether the cargo is taken
into the cell or expelled from the cell, respectively. Two
common molecular processes are essential for vesicular
transport: vesicle fusion and budding. Both processes
require recruitment of various proteins, and localization
of specific lipids.
In this section, we first review the computational studies that
aimed to describe passive diffusion through the membranes,
focusing in particular on how biological membrane compo-
nents change membrane permeability. We, then, move on to
discuss facilitated transport, which has been the target of
extensive computational investigations. Although most simu-
lations have been performed in the membrane environment,
only a subset of them focused on lipids and membranes as an
active part of the transport process. We therefore limit our
discussion to this subset, aiming to categorize common lipid
interaction patterns in channels, carriers, and peripheral lipid
transport proteins. Finally, we review the recent computational
studies that have explored the bulk transport machinery
involved in vesicle fusion and budding, again concentrating on
the role of lipids and their interactions with proteins. Mass
transport through pores formed due to external factors like
electric field, ion imbalance, antimicrobial peptides, and
surfactants is not discussed in this section; extensive reviews
of these topics are given elsewhere.663,664
6.1. Passive Non-Facilitated Mass Transport through
Membranes Depends on Membrane Lipid Composition
and Phase
6.1.1. Water Permeation. Water permeation through
membranes is still not fully understood at the molecular level
due to the rarity of water permeation events observed in
unbiased MD simulations and due to inaccurate water models.
Awoonor-Williams and Rowley665 and Sinoda666 summarized
the relatively up-to-date understanding of the general features
of water permeability through the membranes. The free energy
for water permeation through a generic (DPPC) bilayer slowly
increases in the head and ester group region (0−5 kJ/mol),
followed by a steep increase from the ester group region to the
center of the bilayer (5−27 kJ/mol), slightly decreasing again
at the very center (27−25 kJ/mol). The diffusivity, on the
other hand, is reduced around the headgroup region and
increases again in the hydrophobic core.665 Qiao et al.
proposed thermal fluctuations of the potential energy as the
driving force for water permeation through the membrane.667
An accurate description of water permeation through the
membrane requires that one accounts for polarizability.
Despite its higher computational cost, the use of polarizable
force fields can provide advantages in modeling water
permeation, although this approach does not necessarily
provide estimates that are more accurate. On the other hand,
the coarse-grained MARTINI model, which provides a huge
gain in computational efficiency, appears to describe water
permeability of membranes reasonably well, although the
model lacks chemical details not only for the lipids but also for
water, as it groups four water molecules into a single bead.665
Lipid peroxidation has been shown to affect not only the
membrane physical properties but also its water permeability.
A number of computational studies have shown that water
penetrates deeper into the membranes that contain oxidized
lipids,115,117,668,669 sometimes leading to membrane dam-
age.115,117,669−671 Lis et al.671 investigated the effect of
increasing oxidation on water permeability of DOPC
membranes using MD simulations performed with a united-
atom force field. High oxidation resulted in pore formation
within the simulation time scale, leading to massive water flow
through the membrane. Nevertheless, even a low degree of
oxidation leads to increased water permeability, despite not
causing pore formation within the simulation time scales.
Predictably, the pore formation rate depends on the degree of
oxidation. Once the pore forms, though, water permeation
appears to be independent of the oxidation level.671 Lee et
al.672 simulated coarse-grained models of a membrane
composed of unsaturated lipids, cholesterol, and relatively
low concentrations of oxidized lipids. Their simulations also
captured increased water permeation without pore formation.
The increased water permeability is likely a consequence of
oxidation-induced changes in the membrane properties, such
as increasing curvature, disorder, and lateral lipid move-
ments.672 Overall, these results highlight an important
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mechanism for oxidation caused damage; that is, via interfering
with the selective permeability of biomembranes.
A common aspect of the MD studies of membranes has been
the use of flat bilayers with periodic boundary conditions.
While this is a reasonable approach and sometimes the only
affordable way to simulate the system, passive water
permeation through curved bilayers, which are biologically
relevant, remains rather unexplored. In a recent study, Su et
al.673 explored the osmotic permeability of closed vesicular
systems using coarse-grained simulations. Their results suggest
that the water flux depends on where the salt is placed. A
higher flux is observed when the salt is placed outside the
vesicle than when it is placed inside the vesicle. This is likely
due to the looser lipid structure in the former case. Moreover,
water flux increased linearly with increasing salt concentration
and vesicle surface area regardless of the position of the salt
and showed an Arrhenius dependence on temperature.673
These results suggest that curved membranes and closed
structures might exhibit different behavior than the commonly
studied flat bilayers.
Composition of the membrane determines its permeability
to water and other particles. There is a consensus that
cholesterol decreases water permeability of mem-
branes.665,674−676 Saito et al.674 attributed this effect to the
reduction of cavity density in the membrane center by
cholesterol. Their simulations of DPPC and PSM membranes
showed that higher cholesterol concentrations make these
membranes resemble each other in many physical attributes
and water permeability.674 Issack and Peslherbe676 suggested
that at higher cholesterol concentrations, not only is water
partitioning to the center of the membrane lower, but also the
free energy barriers shift outward. On the other hand,
cholesterol does not appear to influence diffusivity of water
substantially, except in the very center of the bilayer.676
Only a few computational studies has investigated water
permeation through the gel-phase lipid bilayer. Qiao and
Olvera de la Cruz667 performed atomistic simulations of DPPC
and DLPS bilayers in the liquid-crystalline and ordered gel
phases. The phase of the lipids emerged as a significant
determinant of water permeability.667 Using MD-based
permeability calculations, Hartkamp et al.677 showed that the
lipid headgroups and the acyl chain packing density
substantially affect the permeation through gel-phase bilayers.
They also investigated the effects of alcohol and emollients,
which cause nontrivial effects on the permeability.677
Research on permeation through the gel phase lipids is
physiologically very relevant, since, as a model for the skin
barrier, it carries implications on drug delivery through the
transdermal route. Ceramides are an important component of
the stratum corneum (SC) as they support its function as a
barrier. The other major components of SC are cholesterol and
free fatty acids. Das et al.680 performed one of the earliest
simulation studies of SC model bilayers, composed of
ceramides and the other main SC lipid components. Their
results showed a substantially higher barrier for water in these
fully hydrated SC models when compared to phospholipid
bilayers.680 Later, Gupta et al.681 explored the effect of
ceramide chain length on water permeability of pure ceramide
bilayers, showing that increasing chain length decreases the
water permeability.681 In another study,682 the same authors
used a more realistic SC model containing ceramides,
cholesterol, and free fatty acids. This study showed that the
Figure 28. Permeation pathways in the “bricks and mortar” model for the stratum corneum. (A) Schematic representation of the skin layers
(bottom). Adapted with permission from ref 678. Copyright 2014 Elsevier. The “bricks and mortar” model of the SC (top left) and its main
components (top right) are also shown. (B) Full- and (C) low-hydration bilayer models used in MD simulations. Adapted with permission from ref
679. Copyright 2018 PCCP Owner Societies.
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main barriers against permeation of water and many other
small molecules are at the membrane center and headgroup
region.682 Recently, Regno et al.679 explored the permeation
pathways modeling the “bricks and mortar” arrangement of the
stratum corneum (Figure 28A). They used atomistic
simulations of two types of systems: high hydration (Figure
28B), which is a regular single bilayer with a slab of water on
both sides, and low hydration (Figure 28C), which is
composed of two bilayers stacked on top of each other with
little water between layers. The membrane models contained
ceramides, cholesterol, and free fatty acids in different
compositions. While water permeates through the cholester-
ol-rich regions in fully hydrated membranes, no continuous
water pathway exists in low hydration membranes, which are
closer models for the SC skin barrier.679 This finding may
appear counterintuitive considering cholesterol’s role in
increasing packing and reducing membrane permeability.665
However, in contrast to fluid membranes, cholesterol
introduces free volume and disorder in gel-phase membranes,
enhancing their water permeability.679
6.1.2. Amino Acid and Peptide Permeation. The
titration state of the amino acid along with the lipid headgroup
and chain saturation appear to determine the mechanism and
the free energy cost of amino acid insertion into phospholipid
membranes.683−690 Protein conformational changes and
flexibility were suggested to determine the membrane
permeation of pharmaceutically important cyclic pepti-
des.691−693 Moreover, MD simulations were also used to
characterize the insertion of antimicrobial peptides into the
bacterial membranes.694−698
6.1.3. Gas Permeation. Membrane permeability of gas
molecules has been studied using both atomistic699,700 and
coarse-grained simulations701 and recently reviewed by Mayne
et al.702 Overall, the free energy profile for bilayer permeation
of nonpolar gas molecules, such as O2, CO, and NO, features a
well of about −(3−4) kJ/mol in the membrane center.699 The
profile for polar CO2, on the other hand, contains two wells of
about the same depth at the headgroup regions.699 This
suggests that nonpolar gas molecules accumulate in the center
of the membrane, while polar ones like CO2 accumulate in the
headgroup regions. Dotson et al.703 recently showed that while
cholesterol enhances oxygen diffusion in the membrane center,
it decreases the membrane’s permeability for oxygen by
reducing its solubility within the membrane.703 Although
various experimental704−706 and computational studies707−711
have implicated membrane channel proteins as potential routes
for gas permeation, permeation through the lipid phase is likely
the dominant pathway for gas permeation, since it does not
feature high barriers.
Despite their simplicity, the accuracy of models used for gas
simulations is a matter of concern. Recently, Javanainen et
al.712 evaluated 14 different models of O2 based on their ability
to reproduce available experimental data on density, heat of
vaporization, free energy of hydration, and free energy of
solvation in hexadecane. All models reproduce the trends of
these properties qualitatively, but not quantitatively. The
authors also proposed two new models that improve
agreement with experiments on the density, heat of vapor-
ization, and free energy of hydration but still fail to capture the
water−oil partitioning. These results suggest that partitioning
of oxygen and other nonpolar gas molecules into lipid bilayers
may require including electronic polarizability explicitly.712
Cholesterol appears to modulate the permeability of
membranes to gas molecules as well. The eye lens, in
particular, is exceptionally rich in cholesterol. The cholesterol
content of the lens has been suggested to prevent cataract
development by maintaining a low oxygen partial pressure in
the lens. Plesnar et al.713 performed atomistic MD simulations
to estimate the permeability of model membranes with three
different compositions to O2. Placing 200 O2 molecules in the
bulk aqueous phase, they simulated a pure cholesterol bilayer
and a 1:1 POPC/cholesterol mixture, both of which model
cholesterol bilayer domains detected experimentally in the eye
lens, as well as a pure POPC bilayer as a control. They
estimated the permeability coefficient from the position-
dependent concentration and diffusion constants as previously
proposed by Subczynski et al.714 (We refer the reader to
section 6.1.5 for an extended discussion on the methods to
estimate the permeability coefficient from MD simulations.)
The simulation study by Plesnar et al.713 confirm that
cholesterol enhances the barrier against O2 diffusion. In the
pure cholesterol bilayer, which was used as a model of the
experimentally detected pure cholesterol bilayer domains in
the eye lens, the permeability was estimated to be almost 10
times smaller.
6.1.4. Small Molecule Permeation. Understanding the
molecular mechanisms underlying small molecule permeation
through biological membranes is important for pharmaceutical
and health purposes. Particularly, accurate and high-through-
put methods for estimating thermodynamic and dynamic
quantities related to small molecule permeation may aid in
drug design. On the other hand, universal rules are hard to
establish in this context due to the vast diversity of drugs and
lipids.
Many studies have been performed to derive general features
and interaction types that determine the membrane perme-
ability for various groups of small molecules, such as β-blocker
drugs,715 lipophilic drugs,716 and antibacterial hydrophobic
molecules.717 We recommend a recent review by Lopes et
al.718 on drug−membrane interactions for an extensive survey
of experiments and simulations.
Cholesterol has been shown to increase the barrier for small
molecule or drug permeation in many computational studies
including those on the anticancer drugs, such as doxorubi-
cin,719 5-FU,720 and ibuprofen,721 likely due to increased lipid
packing as in the case of water permeability.674 However, this
phenomenon is not universal. For example, while cholesterol
impairs the membrane permeability for the hydrophilic cancer
drug pirarubicin, its effect for the hydrophobic ellipticine,
another cancer drug, is negligible.722 This is likely because
hydrophilic pirorubicin brings water to the membrane core, for
which the free energy cost increases with cholesterol
concentration.722
6.1.5. Estimation of Passive Permeability of Solutes
from Simulations. The solubility−diffusion model relates the
passive permeability to free energy and diffusivity along the
membrane normal making it possible to estimate the
permeability coefficients from simulations.665 On the other
hand, passive permeability calculations have always been a
challenge, as they require calculating both the free energy and
diffusivity. Improving efficiency without losing accuracy has
been the goal in many computational studies. Below, we briefly
summarize recent advances in this area, pointing out the
essential physical and chemical contributions to permeability
and the bottlenecks in its estimation.
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As mentioned earlier, passive permeability calculations
require estimating two position dependent quantities, the
diffusivity and the free energy (or the potential of mean force
(PMF)), each of which are challenging in themselves.
Recently, statistical methods based on maximum likelihood
and Bayesian inference have been developed to estimate
diffusivity.723−725 Lee et al. systematically assessed various
methods for estimating PMF profiles and the position-
dependent diffusivities from MD simulations to calculate the
rate of permeation using the inhomogeneous solubility-
diffusion model. They concluded that all tested enhanced
sampling methods (umbrella sampling with and without replica
exchange, adaptive biasing force with single and multiple-
walkers) for PMF estimation are comparable in accuracy. The
diffusivity estimates appear to be sensitive to the choice of
parameters in both tested methods, one based on generalized-
Langevin and the other on Bayesian inference. Interestingly,
the permeability only requires calculating the PMF and the
diffusivities at the water−membrane interface and at the
membrane center.723 This technical finding reveals the location
of essential interactions that determine the permeability.
Nitschke et al. further suggested that membrane permeation
PMFs are robust, and calculations can be speeded up using
smaller systems, shorter cutoffs, and multiple solute molecules
simultaneously.726
Votapka et al.727 derived a variant of the inhomogeneous
solubility-diffusion model as a function of the mean first
passage time. This variant allows the use of milestoning
methods to estimate the mean first passage time of membrane
crossing and the permeability.727 Dickson et al.728 suggested
that the permeation rates depend on the kinetic rate constants
of three steps: membrane entry, flip−flop at the center, and
membrane exit. Kinetic rate constants of each step estimated
from MD simulations were used to build a structure-kinetic
relationship. This model suggested that the changes in
desolvation and hydrogen bonding for leaving the membrane
determine the rate of flip−flop, while membrane partitioning
determines the rate of membrane exit.728
Common sampling errors in permeation of small molecules
through the bilayers were suggested to originate from “hidden
sampling barriers” at the headgroup region and from the
bending modulus of the membranes. Besides, the estimates
exhibit strong dependence on the initial configuration of the
system.47,729 Neale et al.730 suggested coupling umbrella
sampling windows via Hamiltonian exchange to eliminate
systematic sampling errors and achieve fast statistical
convergence. Comer et al.725 put forward slow orientational
relaxation as a potential source of error and, to circumvent it,
included explicit sampling of the orientation of small
molecules.
Filipe et al.731 assessed various formalisms for obtaining rate
constants from MD simulations concentrating on a physiolog-
ically interesting application: translocation of cholesterol across
bilayers. They compared the translocation rates obtained from
explicit events in long unrestrained simulations with the
estimates obtained with these formalisms. They also derived a
new procedure that uses time intervals between transitions
based on the explicit relaxation frequencies method. The
authors conclude that while most formalisms result in fair
estimates, the method based on explicit relaxation frequencies
outperforms them and is the most reliable. Although the
method requires complementing biased simulations with many
unbiased simulations initiated at the transition state and is not
computationally cheap, it eliminates a degree of uncertainty by
not requiring depth-dependent transverse diffusion coeffi-
cients.731
Overall, the new developments along with various
simplification schemes have made it easier and more reliable
to calculate permeability of small molecules through lipid
bilayers. Important contributions appear to arise at the water−
membrane interface and at the center of the bilayer. The slow
degrees of freedom, such as orientation relaxation, appear as a
major source of sampling error.
6.2. Lipids Modulating Membrane Protein Structure,
Function, and Dynamics in Facilitated Transport
Evidence has been accumulating on the regulation of
membrane transport by membrane lipids directly through the
site-specific protein−lipid interactions and indirectly through
the physical properties of membranes. These effects were
termed “ligand-like allosteric modulation” and “hydrophobic
mismatch-driven modulation” in a recent review by LeVine et
al.732 We group the latter within the allosteric effects of
membrane’s physical properties, which also includes lateral
tension, surface pressure, curvature, etc. Indeed, many channels
and transporters cocrystallized with detergents or lipids (Table
2) support the idea of an integral role of site-specific protein−
lipid interactions. Mechanosensitive channels, on the other
hand, directly exemplify how channels respond to physical
properties of membranes.733 Protein−lipid binding appears to
manifest commonalities across various membrane transport
protein families in characterized structures and support
function by linking functional units, improving overall stability
as well as the stability of different functional conformational
states.734 MD simulations have provided extensive insights into
protein−lipid interactions in various types of membrane
proteins including membrane channels and transporters.602,735
Especially, cholesterol has been established as a key molecule
for modulation of various types of channels and trans-
porters.736
6.2.1. Channels: The Gatekeepers in Facilitated
Diffusion Are Actively Modulated by Membranes. One
of the topics that has received considerable attention in
simulation studies of transport across lipid membranes is the
diffusion facilitated by numerous channels. Given this, we here
discuss the progress in this field quite extensively.
Aquaporins: The Water Channels. Aquaporins are trans-
membrane channels that facilitate the conduction of water and
other small molecules across cell membranes. Among the
membrane proteins characterized structurally to date, aqua-
porins form the group that is the most extensively studied
through MD-based methods. Water permeation via aquaporins
has been studied and reviewed over the last two decades
shedding light to the selectivity and gating mechanisms.737−749
Despite accumulated experimental evidence on the potential
role of lipids and membrane properties modulating aquaporin
activity,750 there are only a few computational studies on this
aspect.
Using multiscale simulations, Stansfeld et al. investigated
lipid interactions with all aquaporins whose structures were
known at the time. Although the simulations did not identify
highly specific lipid binding sites, they showed common lipid
interaction patterns across the studied proteins. Moreover, the
annular lipids surrounding the protein appear to be fluid,
exchanging frequently with the bulk lipids rather than being
tightly associated with the protein surface.751
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Electron crystallography of aquaporin-0 (AQP0) charac-
terized annular lipids that surround AQP0. Aponte-Santamariá
et al.624 evaluated the structure and the dynamics of the
annular lipids using atomistic MD simulations on a system
consisting of AQP0 embedded in a DMPC bilayer. They
further assessed the consistency between MD-generated lipid
conformations with the electron crystallography data. The
results suggested that the annular lipids are similar in MD
simulations and electron crystallography.624 In agreement with
the results of Stansfeld et al.,751 there seems to be no specific
lipid binding. The differences in protein mobility on the
extracellular and intracellular sides appear to lead to
asymmetry in the degree of localization of lipids in each
leaflet, with the more flexible residues on the intracellular side
hindering lipid localization in the intracellular leaflet.
Furthermore, lipid positions are determined by packing of
the acyl chains against the rough surface of the protein and the
effect of the protein on lipid behavior extends beyond the first
lipid shell.624
Later, Briones et al.752 studied the dependence of the
localization and ordering of annular lipids around the AQP0 on
the temperature, lipid phase, and protein flexibility using
atomistic MD. They simulated DMPC-embedded AQP0 in
various conditions to control protein and lipid flexibility. The
authors demonstrated that the restricted protein flexibility due
to restraining its heavy-atom positions enhances lipid local-
ization and ordering around the AQP0. On the other hand,
decreased lipid motion, probed in gel-phase DMPC simu-
lations, did not affect the lipid localization. The authors
suggested that the annular lipids provides a compensatory
mechanism against the hydrophobic mismatch (Figure 29).
Aquaporin was also observed to induce local fluid and gel-like
areas, which was proposed as a potential mechanism driving its
interactions with other membrane components.752
Mechanosensitive Channels: Prime Examples of Protein
Modulation by Physical Properties of the Membrane and
Site-Specific Interactions with Lipids. The interaction
between the large conductance mechanosensitive ion channel
(MscL) family and the bacterial membranes is a prime example
of the crosstalk between lipids and proteins as they modulate
each other. MscLs are mechanosensitive channels activated by
membrane tension. That is, they open in response to osmotic
shock, releasing the built-up osmotic pressure by discharging
ions, water, and even small proteins.753 Thus, MscLs constitute
an essential survival kit for bacteria. These channels are
particularly interesting in terms of interactions between
biomembranes and proteins as they not only manifest site-
specific interactions with the membrane lipids but also react to
the physical properties of the membrane.
Many computational studies on MscL have concentrated on
studying how the physical properties of the membranes change
MscL activity as a part of its function.754−758 Samuli Ollila et
al.759 estimated the mechanical energy change during channel
gating using coarse-grained MD simulations of the open and
closed states of MscL in a DOPC bilayer. They decomposed
this free energy into contributions arising from the area
dilation of the membrane and the protein shape change. Their
results suggest that the protein adopts different conformations
by expanding at the water−lipid interfaces based on the
pressure profile of the membrane.759 Coarse-grained simu-
lations of MscL embedded in pressurized liposomes by
Louhivuori et al.760 captured the spontaneous activation and
deactivation of MscL. Channel opening appeared to proceed
asymmetrically in contrast to the symmetric “iris-like” opening
model. The study captured the release of liposomal stress in
sub-millisecond time scales upon MscL activation.760 Interest-
ingly, Mukherjee et al.761 showed that L-α-lysophosphatidyl-
choline (LPC), an inverted cone-shaped amphipathic lipid
with a single acyl chain, can activate MscL in the absence of
lateral bilayer tension. Found in small amounts in the cell
membrane, LPC does this likely by affecting the interfacial line
tension between the protein and the bilayer.761
The site-specific interactions with lipids and how they may
be involved in the activation mechanism of MscL have also
been characterized in various studies.762 Vanegas and
Arroyo763 studied the mechanism of force transduction
mediated by protein−lipid interactions using MD simulations.
According to this study, the asymmetric distribution of stress
on the protein surface concentrating on the cytoplasmic side
exerts outward forces on the protein. This force pattern
appears to arise from interactions between the lipid head-
Figure 29. Membrane thickening near the AQP0 surface. (A) AQP0
monomers from the top and side views. (B) Average interphosphate
thickness (ThkP−P) and (C) average hydrophobic distance
(Thkhydrop) around AQP0 tetramer. The average ± standard
deviation of the thickness values for a pure DMPC bilayer at 310 K
(fluid-phase, Lα) and at 280 K (gel-phase, Lβ) are indicated on the
color bars. Reprinted from ref 752. Copyright Briones et al. (https://
creativecommons.org/licenses/by/4.0/legalcode).
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groups and a protein motif that contains lysines. Interestingly,
similar motifs exist in the human mechanosensitive channel
K2P1 and bovine rhodopsin.763 Atomistic simulations of
Sawada et al.764 pointed out a particular phenylalanine (F78)
as the tension sensor based on its strong interaction with
membrane lipids. Coupling between membrane tension and
gating involves the first two transmembrane helices.764 An
experimental study supported by atomistic MD implicated the
amphipathic N-terminal helix of MscL in stabilizing the closed
state and coupling the channel to the membrane through a
tension-induced gating mechanism.765
The related mechanosensitive channel of small conductance
(MscS) has also been investigated computationally.766−769
Lipid−protein interactions in the mechanosensing mechanism
of MscS were suggested to play a crucial role. Mutagenesis
combined with MD simulations identified the membrane
tension sensor region of MscS as two transmembrane helices,
where several residues specifically interact with the lipids in a
conformational-state-dependent manner.770 Overall, the
coarse-grained and atomistic simulations implicate specific
lipid−protein interactions to be involved in mechanosensitive
channel function.
Voltage-Gated Potassium Channel Function is Modu-
lated by PIP2 and PUFAs. The voltage-gated potassium (KV)
channels control electrical signal propagation in nerves, muscle
contraction, and hormone secretion.771 Apart from being
important membrane channels, they constitute the third largest
signaling protein family.772 They switch between open and
closed conformations tuning K+ flux in response to changes in
the voltage across the cell membrane. Recently, lipid motion
between different binding sites on the protein surface has been
implicated in the modulation of channel function. Chen et
al.773 combined MD simulations with mutagenesis and
electrophysiology experiments to identify the PIP2 interaction
sites on the KV channel KCNQ2. The simulations captured
PIP2 binding to the S4−S5 linker and infrequent migration to
the S2−S3 linker from the S4−S5 linker. This migration was
linked to deactivation kinetics and appeared to depend on the
functionally important basic residues on the linker.773 Yazdi et
al.774 employed atomistic MD simulations to explore
interactions of the Shaker KV channel in the open and closed
states with polyunsaturated fatty acids (PUFAs). The
simulations showed that the open state of the channel is
stabilized by PUFA interactions with helices S3 and S4 of the
voltage-sensing domain and the linker connecting them. The
larger conformational flexibility of PUFAs likely allows them to
adapt to the channel surface. In contrast, both PUFAs and
saturated lipids interacted less with the closed state of the
channel.774 Moreover, a small-molecule binding site deter-
mined at the interface between the bilayer and helices S3 and
S4 by combined MD and experimental approaches775 supports
the role of this region for lipid−protein interactions.
Other Channels. Since the structural characterization of the
K+ channel by the team of MacKinnon,776−778 channels have
been extensively studied using computational methods for
various mechanistic features including their gating and
selectivity.779−782 Henin et al.783 identified cholesterol binding
sites in intersubunit cavities of the pentameric ligand gated ion-
channel GABAAR transmembrane domain using homology
models of a human GABAAR and suggested a cholesterol-
induced pore opening mechanism.783
6.2.2. Carriers: Facilitators of Primary and Secondary
Active Transport. Carrier proteins are involved in both
passive and active membrane transport. Due to their central
role in these processes, they have been the targets of extensive
structural characterization efforts. Regardless of their energy
coupling mechanism, carrier proteins go through a transport
cycle (Figure 30, the dark green region). The transport cycle
has long been suggested to involve a common mode, called the
alternating-access model.784−786 In essence, this model asserts
that the binding site of the carrier is only accessible from one
side of the membrane at a given time. This is achieved by the
carrier protein going through several conformational states
usually referred to as inward-facing (IF) or outward-facing
(OF) and further qualified as open or occluded (Figure 30)
based on the accessibility of the binding site.
Indeed, the absence of alternating-access would essentially
turn the carrier into a large channel or a nondiscriminating
pore. This would result in the leakage of the cellular contents,
such as nutrients and salts, as well as in the entry of harmful
substances. Moreover, it would waste energy in active transport
by allowing species that are transported against their gradient
to leak back. On the other hand, various computational studies
have identified uncoupled water transport through channel-like
intermediates or water wires in carriers from diverse families
(Figure 30, the light green region). These results explain at
least some of the experimental findings that showed coupled
and uncoupled water and ion transport.787−790 While the
simulations point out imperfect sealing during the alternating-
access mechanism, size and other physical properties of the
channels as well as their transiency are unlikely to render them
deleterious for the cell.787−790 Taken together with the water
Figure 30. A schematic representation of the transport cycle of a
carrier (dark green). The alternating-access mechanism requires
interconversion between functional conformational states: outward-
facing open (OF-o), outward-facing occluded (OF-occ), inward-
facing open (IF-o), and inward-facing occluded (IF-occ). Uncoupled
water or ion transport can occur due to channel-like transient
intermediates (light green). Reprinted with permission from ref 787.
Copyright 2013 Li et al.
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permeation through other membrane channels (including but
not limited to aquaporins) and the sheer amount of mass
transport proteins in cellular membranes, the passive water
permeability of biomembranes is unlikely to be only due to
permeation through the lipid phase.
Nowadays it is unexceptional to find structures of membrane
transporters in various conformational states representing a
different stage of their transport cycle. Moreover, low-
resolution experiments have been used to tap into the
dynamics of the transporters. The intrinsically dynamic
conformational landscape of the membrane carriers, which is
absent in most membrane channels, makes MD a valuable tool
to investigate their transport cycle. Indeed, MD-based
methods, such as Molecular Dynamics flexible fitting,791,792
have been instrumental in generating atomistic models for
membrane transporters793−796 and channels797,798 based on
low resolution cryoelectron microscopy or X-ray scattering
densities, exploiting homology models or available structures in
alternative conformational states. The long time scales of the
transport cycle of carriers bring about challenges for simulation
studies. These challenges, on the other hand, have been partly
circumvented by the improving computational resources and
the developments in MD-based methods. Various enhanced
sampling methods have successfully been used to sample the
transport cycle along carefully chosen collective varia-
bles.799−803 Recently, Latorraca et al.804 captured the
spontaneous OF-o to IF-o conformational transition in
unbiased MD simulations of the sugar transporter Semi-
SWEET, one of the smallest carrier proteins characterized to
date. The simulations depict the alternating access mechanism
at the atomistic scale, revealing a coupling between the
intracellular and the extracellular gates of the substrate-binding
pocket, which prevents their simultaneous opening.804
The use of MD simulations in exploring the conformational
changes during the transport cycle as well as their dependence
on substrate/ion binding in secondary active transporters and
ATP hydrolysis in primary active transporters has been
extensively reviewed.805,806 Here, we review the recent
computational studies on carriers from various families
focusing on protein−lipid interactions and the modulation of
their transport activity by membranes.
Cholesterol Modulates Carrier Proteins, Particularly
Those Involved in Nerve Signaling. Cholesterol is of
particular interest for modulation of membrane proteins.
Groulef et al.736 reviewed the MD studies aiming to delineate
how cholesterol affects the structure, dynamics, and function of
membrane proteins.736 We focus here on the effects of
cholesterol on membrane transport proteins, leaving aside
other membrane proteins not directly involved in mass
transport.
An overarching theme of computational studies of both
primary and secondary active membrane carriers has been the
characterization of the conformational transition pathways. On
the other hand, only a few studies directly explored how the
functional conformational changes depend on membrane
cholesterol. Before we go on for an in-depth discussion, we
note that the reason for the scarcity of computational studies
directly exploring this phenomenon is likely 2-fold. First, the
time scales required for the conformational transitions are too
long for MD. Unfortunately, the presence of cholesterol is
unlikely to raise the stakes for capturing these slowly
progressing dynamic events; on the contrary, it is likely to
hinder it. Second, often the structures of membrane trans-
porters are from prokaryotes. A quick query for the term
“transporter” in the database “Membrane proteins of known
three dimensional structure”268 results in over 300 matches,
and only a few of them are of eukaryotic origin, let alone being
of animal origin.
One of the few computational studies that investigated the
modulatory effect of cholesterol on membrane transporters,
was an atomistic and coarse-grained simulation study of sarco-
and endoplasmic reticulum Ca2+-ATPase.807 This study
suggested a nonspecific effect of cholesterol, as cholesterol
did not appear to interact specifically with the known inhibitor
binding sites.
Cholesterol is an essential component of the neural
membranes and is enriched in the synapses, which are active
sites of neurotransmitter release and clearance. A family of
secondary active transporters, referred to as the solute carrier 6
or the neurotransmitter-sodium-symporter (NSS) family,
couples the Na+ and Cl− gradients to uphill transport of
neurotransmitters to clear them from the synaptic cleft. A
subset of NSS transporters is the monoamine transporters
(MATs) responsible for serotonin, dopamine, and epinephrine
clearance. These transporters are of major clinical interest as
potential drug targets against disorders related to monoamine
dysregulation, including drug addiction, hyperactivity, schizo-
phrenia, and depression.808 Interestingly, the site-specific
interactions of cholesterol with conserved sites on the
monoamine transporters influence their conformational state.
Until recently, computational studies of this important
family have focused on the archetypal NSS orthologue,
bacterial leucine transporter (LeuT).809 LeuT has been the
target of extensive structural and computational investigations,
as it features a conserved structural fold (the LeuT-fold)
shared among diverse transporter families with little sequence
and functional homology.810 The importance of lipid environ-
ment in transporter shape and conformation has been
highlighted by structural differences observed in MD
simulations of LeuT.811 Hydrophobic mismatch quantified by
a hybrid Continuum-Molecular Dynamics approach was
suggested to allosterically regulate the functional conforma-
tional transitions of LeuT812,813 exemplifying the hydrophobic-
mismatch driven allosteric modulation.732 Several computa-
tional studies also captured intermediate conformational
states.814−816 On the other hand, due to its bacterial origin,
LeuT is not suitable for studying key site-specific lipid
interactions in MAT members.
Structural characterization of two MATs bound to
cholesterol in different regions of the protein led to the
subsequent MD studies of cholesterol binding. These
structures belong to the human818 and drosophila819 dopamine
transporter (hDAT and dDAT, respectively), and to the
human serotonin transporter (hSERT).820 In each of these
structures, one cholesterol was bound to a distinct site. Based
on CG simulations of a LeuT-based dimeric hSERT homology
model embedded in a raft-like membrane, Ferraro et al.821
identified six cholesterol-binding spots on the serotonin
transporter (hSERT), four of which appear to be important
for ion binding and transport. For this purpose, they developed
a protocol to determine the hot spots based on residence times
and spatial distribution of cholesterol.821 Laursen et al.822
performed coarse-grained simulations of the recently obtained
crystal structure of SERT820 and characterized cholesterol
binding to a site that was previously identified in dDAT. Their
mutagenesis experiments showed that the mutations that
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inhibit cholesterol binding to this site promote the IF
conformation, whereas those that promote cholesterol binding
lead to the OF conformation.822 A study by Zeppelin et al.817
concentrated on the cholesterol interaction with hDAT
(Figure 31A). Atomistic simulations of hDAT captured the
transition to an IF conformation in the absence of cholesterol,
as well as immobilization of two helices on the intracellular
side in the presence of cholesterol. They also extended the
study to three other MAT members: dDAT, hSERT, and
human norepinephrine transporter. The coarse-grained simu-
lations revealed a common set of cholesterol binding spots in
all MAT members (Figure 31 B).817 Overall, these studies
strongly suggest that the binding of cholesterol to conserved
surface spots on MATs regulates the conformational
transitions important for the transport cycle of these proteins.
PIP2 Modulates the Conformational State and Oligome-
rization of Monoamine Transporters. The N-terminus of
DAT regulates the reverse transport of the neurotransmitter,
namely, its release to the synaptic cleft. However, the structure
of this important segment has not been solved. Khelashvili et
al.823 performed an ab initio structure prediction of the 57-
residue-long N-terminal segment. They carried out atomistic
simulations of the selected model in water with and without
temperature replica exchange in the membrane environment
and attached to the transmembrane region. This segment
appears to interact with the anionic PIP2 or PS lipids in the
bilayers, which favor various binding modes of the N-terminal
segment on the membrane surface.823 In a later study on the
full-length hDAT embedded in PIP2-containing and PIP2-free
membranes, Khelashvili et al.824 captured a spontaneous
transition toward the IF state, as well as release of Na+ and
destabilization of dopamine driven by PIP2 interactions with
the N-terminal segment and an intracellular loop.824
PIP2 has also been implicated by computational studies in
stabilizing the oligomeric forms of dopamine and serotonin
transporters. However, these studies are largely inconclusive or
indirect in identifying the lipid−protein interactions in
oligomerization. Recent evidence has suggested the functional
forms of these transporters as dimers, despite the crystal
structures in the monomeric state. Cheng et al.825 modeled the
dimeric state of hDAT. Although not present in the
simulations, authors hypothesized that PIP2 may be involved
in stabilizing the dimeric interface.825 The energetics of the
identified dimeric interfaces was quantified using Hamiltonian
replica exchange umbrella sampling simulations. The simu-
lations hinted at the potential roles of PIP2 and cholesterol in
oligomerization, but without any certainty.826 A largely
experimental study by Anderluh et al.827 asserted that direct
PIP2 binding mediates SERT oligomerization. In this study,
MD simulations were used to model PIP2 interactions with the
experimentally characterized region.827 It is worth noting that
coarse-grained MD of LeuT dimers suggested phospholipid
and anionic cardiolipin binding to the dimer interface.828 The
collective motions of LeuT and hDAT were suggested to
change upon dimerization.829 Taken together with their likely
role in oligomerization, anionic lipids, especially PIP2, at least
play indirect roles in the conformational changes required by
the transport cycle of MATs. Yet, the direct effect of these
lipids on oligomerization and the transport cycle remains to be
explored.
The Effects of Detergent Micelles on Structure and
Function of Carrier Proteins. The extensive treatments
performed during crystallization make it harder to relate the
obtained structure of the protein to its function in its natural
environment. MD simulations have been instrumental in
relaxing the structures, originally obtained using detergents, in
their natural environment. However, computational studies on
the direct effects of the unnatural crystallization environments
are rare. Recently, Cheng et al.830 developed strategies to
construct micelle models for computer simulations and tested
them on two systems, one of which is the voltage-sensing
domain of KV, to facilitate the computational study of protein−
micelle complexes.830
The bacterial secondary active transporter LeuT, discussed
above in the context of site-specific lipid protein interactions
especially with MATs, has also been examined to characterize
the effects of unnatural lipid environment on the structure of
protein and the annular lipids. Atomistic simulations by
Khelashvili et al.831 showed the formation of a detergent shell
that coats the transmembrane region of LeuT. At high
Figure 31. Annular cholesterol-binding sites on various monoamine
transporters (MATs). (A) The cartoon representation of hDAT from
the top (left) and the side views (center and right). The two
cocrystallized cholesterol molecules are shown in orange licorice
representation. (B) Cholesterol occupancy isosurfaces are shown for
various MATs shown from the top (left) and side views (center and
right). Cholesterol in 5 conserved sites is depicted in orange licorice.
Reprinted from with permission from ref 817. Copyright 2018
Zeppelin et al. (https://creativecommons.org/licenses/by/4.0/
legalcode)
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detergent-to-protein ratios, the simulations captured the
penetration of the detergent molecules into the LeuT
structure, occupying the second substrate-binding site.831
LeVine et al.832 later investigated whether the detergent in
the micellar environment strips away or preserves the annular
lipids around the protein. The simulations suggest that at low
detergent concentrations, the annular lipids remain undis-
rupted, and the detergent molecules cannot penetrate into the
protein. They further showed that larger detergents do not
penetrate into the protein even at high concentrations.832
The micellar environment also influences the functional
conformational states of LeuT. Sohail et al.811 simulated IF-
open LeuT in micellar and bilayer environments. In the
detergent micelle, which reproduces the crystallization environ-
ment, LeuT structure remains stable and open.811 In the
bilayer, however, one of the transmembrane helices moves
substantially, resulting in a different IF-open conformation.
These results confirmed by lanthanide-based resonance energy
transfer experiments indicate that the environment used during
crystallization might affect the captured conformational
state.811 The consequences of the unnatural detergent
environment were acknowledged in a recent study by Adhikary
et al.833 To study the protein in a more natural setting without
labeling, they reconstituted LeuT into nanodiscs and studied
the protein conformational dynamics using hydrogen−
deuterium exchange coupled with mass spectrometry. This
study, which exploited MD for the interpretation of the
experimental data, confirms that the IF to OF conformational
transitions described in detergent micelles take place also in
the lipid environment. Besides, the study also characterized the
differences between IF and OF states in the accessibility and
the conformation of several transmembrane helices and
extracellular loops.833
Lipids are Active Facilitators of the Elevator Mechanism
of the Glutamate Transporter. Another group of neuro-
transmitter transporters is comprised of the glutamate
transporters, which facilitate the clearance of excitatory
amino acids, glutamate and aspartate, from the neural synapse.
As there are no experimental structures available for the human
members, their structures are inferred from the orthologous
bacterial aspartate transporter, GltPH, which features another
conserved fold, called the NhaA-fold.810 Remarkably, GltPH is a
homotrimer assembled symmetrically around a central axis
normal to the membrane. Each monomer contains an N-
terminal scaffold domain that forms the trimeric interface and a
C-terminal transport domain, which moves up and down
against the scaffold during the transport cycle in an elevator-like
mechanism.786 Lezon and Bahar834 proposed that the elevator-
like mechanism can be realized based on the collective motions
estimated by the elastic network models only when the
surrounding lipids are incorporated into the model. This
observation suggests that the membrane plays an active role in
the transport cycle of GltPH.
834 An experimental study by
Akyuz et al.835 combined with atomistic MD simulations
supported the elevator-like mechanism by studying two
mutations that make the bacterial protein similar to its
human orthologue. These mutations were characterized by a
decreased substrate binding affinity and an enhanced transport
rate. MD simulations showed that the mutant proteins
exhibited increased insertion of lipid chains into the interface
between the scaffold and the transport domains, strongly
suggesting that lipids facilitate the elevator-like mechanism.835
ATP Binding-Cassette (ABC) Transporters Maintain
Membrane Asymmetry. Lipid distribution in cellular mem-
branes is inhomogeneous laterally and asymmetric between
leaflets. While the electrochemical potential of a specific lipid
and the physical properties of the membranes partially dictate
its location, active transport of lipids is necessary to maintain
the asymmetry.836,837 Here, the active transport is mainly
primary; that is, it is directly coupled to ATP hydrolysis. Some
ATP binding cassette (ABC) transporters are directly involved
in the transport of sphingolipids, phospholipids, sterols, bile
salts, and fatty acids. Moreover, lipid environment acts as a
reservoir for other types of amphipathic and hydrophobic
substrates. Lipid molecules also influence ABC transporter
function, and some may even be tightly bound, thereby acting
as an essential unit of the functional protein.838 Montigny et
al.836 recently reviewed the proposed mechanisms of flippases
and scramblases involved in active and passive phospholipid
transport, and the regulatory role of lipids in their function.
MsbA is a bacterial ABC exporter, a lipid flippase,
characterized structurally in both IF and OF conformations.
The conformational changes and the coupling between ATP
hydrolysis in the nucleotide binding domains and the
transmembrane domains have been investigated using MD
simulations.839−841 Ward et al.842 explored the distribution of
lipids around MsbA using a multiscale coarse-grained
approach, which optimized the coarse-grained parameters
based on atomistic simulations. Three conformational states of
MsbA were embedded in mixed DOPC/DOPE bilayers
separately. The simulations captured weakly bound annular
lipids around the transmembrane region of MsbA penetrating
into the substrate-binding chamber.842 Bechara et al.843 studied
the endogenous composition of annular lipids around TmrAB,
a potential glycolipid flippase related to MsbA, using both
experiments and MD simulations of a homology model of
TmrAB embedded in a POPE bilayer. They showed that
annular lipids have a constant composition and that negatively
charged lipids tightly associate with the protein.843
P-glycoprotein is another member of the ABC transporter
superfamily existing in animals, fungi, and bacteria. P-
glycoprotein not only moves various compounds across the
plasma membrane but also acts as a flippase.844 Domicevica et
al.845 built a complex coarse-grained lipid bilayer model
composed of POPC, POPE, POPS, sphingomyelin, cholester-
ol, and POPIP asymmetrically distributed in each leaflet in
keeping with the composition of brain epithelial cells. Coarse-
grained simulations of the membrane embedded P-glycopro-
tein complemented by shorter atomistic simulations captured
the formation of an annular lipid belt composed of anionic PS
in the inner leaflet. Cholesterol also appeared to interact
specifically with three sites on the protein.845 Barreto-Ojeda et
al.846 explored possible lipid access pathways to the binding
cavity. They employed coarse-grained simulations of the
inward-facing conformation of P-glycoprotein embedded in
bilayers with different POPC/POPE compositions. The
simulations showed that only lipids of the lower leaflet can
access the cavity without any PC or PE specificity. They also
found that there are key lipid binding residues that are mostly
basic at the portals and mostly hydrophobic and aromatic in
the cavity.846
G Protein-Coupled Receptors Act as Lipid Scramblases.
Although their main function is signaling, and therefore is
discussed in detail in section 7, several G protein-coupled
receptors have been implicated for their scramblase func-
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tion.837 While the scramblase activity of G proteins can be
categorized as neither carrier-like nor channel-like, we note
here that it is a mode of passive mass transport, distinct from
the above-described flippase activity in that it is passive and
thus not directional.
A few computational studies characterized this function of
GPCRs focusing on rhodopsin. Nieminen suggested that
rhodopsin lowers the free energy for POPC flip−flop.848,849
Vercher̀e et al.850 showed that several polar residues on
bacteriorhodopsin exposed to the membrane interact with the
polar lipid headgroups facilitating the phospholipid flip−
flop.850 Recently, Morra et al.847 suggested a similar “credit-
card” mechanism for retinal-free oxin (Figure 32A). They
employed atomistic simulations and generated kinetic models
based on the Markov State Model analysis for the translocation
process. Their results revealed a hydrophilic groove between
two helices, which opens up while the lipid headgroups
translocate through it with the chainsexposed to the membrane
environment (Figure 32B−D).847 Along these lines, Sapay et
al.851 suggested that model transmembrane helices can
facilitate lipid flip−flops by stabilizing the membrane against
deformation during the flip−flop.851 Overall, these results
suggest that the protein surface can act as a rail against which
the phospholipids can slide, leading to faster flip−flop and thus
membrane scrambling.
6.2.3. Peripheral Lipid Transport Proteins. A group of
soluble proteins classified under the lipid transport proteins
facilitates the lipid transfer through the aqueous phase in a cell.
They achieve this by extracting lipids from the membrane by
associating superficially with membranes and carrying them
through the aqueous phase in their buried binding pockets.852
Membrane association and lipid binding of lipid transport
proteins have been investigated using computer simulations.
Phosphatidylinositol-transfer proteins exchange phosphatidyli-
nositol molecules between membranes regulating PIPs signal-
ing. Grabon et al.853 characterized the lipid-binding mode and
a lipid uptake mechanism based on atomistic MD simulations.
The simulations identified a set of conserved residues aiding in
lipid uptake, reducing the free energy barrier and functional
conformational changes.853 Moreover, two computational
studies complementing experiments investigated the conforma-
tional effect of lipid binding in two different members of
oxysterol-binding protein (Osh), sterol/PI(4)P exchang-
ers.775,817
Cholesterol efflux in the late endosomes and lysosomes is
facilitated by a “tag-team duo” formed by Niemann-Pick C
(NPC) proteins 1 and 2, which get their name from the
genetic Niemann-Pick C disease. NPC1 is a transmembrane
protein on the limiting membrane of the lysosomes/late
endosomes. NPC2, on the other hand, is a small soluble
protein. NPC2 shuttles cholesterol between the internal
membranes of the organelles rich in a unique lysosomal/late
endosomal anionic lipid, called bis(monoacylglycero)-
phosphate (BMP). Moreover, NPC2 carries cholesterol and
hands it to the NPC1 N-terminal domain, which through an
unknown mechanism expels the cholesterol through the
glycocalyx-coated limiting membrane.855 Estiu et al.856
estimated an optimized pathway for cholesterol hand-off
from NPC2 to NPC1’s N-terminal domain.856
Enkavi et al.854 investigated the membrane-binding proper-
ties of NPC2 using all-atom simulations and free energy
calculations. The simulations captured NPC2-membrane
binding in two competitively favorable modes (Figure 33).
The first binding mode (Prone) is associated with cholesterol
uptake and release as it places the cholesterol-binding pocket
in direct contact with the membrane. The second binding
mode (Supine), on the other hand, places the cholesterol-
binding pocket away from the membrane surface. The Supine
mode appears to be more favorable overall, and the productive
binding mode (Prone) forms only in BMP-containing
membranes. Interestingly, sphingomyelin hinders the forma-
tion of this mode, counteracting BMP.854 The effect of BMP is
shown to be specific in that another anionic lipid, PG, cannot
reproduce the effects. These simulations suggest a mechanism
by which BMP and sphingomyelin regulate the NPC2-
mediated cholesterol transport.
With the recent discovery of the cryoEM structure857 and
several insightful X-ray structures858,859 of NPC1, the whole
process of cholesterol transport by the full-length NPC1 and
NPC2 can be investigated using MD.
Figure 32. Lipid scramblase function of GPCRs and its mechanism.
(A) Schematic representation of the “credit-card mechanism” for lipid
flip−flop. Adapted with permission from ref 837. Copyright 2006
Springer Nature. (B) The polar groove formed between the
transmembrane helices is filled with water molecules. (C) MD
snapshot showing lipids with their headgroups inserted into the
groove between two transmembrane helices. (D) Continuous lipid
translocation pathway characterized in simulations indicated by
overlaid lipid phosphorus atoms. Adapted with permission from ref
847. Copyright 2018 Elsevier.
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6.3. Membrane−Protein Interactions in Vesicular (Bulk)
Transport
Vesicular transport has a central role in trafficking molecules
both within a cell involving various organelles, such as the
endoplasmic reticulum, Golgi apparatus, endosomes, and
lysosomes and in the uptake (endocytosis) and release
(exocytosis) of vesicle-enclosed material by the cell, as in the
case of neurotransmitter release. Various types of molecules are
required for different vesicular transport pathways. Clathrin
facilitates membrane invagination in the vesicle budding
process, enabling endocytosis of extracellular material on the
plasma membrane. The soluble N-ethylmaleimide-sensitive
factor attachment protein receptor (SNARE) complex, on the
other hand, is responsible for vesicle fusion at the neuronal
synapse allowing docking and subsequent fusion of vesicles.860
Both budding and fusion events in vesicular transport require
extensive membrane remodeling. Here, we review the
computational studies performed on the vesicular transport
machinery involved in vesicle fusion and budding.
6.3.1. Vesicle Fusion. Vesicle fusion requires complex
machinery. Some of the proteins in the machinery are
crystallized and extensive simulations have been performed
to investigate their interactions with each other and the
membrane to shed light on the vesicle fusion mechanism.
The SNARE Complex. One of the most important steps in
neural signaling is the release of neurotransmitters at the
synaptic cleft. This is an exocytotic process, in which the
synaptic vesicles filled with neurotransmitters fuse with the
membrane, releasing the contents to the synaptic cleft.
The SNARE protein complex is the main engine that
facilitates the fusion of synaptic vesicles with the synaptic
membrane. A schematic representation of the complexation
process and the elements involved in it are depicted in Figure
Figure 33. Two membrane-binding modes of NPC2 and their interactions with BMP characterized in extensive biased simulations. (A)
Normalized contact frequency (NCF) is used as a measure of specific interactions with BMP. The Prone mode, which places the opening of the
cholesterol-binding pocket in direct contact with the membrane surface, exhibits extensive specific interactions with BMP, while the Supine mode,
which places cholesterol away from the membrane, does not form such extensive specific interactions. (B) The MD snapshots showing the two
binding modes. The protein is shown in cartoon representation colored based on the NCF values; the membrane is represented as a yellow
transparent surface. BMP residues near the protein and the protein residues with high NCF are shown in licorice representation. Reproduced with
permission from ref 854. Copyright 2017 Enkavi et al. (https://creativecommons.org/licenses/by/4.0/legalcode).
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34. The complex forms when a membrane-attached (t-
SNARE) and a vesicle-attached (v-SNARE) domain associate
during the membrane fusion process. The product of the
complexation is referred to as the trans-SNARE complex. This
complex is composed of four helices contributed by three
proteins: one helix from the v-SNARE protein, synaptobrevin,
and three helices from the t-SNARE proteins syntaxin and
SNAP-25. The energy released during the formation of the
trans-SNARE complex compensates for the repulsive forces
between the membranes and brings them together.
The mechanism of complexation of t- and v-SNAREs is
likened to zipping up, and the resulting trans-SNARE has a
coiled-coil structure. The zipping up of the SNAREs not only
brings the membranes together but also mechanically distorts
them to produce a fusion pore. Figure 35 shows schematic
representations of structures that precede the formation of the
fusion pore. The review by Risselada and Grubmüller863
depicts a mechanism for this complex process based on
molecular simulations and experiments. In essence, the
SNARE complex takes active part in all stages of fusion. (i)
SNARE complex zipping brings the membranes together. (ii)
A stalk intermediate forms, in which one or more splayed lipids
connect adjacent monolayers. Here, the zipping releases energy
to bring the lipid headgroups sufficiently close, while the
transmembrane domain of SNARE perturbs the lipid packing
facilitating the stalk formation. The splayed lipid was suggested
to form the main fusion barrier. (iii) The stalk expands as
driven by the assembly of SNARE complexes. (iv) Finally, the
SNARE complexes facilitate the formation of the fusion pore
by inhibiting a metastable hemifusion diaphragm (Figure 35).
The penetration of the negatively charged C-termini of the
transmembrane domains into the membrane further helps the
opening of a fusion pore.863
The hemifusion diaphragm (Figure 35) is an important
intermediate in membrane fusion, in which the two bilayers are
connected by another bilayer. The hemifusion diaphragm
contains a highly negative membrane curvature at the junction,
where a trilayer structure forms. The simulation studies by
Gardner and Abrams864 using a solvent-free coarse-grained
model originally developed by Cooke et al.865 showed that the
lipid composition modulates the dynamics of the hemifusion
diaphragm. The lipids with negative intrinsic curvature help
stabilize the trilayer structure at the junction. In the presence
of such lipids, the hemifusion diaphragm can relax via lipid
flip−flops, while lateral diffusion dominates the relaxation
mechanism in the presence of lipids with neutral intrinsic
curvature.864
The fusion pores have been generally thought to be
toroidal.866 Various computational studies aimed to character-
ize the shape and the structure of the fusion pore in detail. Yoo
et al.867 compared the coarse-grained and continuum models
for membrane bending in fusion pores. Their results
characterize the fusion pore as a metastable structure with
neither toroidal nor catenoidal shape. The fusion pore
formation likely follows a rim-pore structure near the rim of
the extended hemifusion diaphragm (Figure 35).866 Risselada
et al.866 investigated the shape of the rim pore and the free
energy associated with the rim pore expansion using coarse-
grained simulations. Their analytical free energy model and the
simulations support a nontoroidal shaped rim-pore formation.
Sharma and Lindau869 commented on a nanodisc based study
by Bao et al.868 that showed fusion pores to be formed of both
lipids and proteins. They included coarse-grained simulation
models in the commentary proposing a molecular picture.869
The number of SNARE molecules for completion of
membrane fusion is not clearly known. Recently, Fortoul et
al.870 combined a coarse-grained model of the SNARE
complex calibrated based on all-atom MD simulations and
laser tweezer force measurements with a continuum model for
a membrane that incorporated membrane deformation and
hydration or electrostatic repulsion. The changes in the
equilibrium SNARE membrane-docked configuration were
investigated with a varying number of SNARE complexes. The
model suggested that the distance between the membrane and
the vesicle can be reduced with addition of more SNARE
complexes up to 4−6 complexes in total.870
Zheng871 used nonequilibrium MD simulations to inves-
tigate the unzipping of t- and v-SNAREs. All-atom steered MD
simulations in implicit solvent captured mostly syntaxin
unfolding and thus failed to reproduce the AFM-based
unzipping mechanism, showing sequential unzipping of the
linker domain, the C-terminal domain, and the N-terminal
Figure 34. Schematic model for SNARE-mediated membrane fusion.
The monomers of t-SNARE (I) assemble into the t-SNARE complex
(II) and folds (III). The t-SNARE forms a complex with the v-
SNARE (VAMP2), also binding synaptotagmin and Munc18. (IV)
The complex formed by t- and v-SNARE zips up (V) and initiates
fusion (VI). Reproduced with permission from ref 861. Copyright
2016 Zhang et al.
Figure 35. Schematic representation of intermediate structures in membrane fusion. Adapted with permission from ref 862. Copyright 2006
Rockefeller University Press.
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domain. While coarse-graining based on the Go-model872 also
failed to capture the correct mechanism, coarse-graining based
on a modified elastic network model was successful.871 On the
other hand, a new set of all-atom steered MD in explicit
solvent simulations published shortly after the first set captured
a three-stage unzipping mechanism in agreement with
experiments.873 The short time scales of the simulations and
an insufficient number of repeats do not allow generalization to
an equilibrium regime, however, which can also explain some
of the artifacts such as unfolding of helices.
As mentioned above, synaptobrevin II is an important
component of v-SNARE, which by binding to t-SNARE
proteins syntaxin and SNAP-25 results in the formation of a
stable α-helical four-helix bundle in the coiled-coil SNARE
complex (Figure 34). The synaptobrevin II contains an α-
helical transmembrane domain and an unstructured cytoplas-
mic domain, which includes a conserved juxtamembrane
region connected to the helical transmembrane domain with a
linker region.874
Zipping of the SNARE coiled-coil generates a force that
brings membranes together overcoming the repulsive barrier.
This is accompanied by a change in the synaptobrevin helical
transmembrane domain position.875 Biochemical studies have
earlier shown that extending the C-terminus of synaptobrevin
with charged residues inhibits membrane fusion,875 likely by
preventing the motion of the helical transmembrane domain.
Similarly, attaching protein domains to the C-termini of
SNARE proteins was suggested to arrest membrane fusion in a
hemifused state.876
Lindau et al.877 performed coarse-grained MD simulations
to investigate how the force produced by zipping leads to
fusion pore formation. They showed that piconewton forces
applied on the extravesicular end of the helical transmembrane
domain of synaptobrevin suffice to dislodge the C-terminus
from the inner leaflet of the vesicle membrane. Based on the
coarse-grained simulations and free energy calculations, Lindau
et al.877 proposed a model for fusion pore formation, where the
zipping of two SNARE complexes pulls the two C-terminal
domains into the membrane and leads to consecutive tilting of
the transmembrane domain. The tilting results in a state where
two helical transmembrane domains become parallel to the
plane of the membrane and a stalk is formed, after which the
fusion pore formation completes.877
Blanchard et al.878 used atomistic MD simulations to
characterize the prefusion state of membrane-embedded
synaptobrevin truncated to include only the linker and the
transmembrane domain and reported the insertion depth and
the protein orientation. In this study,878 the authors employed
a membrane model that aims to bypass the time scale
limitations due to slow lipid diffusion, called the highly mobile
membrane mimetic (HMMM) model.879 In HMMM, the
membrane core is represented as an organic solvent, and
headgroups as short-tailed lipids. The simulations initiated at
various tilt angles in the HMMM converged to a tilt angle and
the same insertion depth of W89 and W90, with the
transmembrane and linker regions forming a continuous
helix kinked at G100.878 To verify their results, the authors
later converted the HMMM model to a pure POPC bilayer, in
which the highly tilted state and the conformation were
maintained. Although biochemical studies had shown that
extending the C-terminus of synaptobrevin with charged
residues hinders fusion,875 the extension does not change the
membrane-embedded configuration, suggesting a different
mechanism of action for the extension.878 Another set of
microsecond-scale all-atom MD simulations of truncated
synaptobrevin (transmembrane domain, linker, and juxtamem-
brane domain) and several mutants also confirmed these
results about the role of G100 and the tilt angle of the
protein.874 These simulations by Han et al.874 showed also that
the transmembrane domain drives folding of juxtamembrane
domain along with the connecting linker. This allows synaptin
to adopt to different membrane thickness. In addition, the
linker and juxtamembrane domain perturb and partially
dehydrate the membrane.874 The lipid-regulated conforma-
tional dynamics of synaptobrevin homologue Ykt6 was also
studied recently using computer simulations.880
Han et al.881 used the coarse-grained-based docking assay for
the transmembrane (DAFT) components method to inves-
tigate the oligomerization of wild-type synaptobrevin II. They
showed that synaptobrevin II forms stable right-handed dimers
in agreement with mutagenesis experiments. The docked
structures, later verified using all-atom simulations, revealed
that poly-Val and poly-Leu mutants result in increased and
decreased dimerization propensity, respectively.881
Syntaxin-1A is a part of the t-SNARE complex implicated in
synaptic vesicle docking at presynaptic active exocytosis sites
(Figure 34). PIP2 forms microdomains of about 73 nm size
that sequester syntaxin 1A. In an experimental study combined
with coarse-grained MD, the basic residues at the SNAP-25 C-
terminus were found to be essential for tightly zipped SNARE
complex. Furthermore, this conformational preference of
SNARE is correlated with reduced release rates in point
mutations of these basic residues.882
Munc18a (mammalian uncoordinated-18 protein) (Figure
34) is a member of the Sec1/munc18 protein family, which is
involved in vesicle fusion by binding SNARE proteins.
Phosphorylation of Munc18a by protein kinase C reduces its
affinity for syntaxin-1A.883 To unravel the mechanism for this
affinity reduction due to phosphorylation, Bar-On et al.883
investigated the conformational dynamics of munc18a and its
phosphomimetic mutants computationally. The simulations
showed that phosphomimetic mutants of Munc18a arrest it in
a closed-cavity conformation, which makes syntaxin 1A
binding unfavorable.883
Tethering proteins have been thought to play a role in initial
recognition and attachment of membranes by SNAREs.
Moreover, the transition from the hemifusion intermediate to
a fusion pore manifests a huge free energy barrier (Figure 35),
and a recent study by D’Agostino et al.884 combining in vivo
and in vitro fusion of yeast vacuoles with MD simulation
showed that the tethering proteins are required to overcome
this barrier. The study884 suggests that tethering proteins are
necessary for fusion pore formation; and SNAREs and
tethering proteins form “a single, non-dissociable device”.
The coarse-grained MD simulations in this study884 were
instrumental in showing how binding of the tethering complex
for vacuole and lysosome fusion (the homotypic fusion and
protein sorting complex (HOPS)) to the headgroup region of
the SNARE complex affects the hemifusion stalk geometry
(Figure 35). It was shown that the presence of HOPS,
approximated by a single bead of 14 nm diameter, decreases
the free energy cost by half in the progression from a
hemifusion intermediate to the fusion pore.884
Binding of the cytosolic protein complexin (Cpx) to the
SNARE complex inhibits spontaneous fusion, and thus, also
premature vesicle fusion in the absence of an action potential.
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The equilibrium and nonequilibrium MD simulations of the
SNARE/Cpx complex showed that the accessory helix of Cpx
acts as a “fusion clamp” by binding to synaptobrevin C-
terminus and preventing full SNARE zipping.885 This model
was further used to predict mutations that can enhance Cpx
function in preventing full assembly of the SNARE complex.
These simulations and mutations further support the role of
Cpx in stabilizing the partially unzipped state of the SNARE
complex and preventing its full zipping.886
SNARE molecules are recycled in an ATP-dependent
manner by the 20S supercomplex formed by the ATPase
NSF (N-ethylmaleimide sensitive factor) and SNAPs (soluble
NSF attachment protein). The collective motions of the
individual molecules, estimated using normal-mode analysis,
were used to put forward a SNARE disassembly mechanism.887
Synaptotagmin. Synaptotagmins are a family of Ca2+
sensing proteins in the presynaptic axon terminal. The
synaptotagmin family has 17 isoforms in humans, which have
differing functions and varying Ca2+ binding affinity. They
contain two membrane-targeting domains (C2A and C2B
(Figure 34 A)) with varying lipid selectivity and affinities and
are generally involved in Ca2+ binding. Synaptotagmin 1 (Syt1)
C2B interacts with SNAP25 of the SNARE complex (Figure
34), inhibiting vesicle fusion before Ca influx. On the other
hand, Ca2+ influx results in insertion of the C2 domains into
the membrane, which removes the fusion clamp leading to
fusion.888
Syt1 was shown to induce the bending of the presynaptic
membrane upon binding of Ca2+, ultimately resulting in fusion
pore formation with the help of the SNARE complex. Among
the two C2 domains, only the isolated C2B domain can bend
the membrane despite their similarities in structure, sequence,
and membrane binding affinity. On the other hand, C2B
contains a C-terminal helix rich in lysine and hydrophobic
residues.889 Wu et al.889 hypothesized that the C-terminal helix
plays a role in membrane bending and this requires a transition
from the conformation captured by electron paramagnetic
resonance (EPR) and NMR (helix-up) to another one, in
which the C-terminal helix is in contact with the membrane
(helix down) (Figure 36A). The authors tested this idea by
rotating the helix in pulling simulations (through 16 repeats)
to induce the necessary conformational transition from the
helix-up configuration to the helix-down configuration,
followed by a 200 ns long equilibration to test the stability
of the final configuration. The all-atom MD results indicated
that C2A and the helix-up conformation of C2B cannot bend
the membrane, whereas the helix-down conformation of C2B
can, when placed on the membrane. The authors further
showed, by calculating the PMF using umbrella sampling
simulations, that the helix-down conformation is energetically
favorable when bound to an anionic membrane (Figure 36B).
The simulations captured that the negatively charged lipids
accumulate around the C2B Ca-loop and the C-terminal helix.
The membrane bending, however, appeared to be due to
insertion of some hydrophobic residues into the membrane.
While the simulations for membrane binding, lipid distribu-
tion, and PMF calculations were based on the HMMM model,
membrane bending and pressure profile calculations were
performed using a full membrane model.889
A combined Förster resonance energy transfer, circular
dichroism, and implicit solvent MD simulation study by Fealey
et al.890 recently showed that the structure of Syt1’s
intrinsically disordered region depends on phosphorylation
and the dielectric constant. The study showed that lowering
the dielectric constant of the environment, which mimics
conditions near the membrane surface, stabilizes helical
structures, while phosphorylation of T112, which is known
to modulate exocytosis, destabilizes them. The mechanism
involves formation of a distinct set of salt bridges in a reduced
dielectric and upon phosphorylations that either stabilize or
destabilize the transient secondary structures.890
While Syt1 works in the neurons, Syt7 functions in the
regulation of insulin secretion and manifests stronger
sensitivity to Ca2+. Chon et al.891 performed atomistic MD
simulations to characterize the membrane-bound form of the
Syt7 isoform. This study891 is consistent with an experimental
study by Osterberg et al.888 published in the same issue.
Performed without input from the experimental study,888 the
simulation results helped to explain the underlying differences
between membrane binding of the two isoforms (Syt7 and
Syt1). EPR measurements by Osterberg et al.888 showed that
Syt7 C2A inserts deeper into the membrane when compared
to Syt1 C2A. The atomistic MD study by Chon et al.891 further
showed that Syt7 C2A binds three Ca2+ ions and binds the
membrane with two Ca2+ binding loops.
Figure 36. Conformational transition between helix-up and helix-down configurations in Syt1. (A) Ca2+-bound C2A domain (left) and C2B in
helix-up (center) and helix-down conformations (right). (B) Potential of mean force for the transition from the helix-up to the helix-down
conformation on an anionic membrane. The helix-down conformation (iii) is more stable than the helix-up conformation (i). A shallow barrier (ii)
separates the two conformations. The free energy further reduces as the helix binds to the membrane surface (iv). Adapted with permission from
ref 889. Copyright 2014 Biophysical Society. Published by Elsevier Inc.
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The Exocyst Complex. The exocyst complex is an
evolutionarily conserved octameric protein that plays a crucial
role in exocytosis. It targets post-Golgi secretory vesicles to the
plasma membrane and facilitates their localization and
tethering before vesicle fusion, which is mediated by the
SNARE complex. As such, it plays crucial roles in many
physiological processes, including morphogenesis, cell cycle
progression, and tumor invasion.892
In a combined biochemical and MD simulation study, Zhao
et al.893 showed that Exo70, a subunit of the exocyst complex,
induces tubular membrane invagination on synthetic vesicles
and protrusions on the cell surface. Coarse-grained MD
simulations performed using two different dimer models of
Exocyst complex component 7 (Exo70) (parallel and
antiparallel) showed that wild-type dimers induce sufficient
negative membrane curvature to induce tubulation, whereas
monomers and a mutant that is deficient in lipid binding do
not. The study established Exo70 as a membrane bending
protein.893
The exocyst interacts with the membrane in a highly
controlled manner. Two of its eight subunits, Exocyst complex
component 1 (Sec3) and Exo70, are thought to interact with
the target plasma membrane region before the rest of the
complex is recruited. Sec3 and Exo70p have been suggested to
bind PIP2 in this process.
894 Pleskot et al.894 studied the
molecular details of membrane binding of the individual
subunits using coarse-grained MD. The simulations showed
that both Exo70p and Sec3p-N spontaneously associate with
the membrane. In both cases, PIP2 molecules clustered around
positively charged residues, almost all of which are conserved
in eukaryotes. Another set of simulations also included a small
GTP-binding protein, Rho1p, along with Sec3p-N, which were
crystallized together in the active state. Simultaneous binding
of proteins and involvement of PIP2 suggest a mechanism for
how small GTPases together with PIP2 can localize the
exocyst.894
Although crystal structures of a few subunits of the exocyst
complex were known previously, the structure of the octamer
has only recently been characterized using cryoEM in
combination with the cross-linking mass spectroscopy at 4.4
Å resolution.895 With the recently characterized cryoEM
structure of the full-exocyst complex, we expect that more
simulation studies on the mechanism and membrane
interaction of the complex will follow.
6.3.2. Vesicle Budding. Various proteins are involved in
endocytosis and exocytosis processes each playing a role in
different parts of the cell or at different stages of the
vesiculation. Here we review the computational studies
performed on various proteins involved in vesicle formation,
focusing on the crosstalk between membranes and proteins,
specifically the lipid−protein interactions.
Figure 37. PI clustering resulting from membrane binding of N-BAR and ANTH/ENTH domains. (A) The spontaneous membrane binding of N-
BAR (left), ENTH (middle), and ANTH (right) domains induce PIP2 clustering in CG MD simulations. A snapshot of protein and the trajectory
of individual PIP2 molecules (top), and PIP2 density (bottom) are shown from top view. (B) Number of PIP2 molecules bound to each domain
averaged (±standard deviation) over independent runs. (C) PIP2 local concentration vs membrane-bound protein density for the N-BAR
homodimer. (D) The distance between the ENTH domain and the membrane along the membrane normal (black) and the minimum distance
between ENTH and PIP2 molecules. Spontaneous lipid binding and dissociation events are indicated with arrows. (E) Time evolution of PIP2 local
concentration. Adapted with permission from ref 909. Copyright 2014 Springer Nature.
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Clathrin-mediated endocytosis is a complex process that
recruits a variety of proteins on the membrane surface.
Recently, Milosevic896 reviewed this process in the recycling of
synaptic vesicles. First, PIP2 and the cytosolic domains of
synaptic vesicle proteins recruit the clathrin adaptors to the
membrane. The adaptor proteins, then, recruit the clathrin
light and heavy chains. The light and heavy chains polymerize
to form a triskelion shape evolving into a coated pit that
invaginates the membrane. The GTPase dynamin assembles
into a collar-like coat in the neck of the pit and cleaves the
coated pit using the energy from GTP hydrolysis. Then,
synaptojanin-1 hydrolyzes PIP2, promoting the dissociation of
the adaptors. The disassembly of clathrin is facilitated by 70
kDa heat shock protein (Hsc70), an ATPase, and auxilin.896
Bin/Amphiphysin/RVS (BAR) domain-containing proteins
detect membrane curvature in the above-described process and
work together with dynamin in cleavage of the coated pit.897
Proteins containing the Bin/Amphiphysin/Rvs (BAR) domain
are responsible for curving the membrane in various biological
functions, including endocytosis and trafficking. BAR domains
manifest a crescent shape with diverse curvatures, lengths, and
affinity for different membranes. Membrane sculpting proper-
ties of BAR domains have been investigated using simulations
at various resolutions. Membrane curvature due to the binding
of N-BAR domain (Bar domains that contain a N-terminal
amphipathic helix)898 as well as the roles of N-terminal
amphipathic helices899,900 and PIP2 lipids in the membrane-
association900 have been captured in atomistic simulations.
Takemura et al.901 suggested that salt-bridge formation
between the lipids and the inverse BAR (I-BAR) domain
increases the local lipid density and leads to curvature
generation.
Arkhipov et al.902 investigated the collective effects of BAR
domain lattices using coarse-grained models. The shape-based
and residue-based coarse-graining schemes successfully cap-
tured membrane bending902 and tubulation by lattices made of
N-BAR domains.903 Yu and Schulten904 used atomistic
simulations and a shape-based coarse graining scheme to
model F-BAR domains. Their simulations captured tubulation
induced by F-BAR domain lattices.904 Lyman et al.905
suggested that water between the membrane and the positively
charged concave surface of BAR screens electrostatic
interactions. Electrostatics, therefore, is unlikely to be the
main driving force in curvature sensing and membrane binding
of BAR domains.905 Recently, microscopy, mathematical
modeling, and coarse-grained MD simulations suggested that
the BAR domains are not densely packed on the tube, covering
only 30−40% of the tube surface, and that the amphipathic
helices are not needed for forming the BAR scaffold.906
Moreover, Ayton et al.907 used mesoscale continuum models
to investigate N-BAR domain induced vesiculation and
tubulation. As additional reading, protein mediated membrane
remodeling studied by multiscale simulations was reviewed
recently elsewhere.908
BIN1 (M-Amphiphysin2) coordinates dynamin-mediated
vesicle fission and is involved in the biogenesis of muscle cell
T-tubules. While the N-BAR domain of amphiphysin dimerizes
and binds to the negatively charged regions of the membrane,
C-terminal SRC homology 3 (SH3) domain binds to the
proline-rich domain of dynamin, a eukaryotic GTPase involved
in cleavage of the clathrin-coated vesicles.909 Picas et al.909
showed that BIN1 clusters PIs (phosphoinositides, referring
mostly to phosphatidylinositol 4,5-bisphosphate here) and the
PI clustering results in dynamin recruitment. In this process,
while the N-BAR domain controls the dynamin recruitment
kinetics, the SH3 domain drives the dynamin accumulation on
the membranes. The PI clustering appears to be a general
property of proteins that interact with PI (tested also on PI-
binding ANTH/ENTH domains). While curvature generation
is not necessary for PI clustering, it amplifies the effect. The
study also included coarse-grained MD simulations, which
showed spontaneous association of the N-BAR (and ANTH/
ENTH domains) with the membrane (Figure 37D), which
results in increased PIP2 local concentration and density
(Figure 37A,C,E). All domains induced clustering of up to 9
PIs with a diffusion-driven mechanism (Figure 37B), in which
PIs remain free to dissociate, and thus interact with the
recruited proteins, such as dynamin.909
Auxilin I is a protein tyrosine phosphatase involved in
clathrin-mediated endocytosis in neurons. By binding to
clathrin-coated vesicles, auxilin I recruits HSPA8/Hsc70,
which starts uncoating clathrin-coated vesicles. Multiscale
simulations of the wild-type and mutant auxilin 1 showed that
negatively charged lipids (especially PIP2) enhance auxilin-
membrane binding and the role of phosphatase tensin-type
(PTEN-like) domain in the process.910
Dynamin mediates vesicle scission in a GTP-hydrolysis-
dependent manner by oligomerizing around the neck of
clathrin-coated pits. Crystal structures of the nucleotide-free
dynamin dimer911 and tetramer912 have been characterized.
These structural studies911,912 were complemented with MD
simulations for interpretation. Docking in combination with
MD and linear interaction energy calculations was used to
explore the binding sites of a clathrin inhibitor (bolinaqui-
none).913
A combined experimental and MD study by Pinot et al.914
showed that polyunsaturated phospholipids enhance the
activity of dynamin and endophilin, another BAR domain
protein, in deforming synthetic membranes and vesiculation
and, thus, accelerate endocytosis. The study914 showed that
polyunsaturated phospholipids make the membrane easy to
deform under a pulling force. Pinot et al.914 assessed the
conformation of the membrane lipids using coarse-grained
MD, in which they applied a pulling force to a
phosphatidylcholine bilayer. Under the pulling force, a tube
extended, from which a vesicle separated at some point. During
this process, the polyunsaturated chain conformationally
adapted to membrane curvature and filled the voids.914
Epsin is involved in clathrin-coated vesicle-mediated trans-
port by both promoting membrane curvature and recruiting
accessory proteins.915 The epsin N-terminal homology
(ENTH) domain was indicated in membrane remodeling by
specifically interacting with PIP2 and inserting the N-terminal
amphipathic helix into the membrane.916 Tourdot et al.916
developed multiscale computational models that combined
coarse-grained MD simulations with continuum Monte Carlo
field-based approaches to investigate the protein−membrane
interactions and the resulting membrane curvature. The
coarse-grained MD simulations by Tourdot et al.916 showed
that PIP2 is necessary for membrane-binding of the ENTH
domain of epsin, which induced positive curvature on the
membrane.916 Combination of EPR and multiscale MD
simulations suggested that ENTH domains aggregate and
form dimers or higher order oligomers, with arrangements
depending on the properties of the local curvature.915
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Overall, the simulation studies presented here concentrated
on individual elements involved in vesiculation. MD has made
important contributions in understanding the membrane-
sculpting role by BAR domains. Moreover, lipid−protein
interactions have been characterized for many proteins
involved in different stages of vesicle budding, especially the
role of PIP2 lipids.
6.4. Challenges
In this section, we covered the role of biomembranes in mass
transport. Cells have evolved various mechanisms for mass
transport, regulated in particular by membrane-associated
proteins. Biomembranes are not only barriers against mass
transport but also actively involved in controlling what gets in
to and what gets out of the cells.
Here, we first described how various small molecules,
including water, can get through pure lipid bilayers in a
nonfacilitated manner. These nonfacilitated transport mecha-
nisms have many implications for drug design and delivery. A
particular theme that comes up here is the role of cholesterol in
decreasing membrane permeability by modulating the
structural properties of the membranes. On the other hand,
this property appears to depend on the membrane phase.
Despite advances in MD methodology, estimation of passive
permeability of small molecules is a challenging task and
requires large resources. This issue is further aggravated by the
complexity of the real membranes in terms of lipids and other
components. With increasing resources in the future, it may be
possible to use MD as a high-throughput method for
estimation of passive permeability of biomedically important
molecules.
We, then, moved on to describe the contributions of MD
simulations in discovering how protein−lipid interactions are
involved in the regulation of channel and carrier proteins that
facilitate mass transport. Lipids appear to modulate these
proteins both by site-specific interactions and by altering the
physical properties of the membranes. Specific lipid−protein
interactions have been characterized in various secondary
transporters, regulating the localization of the protein and the
transport dynamics. The regulatory roles of membrane physical
properties are well characterized through experimental and
computational studies, especially for mechanosensitive chan-
nels.
Considering the alternating access mechanism for primary
and secondary active transporters and gating mechanisms of
various channels, the physical properties of the membrane
likely constitute a general mechanism for functional modu-
lation of mass transport. For example, lateral pressure changes
may hypothetically induce opening of channels and may even
change their specificity by rearranging residues in the
selectivity filters. Similarly, differential lipid packing in
opposing leaflets would lead to different conformational states
stabilized in membrane transporters, modulating their
efficiency in transport. On the other hand, the effect of site-
specific protein−lipid interactions and the physical properties
of the membrane on the mechanism and the energetics of
carriers and channels have not been extensively studied
computationally. Here, the particular challenge is that the
required conformational changes fall beyond the time scales of
simulations, so their investigation is usually performed using
biased and enhanced sampling methods, which usually require
identification of various relevant slow degrees of freedom as
collective variables. Obtaining quantitative results requires
huge computational resources. Lipids constitute another level
of complexity: their slow dynamics may result in convergence
problems and dependence on the initial configuration used in
the simulations.
Finally, we covered recent simulations of vesicle budding
and fusion machinery. These processes have been studied
mostly using coarse-grained models due to the vastness of the
systems. Most atomistic simulations performed until now have
not investigated the whole process but instead considered how
individual members of the complexes might function in
isolation. Overall, models studied by MD simulations have
established themselves for investigating mass transport, due to
their resolution and ability to capture dynamics. Both vesicle
fusion and budding are membrane-remodeling processes.
Studying membrane remodeling using simulations requires
large systems even for the coarse-grained simulations. Besides,
each step requires various protein−protein and protein−lipid
interactions and protein conformational changes, each of
which are challenging to tackle with both coarse-grained and
atomistic simulations. Therefore, limitations of time and length
scales are the major barrier against progress.
7. LIPIDS CONTRIBUTE TO SIGNALING, BUT HOW?
Cells are separated from their native environment by biological
membranes. The plasma membrane of eukaryotic and
prokaryotic cells is a bilayer composed of lipids, into which a
plethora of different proteins is embedded. Lipids are involved
in the formation of basic structures in cells and tissues,
regulating the intertissue communication, immunological
functions, energy metabolism, and ultimately, the cell survival.
Plasma membrane contains thousands of different lipid types.
It is safe to assume that they all have an important role to play
in cells, yet their functions are not well understood. The
understanding of lipid properties and the interplay between
lipids and other components of biological membranes is
currently the biggest challenge in cellular biology and
biophysics. A substantial amount of research has been carried
out over the years to clarify the importance of lipid classes.
This knowledge is of great importance; however, it is just the
tip of the iceberg. Each lipid class has its own subclasses that
differ in the length of hydrocarbon chains, the degree of
saturation, charge, structural modifications, and many others.
About 42000 lipid species have been identified917,918 as
biologically relevant to date (statistics from April 2018).
However, studies on the molecular mechanisms by which
lipids regulate cellular processes and signaling have been
restricted to a rather small number of systems. Meanwhile,
only recently the role of lipids in modulating the activation of
integral proteins has been appreciated.54,734,919−926 This idea
of lipids as modulators of protein activation has often been
discussed to arise from specif ic interactions, where lipids are
bound to the protein and act as its integral partners, or from
membrane-mediated interactions, where the physical properties
of the membrane control, in part, protein conformations and
their activation.
In this section, we discuss the knowledge generated by
computer simulations regarding the role of lipids in different
aspects of cellular signaling. First, we focus on lipid signaling in
the absence of proteins. We discuss the interleaflet trans-
location (so-called f lip−f lop) of lipids and briefly review the
MD studies where spontaneous lipid flip−flops have been
reported. We further discuss data based on free energy
methods commonly used to calculate the free energy barrier
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for interleaflet lipid translocation. Next, we discuss the role of
lipid−protein interactions in the regulation of receptor
signaling. In this part, we focus our attention on computational
studies where specific lipid-binding sites have been revealed. G
protein-coupled receptors and transmembrane channels are
here used as the main context of our discussion. We close this
section by discussing how computer simulations can help us in
understanding the role of protein post-translational modifica-
tions in signaling, since it turns out that here, too, the role of
lipids in the signaling processes can be significant.
7.1. Lipid Signaling: Translocation of Lipids across
Biological Membranes
Since the seminal work by Bretscher in the early 1970s,927 it
has been known that the erythrocyte membrane is enriched in
phosphatidylcholine and sphingomyelin in the outer (exoplas-
mic) leaflet and in phosphatidylserine, phosphatidylethanol-
amine, and phosphatidylinositol in the inner (cytoplasmic)
leaflet. Currently, it is established that biological membranes
are not only asymmetric with respect to the composition of
leaflets144 but also laterally heterogeneous.497,928 Recent
advances in structural biology929 and lipidomics61 have
revealed that the composition of cell membranes varies
substantially according to cell age, origin, metabolic state,
and spatial location resulting in a rather complex matrix of
lipid−protein interactions. Several functional roles for
asymmetric lipid distribution in plasma membranes have
been suggested. For instance, regulatory proteins such as
spectrin,930,931 protein kinase C,932 and annexin933 appear to
localize to the cytoplasmic face of the membrane due to their
interactions with phosphatidylserine. The disruption of lipid
asymmetry leads to exposure of phosphatidylserine on the
outer surface of the plasma membrane, which in turn serves as
a trigger for macrophage recognition of apoptotic cells.934,935
Several severe diseases and fatal conditions, such as
Alzheimer’s disease,936 cancer,937,938 and atherosclerosis939
have been associated with the disruption of lipid asymmetry.
Passive transbilayer diffusion of lipids (also known as f lip−
f lop, transbilayer translocation, or transbilayer movement) is one
of the multiple mechanisms contributing to the maintenance of
lipid homeostasis in biological membranes. The term f lip−f lop
was first used by Kornberg and McConnell940 to describe “the
transverse motion of phospholipids” in lipid membranes. The
spontaneous translocation of phospholipids across a bilayer has
been postulated to be extremely slow (with a rate of about
10−15 s−1), corresponding on average to a single lipid flip−flop
event every 24 h.940,941 However, the data reported in the
literature lacks consensus. For instance, the published
cholesterol flip−flop times range broadly from 3 s to tens of
minutes.942,943 More recent studies have suggested that the
flip−flop halftime for cholesterol is shorter than 1 s.944
Bruckner et al.,945 using an NMR-based technique, showed
that cholesterol residence time in a single leaflet of a bilayer is
below 10 ms. However, in 2011, Garg and co-workers946
reported based on neutron scattering that the cholesterol flip−
flop halftime is in the range of hundreds of minutes. These
striking discrepancies can be attributed to the sensitivity of
flip−flop processes to chemical and physical membrane
properties, lack of standardized experimental procedures, and
the intrinsic difficulty to detect flip−flops in the first place.
Theoretical and computational studies can alleviate the
above-mentioned difficulties by providing detailed insight in
the nanoscale. During the last 15 years, this approach has been
used quite successfully to provide molecular-scale under-
standing for the energetics and kinetics of lipid flip−flops in
biological membranes. Here, we summarize these efforts and
the lessons we can learn from them.
7.1.1. Spontaneous Lipid Flip−Flop. Classical MD
simulations (combined with Monte Carlo approaches) have
been used to describe lipid flip−flop processes ever since the
pioneering work by Imparato et al.947 published in 2003. In
this study, lipids were modeled as flexible chains of beads, and
water was represented as a single bead. The combination of
Lennard-Jones and soft repulsive potentials was used to model
hydrophilic and hydrophobic interactions. This simplistic
model was able to reproduce the experimentally observed
fact that the flip−flop rate decreases with increasing lipid chain
length.948,949
In the early atomistic simulations of phospholipids, only a
few isolated lipid flip−flop events were observed under specific
conditions such as in the vicinity of membrane defects
(transient water pores). A spontaneous lipid flip−flop was
first noted during the self-assembly of a DPPC vesicle950 and
later confirmed by direct observations of lipid translocation
events under a variety of conditions: in the presence of
membrane perturbing agents such as dimethyl sulfoxide
(DPPC, DMPC, or POPC)951 or butanol (DPPC)952 or
antimicrobial peptides (DPPC)694 and in physiologically
relevant conditions, such as under an ion concentration
imbalance across a lipid membrane (POPC).953 The study by
Gurtovenko and Vattulainen954 is particularly appealing since
it proposed a water pore-facilitated mechanism for phospho-
lipid flip−flop. Based on 50 successful flip−flop events, the
data demonstrated that lipid flip−flops occur spontaneously in
protein-free phospholipid membranes under physiological
conditions through transient water pores on a time scale of
tens of nanoseconds (see Figure 38). Gurtovenko and
Vattulainen suggested that the appearance of a transient defect
in a lipid bilayer inevitably leads to diffusive translocation of
lipids through the pore, and the diffusive motion through the
defect is driven by thermal fluctuations. While the flip−flop
process takes place very rapidly, in a time scale of 10−50 ns,
the rate is dictated by the time needed to create a pore.
For sterols, similarly only a few isolated flip−flop events
have been observed in atomistic simulations. Probably the first
spontaneous sterol flip−flop found through atomistic MD
simulation was reported by Roǵ et al.955 in 2008. In the 200 ns
long simulation, the authors observed two flip−flop events of
cholestenone in a DPPC bilayer, while no flip−flop events
were observed for cholesterol. Interestingly, the cholestenone
flip−flop occurred without bilayer perturbations in terms of a
push-in mechanism:956 a sterol molecule first moves toward the
bilayer center, then it rotates at the center of the lipid bilayer,
and finally diffuses to the opposite leaflet. In another study,957
the authors examined the behavior of cholesterol in a bilayer
composed mainly of monounsaturated phospholipids with
varying chain length (diC14:1-PC and diC22:1-PC). The
simulations uncovered that in the bilayers composed of short-
chain lipids, cholesterol exhibited broad orientational distribu-
tions. During 50 ns of atomistic simulations, a single
cholesterol flip−flop was observed. The authors concluded
that cholesterol flip−flop is an intrinsic feature of disordered
bilayers. More recently, Choubey et al.958 studied cholesterol
translocation in DPPC bilayers using large-scale atomistic MD
simulations. Over a period of 15 μs of simulation, the authors
observed 24 translocation events with a rate constant of 3 ×
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104 s−1. Once a flip−flop event had triggered, it took a
cholesterol molecule an average of 73 ns to migrate from one
bilayer leaflet to the other. Extensive 24 μs all-atom simulations
have also been performed by Baker and Abrams,959 who
simulated three model membrane systems composed of ∼50
mol % cholesterol, ∼50 mol % DPPC, and a single α-helical
transmembrane protein. The authors observed one sponta-
neous cholesterol flip−flop. They concluded that the
discrepancy with the results reported by Choubey et al.,958
where cholesterol flip−flops were more frequent, stemmed
from the higher cholesterol content (50 mol %) in the study by
Baker and Abrams; it is known that cholesterol typically
increases the free energy barrier of sterol flip−flop.960
Meanwhile, seven cholesterol flip−flop events were reported
in the atomistic simulations of a DPPC bilayer containing 10
mol % cholesterol.53 Interestingly, cholesterol molecules
positioned themselves at the boundary regions of fluid,
cholesterol-rich nanodomains. This type of sorting is expected
to promote cholesterol availability for cholesterol-binding
membrane proteins, translocation, and thereby transmembrane
transport of cholesterol. The authors highlighted that this
behavior was unique for cholesterol and was not observed for
cholesterol analogs. It is worth mentioning that all spontaneous
flip−flop events that were observed occurred at the boundary
of cholesterol-rich nanodomains.
Very recently, Kulig et al.164 proposed a new mechanism for
the translocation of selected sterols. In this study, the authors
explored the behavior of tail- and ring-oxidized sterols in
POPC bilayers using all-atom MD simulations (Figure 39).
Unlike in other flip−flop mechanisms,945,961−964 where a sterol
molecule changes its orientation by rotation to accommodate
its hydroxyl group at the membrane−water interface, in the
bobbing mechanism, this molecular rotation was not needed
(Figure 39). The mechanism was observed for tail-oxidized
sterols (such as 27-hydroxycholesterol), where the chemical
structure contains an additional hydroxyl group at the end of
the sterol tail, rendering the molecule hydrophilic at both of its
ends. In unbiased MD simulations of 27-hydroxycholesterol,
Kulig et al. observed about 20 translocation events during
simulations of 800 ns, while no flip−flop events were detected
in analogous systems with cholesterol or ring-oxidized sterols
(7β-hydroxycholesterol).
The development of the MARTINI force field965,966 has
enabled MD simulations to readily reach time scales beyond
microseconds even for system sizes that are considerably larger
than those used in typical atomistic simulations. Consequently,
the long time scales sampled in MARTINI simulations have
improved chances to observe sufficiently many flip−flop events
and therefore to more accurately estimate the lipid flip−flop
rates. In this spirit, recent work by Ingoĺfsson et al.596 reported
MARTINI simulations of an idealized mammalian plasma
membrane. Mixtures of about 20 000 lipids, containing more
than 60 different lipid types, were simulated over a time scale
of 40 μs. Thousands of flip−flop events of cholesterol,
ceramide, and diacylglycerol were observed. The rate of
cholesterol flip−flop was reported to be intermediate between
the rates found for saturated and unsaturated lipids. The rate of
diacylglycerol flip−flop was comparable to that of cholesterol,
and it was 2 orders of magnitude faster than for ceramide.
Ogushi et al.967 investigated the flip−flop dynamics of
cholesterol, PODAG, and SCER in DAPC, SAPC, and POPC
bilayers. Surprisingly, they found that the flip−flop rate
followed a slightly different order (cholesterol ≫ PODAG
≫ SCER) compared to the trend reported by Ingoĺfsson et
al.596 The difference may stem from the tiny samples used in
the Ogushi et al.967 study, where bilayers contained only 42
lipids.
The large-scale coarse-grained MD simulations have also
been used to explore the effect of lipid headgroup charge, acyl
chain saturation, spontaneous membrane curvature, and
surface tension on cholesterol distribution and dynamics in
model membranes.212,968,969 Systems containing 1000 to 4000
lipids were simulated for 12−15 μs. The authors concluded
that the distribution and the flip−flop dynamics of cholesterol
were strongly dependent on the lipid composition, with the
mean flip−flop times ranging between 80 and 250 ns. These
studies also confirmed that the flip−flop rate decreases with
Figure 38. Snapshots from the molecular dynamics simulations
showing the pore-mediated lipid flip−flop. Only the flip−flopping
lipid is shown; water is shown in red and white, acyl chains of the
flip−flopped lipid are shown in yellow, and its choline and phosphate
groups are shown in orange and green, respectively. Reproduced with
permission from ref 954. Copyright 2007 American Chemical Society.
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lipid chain saturation and that the headgroup charge has
similar, though weaker, effects.
7.1.2. Free Energy Methods. Despite significant efforts,
the statistically valid sampling of lipid transbilayer movement
events by brute force MD simulations is still out of reach,
especially in the case of phospholipids. To improve sampling,
the strategy commonly known as umbrella sampling is often
used. This technique allows determination of the free energy
profile (or potential of mean force) of lipid motion across a
membrane. In this method, the lipid bilayer is usually divided
into 40−50 windows along the membrane normal direction. In
each of them, one carries out an MD simulation where the
molecule is constrained to stay in a given window, and the full
set of simulations allows one to compute the free energy profile
across the membrane. There are excellent reviews970,971
discussing the umbrella sampling method in detail.
Based on atomistic and coarse-grained umbrella sampling
simulations961,972,973 for a series of PC lipids, the time of lipid
flip−flop of short-chained saturated lipids (such as DLPC) was
orders of magnitude faster than for longer lipids (such as
DPPC). The lower cost of pore formation and the larger
stability of pores in thinner bilayers can explain this behavior.
In unsaturated lipid bilayers, the flip−flop rate was much
slower than in saturated ones.961 The authors attributed this
behavior, which is contradictory to the observation that the
presence of double bonds increases bilayer fluidity, hence
facilitating pore formation, to the force field used for the
double bond description. Meanwhile, experimental data have
shown that pore formation is reduced with increasing
cholesterol content.974 This suggests that for increasing
membrane fluidity, pore formation and therefore also flip−
flop rates would actually increase.
Fluorescence measurements and united-atom MD simu-
lations using the Berger force field975,976 showed that the
oxidation of PC lipids in mixed PC/PS membranes,
characterized by the truncated sn-2 acyl chain, enhanced the
flip−flop of POPS and stabilized the formation of water pores
(Figure 40). The authors suggested that “oxidative attack on
membrane phospholipids could represent a causative factor
inducing as such the loss of phospholipid asymmetry in
apoptosis and cancer, resulting in the exposure of PS on the
outer surface of the affected cells.” Similarly, Razzokov et al.977
found that an increase in POPC peroxidation (without acyl
chain truncation) could also lead to a decrease of the free
energy barrier for PS translocation through mixed POPC/
POPS bilayers.
Very recently, Lin et al.978 calculated the PMF profiles for a
DPPC bilayer in the presence of ion imbalance. Based on the
coarse-grained simulations, the authors reported that, under
these conditions, the free energy barrier of lipid flip−flop on
the extracellular leaflet of the bilayer is much lower than that
on the intracellular leaflet. The PMF calculations suggested
that the asymmetric free energy profile was due to the ionic
imbalance across the membrane. The asymmetry of lipid flip−
flop and the possible subsequent lipid accumulation on the
intracellular leaflet under physiological conditions has sub-
stantial implications for fusion of vesicles, protein trans-
location, signaling, and transport of molecular cargo in cell
membranes.
The PMF calculations were also used for cholesterol,
palmitoyl-ceramide, and palmitoyl-oleoyl-diacylglycerol in
pure POPC bilayers in a 1:1:1 mixture of PSM, cholesterol,
and POPC.979 For all three lipid types, the translocation
process happened without the assistance of water defects (see
Figure 41). Interestingly, the flip−flop barriers were signifi-
cantly higher in raft-like bilayers (composed of PSM, POPC,
and cholesterol in a 1:1:1 molar ratio), which translated into
orders of magnitude slower flip−flop times. This result is of
possible biological importance and was explained by higher
stiffness and lower fluidity of the raft-like bilayers. In a pure
POPC bilayer, the flip−flop rate followed the order:
Figure 39. Snapshots from the MD simulation showing the
translocation process of (A−C) 27-hydroxycholesterol and (D−F)
7β-hydroxycholesterol across a membrane. Shown here are the 7β-
and 27-hydroxyl groups (green), the 3β-hydroxyl group (red), the
oxysterol ring/tail structures (orange), the POPC headgroup (cyan),
and lipid chains (gray). Reproduced with permission from ref 164.
Copyright 2018 American Chemical Society.
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cholesterol > diacylglycerol > ceramide. Similarly, atomistic
MD simulations in raft-like bilayers (POPC/PSM/cholesterol
in the 2:1:1 ratio; POPC/PSM/cholesterol/cholestenone with
the 2:1:0.8:0.2 ratio) were performed to compare the behavior
of cholesterol and its analog cholestenone.184 It was concluded
that cholestenone reduced membrane order, shortened the
flip−flop duration, and desorbed more readily from mem-
branes than cholesterol.
More recently, Kulig et al.164 calculated the PMF profiles for
the translation of oxysterol molecules (7β-hydroxycholesterol
and 27-hydroxycholesterol) in POPC bilayers. The study
showed that the free energy barriers of oxysterol flip−flop were
strongly dependent on the chemical structure of the trans-
locating molecule. The tail-oxidized sterols tended to trans-
locate faster (with the flip−flop rate of 1.56 × 10−3 ns−1 as
estimated from the unbiased MD simulation) compared to the
ring-oxidized sterols (where no spontaneous translocation
event was observed). The behavior of ring-oxidized sterols was
very similar to that of cholesterol. Given that the tail-oxidized
sterols often act as signaling molecules in living cells, the paper
hypothesized that the higher flip−flop rate of tail-oxidized
sterols has biological implications. Indeed, 25-hydroxycholes-
terol, for instance, transfers rapidly from cell membranes to the
endoplasmic reticulum with a rate that is a hundred times
larger compared to that of cholesterol.980,981
The one-dimensional PMF often used to describe the
energetics and kinetics of the lipid flip−flop assumes that the
reaction coordinate of the process is one-dimensional. In
reality, other degrees of freedom can also play a role: large-
scale membrane deformations and undulations and molecular-
scale features such as local density fluctuations that can
drastically change the translocation path and the immediate
environment where the flip−flop of the molecule in question
takes place. Nevertheless, there have been only a few attempts
to go beyond the one-dimensional description of lipid flip−
flops. One of these attempts was successfully implemented by
Parisio et al.,964 who calculated the rates and free energy
barriers associated with the flip−flop of various steroids in
DPPC bilayers. In this work, the flip−flop process was
described as diffusion on the free energy surface defined by
lipid orientation and rotation. As variables to describe the
translocation process, the authors used the position of the
center of mass of a steroid molecule along the bilayer normal
and the tilt angle of the steroid’s long molecular axis with
respect to the membrane normal. The free energy surface was
calculated using the atomistic description of steroid molecules
and an implicit representation for the water-membrane
environment. The flip−flop rate was estimated by solving the
Master Equation that governs the transitions between the free
energy minima, with transition rates evaluated from the
Figure 40. Flip−flop of the POPS molecule in the oxidized membrane. Color-coding: PoxnoPC lipids (yellow), O atoms (pink), and H atoms of
water (gray), POPS acyl chains (blue), and O atoms of the carboxylic group of POPS headgroup (red). Reproduced with permission from ref 975.
Copyright 2011 Biophysical Society. Published by Elsevier Inc.
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Kramers theory.982−984 In this model, the anisotropy and the
nonuniformity of the environment were taken into account in
terms of gradients of density, dielectric permittivity, acyl chain
order parameters, and lateral pressure across the lipid
bilayer.985 The study concluded that the steroid flip−flop
occurs, in general, in a nonconcerted way, with the rotation
and translation taking place as two separate steps. Two
possible translocation pathways were uncovered. In the first
pathway, the steroid rotated and then crossed the bilayer
midplane in an upside-down orientation (also known as the
rotating f lip−f lop mechanism).956 In the second pathway, the
steroid first diffused to the opposite leaflet without substantial
changes in its orientation, and then rotated. A common feature
in both pathways was their initial phase that started by the
embedding of the polar steroid headgroup to the hydrocarbon
interior of the bilayer, by either rotation or translation of the
molecule. This embedding turned out to be the rate-limiting
step in both pathways due to its high free energy barrier. The
values of the flip−flop rates calculated by Parisio et al.964 seem
to be generally faster than the measured ones.
A very similar approach was applied by Wei and Pohorille986
to the case of protonated oleic acid in a POPC bilayer. About
50 flip−flop events were observed over a period of several
microseconds of atomistic simulations. Good agreement with
other studies was found confirming that the flip−flop of fatty
acids can be described, in a similar way to lipid flip−flops, as a
two-dimensional diffusive process. Atomistic two-dimensional
umbrella sampling simulations were also reported by Jo et
al.,963 where two-dimensional PMFs were calculated for
cholesterol as a function of sterol position inside the bilayer
and its tilt angle with respect to the bilayer normal. Flip-flop
occurred through a sliding mechanism956 (Figure 42), and the
free energy barrier was shown to be significantly lower in a
polyunsaturated membrane (DAPC) than in saturated (DPPC,
POPC) bilayers.
As described above, the calculations of one-dimensional and,
to a smaller extent, of two-dimensional PMF profiles have
become standard practice for an approximate estimation of
flip−flop rates and lipid kinetics. Thus, caution is needed with
regard to the degrees of freedom taken into consideration in
the PMF calculations. The common assumption that the
movement of the lipid directly along the bilayer normal is the
only slow degree of freedom (and therefore also the rate
limiting step) is not always the case. Inadequate sampling of
the other slow degrees of freedom such as rotation and the
diffusion of other molecules to organize the membrane
structure in the immediate vicinity of the translocating
molecule to be optimal for its translocation, may lead to
inaccurate estimation of the free energy barrier. These issues
are discussed in refs 987 and 988. To alleviate some of the
limitations of the umbrella sampling method, other free energy
based methods and enhanced sampling techniques can be
used.802,989−991 Finally, alternative ways of rate constant
evaluation from molecular dynamics simulations have been
proposed.731
Concluding, lipid membrane composition and its lateral and
interleaflet asymmetry is an essential and handy tool used by
cells to modulate and control biological processes that take
place in biological membranes and in their vicinity. Mechanical
properties of biological membranes and the transport across
them are dependent on membranes’ molecular composition.
The lipid flip−flop is one of the passive mechanisms used in
living cells to maintain the homeostasis between bilayer
leaflets. However, despite the fact that lipid flip−flop has been
the subject of intensive experimental and computational
investigations since the beginning of the 1970s, a clear and
comprehensive picture, as well as detailed understanding of the
factors regulating translocation is still missing. This is, in part,
due to experimental difficulties to monitor the time evolution
of lipid asymmetry. An important deficiency is also the lack of
appropriate protocols to measure translocation in a stand-
ardized fashion. The molecule that suffers from this situation
most is cholesterol, since unlike many other lipids, for
cholesterol there are no enzymes (such as sphingomyelinases
for sphingomyelin or phospholipases for phospholipids) that
would break it down, such that its asymmetric transmembrane
distribution could be explored under native conditions.
Currently, despite many attempts, there is still considerable
confusion as to the distribution of cholesterol across cell
membrane structures. Interested readers are referred to refs
145 and 201. Meanwhile, the tremendous progress in the
development of computer simulation software and hardware
has brought us to a situation where detailed studies of
spontaneous lipid flip−flop events in atomistic resolution are
possible. Free energy based methods combined with molecular
dynamics simulations provide a method of choice to calculate
the free energy barriers of lipid translocation, and nonbiased
MD simulations over extended time scale will provide
adequate sampling of average flip−flop rates. While MD
simulations also have their limitations, it is clear that in the
coming years, new knowledge on molecular aspects of flip−
flop processes will be provided. When combined with
Figure 41. Snapshots from the MD simulation showing the
translocation of ceramide and cholesterol in model membranes. In
the snapshots, water is shown in red thick licorice, lipid chains in gray
lines, and phosphorus and nitrogen atoms in tan and blue balls. The
restrained ceramide or cholesterol are thick cyan lines, and the oxygen
of the restrained cholesterol is a yellow ball. Reproduced with
permission from ref 979. Copyright 2012 the American Society for
Biochemistry and Molecular Biology, Inc.
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experiments, the future work not only will clarify the details of
passive flip−flops but also will bring out ideas of how these
processes are actually involved in signaling.
7.2. Specific Lipid Binding Regulates Protein Activity
Lipid−protein interactions are involved in many biological
processes and are of prime interest in, for example, drug
discovery, as about 60% of pharmacological targets are integral
or peripheral proteins.992,993 Advances in lipidomics61 and the
structural biology of membrane proteins929,994 have revealed a
vast complexity of biological membranes. The Protein Data
Bank995 contains three-dimensional structures of ∼4654
membrane proteins (or their subdomains), and about 42000
lipid species have been identified917,918 as biologically relevant
(statistics from April 2018). However, studies on the molecular
mechanisms by which lipids regulate protein structure and
function, and ultimately cellular physiology, have been
restricted to a rather small number of proteins. Here, we
summarize recent theoretical studies that have identified
specific lipid interaction sites on the surface of membrane
proteins. For practical reasons, we focus our attention on
selected proteins in the context of G protein-coupled receptors
and transmembrane channels.
7.2.1. G Protein-Coupled Receptors. G protein-coupled
receptor (GPCR) proteins form a prominent family of cell
surface receptors that respond to an array of chemically diverse
ligands and transduce extracellular signals into intracellular
responses.996 Due to the significant involvement of GPCRs in
the regulation of physiological processes, these receptors are of
great medical importance as they are targeted by 30−40% of
the currently marketed drugs.993 GPCRs comprise the largest
protein superfamily in mammalian genomes. They share a
common seven-transmembrane topology (see Figure 43) and
mediate cellular response to a variety of extracellular signals
ranging from photons and small molecules to peptides and
proteins. The mechanism by which these receptors translate
extracellular signals into cellular changes includes the
activation of the receptor by an agonist, the dissociation of
the G protein into the α and βγ subunits, and activation or
inhibition of various downstream effector molecules by the G
protein subunits. Signal transduction by GPCRs is fundamental
for most physiological processes, spanning from vision, smell,
and taste to neurological, cardiovascular, endocrine, and
reproductive functions, thus making the GPCR superfamily a
major target for therapeutic intervention and an essential
subject of experimental and computational studies.
The early experimental studies, nicely reviewed by Oates and
Watts,998 have shown that cholesterol is a major player in
providing a preferred environment for the functions of GPCRs.
This was originally attributed to cholesterol’s ability to order
lipid bilayers149 and to the receptor’s requirement for
cholesterol-rich domains in order to function properly.999,1000
The presence of specific cholesterol binding sites was also
postulated1001 and later confirmed by cocrystallized cholesterol
molecules in many GPCR crystal structures1002−1004 (see also
Table 2). It was postulated that cholesterol can modulate
various aspects of GPCR signaling including ligand bind-
ing,1005−1007 stability,924,925 and oligomerization.1008,1009 Yet
cholesterol is not the only lipid modulating GPCR function.
Experiments have shown that polyunsaturated fatty acids
(PUFAs), in particular those containing docosahexaenoic acid,
enhance the function of rhodopsin.1010−1014 Similarly,
phosphatidylethanolamine headgroups have been demonstra-
Figure 42. Different mechanisms of lipid flip−flop. (top) Push-in
flip−flop. (middle) Sliding flip−flop. (bottom) Rotation flip−flop.
Water particles are shown as blue spheres and lipid molecules
performing a flip−flop are colored, whereas other lipid molecules are
gray. Adapted with permission from Arai et al.956 Copyright 2014 AIP
Publishing.
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ted to influence the photochemical activity of rhodopsin
directly and therefore participate in the molecular mechanism
of vision.1013 MD simulations have been successfully applied to
identify lipids modulating the receptor function in a range of
GPCRs including rhodopsin,1015−1020 the serotonin 1A and
serotonin 2A receptor,1021−1025 the cannabinoid 2 recep-
tor,1026 the sphingosine 1-phosphate receptor 1,56 the A2A
adenosine receptor,57,1027−1029 the dopamine D2 receptor,
57
the β2-adrenergic receptor
54,1030−1032 and the β1-adrenergic
receptor.1033 Below, we discuss some of them in detail.
In the study by Lee and Lyman,1029 the ligand-bound A2A
receptor was simulated by means of atomistic MD simulations.
Two 800 ns simulations of A2A in a POPC/cholesterol (with a
4:1 molar ratio) bilayer were performed. The study reported
three distinct cholesterol-binding sites on the surface of A2A
(see Figure 44). Once bound, cholesterol molecules occupied
each of the binding sites for the rest of the simulation. One of
the theoretically predicted cholesterol binding sites has been
experimentally corroborated in the high-resolution crystal
structure of the A2A receptor published by Liu et al.
1034 Two
other binding sites have not been experimentally confirmed
yet, which may be due to the relatively weak (on the order of
RT, as estimated using the Boltzmann equation) and dynamic
nature of lipid−protein interactions in these sites.
Coarse-grained MD simulations were used to analyze the
molecular nature of GPCR−cholesterol interactions for the
serotonin 1A receptor.1025 In this study, the receptor was
embedded in a POPC bilayer with different cholesterol
contents (10, 30, or 50 mol %). Multiple interaction sites
were identified based on the calculated cholesterol occupancy
times. More detailed analysis revealed relatively low propensity
to bind cholesterol in these sites. Interestingly, the highly
conserved cholesterol recognition amino acid consensus
(CRAC) motif, present on the transmembrane helix 5, was
reported to have high cholesterol occupancy, which may
confirm its putative role as a cholesterol-binding motif.
However, studies on a closely related serotonin 2A
receptor1023 identified different cholesterol binding sites,
raising the question of how to evaluate the relevance of
simulation-based predictions unless biochemical (mutagenesis)
data are available.
Very recently, the study by Morra et al.847 employed large-
scale all-atom simulations (over 50 μs of simulation time) of an
opsin embedded in a lipid membrane composed of POPC and
POPG in a molar ratio of 9:1. The MD simulations revealed a
lipid translocation pathway on the surface of opsin, enabling
passive flip−flop from one leaflet to another. The lipid pathway
was localized in the region between transmembrane helices 6
and 7. The relative movement of these helices and specific
repositioning of amino acid chains created the appropriate
environment for the penetrating lipids. The pathway started on
the IC side by random change in conformation in Y3067.53 that
repositioned the tyrosine side chain away from transmembrane
helix 6 followed by the disengagement of the E2496.32/K3117.58
pair of residues. These conformational changes resulted in ∼10
Å separation between the IC ends of transmembrane helices 6
Figure 43. Schematic structure and topology of GPCRs. Reproduced with permission from ref 997. Copyright 2016 American Chemical Society.
Figure 44. Predicted cholesterol-binding sites. (A, top panel)
Cholesterol in the extracellular leaflet shown from the top. (B, top
panel) Cholesterol the intracellular leaflet shown from the bottom.
(bottom panels) Side views showing the positions of the cholesterols
for each interaction site. The cholesterols resolved in the high-
resolution structure of Liu et al.1034 are shown as orange sticks.
Reproduced with permission from ref 1029. Copyright 2012
American Chemical Society.
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and 7, increasing hydration and enabling lipid headgroup
penetration. The opening of the narrowest region between
TM6 and TM7 (on the level of C2646.47) widened by ∼5 Å
resulting in a continuous, water-containing hydrophilic path-
way. Finally, lipids moved in a manner consistent with the
credit card reader mechanism suggested previously in another
study.837 Overall the protein-aided lipid translocation event
took place on a time scale of about 33 μs, which is consistent
with the experimentally estimated rate of lipid scram-
bling,1035,1036 highlighting that specific lipid−protein inter-
actions can modulate the translocation of lipids in biological
membranes.
Manna et al.54 used extensive all-atom simulations (over a
period larger than 100 μs) to study how the allosteric binding
of cholesterol to the β2-adrenergic receptor (β2AR) modulates
its conformation and dynamics. The study identified three
cholesterol-binding sites on the surface of β2AR, two on the
intracellular side (IC1 and IC2) and one on the extracellular
side (EC1) (see Figure 45). The reported IC1 binding site
matched the location of cholesterol observed in the crystal
structure of β2AR.
256,1004 The occupancy of two cholesterol
molecules reported at EC1 was in turn in good agreement with
the crystal structure of the adenosine A2A receptor,
1034 which is
closely related to β2AR, while IC2 is a prediction that remains
to be tested through experiments. Altogether, the study
provided pioneering evidence that cholesterol binds to β2AR
allosterically and the binding alters the conformational state of
the receptor.
Genheden et al.1037 investigated the deep cholesterol
binding sites on the surface of β2AR and A2A receptors. The
coarse-grained MD simulations detected a number of deep
cholesterol binding sites on both receptors. The authors
showed that the requirements for cholesterol binding are
modest: just a potential hydrogen bond partner close to a cleft
or hole on the surface.
Yuan et al.1038 studied the activation of the sphingosine 1-
phosphate receptor 1 (S1P1) using all-atom MD simulations.
The study reported five 700 ns long MD simulations of S1P1
either in apo form or bound to antagonist ML056 or natural
agonist sphingosine 1-phosphate (S1P). Detailed analysis of
the simulations showed that, upon S1P binding, lysophospho-
lipid triggered movements of the intracellular ends of some of
the transmembrane helices. The activation mechanism then
proceeded in four stages (see Figure 46). First, it involved the
binding of S1P to its binding site, which led to the flipping of
W2696.48 (step 1). This was followed by alterations in the
conformation of the side chain of F2656.44 located next to
W2696.48 (step 2), and rearrangement of the centrally situated
residues including N631.50, D912.50, S3047.46, and N3077.49,
which facilitated the redirected flow of water molecules inside
the receptor (step 3). Finally, one observed the influx of water
molecules at the intracellular part of the receptor, leading to
limited motions of the cytoplasmic ends of the transmembrane
helices (step 4). These movements led to the opening of the
protein structure, subsequently allowing G protein binding.
Hurst et al.1026 studied the interactions of the cannabinoid
CB2 receptor with sn-2-arachidonoylglycerol (2-AG) using
atomistic MD simulations. The results of this study suggest
that 2-AG (which contains the polyunsaturated arachidonic
acid chain (20:4, n-6)) can enter CB2 at the interface of the
transmembrane helices 6 and 7, causing the formation of an
opening between the helices. This association with the
interface of the transmembrane helices 6 and 7 appeared to
be very specific: even when 38 2-AGs were placed all around
CB2, partitioning occurred only at the interface of the
transmembrane helices 6 and 7.
7.2.2. Channels. Pentameric ligand-gated ion channels
constitute a family of integral membrane proteins whose
permeability to specific ions is increased upon agonist binding.
As their name suggests, pentameric LGICs consist of five
subunits that are arranged in the (pseudo) C5 symmetry
around a central pore. The extracellular domain has a β-
sandwich immunoglobulin-like structure, while the trans-
Figure 45. Schematic representation of three main cholesterol
interaction sites in β2AR. Adapted with permission from ref 54.
Copyright 2016 Manna et al. (https://creativecommons.org/licenses/
by/4.0/legalcode).
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membrane domain is composed of four helices (M1 to M4)
that span the membrane (see Figure 47). Relatively few
computational studies have investigated interactions between
pentameric ligand-gated ion channels and cholesterol. Baier et
al.1039 used docking and short MD simulations to identify
cholesterol-binding sites on the surface of the nicotinic
acetylcholine receptor (nAChR). Three cholesterol molecules
could be docked on the transmembrane segments of each
nAChR subunit, rendering a total of 15 cholesterol molecules
per nAChR. Cheng et al.1040 investigated interactions of
nAChRs with membrane cholesterol and anionic lipids
(POPA) in atomistic MD simulations that lasted over 10 ns.
The penetration of the intersubunit cavities by phosphatidic
acid acyl chains was observed.
More recently, Heńin et al.783 focused on γ-aminobutyric
acid receptor type A (GABA(A)) and used docking to identify
five cholesterol-binding sites. Subsequent atomistic MD
simulations were performed starting from the configuration
where sterols were bound in all of these sites. Over the course
of 200 ns long simulations, three cholesterol-binding sites
remained occupied, though cholesterol molecules underwent
some reorientation. Cholesterol molecules, bound in the
remaining two binding sites predicted by docking, were
observed to exchange, unbind, and spontaneously rebind.
In a study by Singh et al.,1042 the structural basis for
cholesterol inhibition of large conductance Ca2+ and voltage-
gated K+ channels, also known as “big potassium” (BK)
channels, was investigated in the BK channel-forming protein
Cbv1 by a combination of MD simulations, site-directed
mutagenesis, and single-channel electrophysiology. The study
showed cholesterol action to be mediated by the cytosolic C
tail domain, in which seven CRAC motifs were present. MD
simulations identified the interactions involved in the ion
channel−cholesterol recognition. Simulations of four versions
of the cytosolic C tail domain with cholesterol placed in the
vicinity of the CRAC motif were further conducted. The study
concluded that the sensitivity of the BK channel for cholesterol
arises from the membrane-adjacent CRAC4 motif, in which a
specific sequence of amino acid residues senses cholesterol.
However, cumulative truncations or amino acid substitutions
in other CRAC motifs progressively blunted cholesterol
sensitivity, documenting the involvement of multiple CRACs
in the cholesterol−BK channel interaction.
Rosenhouse-Dantsker et al.1043 used a combination of
molecular docking, MD simulations, and mutagenesis studies
to determine putative cholesterol binding sites for the inwardly
rectifying potassium (Kir2.1) channel (see Figure 48). Based
on clustering of the results from cholesterol docking, six
possible binding sites were suggested, and 50 ns MD
simulations were performed for each of the binding modes.
During the simulations, five of the initially proposed sites
merged into two distinct binding regions located between the
adjacent subunits of the channel, while a sixth position led to
the dissociation of cholesterol from the protein surface (see
Figure 46. Activation mechanism of S1P1. Steps 1 and 2, binding of
agonist (S1P). Step 3, rearrangement of centrally located residues
facilitate the redirected flow of water molecules inside a receptor. Step
4, motion of cytoplasmic parts of transmembrane helices. Reproduced
with permission from ref 1038. Copyright 2013 Yuan et al. (https://
creativecommons.org/licenses/by/4.0/legalcode).
Figure 47. Schematic representation of GLIC. (top) GLIC viewed
from the plane of the membrane. (bottom) Transmembrane part of
GLIC viewed from the extracellular side. Lipids are depicted in
orange. Adapted with permission from ref 1041. Copyright 2008
Springer Nature.
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Figure 48). The location of cholesterol-binding regions
suggested that cholesterol modulates the channel function by
affecting the pore-lining transmembrane helix that is
responsible for the channel gating either directly or through
the interface between the N- and C-termini of the channel.
The study highlights the importance of combining docking
with MD simulations, rather than relying on the docking
results alone.
Very recently, Duncan et al.606 reported large-scale coarse-
grained MD simulations of Kir2.2 channels embedded in
membranes of varying degree of lipid complexity and protein
crowding. In this study, 144 copies of Kir2.2 were embedded in
lipid membranes whose lipid composition was quite complex.
The authors reported that in the simulations containing PIP2,
headgroup interactions with Kir2.2 channels extended further
from the transmembrane domain onto the cytoplasmic domain
of the channel as compared to a PIP2-deficient system. The
radial distribution functions indicated that in membranes with
PIP2, the principal lipids surrounding the Kir2.2 channels were
PIP2 in the cytoplasmic leaflet and GM3 in the outer leaflet. In
the inner leaflet, phosphatidylserine was the second most
popular lipid in the annular shell around Kir2.2. In the absence
of PIP2, the abundance of phosphatidylserine at the protein
surface was increased, but not to the extent of PIP2 in the PIP2-
containing simulation. The study highlighted the preference of
Kir2.2 to interact with PIP2 in the inner leaflet and with GM3
in the outer leaflet, as has also been shown for the EGF
receptor.1044 Further, the study suggested that the oligomeri-
zation of Kir2.2 channels is affected by the lipid environment:
in a pure PC bilayer, Kir2.2 oligomers appeared to be bigger
and less branched as compared to those in a membrane whose
lipid composition was considerably more complex.
Schmidt et al.1045 also studied PIP2 binding to Kir2.2
channels using multiscale MD simulations. The method was
based on coarse-grained simulations to predict the initial PIP2
binding events that were then refined by subsequent atomistic
simulations. The simulations were then compared to the
crystal structures of Kir2.2 with either PIP2 (PDB entry 3SPI)
or phosphatidic acid (PDB entry 3SPC) to validate the
computational predictions. The multiscale simulations that
used the protein coordinates from 3SPI as the starting
structure predicted the PIP2 headgroup to attach to the same
cluster of basic residues that was observed also in the crystal
structure. Similarly, when the ligand-free 3SPC structure was
used as the starting point for the multiscale simulations of PIP2
binding, there was good agreement between the multiscale
simulations and the crystal structure.
O’Connor and Klauda carried out MD simulations of an
aquaporin-0 tetramer in a pure DMPC bilayer and a mixed
DMPC/cholesterol bilayer (1:1 ratio)1046 to investigate how
aquaporin-0 has evolved to prefer membranes with high levels
of cholesterol (aquaporin-0 has been found in ocular lens fiber
membranes in high concentrations). During 100 ns simu-
lations, aquaporin-0 remained stable both in the presence and
in the absence of cholesterol. However, in the presence of
cholesterol, larger hydrogen bond occupancies and longer
hydrogen bond lifetimes were observed between aquaporin-0
and the surrounding lipids as compared to a cholesterol-free
membrane, indicating that the presence of cholesterol
modulates the dynamical properties of the channel. Interest-
ingly, several aromatic residues on the surface of the protein
were identified to form stable interactions with cholesterol.
These observations suggest that the membrane-exposed parts
of aquaporin-0 have evolved to favor cholesterol-rich
membranes.
Finally, there is reason to mention the relevance of
mechanosensitive channels as, for example, sensors for osmotic
homeostasis. Recent simulation work in this context has been
quite limited, though, so it is not discussed here in
considerable length. Interested readers are referred to refs
764, 1047, and 1048.
7.2.3. Other Membrane Proteins. Specific lipid binding
sites on the surface of membrane proteins and the role of lipids
in modulating protein activation have been addressed in a
Figure 48. Cholesterol binding to the Kir2.1 channel. (left) A ribbon representation of two adjacent subunits of Kir2.1 (pink and gray). (right) A
schematic model showing the location of the two cholesterol-binding sites. Reproduced with permission from ref 1043. Copyright 2013 the
American Society for Biochemistry and Molecular Biology.
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number of MD studies not described in detail in this review.
These include lipid binding to sarco- and endoplasmic
r e t i c u l um Ca 2 + -ATPa s e s , 8 0 7 r e c ep to r t y r o s i n e
kinases,919,1044,1049−1053 capsaicin receptor TRPV1,1054
nAChR,1055−1057 voltage-sensitive potassium channel
Kv7.1,1058 UraA H+-uracil symporter,1059 voltage-gated
potassium channel,773 neurotensin receptor 1,1060 and
integrin.1061,1062
Concluding, extensive multiscale MD simulations enable us
to characterize the interactions of membrane proteins with
lipids, thereby extending and complementing the information
obtained from experimental studies. It is now possible to
identify the lipid binding sites on integral proteins and, in part,
to identify specific lipid compositions needed to activate
membrane proteins or maintain their function. MD simulations
can also provide atomistic details of protein selectivity, and
they can be used to explore how multiple ligands compete. In
crowded and complex environments similar to those studied in
vivo, simulations of large ensembles of proteins can offer
valuable insights into the actual effects of lipid−protein
interactions in multicomponent membranes.
7.3. Structural Modifications of Proteins Modulate Their
Interactions with Biomembranes
In living cells, proteins generate diverse functions related to
immune defense, catalysis, and transport. The human gene set
has been estimated to include ∼25 000 genes.1063 At the same
time, the human proteome is considered to be much larger,
including more than 1 million proteins.1064 Protein diversity
stems from not only the alternative splicing of the mRNA but
also post-translational and other structural modifications of
proteins. These modifications increase the variety of possible
protein structures and functions through chemical moieties
covalently attached to the amino acid residues. Over 200
different types of, for example, post-translational modifications
have been identified as functionally active. These modifications
include in particular phosphorylation, glycosylation, methyl-
ation, acetylation, and amidation; see UniProt1065 for a more
detailed list of post-translational modifications. They modulate
many aspects of cellular physiology, such as metabolism,
immunity, signal transduction, and protein stability.1066−1070
A relatively small number of computational studies has
investigated the role of post-translational modifications on the
structure and function of the proteins, and only a few studies
have tried to elucidate the role of post-translational
modifications in lipid−protein interactions.
Fonseca-Maldonado et al.1071 used mutagenesis and MD
simulations (GROMOS96 force field) to study the effect of
glycan content and glycosylation position on the stability of
xylanase A. The majority of glycosylated mutants presented
there increased thermostability as compared to the deglycosy-
lated counterparts. The study showed that the position of
glycosylation rather than the number of glycosylation events
determined the increase in thermostability. MD simulations
also indicated that the clustered glycan chains tended to favor
less stabilizing glycan−glycan interactions, whereas the more
dispersed glycosylation patterns preferred stabilizing protein−
glycan interactions.
Lu et al.1072 used Langevin dynamics simulations on a
coarse-grained off-lattice 46-β barrel model protein that was
glycosylated by glycans with different hydrophobicities and
glycosylation sites to examine the effect of glycans on protein
folding and stability. The glycan portion of the glycosylated
protein contained 14 beads that had tunable hydrophobicity.
For relatively hydrophilic glycans introduced at flexible peptide
residues, conformational stability and folding was observed to
increase. Meanwhile, when glycans were introduced at
conformationally restricted peptide residues, only those
glycans that were hydrophilic or very weakly hydrophobic
contributed to increasing protein stability; however they also
hindered protein folding due to increasing free energy barriers
between the folded and unfolded states.
Subedi et al.1073 studied the extracellular domain of human
CD16A (Fc γ receptor IIIa) that contains five N-glycosylation
sites. They employed NMR experiments and all-atom MD
simulations to identify the glycosylation site that contributed
to antibody binding. A preliminary 850 ns simulation of the
extracellular domain of CD16A revealed that based on the
analysis of root-mean-square fluctuations (Figure 49) the N45
N-glycan experienced less motion than other N-glycans at the
N38, N74, N162, and N169 positions. The GlcNAc residue in
the N45 position established two critical interactions with E68
and D64 that were maintained for the duration of the 1 μs
production simulation. The importance of these contacts was
verified in a separate 1 μs all-atom simulation of deglycosylated
CD16A, where the authors observed that the N45 N-glycan
enhanced the expression of CD16A. The CD16A mutants
Figure 49. All-atom molecular dynamics simulation of N-glycosylated
CD16A. The N162 N-glycan samples a large space (blue cloud)
unlike the N45 N-glycan with restricted mobility (gray cloud).
Reproduced with permission from ref 1073. Copyright 2017
American Chemical Society.
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without the N45 N-glycans were shown to express with a
meager yield.
Recently, Kaszuba et al.919 performed extensive atomistic
MD simulations of the monomeric N-glycosylated human
epidermal growth factor receptor (EGFR) in biomimetic lipid
bilayers. The receptor was embedded in a membrane
composed of a ternary lipid mixture of DOPC, SSM, and
cholesterol. This plasma membrane composition was designed
to mimic, as tightly as possible, the experimental conditions
used for biochemical reconstitution of EGFR in proteolipo-
somes. MD simulations showed that the presence of glycan
residues (Man3GlcNAc2) significantly altered the relative
arrangement of the individual receptor subdomains and their
alignment on the lipid membrane. The glycan moieties were
found to function as molecular buffers, lifting several domains
of EGFR away from the plane of the lipid bilayer and
rearranging them with respect to each other (Figure 50). The
elevation of the EGFR structure above the membrane surface
was particularly substantial in the case of subdomains DI and
DIII (located in the ectodomain of the receptor), which
together contribute to the ligand binding. The study reported
that only the N-glycosylated receptor adopted a conformation
that was in good agreement with previous experimental Förster
resonance energy transfer (FRET) studies regarding the
Figure 50. Snapshots from the MD simulation (1000 ns) of the glycosylated (left) and nonglycosylated (right) EGFR in DOPC/SM/cholesterol
membranes. The receptor structure is color-coded throughout the panels as follows: TM domain (orange); subdomains DI (blue), DII (green),
DIII (yellow), and DIV (red); intracellular TKD (salmon); glycans (purple). Adapted with permission from ref 919. Copyright 2015 Kaszuba et al.
Figure 51. Simulation snapshots of nonglycosylated CD2 in (top, left) Ld and (top, right) Lo bilayers and of glycosylated CD2 in (bottom, left) Ld
and (bottom, right) Lo bilayers. Color code: DOPC (orange), cholesterol (yellow), SM (cyan), CD2 domain 1 (dark blue), CD2 domain 2 (red),
CD2 transmembrane helix (black), and lipid carbohydrate chains (light blue). The glycosylated protein structure was prepared with the DoGlycans
tool.1077 Reproduced with permission from ref 1076. Copyright 2017 American Chemical Society (https://creativecommons.org/licenses/by/4.0/
legalcode).
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distance between the EGFR ectodomain and the lipid
membrane.1074,1075 In essence, the study by Kaszuba et al.
provided compelling evidence that glycosylation can play a
critical role in ligand binding and thus membrane receptor
activation.
The effect of glycosylation and lipid−protein interactions
was also studied by Polley et al.1076 using atomistic MD
simulations. The authors focused on the membrane-bound
CD2 protein, which is a small cell adhesion receptor expressed
by human T-cells and natural killer cells. The receptor was
embedded in big patches of a multicomponent liquid-ordered
membrane composed of sphingomyelin (d16:1/16:0), DOPC,
and cholesterol. As a control system, one used a single-
component DOPC bilayer in the liquid-disordered phase. The
study reported that the orientation of the ectodomain of CD2
depended critically on CD2 glycosylation as well as local lipid
composition (see Figure 51). In the liquid-disordered bilayer
without glycosylation, the ectodomain lay down on the
membrane surface. For the same liquid-disordered bilayer
with glycosylation, the ectodomain of CD2 was positioned
more upright, indicating that the presence of glycans plays a
role in CD2 orientation. Without glycosylation in the liquid-
ordered system, the ectodomain of CD2 fluctuated around an
upright position; however, the most significant change was
observed when the liquid-ordered bilayer hosted glycosylated
CD2, where the protein assumed a constitutively upright
position. Detailed analysis of MD results showed that the
tilting of the membrane protein ectodomain was driven by
electrostatic interactions between CD2 and lipids around it.
The tilt of the CD2 ectodomain largely disappeared when the
positively charged amino acids, which interacted with the
DOPC headgroups, were deprotonated. The effect of
glycosylation on the CD2 orientation appeared to be due to
steric effects; glycans in the ectodomain of CD2 acted as a
steric barrier, preventing association with the membrane
surface. The influence of these glycans was enhanced in the
liquid-ordered membrane environment, presumably due to
mechanical effects such as the cholesterol-induced increase in
order and reduction of membrane elasticity. Altogether, the
study by Polley et al. demonstrated how glycosylation and
lipid−protein interactions can influence receptor conformation
and visibility for the receptor’s ligands in a concerted fashion.
Lakkaraju et al.1078 employed fluorescence microscopy,
radiolabeling, and atomistic MD simulations to study the
role of palmitoylation in calnexin localization. Calnexin is a
major endoplasmic reticulum chaperone involved in glyco-
protein folding. Its palmitoylation leads to preferential
localization of calnexin to the perinuclear rough endoplasmic
reticulum, at the expense of endoplasmic reticulum tubules.
Using MD simulations, the authors analyzed whether the
presence of palmitoylation modifies the structure of the
transmembrane domain or the cytosolic tail of calnexin. It
appeared that palmitoylation did not affect the proline-induced
kink and only marginally affected the calnexin tilt. The MD
simulations, however, predicted a palmitoylation-dependent
orientation of the cytosolic tail with respect to the helix axis.
These simulations, combined with the asymmetric nature of
calnexin transmembrane domain, revealed the exciting
possibility that the presence of palmitoyl chain may affect
the conformation of calnexin, which, in turn, could alter its
affinity for membrane domains or its ability to interact with
proteins in the membrane or the cytoplasm.
Thukral et al.1079 used coarse-grained MD simulations to
unravel the molecular mechanism underlying recruitment and
insertion of lipid-anchored microtubule-associated protein light
chain 3 (LC3) into lipid membranes. LC3 is a crucial protein
required during autophagy and the authors studied one of its
unique covalent modifications. The cytosolic form of LC3 was
reversibly linked to phosphatidylethanolamine, resulting in
lipid-modified LC3 that associates with the autophagosome
membrane. Fifteen independent simulations were conducted
starting from a structure of LC3-PE placed about 8 nm from
the center of a bilayer composed of POPC. Spontaneous
insertion of the hydrophobic anchor of the protein into the
membrane was observed in 14 of 15 trajectories. In these 14
cases, once the PE was inserted into the hydrophobic core, the
lipid−protein interactions became stable, and no dissociation
events were observed. In most of the cases, the insertion
occurred within 4 μs of the simulation. The initial step of the
protein insertion into the lipid bilayer involved protein docking
to the surface of the membrane. After the protein was bound
entirely, a subsequent stepwise insertion of the acyl chains
progressed in a concerted manner, with the two acyl chains
inserting themselves to the membrane one after the other.
Finally, the lipid anchor of the protein was completely buried
in the membrane along with the acyl chain of POPC lipids
(Figure 52). Based on several spontaneous insertion events and
in vitro experimental studies, the authors were able to identify
the critical residues facilitating the LC3 membrane-targeting
process, namely, the basic residue patch consisting of K65,
R68, and R69 in the α-helix III region.
Figure 52. Schematic snapshots showing the mutated residues at the pre- and postinsertion states of the LC3 protein. Adapted with permission
from ref 1079. Copyright 2015 Biophysical Society. Published by Elsevier Inc.
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The atomic details of the association of K-Ras with POPC/
POPG (4:1 molar ratio) bilayers1080 have also been studied
extensively using all-atom MD simulations. K-Ras is farnesy-
lated at the C-terminal cysteine and has a stretch of eight lysine
residues immediately upstream of the farnesylated cysteine.
Using MD simulations, Janosi and Gorfe showed that K-Ras
was tethered to the lipid bilayer surface by specific lysine−
POPG salt bridges and by nonspecific farnesyl−phospholipid
van der Waals interactions. Unexpectedly, however, only five of
the eight K-Ras lysine residues were found to interact with the
lipid bilayer directly. Interestingly, the positively charged K-Ras
anchors pulled the negatively charged POPG lipids together,
leading to the clustering of the POPG lipids around the
proteins. A subsequent study by Prakash et al.1081 showed that
GTP-bound K-Ras also interacted with a negatively charged
POPC/POPS membrane and that this interaction involved
multiple distinct orientations of the protein. Among these, two
highly populated states accounted for ∼54% of the conformers
whose catalytic domain interacted directly with the bilayer. In
one of these states, membrane binding involved helices 3 and 4
of the catalytic domain in addition to the farnesyl tag and
poly(lysine) motif. In the other orientation, β-strands 1−3 and
helix 2 on the opposite face of the catalytic domain contributed
to the membrane binding.
Edler et al.1082 employed atomistic and coarse-grained MD
simulations of the truncated C-terminal hypervariable region
(HVR206−215) of Rab5 in three model membranes of
increasing complexity (a pure POPC bilayer, a ternary
membrane with cholesterol and palmitoyl-sphingomyelin, and
a six-component early endosome model membrane composed
of POPC, cholesterol, palmitoyl-sphingomyelin, POPE, POPS,
and phosphatidylinositol 3-phosphate (PI(3)P)). Rab5 is a
crucial regulator of endosomal trafficking processes and a
marker for the early endosomes. HVR206−215 of Rab5 was
post-translationally modified at two cysteine residues to
accommodate two geranylgeranyl anchors (C20 carbon chain
length), thus associating Rab5 with the membrane. The study
reported that the two adjacent geranylgeranyl chains in one
HVR206−215 moiety showed anticorrelated motions. That is, if
one chain was deeply inserted into the bilayer, the other was
allowed to bend toward the membrane surface. The average
insertion depth of the geranylgeranyl chains depended on the
thickness of the surrounding membrane and was always 38−
39% of the bilayer thickness. This indicates that the lipid
anchor did not penetrate the central region of the lipid bilayer,
which is in agreement with 2H solid-state NMR experiments
showing that the anchors adapt their insertion depths to the
surrounding lipids.1083
Zhang et al.1084 used all-atom MD simulations to study the
behavior of palmitoyl and farnesyl anchors in raft-like and non-
raft-like lipid membranes. A peptide derived from helix VIII
(residues 316−328) of rhodopsin was selected as a model
peptide to bear farnesyl or palmitoyl anchors. The lipid model
membranes were composed of DSPC, POPE, and cholesterol
in a 2:1:1 molar ratio to mimic the inner leaflet of functional
membrane domains in living cells. Detailed analysis of the
simulations showed that the palmitoyl anchors behaved in a
more ordered fashion, were packed tighter with the lipids in
the raft-like membrane, and diffused at a slower rate than
farnesyl anchors. Authors reported that the palmitoyl chains
preferred to associate with the saturated chains of lipids and
cholesterol molecules, while farnesyl chains were more prone
to association with the saturated and unsaturated chains. For
non-raft-like membranes, these two lipid anchors had roughly
the same preference for all lipids. Additionally, the presence of
the palmitoyl anchors caused cholesterol to orient itself in
more perpendicular manner to the membrane surface, ordered
the lipids next to the anchor, and reduced lateral lipid motion
significantly, compared to farnesyl anchors. On the other hand,
POPE and DSPC became much less ordered, cholesterol
became more tilted, and the bilayer became more fluid when
the two types of lipid anchors were inserted in non-raft-like
membranes.
The above examples clearly demonstrate the emerging
crucial role of MD simulations in unraveling the role of post-
translational protein modifications in lipid−protein interac-
tions and protein function. MD simulations enable us to
identify the atomistic mechanisms underlying protein recruit-
ment into specific lipid bilayers, which, in turn, allow us to
understand the function of integral proteins in critical cellular
processes.
7.4. Challenges
It is now established that cell membranes are not merely elastic
sheets hosting membrane and peripheral proteins to carry out
their function, but the lipid membranes themselves actively
participate in cellular physiology, including, for example,
metabolism, immunity, and signal transduction. Given this,
cells use lipid membrane composition and its lateral and
interleaflet asymmetry as tools to modulate and control
biological processes where biological membranes are involved.
Understanding how membrane lipids control protein con-
formation and activation is therefore crucial to comprehend
how plasma membranes work, and to clarify how, for example,
changes in membrane lipid content modulated by disease and
diet influence membrane protein activation.
As to the topics discussed in this section, it is obvious that
there are challenges, which need to be addressed in the
foreseeable future. While there are thousands of simulation
articles published on membrane proteins, only a few of them
have elucidated the importance of post-translational and other
structural modifications, such as glycosylation. Yet experiments
show very clearly that they can play a decisive role for ligand
binding and therefore activation. It is hard to understand why
glycosylation would not be included in a simulation model if
the protein in question is known to be glycosylated in native
conditions. Moving on, it is generally considered that lipid
translocation is one of the means used by lipids in cellular
signaling. In translocation of phosphatidylserine, the biological
context is understood (apoptosis), but what is the signaling
pathway associated with the translocation of other lipid types?
These and the many other challenging questions remain to be
addressed.
As this section has demonstrated, MD simulations can be
extremely valuable to better understand the molecular-scale
interplay between membrane proteins and their lipid environ-
ment. Improving quality of the simulation models, increasing
computing capacity together with specialized simulation
engines, and the continuously increasing extent and accuracy
of membrane protein structures will strengthen the added
value given by simulations even further.
8. HOW LIPIDS INFLUENCE MEMBRANE PROTEIN
ACTIVATION AND FUNCTION?
The structure and function of membrane proteins are firmly
connected to their lipid environment.926 Due to the lateral and
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interleaflet heterogeneity of cell membranes, proteins are
sorted between different lipid domains and recruited to specific
locations as they form functional complexes.144,1085,1086 This
compartmentalization is extremely important for many cellular
processes, such as signaling,1087 membrane fusion,1088 and
protein trafficking.1089 The post-translational pathway of
membrane-protein trafficking to the plasma membrane
involves the transport of proteins between different membrane
compartments. Proteins are modified in these membrane
compartments (such as, endoplasmic reticulum or Golgi
apparatus) usually through post-translational modifications
by the linkage of complex oligosaccharide chains. Intracellular
transport is often mediated by vesicular intermediates that bud
from one cellular compartment and fuse with the next one.
Lipids are present at almost every step of protein trafficking
and have been shown to modulate the protein activation and
function. For example, phosphatidylinositols have been
demonstrated to control many cellular events, such as the
organization and dynamics of critical signaling pathways, the
actin cytoskeleton rearrangement, and the intracellular vesicle
trafficking.1090−1092
In this section, we discuss how lipids influence the function
and activation of membrane proteins. First, we highlight some
recent computational research that has allowed one to better
understand the effects of annular lipids in protein aggregation
and signaling. We review recent advances in computational
studies on lipid-mediated protein sorting and compartmental-
ization. We show how computer simulations can aid in the
elucidation of the role of lipids in recruiting proteins into
specific lipid nanodomains or membrane phases.
Next, we focus on the allosteric binding of lipids and its
effect on the structure and dynamics of membrane receptors.
We show how cholesterol and charged lipids can inhibit ion
channel function and alter the dynamics of G protein-coupled
receptors.
In the second part of this section, we move on to lipid-
mediated interactions between biological membranes and drug
molecules. Here, we focus our attention on recent MD
simulation studies that have explored the interactions of
anesthetics and neurotransmitters with biological membranes.
We close this section by reviewing how phosphatidylinosi-
tols and other charged lipids modulate the binding of
peripheral proteins. We show that many of these proteins
interact electrostatically with negatively charged lipids. It turns
out that this interaction can play different roles given that
anionic lipids not only attract peripheral proteins toward the
membrane surface but also can dictate the reorientation of
proteins on the bilayer surface.
8.1. Lipids Form a Lipid Corona around Membrane
Proteins
The number of lipid molecules surrounding the membrane-
spanning domain has been deduced for several proteins from
EPR spin labeling studies, which quantify the association of
immobilized lipids with membrane proteins.1093 Interestingly,
an almost complete annular lipid shell was resolved for the
trimeric bacteriorhodopsin. Based on this structure, 24 lipids
were calculated to cover the membrane-spanning region of the
trimer, and six additional lipid molecules were needed to fill
the central pore.270,1094 However, most of the membrane
protein structures that have been resolved contain only a few
lipid molecules (see Table 2), which belong to the first annular
shell. This may be the result of exhaustive purification
procedures in the presence of detergents that are necessary
to obtain purified material for crystallization. The annular
lipids mediate interactions between the membrane protein and
the bulk lipid bilayer and are essential for the vertical
positioning of the protein in a bilayer, to flatten the protein
surface that is often rough, and to integrate the protein tightly
into the membrane. More importantly, an increasing number
of studies have reported the dominant role of annular lipids in
the stabilization of protein structures and the modulation of
protein functions. Here, we therefore discuss how recent
computational studies have unraveled questions dealing with
the functional role of annular lipids.
Schmidt et al.1095 employed biophysical, biochemical, and
computational techniques to quantify the influence of anionic
versus zwitterionic lipids on the stability of the integrin αIIbβ3
transmembrane complex. The study showed that the head-
group of anionic lipids competed for electrostatic interactions
within the integrin αIIbβ3 transmembrane complex, but the
net stability of its critical internal electrostatic interaction was
not compromised, and an overall transmembrane complex
stabilization was induced. The observed stabilization in the
presence of anionic lipids, the magnitude being up to 0.5 kcal/
mol, is a significant contribution to the threshold of the
integrin αIIbβ3 receptor activation, which is 1.5 ± 0.2 kcal/
mol in a POPC bilayer. It is worth mentioning that the integrin
αIIbβ3 does not possess a high-affinity anionic lipid-binding
site, which means that the annular lipids were fully responsible
for the observed effects. The results suggest that anionic lipids
enhanced the membrane protein stability by merely stabilizing
the transmembrane helix−helix association.
The role of interfacial lipids in stabilizing membrane protein
oligomers was explored by Gupta et al.828 using mass
spectroscopy combined with biochemical and computational
techniques. Several transmembrane proteins with low oligo-
meric stability, as determined experimentally, were embedded
into complex lipid bilayers containing cardiolipin, POPG,
POPE, and POPC. The coarse-grained simulations revealed
that cardiolipin acted as a “bidentate” ligand, bridging the
subunits of LeuT protein together and shifting the equilibrium
from a monomer to a functional dimer for the Vibrio splendidus
sugar transporter SemiSWEET. They also showed that lipid
binding was obligatory for the dimerization of NhaA (Na+/H+
antiporter). The results suggest that interfacial lipids modulate
the functions of these proteins since, for both SemiSWEET
and NhaA, the existence of a stable dimeric state is considered
to be critical for their mechanistic pathways.785
Eggensperger et al.1096 used all-atom MD simulations to
study the role of the annular lipid belt in allosteric modulation
and inhibition of the antigen translocation complex (TAP).
Computer simulations started from the 96-lipid POPE/POPG
(in 3:1 molar ratio) or POPC/POPG (in 3:1 molar ratio)
nanodisc that hosted TAP. Subsequently, 74 lipids were
removed in seven consecutive steps leading to a 22-lipid
nanodisc with TAP. Simulations showed that 22 lipids were
sufficient to form the annular belt around the TAP complex.
Interestingly, this lipid belt was shown to be essential for high-
affinity interactions and inhibition of TAP by viral inhibitors.
An ABC transporter, TmrAB, was studied using mass
spectroscopy and all-atom MD simulations by Bechara et al.843
who identified and monitored the composition of a part of the
annular lipid belt bound to a heterodimeric membrane protein
complex. Twenty-four different phospholipid species were
detected together with various tetra- and hepta-acylated lipid A
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species in four independent protein preparations. Interestingly,
most of the phospholipids were found to be unsaturated. MD
simulations of model structures of TmrAB explored in pure
POPE and POPC bilayers revealed that about 20 phospholipid
headgroups surrounded the protein and formed an annular belt
around the protein (Figure 53). Mass spectroscopy showed
that a subset of annular lipids was invariant in composition,
with negatively charged lipids binding tightly to TmrAB. The
authors hypothesized that the lipid belt is vital for the ATPase
activity of TmrAB, which is in line with previous experimental
observations that phospholipids stimulate and stabilize the
ATPase activity of several different ABC transporters.
All-atom and coarse-grained simulations were employed by
Guixa-̀Gonzaĺez et al.57 to study the mechanism by which
polyunsaturated lipids modulate the aggregation of GPCRs.
They performed extensive MD simulations of the self-assembly
process of A2A adenosine and D2 dopamine receptors
simultaneously embedded in multicomponent lipid bilayers,
reaching an exceptionally long simulation time of nearly 4 ms.
The simulations uncovered that the kinetics of GPCR
aggregation is modulated by the membrane docosahexaenoic
acid (DHA, 22:6ω3) level: low DHA (as observed in many
pathological conditions) substantially decreased the receptors’
ability to oligomerize (see Figure 54). The authors observed
the formation of a lipid shell around the receptors, and this
shell was found to be mostly populated by phospholipids with
DHA chains. Interestingly, the assembly of the DHA shell
around the receptors is in agreement with both experi-
ments1097 and simulations,1020 showing aggregation of DHA
around rhodopsin. The paper therefore suggested that the
DHA solvation shell could play two critical roles in modulation
of GPCR oligomerization: (a) receptors covered by DHA will
partition into DHA-rich domains, which reduces the effective
sampling area of receptors in the bilayer and increases the
number of receptor−receptor encounters, therefore speeding
up the oligomerization process; (b) the presence of the DHA
shell enhances the ability of receptors to engage in protein−
protein contacts, which, in turn, increases the receptor’s
effective oligomerization radius.
Coarse-grained simulations of the sphingosine 1-phosphate
receptor 1 (S1P1)56 in a model lipid bilayer provided further
insight into the possible lipid modulation of GPCR
oligomerization. Analysis of the trajectories showed that the
Figure 53.MD simulations of inward and outward models of TmrAB in a lipid bilayer. Models of TmrAB inward (left) and outward (right), based
on structures of Sav1866 (PDB ID 2HYD) and TM287/288 (PDB ID 3QF4). Reproduced with permission from ref 843. Copyright 2015 Springer
Nature.
Figure 54. GPCR aggregation in high and low DHA membranes.
Snapshots of (left) healthy (high DHA) and (right) disease-like (low
DHA) systems after 60 μs of CG-MD simulation. Reproduced with
permission from ref 57. Copyright 2016 Guixa-̀Gonzaĺez et al.
(https://creativecommons.org/licenses/by/4.0/legalcode).
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main protein−lipid interactions present in the system were
those with PIP2, cholesterol, and GM3. The intracellular side
of the receptor contained basic residues, which formed
frequent interactions with PIP2 headgroups. Given that the
interactions between PIP2 and S1P1 were almost evenly
distributed around the receptor surface, the negatively charged
lipids seemed to form an annulus around the protein (see
Figure 55). These strong annular interactions were found in all
144 S1P1 receptors for over 75% of the simulation time.
Similarly, lipid-exposed hydrophobic residues of the receptor
were observed to form interactions with cholesterol over the
entire simulation time, and the annulus of cholesterol was also
developed around the receptor (see Figure 55). Interestingly,
the interaction between PIP2 and S1P1 was stable and specific,
with the lipids remaining bound to the receptor throughout the
whole simulation. In contrast, cholesterol interactions were
more transient involving dissociation and association events
(in a sub-microsecond time scale) throughout the simulation.
The formation of dimers, trimers, and occasionally higher
oligomers was observed. The detailed analysis suggested that
cholesterol may mediate the protein−protein interactions.
The above studies demonstrate the functional roles of
annular lipids in many cellular processes spanning from protein
stability alternation, through receptor activation modulation, to
membrane protein dimerization effectors. Due to the constant
progress in computational techniques development, all these
cellular functions of annular lipids can now be studied at the
molecular level using MD simulations. In the future, MD-based
studies may help in answering questions regarding the role of
annular lipids in the plasma membrane, the formation of
annular lipid belts, and their cellular function.
8.2. Lipid-Mediated Protein Sorting
Although both lipids and integral membrane proteins have
been studied quite extensively, the molecular properties that
dictate the specific interactions between them and the cellular
functions that emerge from their interplay remain poorly
understood. These include particular protein−protein and
protein−lipid interactions, and indirect lipid-mediated inter-
actions. Here, we discuss recent computational studies
highlighting the importance of lipid-mediated protein sorting.
Coarse-grained MD simulations and confocal fluorescence
microscopy were employed by Schaf̈er et al.1098 to investigate
peptide sorting under different hydrophobic mismatch
conditions. The simulations uncovered that model trans-
membrane helices, such as WALP peptides, do not like to
reside in the liquid-ordered phase. Instead, they were observed
to partition into the liquid-disordered phase spontaneously.
The authors suggested that the lateral sorting process was
governed by the collective motion of both lipids and peptides,
which facilitated the trafficking of transmembrane helices by
the transient formation of islands of unsaturated lipids
disrupting the ordered domain. The driving force for the
observed protein sorting was the enthalpic cost associated with
the presence of a cylindrical object (the transmembrane helix)
Figure 55. Protein−lipid interactions in the GPCR system. The color
scale shows the mean fraction of time there is an interaction with all
144 repeats of the S1P1 receptor. (top) Interactions between the
phosphoryl headgroup of PIP2 and the receptor. (bottom)
Interactions between the cholesterol molecule and the S1P1 receptor.
Reproduced with permission from ref 56. Copyright 2015 American
Chemical Society.
Figure 56. Two binding modes of H-Ras. (left) Perpendicular orientation of the catalytic domain with respect to the membrane plane. (right)
Semiparallel orientation of H-Ras with respect to the membrane plane. Reproduced with permission from ref 1100. Copyright 2013 Li and Gorfe.
(https://creativecommons.org/licenses/by/4.0/legalcode)
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00538
Chem. Rev. XXXX, XXX, XXX−XXX
CS
inside the ordered lipid phase. De Jong et al.1099 extended this
study to investigate the role of lipid anchors in steering the
sorting of membrane proteins. They considered the peripheral
proteins N-Ras and H-Ras, which have a farnesyl anchor
together with one or two palmitoyl anchors, respectively. The
simulations showed that peripheral Ras proteins partition to
the Lo or Ld phase depending on the lipid anchor type. Double-
palmitoylated H-Ras preferred the Lo phase, whereas singly
palmitoylated N-Ras resided at the phase boundaries.
Interestingly, depalmitoylated H-Ras, with only a farnesyl
anchor remaining, partitioned into the Ld phase. It is worth
mentioning that the addition of GM1 decreased the preference
of the transmembrane peptides toward the Ld phase even
further. It was hypothesized that this indicates the essential role
of GM1 in the recruitment of transmembrane proteins to
membrane rafts.
Similarly, Li and Gorfe1100 used coarse-grained MD
simulations to study the molecular mechanism by which H-
Ras proteins form nanoclusters in model lipid membranes.
Two different conformations of H-Ras, representing active and
inactive states of the protein, were embedded into the lower
leaflet of a mixed lipid bilayer composed of 3480 DPPC, 2304
DLiPC, and 1536 cholesterol molecules (corresponding to the
ratio of 5:3:2). The authors reported that irrespective of the
initial conformation, a single, large aggregate was formed at the
end of the simulations and that the aggregation did not seem
to require lipid domain formation. However, the two binding
modes (see Figure 56), which were characterized by a different
orientation of the G domain with respect to the membrane,
differed in dynamics and organization during and after
aggregation.
Yoo and Cui studied gramicidin A (gA) dimer association
with biological membranes1101 using coarse-grained MD
simulations in combination with the potential of mean force
and stress field calculations. Three lipid bilayers were studied
to probe the effects of hydrophobic mismatch, with the degree
of negative mismatch increasing along the sequence of DMPC,
DPPC, and DSPC. It was observed that the association of gA
dimers strongly depended on the degree of hydrophobic
mismatch, the estimated binding free energy being >10 kcal/
mol in a DSPC bilayer. Analysis of configuration entropy, lipid
orientation, and stress distribution revealed that the annular
lipids made a substantial contribution to the association of two
gA dimers. The study highlights the importance of annular
lipids and their energetic contributions in processes, where a
significant reorganization of lipids near proteins is involved.
Parton et al.605 conducted coarse-grained MD simulations of
hemagglutinin clusters in domain-forming bilayers to inves-
tigate the association of hemagglutinin with lipid rafts under a
high local protein concentration. The simulations revealed an
increase in the proportion of raft-type lipids (saturated
phospholipids and cholesterol) in a membrane patch spanned
by the protein cluster. Interestingly, the lateral diffusion of
unsaturated lipids was significantly reduced within the cluster,
while saturated lipids were unaffected. They hypothesized that
steric crowding, resulting from the presence of slowly diffusing
proteins, increased the chemical potential of unsaturated lipids
within the cluster region. This led to the conclusion that the
local aggregation of hemagglutinin was sufficient to drive the
association of the protein with raft-type lipids.
More recently, coarse-grained MD simulations were used to
investigate the interactions of the binding units of cholera toxin
(CTB) with mixed GM1/DPPC membranes.1102 The
simulations showed alteration of the lipid structure induced
by CTB binding. Detailed analysis of the trajectories revealed
that CTB bound explicitly to GM1 mostly via multivalent
electrostatic interactions between the charged residues of CTB
and the oligosaccharide headgroups of GM1. Interestingly, an
entirely bound CTB could cross-link up to 15 GM1 molecules
into the protein-binding pocket. The cross-linking gave rise to
the formation of CTB-sized and less ordered nanodomains that
were enriched in GM1. Such a protein-bound nanodomain
resembled a lipid raft with an order that was distinct from the
bulk lipids.
Computer simulations were utilized by Pezeshkian et
al.1103,1104 to explore the clustering of the B subunit of the
parental Shiga toxin from Shigella dysenteriae (STxB). Using a
wide range of computational techniques, the authors found
that the lipid-chain length mismatch and the compositional
mismatch between the local membrane environment near the
toxin particles and the bulk membrane were not required for
STxB clustering. What is more, the simulations and experi-
ments showed that reducing the rigidity of the bound STxB
nanoparticles or displacing them from the membrane surface
eliminated the clustering process. Strikingly, this was
accompanied by a loss of STxB nanoparticle-mediated
suppression of membrane fluctuations, strongly suggesting
that the fluctuation-induced forces generated the attraction
between the STxB nanoparticles that sufficed to facilitate the
clustering. The paper hypothesized that this generic sorting
mechanism should be operational between any sufficiently
rigid nanoparticles that can bind tightly to a fluid phase lipid
bilayer.
Figure 57. Preferential sorting of the entire CD3ϵ chain in mixed ordered and disordered membranes. The CD3ϵ chain (magenta) was inserted
into a preequilibrated Lo−Ld membrane patch composed of DPPC (green), cholesterol (white), DUPC (red), and POPG (orange) in a 4:3:2:1
molar ratio. Reproduced with permission from ref 1105. Copyright 2015 Biophysical Society. Published by Elsevier Inc.
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Loṕez et al.1105 used coarse-grained MD simulations to
study the influence of different lipid bilayer compositions on
the membrane association of the CD3ϵ cytoplasmic tails of the
cluster of differentiation 3 T-cell receptor. The simulations
suggested that the CD3ϵ tail preferentially bound to the
negatively charged lipids (PG and PI) and that this binding
was strengthened by the canonical immunoreceptor tyrosine-
based activation motif. In contrast, zwitterionic lipids provided
a less favorable environment for binding. The study revealed
that the external shell of local positive charges, present in the
zwitterionic lipids (choline groups), and the tight lipid packing
in more ordered lipids (such as DPPC) was responsible for the
decreased binding of the CD3ϵ tail. The study also
demonstrated that the entire CD3ϵ chain preferentially
localized in the boundary region between the Lo and Ld
domains when incorporated as a monomer (see Figure 57).
However, the chemical potential of the CD3ϵ chain was
affected by the addition of GM1, which shuttled the CD3ϵ
chain into the Lo domain (Figure 57) through specific
interactions with the extracellular domain.
Very recently, coarse-grained simulations were employed to
explore the behavior of the transmembrane domain of amyloid
precursor protein (APP) that was affected by the lipid raft
microenvironment. Sun et al.1106 showed that the trans-
membrane domain of APP was attached at the boundary of the
lipid raft and that this anchoring relied on the conserved
hydrophobic motif of V710xxA713xxxV717xxxV721. However,
monomers and homodimers of the transmembrane domain
of APP were not observed to enter the lipid raft. Moreover, the
dimerization of the transmembrane domain of APP was
disrupted by the lipid raft. The study suggested that the driving
forces of this disruption were derived from the combined
regulation of the saturated lipids and cholesterol molecules
rather than from the binding competition of cholesterol to the
transmembrane domain of APP.
Lorent et al.1107 quantified the raft affinity for dozens of
protein transmembrane domains using both experiments and
coarse-grained simulations. They suggested that transmem-
brane domain area and length and the presence of
palmitoylation affected protein raft partitioning. They found
that plasma membrane proteins had a higher raft affinity than
those of intracellular membranes. These findings are consistent
with the hypothesis that trafficking to the plasma membrane is
partially mediated by raft domains and explains the observation
that plasma membrane is enriched in proteins containing long
and thin transmembrane domains.1108
Coarse-grained and atomistic MD simulations comple-
mented by free energy calculations were employed by Lin et
al.1109 to study the sorting of the linker of activation of T cells
(LAT) between coexisting membrane domains. MD simu-
lations revealed that palmitoylation and hydrophobic length
were essential for preferential interactions between the
transmembrane domain of LAT and the lipids in the ordered
phase: The simulations showed that long palmitoylated
peptides interacted more preferentially with liquid-ordered
domain lipids as compared to shorter and depalmitoylated
peptides. Interestingly, an enrichment of peptides at the Lo/Ld
interface was observed. It was suggested that this effect
stemmed from “an inherent polarity of the peptide with respect
to its interaction with the coexisting phases.”
Kaiser et al.1110 used atomistic MD simulations and
biochemical experiments to study the lateral sorting of
transmembrane peptides by cholesterol-mediated hydrophobic
mismatch. The authors demonstrated that the presence of
cholesterol forces the membrane, containing high amounts of
transmembrane peptides, to undergo collective rearrangement.
This research suggests that steric confinement of lipid acyl
chains by cholesterol may be one of the physiological roles of
cholesterol.
Grau et al.1111 explored the role of hydrophobic mismatch
on transmembrane helix packing in a cellular environment
using atomistic MD and biochemical experiments. Using the
dimerization of glycophorin A as a test case, they showed that
biological membranes can accommodate transmembrane
homodimers with a wide range of hydrophobic lengths. This
study indicates that biological membranes can adapt to
structural deformations through compensatory mechanisms
that emerge from their complex structure and composition to
alleviate membrane stress.
Summarizing, lipid-mediated protein sorting and compart-
mentalization are crucial in many cellular processes, and their
disruption leads to severe pathological conditions. However,
lipid-mediated protein sorting is still poorly understood, and
more studies bridging computational and experimental
approaches are needed to understand the molecular mecha-
nisms in sufficient detail.
8.3. Allosteric Modulation of Membrane Proteins by Lipids
For decades, the development of ligands in traditional drug
discovery has focused on targeting membrane receptors’
orthosteric binding sites defined as sites where the endogenous
ligands bind to elicit signal transduction. This approach has
guided the development of classical orthosteric ligands that
directly activate the target receptor (agonists) or block the
actions of the endogenous ligand (antagonists/inverse
agonists). However, in recent years there has been increasing
therapeutic interest for effector molecules that bind to other
than the receptor’s (orthosteric) active site. These sites are
known as allosteric. Many allosteric modulators have little or
no agonist or inverse agonist activity themselves, but they
affect the receptor’s response to endogenous agonists and
other ligands. Allosteric modulators usually elicit a conforma-
tional change in the receptor structure while still allowing, in
many cases, simultaneous binding of orthosteric ligands−thus
modulating the pharmacological characteristics of the orthos-
teric agent.
There is a growing number of experimental studies
demonstrating the putative role of membrane lipids as
allosteric modulators of membrane protein function. For
example, the lipid sensitivity of nAChR has been known since
the earliest attempts to isolate and reconstitute nAChR
function in model membranes. nAChR must be purified in
the presence of lipids and then placed in a bilayer with an
appropriate lipid composition1112 to recover agonist-induced
channel flux. Both anionic lipids, such as phosphatidylserine or
phosphatidic acid, and neutral lipids, such as cholesterol or
diacylglycerol, appear to be necessary for the receptor’s
activity.1113−1115 Lipids also play an essential role in regulating
receptor kinase EnvZ function both by the interaction with the
transmembrane segments and by the interplay with non-
embedded peripheral domains. Specifically, the dynamics and
the activity of a glycine-rich motif that is critical for
phosphotransfer from ATP1116 is allosterically modulated by
the lipid membrane. Furthermore, it has been shown that the
lipid composition has a profound regulatory effect on kinase
domain activation of the human epidermal growth factor
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receptor,1117 where the ganglioside GM3 inhibited the
autophosphorylation of the EGFR kinase domain. These
results demonstrated that GM3 exhibits the potential to
regulate the allosteric structural transition from an inactive to a
signaling EGFR dimer by preventing the autophosphorylation
of the intracellular kinase domain in response to ligand
binding.
Here we summarize the computational studies where lipids
have been shown to act as allosteric modulators, thereby
modulating the structure and the dynamics of membrane
proteins. In this context, lipids bound to specific lipid binding
sites reviewed in section 7 can also be seen as potential
allosteric modulators, though it is not always clear whether
these interactions modulate receptor activity.
Coarse-grained molecular dynamics simulations were used
to study the interaction of the β2-adrenergic receptor with
membrane lipids and to explore the direct and indirect
membrane effects that could be important in receptor
dimerization.1030 The analysis of the local membrane thickness
around the receptor, embedded in a bilayer with 0 and 50 mol
% cholesterol, showed hydrophobic mismatch at helices 1/7
and 4/5, which was partially alleviated in the presence of
cholesterol. In the absence of cholesterol, the receptor
dimerization was observed via the interface involving trans-
membrane helices 4 and 5, while in the presence of cholesterol
dimers with a different interface (involving transmembrane
helices 1 and 2) were formed. Detailed analysis of the
trajectories also revealed several cholesterol binding sites;1118
one of them was found on the transmembrane helix 4. The
authors hypothesized that in the cholesterol-containing bilayer
this site was occupied by sterol and the dimerization through
transmembrane helices 4 and 5 was disrupted. The result
seems to suggest the alleged role of cholesterol in GPCR
dimerization involving direct competition of protein−lipid and
protein−protein interactions.
Manna et al.54 used extensive all-atom simulations to clarify
the mechanisms responsible for the modulatory role of
cholesterol on the β2-adrenergic receptor. In a cholesterol-
free DOPC bilayer, the receptor was found to adopt a wide
range of conformations both on the ligand binding side and on
the G protein side. In the presence of cholesterol, the situation
changed dramatically, and the conformational flexibility of the
receptor was significantly reduced. The receptor stayed
predominantly in one conformation, and no further opening/
closing of the ligand-binding site or G protein-binding sites
was observed. The restriction of receptor flexibility occurred in
bilayers with cholesterol concentration above 5 mol %. At
lower levels (2 and 5 mol %), the distribution of the receptor’s
conformation was broader and comparable to that of a
cholesterol-free membrane. The authors ruled out the
possibility that changes in physical membrane properties
(such as bilayer thickness and lipid acyl chain order) would be
responsible for the restriction of the conformational dynamics
of the receptor and concluded that the cause of the observed
changes in β2-adrenergic receptor conformation and dynamics
is the specific binding of cholesterol to the receptor.
In their atomistic study on the effect of membrane
properties on the A2A adenosine receptor, Ng et al.
1028
demonstrated that the bulk properties of lipid membranes
could also modulate the dynamics of the receptor. In this
study, the distinct chemical nature of POPC and POPE lipids
resulted in different dynamic behavior of the receptor. The
principal component analysis revealed that different receptor
dynamics stemmed from a combination of the different loop
movements (overall more mobile in POPC as compared to
POPE bilayer) and the divergent interhelical motions between
the two lipid systems. The authors hypothesized that this effect
could be a consequence of protein adaptation to the changing
hydrophobic thickness in POPC and POPE bilayers.
Zhang et al.1119 employed all-atom molecular dynamics
simulations, mutagenesis, and electrophysiological measure-
ments to study the effect of PIP2 on the voltage sensitivity of a
voltage-gated potassium channel. As a case study, they used
KCNQ2, which is a member of the KQT family of slowly
activated outwardly rectifying potassium channels. The analysis
of both experimental and computational data suggested that
PIP2 upregulated both the current amplitude and the voltage
sensitivity of KCNQ2 and that PIP2 preferentially interacted
with the S4−S5 linker of the open-state KCNQ2 channel. On
the other hand, in the closed state, PIP2 only interacted with
the S2−S3 loop (see Figure 58). Interestingly, the disruption
of the interaction of PIP2 with the S4−S5 linker might decrease
both the voltage sensitivity and the current amplitude, whereas
disruption of the interaction with the S2−S3 loop only altered
the current amplitude of the channel. The results strongly
indicated the involvement of PIP2 allosteric modulation in the
mechanism of action of KCNQ2.
Delemotte et al.1120 used atomistic MD simulations to study
the membrane-bound Kv1.2 channel subjected to a hyper-
polarized potential. They used biased and unbiased MD
simulations to reveal the initial steps of the voltage sensor
domain participation in the channel deactivation mechanism.
The simulations showed that the conformational changes
taking place within the voltage sensor domain involved a
zipper-like motion of the basic residues, resulting in sequential
ion pairing with nearby counter charges from the voltage
sensor domain and lipid headgroups from both the upper and
lower membrane leaflets. The presence of lipid headgroups was
essential, and it was shown to have a dramatic effect on the
voltage-gated channel function in general. For example, the
Figure 58.Mechanism of PIP2 action on the KCNQ2 channel. PIP2 is
anchored at the S2−S3 loop in the closed state (bottom). Upon
channel activation, PIP2 interacts with the S4−S5 linker (top). PIP2 is
shown in magenta. Reproduced with permission from ref 1119.
Copyright 2013 Zhang et al.
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activation of K+ voltage-gated channels may be disrupted when
they are embedded in bilayers formed by cationic lipids.1121
What is more, the removal of the lipid headgroups by enzymes
also resulted in immobilization of the voltage sensor domain
motion, thereby inhibiting channel function.1122,1123
Lingwood et al.1124 employed a set of experimental and
computational methods to study the modulation of glyco-
sphingolipids by cholesterol. Glycosphingolipids are essential
communication devices used by cells for signaling, microbial
and cellular adhesion processes, and immunological recog-
nition. The paper showed that membrane cholesterol is a
critical molecule in regulating glycolipid conformation and
therefore receptor function. Cholesterol changed receptor
availability by inducing a membrane-parallel glycolipid head-
group configuration. This feature seemed to have a crucial role
in the presentation of erythrocyte blood groups and in the
exposure of sperm sugar residues during conversion to the
fertile state.
The interactions between serotonin 1A receptor and
ganglioside GM1 were studied by Prasanna et al.1125 using
coarse-grained MD simulations. Ten independent simulations,
each 10 μs long, were used to examine the molecular basis of
the interaction of GM1 with the serotonin 1A receptor.
Simulations showed that GM1 interacted with the serotonin
1A receptor predominantly at the extracellular loop 1 and
precisely at the sphingolipid-binding domain. This motif
consisted of a specific combination of aromatic, basic, and
turn-inducing residues, and was evolutionarily conserved. The
interaction of the sphingolipid-binding domain with GM1
appeared to stabilize the specific conformation of the receptor.
The population of this conformation also increased in the
presence of cholesterol. The results suggest a direct role of
lipid−GPCR interaction in modulating ligand binding and
receptor function.
Here, we reviewed the recent progress in elucidating
allosteric modulation utilizing MD simulations. The above-
discussed studies demonstrate the significance of computa-
tional approaches in unraveling the molecular mechanisms of
protein allosteric regulation by lipids. Generally speaking,
regulation of protein structure and function is crucial to all
organisms. All cellular processes are carefully controlled. If the
control machinery fails, then the outcome is often a disease.
While allosteric regulation is one of many means of cellular
control, it is also a particularly interesting and not well
understood one, stressing the importance of exploiting
computer simulations to further our understanding of lipid-
based allosteric modulation mechanisms.
8.4. Lipids Mediate Interactions of Drugs and Other Small
Molecules with Proteins in Biomembranes
Interaction of drugs and small molecules with biological
membranes is a critical and somewhat complicated process in
living cells. For instance, 60% of currently marketed
pharmaceuticals target peripheral and membrane proteins,993
making the binding of small molecules with membranes one of
the critical steps in pharmacodynamics. Further, many
membrane-bound transporters and membrane proteins have
their binding sites located deep in a bilayer, thus the
understanding of the dynamics of drugs bound to membranes
is crucial both for drug discovery and drug delivery. Below, we
review recent MD simulation studies in this context, paying
particular attention to the interplay of anesthetics and
neurotransmitters with biological membranes.
8.4.1. Anesthetics. Arcario et al. performed atomistic MD
simulations of desflurane1126,1127 to study its binding to the
Gloeobacter violaceus ligand-gated ion channel. Simulations
revealed two anesthetic binding sites: the TM1 site, which was
previously observed in the experimental studies,1128 and the
TM2 site, which has not yet been confirmed experimentally.
Interestingly, to reach both binding sites, the desflurane must
f irst partition to the lipid membrane. Moreover, the study
observed asymmetric binding of desflurane to the channel, and
this binding promoted a specific conformational change of the
protein, resulting in dehydration of the central ion pore and
creation of a 13.5 kcal/mol barrier to ion translocation.
The role of the lipid bilayer in capsaicin binding to the
transient receptor potential vanilloid subtype 1 (TRPV1) was
studied by Hanson et al.1129 TRPV1 is a heat-sensitive ion
channel also involved in pain sensation, with an intracellular
capsaicin binding site. Atomistic MD simulations of capsaicin
in a POPC bilayer showed capsaicin to undergo translocation
from the extracellular to the intracellular leaflet, thereby
crossing a barrier of 6 kBT as estimated by the potential of
mean force calculations. The spontaneous capsaicin trans-
location was also observed in unbiased simulations. The results
suggest a possible mechanism for capsaicin binding to TRPV1:
capsaicin penetrates the lipid bilayer, and then flips from the
extracellular to the intracellular leaflet to access the TRPV1
binding site.
An impressive set of over 500 independent coarse-grained
MD simulations were carried out by Melo et al.1130 to study
the effect of alcohol on the opening of the mechanosensitive
MscL channel. The simulations demonstrated the MscL
opening time to increase with the addition of unbranched
alcohols. This effect saturated at longer alcohol chain lengths
and higher alcohol concentrations. Fluorescence assays verified
the theoretical predictions. Detailed analysis indicated that the
alcohol-induced stabilization of the closed state of the MscL
channel originated not from specific alcohol−MscL inter-
actions but from the combination of the alcohol-induced
changes to a number of bilayer properties (area per lipid,
bilayer thickness, area compressibility, lipid diffusion, and
average lipid chain order parameter) and modulation of the
MscL−bilayer interface.
Jerabek et al.1131 studied the membrane-mediated effect of
ketamine on ion channels. MD simulations showed that the
membrane thickness and lateral area per lipid were not affected
by the addition of ketamine (up to 8 mol %). However,
significant changes in the lateral pressure were observed within
the membrane−water interface due to the insertion of
ketamine. It was hypothesized that these changes would be
substantial enough to affect the probability of membrane ion
channel opening.
Mojumdar and Lyubartsev1132 examined the structural and
dynamical properties of a local anesthetic (articaine) in DMPC
bilayers. MD simulations for the neutral and protonated forms
of articaine inserted in fully hydrated lipid bilayers revealed
that while some properties of these two anesthetics were very
similar (for example, the location in a lipid bilayer and the
effect on the lipid headgroup angle), some other properties
differed substantially (for example, the orientation of the
charged form in the membrane and the hydrogen bonding
network). Interestingly, the presence of the neutral articaine
molecules in model bilayers increased the electrostatic dipole
potential inside the bilayer due to the dipole moments of the
articaine’s carbonyl groups and their preferential orientation in
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the bilayer. Given that the neutral form of articaine is
predominant at neutral pH and the electrostatic potential of
the lipid bilayer governs the functionality of ion channels, it is
possible that the anesthetic effect of articaine stems from its
perturbation of the membrane dipole moment, which, in turn,
disrupts the normal operation of voltage-gated ion channels.
Articaine was also a subject of research in another MD study
conducted by Skjevik et al.1133 The simulations showed that
the increased ability of articaine to reach the bone tissue in
comparison with other local anesthetics is due to its ability to
form intramolecular hydrogen bonds. The authors hypothe-
sized that this H-bonding network may be responsible for the
higher lipophilicity of articaine, which, in turn, would improve
its therapeutic efficiency.
Cascales et al.1134 performed a series of MD simulations of
benzocaine insertion into symmetric lipid bilayers composed of
different ratios of DPPC and DPPS. Biased MD simulations at
different temperatures indicated that a maximum in the free
energy profile was located at the membrane−water interface
region. The free energy barrier appeared to be exponentially
dependent on the DPPS content in the lipid bilayer. However,
the minimum free energy within the lipid bilayer remained
almost independent of the lipid composition. By repeating the
simulations at different temperatures, the authors demon-
strated that the spontaneity of benzocaine insertion into the
lipid bilayer was due to an increase in entropy associated with
the insertion process.
Propofol is an anesthetic widely used for inducing general
anesthesia, and it binds to pentameric ligand-gated ion
channels with high affinity.1128 Hansen et al.1135 used MD
simulations and experiments to study propofol behavior in
DPPC bilayers. The simulations revealed that the depth of
propofol molecules inside the lipid bilayers coincided with the
depth of the protein’s binding sites. Additionally, the drug
molecules in the membrane ordered the lipid acyl chains, but
contrary to that with cholesterol, the ordering effect was
observable only for carbon atoms near the membrane−water
interface.
The interactions between enfuvirtide and lipid bilayers were
the subject of studies conducted by do Canto et al.1136
Enfuvirtide is a peptide, which reduces HIV progress by
inhibiting the fusion of the HIV envelope with the cell
membrane. The simulations indicated that enfuvirtide
interacted less with model lipid bilayers as compared to
other more efficient peptides. It was hypothesized that the
ability to communicate with biological membranes is crucial in
the development of potent anti-HIV drugs; low affinity to lipid
bilayers implies low local concentration of the peptide, which,
in turn, affects the bilayer surface’s ability to act efficiently as a
reservoir for the antifusion peptide. This suggestion was later
confirmed in a study by Leonis et al.,1137 where a favorable
conformation of darunavir (human immunodeficiency virus
type 1 protease inhibitor) was maintained by the hydrogen
bonds formed between lipids and water.
The above examples show that anesthetics can fulfill their
function in the cells either by directly modulating protein
structures or by altering the physical properties of membranes
in which they reside. The latter mode of action can change the
fluidity, order, or lateral pressure profile of lipid bilayers, which,
in turn, affects the bioavailability and efficiency of a given drug.
Further, for completeness, there is reason to mention that the
anesthetic−membrane interactions have recently been ad-
dressed also in many other MD studies not described in detail
in this review. These include the effects of bromoform,1138
sevoflurane,1139 tetracaine and caffeine,1140 lidocaine and
chloroform,1108,1127 articaine,1141 xenon,1142 bupivacaine,1143
benzocaine,1144,1145 diethyl ether and enflurane,1146−1148
halothane,1146,1149,1150 and alkylphenols.1151
8.4.2. Neurotransmitters. Neurotransmitters are endog-
enous small molecules unevenly distributed in the neuronal
tissues with concentrations reaching rather high levels inside
the synaptic vesicles1152,1153 and in the synaptic clefts.1154 Such
high concentrations of neurotransmitters should allow neuro-
transmitter partitioning into synaptic membranes, if the
partition coefficients and rates of diffusion were sufficiently
high. Indeed, Seeger et al.1155 showed experimentally that the
interaction between serotonin and neutral membranes results
in a decrease of the membrane main phase transition
temperature. Neurotransmitters may also affect neuronal
signaling through direct ligand−neuroreceptor interactions as
well as through an indirect lipid-mediated mecha-
nism.1153,1156,1157 Here, we review recent computational
studies that have shed light into the molecular mechanisms
of neurotransmitter modes of action.
Peters et al.1158 used MD simulations to study the
interactions between a series of neurotransmitters (γ-amino-
butyrate, glycine, acetylcholine, and glutamate) and a DPPC
bilayer. The simulations uncovered that the charged neuro-
transmitters demonstrated the lowest lipid membrane affinity,
while zwitterionic and polar neurotransmitters showed
moderate affinity. The membrane affinity of neurotransmitters
was ranked as follows: acetylcholine ≈ glutamate ≪ γ-
aminobutyrate < glycine. Glycine penetrated the bilayer the
most, with the deepest location being close to the glycerol
backbone of lipids. However, even at this position, it was
strongly hydrated. Free energy profiles obtained from umbrella
sampling simulations showed a minimum of about 0.48−0.72
kcal/mol close to the membrane−water interface for acetylcho-
line and glutamate, while for γ-aminobutyrate and glycine, a
minimum of, respectively, 0.48 and 1.2 kcal/mol was observed
in the vicinity of the lipid glycerol backbone.
MD simulations in combination with thermodynamic
measurements were applied to study the interaction of
serotonin with DPPC and DOPC bilayers.1159 Serotonin is a
monoamine neurotransmitter, which is commonly considered
to be a significant contributor to the feeling of happi-
ness.1160,1161 Peters et al.1159 demonstrated through MD
simulations and thermodynamic measurements that serotonin
interacted strongly with DPPC and DOPC bilayers, which is
highly unusual for a hydrophilic solute like serotonin (the oil−
water partitioning coefficient for serotonin is well below one).
The authors hypothesized that this behavior stems from
specific neurotransmitter−lipid interactions. Indeed, as the
most prominent interaction the MD simulations identified the
salt-bridge between the amine group of serotonin and the lipid
phosphate group. This salt-bridge anchored the positively
charged serotonin at the membrane−water interface, with the
aromatic ring system pointing inward. The most probable
serotonin location was identified to be between the phosphate
and the carbonyl groups of the lipid bilayer. Interestingly, the
deprotonated form of serotonin showed the opposite
orientation, with the amine group pointing toward the
membrane core.
The interactions of dopamine and its precursor L-dopa with
membrane lipids were investigated by Orlowski et al.1162 using
atomistic MD simulations. They demonstrated that both
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dopamine and L-dopa interact with lipid headgroups via
hydrogen bonds and electrostatic interactions. These inter-
actions anchored the neurotransmitter molecules to the
membrane−water interface. Interestingly, the strength of
neurotransmitter−lipid interactions strongly depended on the
lipid type. In the mixed-lipid bilayer containing anionic
phosphatidylserine, one observed complete adsorption of
both dopamine and L-dopa at the bilayer surface. However,
this adsorption was incomplete at the surface of a pure
zwitterionic PC bilayer. The study hypothesized that the
excessive association of dopamine and L-dopa with the lipid
bilayers containing phosphatidylserine may limit the free use of
dopamine as a synaptic transmitter, which, in turn, could be a
possible molecular mechanism responsible for some of the
neurodegenerative disorders. This hypothesis agrees with a
post-mortem study on the brain lipid composition, where it
was shown that, in schizophrenic patients, the levels of
phosphatidylcholine, sphingomyelin, and galactocerebrosides
were decreased, while the phosphatidylserine level was
increased.1163,1164
Wang et al.1165 drew similar conclusions regarding the role
of anionic lipids. In this study, based on dialysis equilibrium
studies, calorimetric measurements, and MD simulations, the
authors studied an anionic (glutamate), a cationic (acetylcho-
line), and two zwitterionic (γ-aminobutyric acid and glycine)
neurotransmitters in lipid bilayers of different compositions.
The simulations revealed that the zwitterionic neurotransmit-
ters were attracted to lipid membranes containing anionic
lipids, with their local concentration at the membrane−water
interface being 5−10 times larger than in the aqueous bulk.
This attraction was mainly driven by electrostatic interactions
of the neurotransmitter amine group and the lipid phosphate
group.
Shen et al.1166 used atomistic MD simulations to study the
insertion dynamics of several neurotransmitters (methionine
enkephalin, leucine enkephalin, dopamine, acetylcholine, and
aspartic acid) at the atomic scale. The simulation results
showed that the methionine enkephalin, leucine enkephalin,
and dopamine were able to insert freely into both POPC and
POPE membranes and that the aromatic residues guided this
insertion. However, only a limited number of neurotransmitter
molecules were able to diffuse into the lipid membrane,
suggesting the existence of an intrinsic mechanism by which
the lipid membrane is protected from being destroyed by
extreme insertion of neurotransmitters. In contrast, acetylcho-
line and aspartic acid were observed to diffuse freely in the
solution and never be incorporated into the lipid bilayers.
Experiments and MD simulations were also employed to
study the effect of melatonin on the DPPC and DOPC
bilayers.1141,1168 The simulations revealed that melatonin
increased the lipid headgroup area and decreased the thickness
of model bilayers by disordering the lipid hydrocarbon chains,
thus increasing membrane fluidity. When both melatonin and
cholesterol were present in the systems, the compression
Figure 59. Mechanisms of neurotransmitter release. (A) Classical membrane-independent mechanism and (B) membrane-dependent mechanism.
Reproduced with permission from ref 1167. Copyright 2016 Postila et al. (https://creativecommons.org/licenses/by/4.0/legalcode).
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isotherms were close to those of the pure lipid monolayer
systems, indicating that melatonin was able to alleviate
cholesterol’s effects.
An extensive set of atomistic simulations were conducted by
Postila et al.1167 to probe the neurotransmitter interactions
with postsynaptic lipid membranes. In this study, 13
neurotransmitters were simulated in multicomponent model
bilayers mimicking postsynaptic membranes. The simulations
revealed that neurotransmitters explored in this study fall into
two categories: membrane-binding (dopamine, serotonin,
epinephrine, norepinephrine, melatonin, and adenosine) and
non-membrane-binding (γ-aminobutyric acid, acetylcholine,
serine, aspartate, and glutamate). Interestingly, this classifica-
tion agrees with the location of the neurotransmitter-binding
sites in the synaptic receptors. G protein-coupled receptors
were found to be receptors for membrane-binding neuro-
transmitters with a membrane-buried ligand-binding site (see
Figure 59). In contrast, the non-membrane-binding neuro-
transmitters were demonstrated to have extracellular ligand-
binding sites positioned above the cell membrane surface (see
Figure 59). Atomistic MD simulations provided substantial
evidence that the neurotransmission process follows either the
membrane-independent or the membrane-dependent mecha-
nism, and that the receptor’s ligand-binding site position has a
decisive role in the selection between these two mechanisms.
Very recently, Mokkila et al.1169 studied the effect of
physiologically relevant ions (Na+, K+, Ca2+) on dopamine−
membrane interactions using atomistic MD simulations.
Cations are essential components of neurosignaling; hence
the influx of Ca2+ ions into the presynaptic neuron is a trigger
for neurotransmitter release.1170 This work showed that high
calcium levels could efficiently decrease dopamine binding to
phosphatidylcholine lipid bilayers. Based on these results and
the fact that the intravesicular space of presynaptic vesicle is
kept at a pH of 5.6, assuring that the phosphatidylserine
present in the inner leaflet is efficiently rendered neutral, the
authors argued that the lipid content and the low pH inside the
vesicles, together with an active inward pumping of divalent
cations prevents neurotransmitter accumulation at the inner
leaflet surfaces of the presynaptic vesicles. The dopamine−lipid
bilayer simulations described in this study allow one to draw
the conclusion that both the inner leaflet phospholipid
composition and the divalent cation content of the presynaptic
vesicles are somehow optimized for neurotransmitter release
into the synaptic cleft.
In summary, the above examples show that MD simulations
can be successfully applied to study not only the lipid bilayer−
protein interactions but also the membrane−small molecule
interplay in cellular membranes. The simulations of model
membranes can elucidate how neurotransmitters and anes-
thetics interact with lipid bilayers, thus expanding our
understanding of their therapeutic actions. Finally, the
atomistic insight into membrane−small molecule interactions
enables us to understand the membrane-independent as well as
the membrane-dependent mechanisms of anesthesia and
neurosignaling.
8.5. Lipids Guide the Binding of Peripheral Proteins to
Biological Membranes
Peripheral membrane proteins constitute a family of a
structurally diverse subset of membrane proteins involved in
cellular signaling.1171 They play a pivotal role in the initiation
of key biological processes such as the blood coagulation
cascade1172 or viral fusion.1173 The essentiality of lipid
membranes in the binding and activity modulation of
peripheral membrane proteins is well established, but more
work is needed to clarify the coupling between specific
protein−lipid interactions and observable protein action.
Experimental studies on peripheral proteins, especially the
determination of three-dimensional membrane-bound struc-
tures, are challenging. Even when the crystal structure has been
solved, the dynamic properties such as the activation
mechanism upon ligand binding or large-scale conformational
changes due to allosteric protein−lipid interactions cannot be
addressed, since after all the crystal structure is static. The
difficulty to crystallize membrane-bound peripheral proteins
and to solve their three-dimensional structure using, for
example, X-ray diffraction stems from the transient character of
interactions between peripheral proteins and biomembranes,
and the fact that peripheral proteins function at the
membrane−water interface where the electrostatic environ-
ment changes rapidly. There are also other experimental
methods able to shed light on protein structure, such as NMR,
EPR, FRET, and small-angle X-ray scattering (SAXS), but the
information they provide about protein−lipid interactions is
usually insufficient to determine the protein−membrane
interface, which is crucial to understand the mechanism of
action of peripheral proteins.
The binding of peripheral membrane proteins with lipid
membranes is classically described as an electrostatically driven
process followed by the insertion of hydrophobic groups into
the lipid bilayer. Electrostatic forces between the negatively
charged bilayers and clusters of basic amino acids on the
protein surface bring the protein into a specific, binding-prone
orientation relative to the lipid bilayer. In essence, electrostatic
forces play a significant role in the function of peripheral
membrane proteins.1174,1175 Experimental and computational
studies have revealed that nonspecific electrostatic interactions
can contribute up to a few kilocalories per mole to the overall
protein−membrane affinity and that each basic amino acid
contributes up to 1 kcal/mol to the total binding free
energy.1175−1177
Here, we discuss recent computational studies trying to
address the question−how do biological membranes guide and
modulate the binding of peripheral proteins? We focus our
attention on anionic lipids, with the strongest interest in
phosphatidylinositols.
8.5.1. Phosphatidylinositols. Several MD studies have
recently investigated the interactions of various peripheral
membrane proteins with phosphatidylinositols (PIs). The
importance of the PI lipid interactions with peripheral proteins
is highlighted by the fact that, for example, they appear to be
specifically involved in the control of many cellular events,
such as the organization and dynamics of critical signaling
pathways, the actin cytoskeleton rearrangement, and the
intracellular vesicle trafficking.1090−1092 What is more, the
unique feature of PIs, which can be synthesized rapidly and
degraded in discrete membrane domains, makes them ideal
regulators of fast and dynamic mechanisms of cell regulation.
A neuron-specific membrane-binding protein, called auxilin-
1, was studied by Kalli et al.910 This protein is involved in the
late stage of clathrin-mediated endocytosis, which enables
extracellular material, including membrane receptors and
ligands, to be imported into cells through the formation of
clathrin-coated vesicles.1178 Auxilin-1 binds to the newly
budded clathrin-coated vesicles and facilitates the recruitment
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of the uncoating enzyme that removes the clathrin coat. To
fulfill its function, auxilin-1 has to attach correctly to the lipid
bilayer surface. Kalli et al.910 suggested a model for the
protein−membrane encounter of the auxilin-1 phosphatase
and tensin homologue (PTEN)-like domain using multiscale
MD simulations. They showed that the negatively charged
Figure 60. PH domain binding to PIP2 lipids. (left) Simulation snapshot of a PH domain in the bound state with PIP2. The PH domain is shown in
gray; DOPC phosphorus atoms are depicted as pink spheres. (right) Potential of mean force profiles for the PH domain of the ACAP1BAR‑PH
protein dimer bound to PIP2 at pocket 1 and pocket 2. Reproduced with permission from ref 1184. Copyright 2017 American Chemical Society.
Figure 61. Pleckstrin homology domain−PIP complexes. Alignments of the PH/PIP complexes were derived from the MD simulations.
Reproduced with permission from ref 1185. Copyright 2016 Yamamoto et al. (https://creativecommons.org/licenses/by/4.0/legalcode).
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lipids (especially PIP2) enhance the binding of the auxilin
PTEN-like domain to lipid bilayers and facilitate its correct
orientation with respect to the membrane. Subsequent in silico
mutations of three basic residues in the C2 subdomain of
auxilin were observed to perturb its interaction with the lipid
bilayer and result in changing the protein orientation.
Interestingly, the interaction of membrane-bound auxilin-1
with negatively charged lipid headgroups resulted in clustering
of PIP2 in the adjacent bilayer leaflet. Similarly, Kalli et al.
1179
reported the clustering of PI lipids around a voltage sensitive
phosphatase PTEN domain (Ci-VSP PD). Simulations
suggested that PIP3 lipids bind to Ci-VSP PD in the vicinity
of the protein active sites and that this binding is structurally
similar to that of auxilin PTEN. The authors proposed a novel
mechanism of association of PTEN with a lipid bilayer,
including protein reorientation to optimize its interactions with
PIP molecules. In contrast to auxilin PTEN, Ci-VSP binds
directly to PIP-containing membranes without a subsequent
reorientation step.
The pleckstrin homology (PH) domain of the general
receptor of phosphoinositides 1 (GRP1) selectively binds to
PIP3 lipids. The GRP1 PH domain has been the focus of a
number of computational studies1180−1183 using a wide range
of simulation methodologies. MD simulations revealed both
translational and orientational electrostatic steering of the PH
domain toward the PIP3-containing bilayer surface. Computa-
tional studies also suggested that the background anionic
phosphatidylserine lipids play a critical role in the initial stages
of protein recruitment to the membrane surface through
nonspecific electrostatic interactions. The experimentally
observed preference of GRP1-PH for PIP3 over PIP2 and the
presence of a noncanonical PIP-interaction site observed
previously in other PH domains but not in GRP1-PH were also
revealed. These studies demonstrate how combining Brownian
MD, coarse-grained MD simulations, and umbrella sampling
can elucidate the molecular mechanisms and energetics of
interactions between peripheral membrane proteins and
complex cellular membranes.
Similarly, the BAR-PH domain of ACAP1 protein was a
subject of computational studies by Chan et al.1184 The
ACAP1 protein belongs to the GTPase-activating proteins that
act on the ADP-ribosylation factor (ARF) family that also
serves as a vital component of a clathrin complex for endocytic
recycling. The authors investigated the molecular details of the
protein−lipid interactions of ACAP1BAR‑PH protein using both
restrained and unbiased atomistic MD simulations as well as
free-energy umbrella sampling calculations. The simulations
revealed that the PH domains of an ACAP1BAR‑PH dimer
underwent orientation changes during the membrane binding
process. The study showed two PIP2-binding pockets on the
PH domain. Preference of the PH domain binding to PIP2
lipids over POPS lipids was explained by the comparison of the
PMF profiles generated by umbrella sampling simulations (see
Figure 60). Exploring the free energy surface of the protein−
lipid systems uncovered a much deeper free energy well when
PIP2 was in either binding pocket of the protein, compared to
the case of POPS.
Recently, Yamamoto et al.1185 reported MD simulations of
the membrane localization and interactions of 13 different PH
domains (see Figure 61). The study showed that the β1/β2
loop region of PH domains is the primary PIP-binding site.
The simulations were also able to identify secondary
(noncanonical) lipid-binding sites on PH domains, suggesting
that multiple lipid interactions were crucial for the binding of
PH domains to membranes. In addition to the PIP binding
sites, the clustering of PIP lipids around the PH domains was
observed. To this end, the authors developed a computational
protocol employing both coarse-grained and atomistic MD
simulations that could yield structural data for PH/PIP
complexes. These structures are directly comparable to the
structures obtained from NMR and X-ray crystallography. The
authors showed that a high-throughput coarse-grained
simulation approach, generating ensembles of simulations,
can successfully be used to study the structural and dynamic
features of the association of peripheral membrane proteins
with model membranes.
Atomistic MD simulations of a homologue oxysterol binding
protein (Osh4) were used to characterize the structure and
molecular mechanism of protein attachment to various model
lipid membranes.1186 A single binding conformation was found
regardless of the nature of the negatively charged lipid used.
Membrane binding of Osh4 was relatively fast (about 100 ns)
and remained stable for at least 1 μs. The study showed that
Osh4 interaction with the lipid membrane primarily involves
electrostatic interactions, but a hydrophobic anchor (phenyl-
alanine loop) and specific hydrogen bonding also promote
stable Osh4−membrane interactions.
Pleskot et al.1187 studied the interactions of the actin-
capping protein (CP) with phosphatidic acid and PIP2. CP
binds to the barbed end of actin filaments and inhibits both
addition and loss of actin monomers at this end. The ability of
CP to bind filaments is highly regulated by signaling
phospholipids, which inhibit CP activity. Using homology
modeling, molecular docking, and coarse-grained MD
simulations, the authors addressed the high-affinity interactions
between plant CP and membranes containing PA. A similar
study has been done for systems containing animal CP and
PIP2.
1187 Computational studies identified some structural
differences in the C-terminal part of the protein, leading to
different binding of membrane lipids by animal and plant CP.
The study was also able to locate the PA-binding domain of
plant CP and experimentally showed that it was sufficient to
drive membrane binding in vitro.
Actin-capping protein is not the only protein taking part in
the organization and dynamics of the actin cytoskeleton
modulated by membrane phosphatidylinositols.1189 Combina-
tion of mutagenesis and biochemical experiments together with
atomistic MD simulations has been utilized in a very recent
study to elucidate how mouse twinfilin-1 interacts with
phosphatidylinositols.1188 The study revealed that the high-
affinity lipid-binding site is located at the C terminal region of
twinfilin and that the actin depolymerizing factor homology
domains bind to phosphatidylinositol-rich domains only with
low-affinity. MD simulations showed that twinfilin is initially
tethered to the membrane through its C-terminal tail and that
this interaction leads to subsequent association of actin
depolymerizing factor homology domains with the bilayer,
resulting in inhibition of their actin-binding properties. This
study shows that atomistic MD simulations combined with
biochemical experiments can provide a detailed molecular
mechanism of the twinfilin inhibition by phosphatidylinositols
(see Figure 62). Since twinfilin promotes actin filament
disassembly and inhibits their growth, the authors hypothe-
sized that phosphatidylinositols could control twinfilin local-
ization and regulate its activity during lamellipodial protrusions
and retractions.
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Multiscale MD simulations using both atomistic and coarse-
grained resolutions were used to investigate the interaction and
the binding of α-tocopherol transfer protein (α-TTP) to PIP2
lipids,1190 both when they were bound in the protein’s cavity
and while they were embedded in the plasma membrane. The
simulations revealed that a single PIP2 molecule is able to
stabilize the anchoring of α-TTP to the membrane surface.
Protein binding occurred by direct interaction of the negatively
charged lipid headgroup with the positively charged patch of
amino acids at the surface of the protein near the opening of
the ligand-binding cavity. This electrostatic attraction turned
out to be very stable. When PIP2 was incorporated into the α-
TTP binding cavity, the fast detachment from the membrane
into the bulk water was observed, consistent with the loss of
the anchoring group and the putative role of α-TTP lipid
exchange between the endosome and the plasma mem-
brane.313
Figure 62. Model of the inhibition of twinfilin-1 by a phosphoinosi-
tide-rich membrane. Reproduced with permission from ref 1188.
Copyright 2018 the American Society for Biochemistry and Molecular
Biology.
Figure 63. Snapshots from the MD simulations depicting (left) the CT-monolayer and (right) the mutated-LT1-monolayer systems. POPC and
GM1 molecules are shown as silver lines and cyan bonds, respectively. Individual subunits such as B1, B2, B3, B4, and B5 are presented separately
as red, blue, green, mauve, and yellow spheres, respectively. Reproduced with permission from ref 1194. Copyright 2014 American Chemical
Society.
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PROPPIN (β-propellers that bind polyphosphoinositides)-
membrane binding was studied by Busse et al.1191 using
isothermal titration calorimetry, stopped-flow measurements,
mutagenesis studies, and MD simulations. The simulations
revealed that the 6CD loop is an anchor for PROPPIN-
membrane binding based on the observation that this was the
region of the protein that inserted most deeply into the lipid
bilayer. Subsequent mutagenesis studies showed that both
hydrophobic and electrostatic interactions play a role in
membrane insertion of the 6CD loop. The authors proposed a
model for the PROPPIN−membrane binding in which
PROPPINs are initially attracted to the membrane surface
through nonspecific electrostatic interactions and then retained
at the membrane through specific PIP binding.
Ghosh et al.1192 used MD simulations to identify the AtSfh1
pattern of Sec16-nodulin as a PIP2-binding region. The study
showed that the nodulin peptide binds firmly to the lipid
membrane. The protein interacted with the lipid membrane
mostly via H-bond interactions with PIP2 molecules. The
simulations predicted that a single peptide could bind to one,
two, or three PIP2 molecules with similar probabilities (about
30%). Interestingly, the number of H-bonds established
between the peptide and PI(3,5)P2 differed significantly as
compared to PI(4,5)P2. Based on this observation, the authors
speculated that the binding of PI(3,5)P2 is weaker than that of
PI(4,5)P2.
The lipid membrane anchoring of HIV-1 myristoylated
matrix domain protein was simulated using coarse-grained MD
simulations.1193 Preferential binding of PIP2 headgroups to the
highly basic region of the matrix domain was reported.
Interestingly, the matrix domain was able to confine PIP2 lipids
all around its surface after having found a stable orientation at
the membrane surface.
In summary, many peripheral proteins contain clusters of
basic residues on their surface that interact electrostatically
with negatively charged lipids such as PI. The computational
studies presented above suggest different roles for PI in the
interactions of peripheral membrane proteins with lipid
bilayers. Anionic lipids seem to attract peripheral proteins
toward the membrane surface and then also bind specifically to
the proteins. Further, PI-facilitated reorientation of the protein
and clustering of PI lipids near protein surfaces have been
observed.
8.5.2. Other Charged Lipids. The effect of ganglioside
GM1 binding to cholera toxin was studied by Basu and
Mukhopadhyay1194 using atomistic MD simulations. Starting
from the initial structure where the five units of the cholera
toxin B subunit bind with five GM1 lipids (Figure 63), the
simulations showed that only three of the five units remained
bound and the whole cholera toxin tilted such that the three
binding subunits reached deeper into the membrane.
Interestingly, after binding of cholera toxin to the GM1-
containing lipid layer, the lipid curvature and the protein
orientation changed. Lipids that were lying just under the
cholera toxin pentameric hole moved to the corner of the lipid
monolayer and thus made an empty void so that cholera toxin
could pass through it. Therefore, these results suggest a
putative mechanism for the early stage alteration of lipid
structure, allowing penetration of the lipid bilayer by cholera
toxin. No such behavior of the LT1 mutant (E. coli type I heat
labile toxin; closely related to cholera toxin regarding structure
and function1195) was observed.
Very recently, Rissanen et al.71 revisited the cholera toxin
binding to GM1 and acyl-chain labeled bodipy-GM1. The
paper explored the partitioning of these gangliosides in the Lo
and Ld phases using atomistic MD simulations and cholera
toxin binding experiments. MD simulation data showed that
GM1 headgroup localization and geometry were sensitive to
the membrane environment and that the presence of the
bodipy label caused a deeper penetration of bodipy-GM1 into
Figure 64.Membrane binding modes of talin F2F3. (A) Initial configuration of the talin F2F3 (green cartoon). (B−D) The three distinct stages in
talin interactions with lipid membrane. (E) The C-α center of mass trajectory of each membrane binding moiety (i.e., MOP, FAP, and membrane
anchor) projected onto the membrane normal. The dashed line indicates the average position of the upper leaflet phosphate moieties. Reproduced
with permission from ref 1196. Copyright 2014 Biophysical Society. Published by Elsevier Inc.
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the membrane in the Lo domains. It was hypothesized that
these changes could render the bodipy-GM1 headgroup
partially inaccessible to cholera toxin. Indeed, the experimental
binding data showed that the overall binding of cholera toxin
to bodipy-GM1 was reduced in comparison to GM1, especially
in the Lo liposomes. This study confirmed at the molecular
level that the presence of a fluorophore on the acyl chain,
rather than changing the headgroup geometry, largely excluded
the bodipy-GM1 molecules from the Lo membrane environ-
ments, where native GM1 lipids seemed to be enriched.
All-atom MD simulations were used to address how
membrane binding modulates the structural and dynamical
properties of talin to activate integrin optimally.1196 The talin
head domain consists of four subdomains, namely, the F0, F1,
F2, and F3 subdomains. The F2 and F3 subdomains are crucial
for the membrane binding process and the activation of
integrin at the membrane surface.1197 It was shown that the F3
subdomain is sufficient for integrin activation;1198 nevertheless,
the interactions between talin’s positively charged membrane
orientation patch in the F2 subdomain (see Figure 64) and
anionic lipids enhance the rate of integrin binding and
activation. Arcario and Tajkhorshid1196 performed five
independent simulations of the talin F2F3 subdomain binding
to the PS bilayers. In all simulations, the talin F2F3 subdomain
spontaneously bound to the membrane, and the basic
membrane orientation patch residues played a crucial role in
attracting talin to the anionic bilayer surface. The authors
reported that the membrane binding of talin (see Figure 64)
proceeded through three distinct steps: initial electrostatic
recruitment of the F2 subdomain to anionic lipids, insertion of
an initially buried (and conserved) hydrophobic anchor into
the membrane, and an association of the F3 subdomain with
the membrane surface through a massive conformational
change.
Interactions of protein kinase C-α (PKCα) C1A and C1B
domains were the subject of the experimental and computa-
tional studies reported by Li et al.1199 and Ziemba et al.1200
Atomistic MD simulations coupled to experiments uncovered
the mechanism of PKCα activation, where both C1A and C1B
domains bound to the bilayer during activation but after PKCα
association with the lipid membrane. In this mechanism, the
C1A domain was recruited first with strong interactions to PS
(coactivator) and DAG (activator) lipids, followed by the C1B
domain, which was preferentially bound to phorbol-12-
myristate-13-acetate (activator).
An extensive set of atomistic MD simulations and free
energy calculations were exploited by Enkavi et al. to clarify the
molecular mechanism of the Niemann-Pick Protein C2
(NPC2) binding to the lipid bilayers and to characterize the
role of lipids associated with the binding process.854 NPC2 is
the critical protein involved in cholesterol efflux from late
endosomes/lysosomes. Two competitively favorable mem-
brane-binding orientations of NPC2 with a low interconver-
sion barrier were observed in atomistic simulations. The
detailed descriptions of these binding modes are given in
section 6.2.3. Atomistic simulations revealed that sphingomye-
lin neutralized the effect of bis(monoacylglycero)phosphate by
hindering the Prone binding mode (associated with cholesterol
uptake and release) without affecting the Supine orientation
(not taking part in cholesterol transport). This study clearly
shows that lipids modulate NPC2-mediated cholesterol
transport either by favoring or disfavoring the Prone binding
mode.
Zhang et al.1201 studied the binding of the RecA protein at
the surface of model membranes. RecA is a DNA repair
protein that plays an essential role in homologous recombi-
nation and mediates the bacterial SOS response. The highly
mobile membrane mimetic model and all-atom simulations
were used to study how different anionic lipids (PG/CL versus
PS) perturb RecA binding to the membrane. Contrary to PG-
and CL-containing membranes, ionic H-bonds between the
carboxylate group of phosphatidylserine and several lysine
residues in the C-terminal region of RecA were shown to
stabilize the parallel binding orientation.
Summarizing, our understanding of how peripheral mem-
brane proteins interact with lipid membranes has significantly
improved during recent years, as more accurate experimental
and computational techniques have been developed. However,
resolving the molecular mechanisms and the details of the
binding process remains challenging. The simulation data
presented in this section show convincingly that specific
structural features are often significant in determining the
properties of charged lipids. While MD simulations can predict
the molecular mechanisms of the association of peripheral
membrane proteins with model lipid bilayers, the challenge is
to combine the multiscale MD approach and experimental
techniques and to use them in a concerted manner to obtain a
comprehensive view of what happens at both small and large
scales in time and space in a cellular context.
8.6. Challenges
The main challenge in cellular biology is to understand the
interplay between proteins and the other molecular compo-
nents that modulate protein activation in cell membranes. Cell
membranes are complex mixtures of lipids, proteins, and
carbohydrates arranged into two asymmetric leaflets. Lipids
have been shown to play a significant role in maintaining a
healthy body, for example, by regulating neurotransmission,
ligand binding, cell signaling, and protein sorting. However, a
molecular-scale picture of how lipids are involved in these
essential biochemical processes is still often lacking. Yet, it is
known that an altered lipid content may lead to diseases and
pathological conditions, such as cancer, diabetes, or respiratory
syndromes.1202−1205 This section, therefore, discussed the role
of lipids in membrane protein activation and function as it has
been revealed by recent computational studies.
The discussed examples show clearly that the MD
simulation method is an exceptionally useful tool to unravel
the complexity and consequences of protein−lipid interactions.
Computer simulations have been able to clarify the role of
lipids in, for example, allosteric regulation of membrane
receptors, preferential binding of peripheral proteins to the
cellular membranes, protein sorting mechanisms, and neuro-
transmission. In all of these processes, MD simulations have
been able to reveal both direct and indirect effects of lipids, as
well as to differentiate between these two types of lipid
modulation mechanisms.
Meanwhile, there are numerous interesting research topics
that also call for clarification, but they are so resource-intensive
that they are almost impossible to address by the current
supercomputers. For instance, what is the molecular picture of
membrane protein oligomerization, and how exactly do the
lipid coronas facilitate the formation of protein super-
complexes? What is the role of protein−lipid interactions in
membrane fusion and fission? Given that there are thousands
of different lipid species in cells, which spend the minimum
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amount of energy to function, it is safe to assume that this
plethora of different lipids is, indeed, needed for cell survival.
However, what is the functional role of the numerous different
lipid species in cellular metabolism?
During the past decade, the applicability of MD simulations
has accelerated tremendously due to increasing computational
power, advances in the development of massively parallel
algorithms, and the development of accurate simulation
models. This progress continues at a rapid pace, and it is
likely that atomistic simulations of lipid-assisted membrane
protein activation over multi-millisecond time scales are
feasible sooner than one might even hope.
9. HOW DO BIOMEMBRANES USE LIPIDS TO STORE
ENERGY?
Cells store energy (i) in the covalent chemical bonds of energy
storage molecules and (ii) in the electrochemical ion gradients.
Lipids and biomembranes are directly involved in both modes
of energy storage. In the first mode, lipids carry the energy
directly in their chemical bonds. These storage lipids such as
triacylglycerols and cholesteryl esters (CEs) are transported
within carrier particles, such as lipid droplets and lipoproteins.
In the second mode, biomembranes act as an interface between
two compartments across which cells build up electrochemical
gradients akin to a reservoir created by a dam.
In this section, we first focus on the lipid storage organelles
known as lipid droplets. We then move on to lipoproteins and
cover their different structural stages. In the second part of this
section, we concentrate on the second mode of energy storage.
We review how lipids, especially cardiolipin, modulate the
machinery involved in the storage of energy in terms of
electrochemical gradients. The discussion below concentrates
on recent progress in simulating these phenomena.
9.1. Energy Storage in Chemical Bonds
9.1.1. Lipid Droplets. Lipid droplets (LDs) are the
cytoplasmic storage organelles for neutral lipids, such as
triglycerides, CEs, and retinyl esters. They play crucial roles in
energy and lipid metabolisms. LDs are linked to many diseases,
such as obesity, atherosclerosis, and fatty liver disease. Indeed,
LD accumulation likely serves protective functions in lipid
metabolism malfunction. Recent advances have highlighted
that LDs have many biological roles other than being passive
cytosolic storage units. LDs are highly dynamic and tightly
regulated, serving as hubs not only for fatty acid trafficking but
also for protein trafficking and maturation. Moreover, LDs
emerge as essential modulators of nuclear function and lipid
signaling.1206 The modulatory roles of LDs mainly depend on
regulated lipid and protein exchange between LDs and other
organelles, mostly nuclei and mitochondria.1206 LDs might,
also, act as general protein sequestration sites that take part in
protein delivery and storage and foster protein−protein
interactions and protein complex assembly.1206 Furthermore,
LDs are involved in immune response, and they store antiviral
and antibacterial proteins. On the downside, hepatitis C virus
(HCV) maturation requires LD accumulation.1206
Energy storage and lipid metabolism make LDs indispen-
sable components of adipose tissue, the liver, and the intestine.
Similarly, LDs are also abundant in the nervous system where
they support signaling among other membrane functions. LD
overaccumulation in neurons and glia is associated with
neurodegeneration. We refer the reader to three excellent
reviews on general LD biology,1207 LD biogenesis,1208 and
emerging roles of LDs.1206 In this section, we cover the
computational studies of LDs performed in recent years.
Lipid Droplet Models: Simulations of Atomistic Lamellar
Lipid Trilayer Models and Coarse-Grained Spherical Bodies.
Due to the complexity of the lipid droplets and scarcity of
atomic-scale information on the structure of LDs, most studies
of LDs require either coarse-grained or simplified atomistic
models. An approach commonly used in atomistic LD models
is the lamellar trilayer model, in which two monolayers of
phospholipids sandwich a cholesteryl ester/triglyceride phase.
Complex models loyal to the natural spherical shape of LDs
require coarse-graining. Using coarse-grained simulation
approaches, LDs can be modeled as spherical bodies with
cholesteryl CEs, triglycerides (TGs), or triacylglycerols
(TAGs) forming a region in the core, sheeted with a
monolayer of phospholipids.
Lamellar lipid trilayers have been used as models of LDs and
similar emulsion droplets. Hennere ́ et al.1209 performed
simulations of POPC at the water−triglyceride (trilinoleoyl-
glycerol) interface. In this lamellar trilayer model, the
headgroup conformations and interactions were similar to
those in a POPC bilayer, but the acyl chain properties showed
small differences.1209 Hennere ́ et al.1210 later increased the
complexity of the system by introducing more lipid types to
the monolayer and the triglyceride phase to mimic the
composition of a commercial lipid emulsion. This more
complex lipid composition in the monolayer resulted in the
increase of acyl chain disorder, head group hydration, and area
per lipid, when compared to bilayers of the same
composition.1210 The trilayer system of Koivuniemi et al.1211
consisting of POPC monolayers sandwiching a cholesteryl
oleate (CO) phase showed that CO slightly interdigitates into
the POPC monolayers but does not substantially affect the
POPC structure.1211 Lamellar trilayer models have also been
employed in several studies that aimed to characterize the
effect of curvature on protein−LD interactions,1212 interfacial
tension of high-density lipoprotein (HDL) and low-density
lipoprotein (LDL) models,1213 the surface properties of LDs,
protein targeting,1214,1215 and the tear-fluid lipid layer.1216,1217
Coarse-Grained Simulations on Lipid Droplet Formation.
To investigate LD formation, Khandelia et al.1218 explored the
distribution of TAGs inside a POPC bilayer with coarse-
grained simulations using triolein (TO) as model TAG. They
initiated simulations where they replaced some POPC in the
bilayer with TO amounting to two different concentrations:
one above (5.2% w/w) and one below (2.3% w/w) the TAG
solubility in POPC (3% w/w). To verify the observations
further, they also simulated the self-assembly of a random
dispersion of POPC, TAG, and water molecules. The
simulations showed that the number of TOs that remain
intercalated within POPC is limited by its solubility, and the
rest of the TOs partition into disk-shaped aggregates in the
center of the membrane. The blisters (Figure 65) formed due
to aggregation were stable and exchanged TOs with the
interface. These results suggest a possible mechanism for the
growth of LDs inside the endoplasmic reticulum membrane
and lipid signaling in cancer cells, which have high amounts of
TAGs.1218
Coarse-Grained Simulations on the Distribution of Lipids
in Lipid Droplets. Chaban and Khandelia1219 studied the
distribution of lipids inside the triolein LDs. Coarse-grained
simulations of spherical LD models composed of different
mixtures of POPC, POPE, TO, and cholesterol showed that
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cholesterol is mostly located inside the lipid core within the
TO phase. Cholesterol did not form crystals and existed
primarily alone with only a small proportion forming dimers.
POPC and POPE formed a monolayer on the surface of the
LD, minimizing the surface tension at the LD−water interface.
Further, POPE did not affect the distribution of lipids, and the
thickness of the monolayer was almost equal to the thickness
of one leaflet in a bilayer with the same composition.1219
The storage form of cholesterol, CEs, is a significant
component of LDs and has a lower solubility in the bilayer
than cholesterol. Investigating CE distribution in the LD is
essential, as the surface exposure of CEs possibly determines
the efficiency of acid lipases, which operate on the LD surface.
Thus, Chaban and Khandelia followed up on the above
work1219 by incorporating CO, a CE family member, instead of
cholesterol in the spherical LD models.1220 They reported that
CO forms a single phase with the TO in the LD core and is
little soluble in the monolayer. Due to the hydrophilic groups,
the LD core manifests long-range order that decays toward the
center of the LD. The authors also observed that the excess of
POPC and POPE forms inverted micelles in the LD core. The
intercalation of TO into the monolayer and some degree of
water−TO interactions in both works by Chaban and
Khandelia1219,1220 suggest a potential mechanism for LD
fusion.
Binding of Proteins on the Lipid Droplet Surface.
Recently, LDs emerged as protein sequestration and exchange
sites.1208 The proteins that bind to the endoplasmic reticulum
and the Golgi apparatus also bind the LDs specifically. Many
cytosolic LD-binding proteins contain an amphipathic helix
(AH), which recognizes the endoplasmic reticulum and the
Golgi apparatus by the lipid-packing defects. The unique
surface properties of LDs have recently been suggested to
underlie their specific interactions with proteins. Bacle et al.1215
simulated united-atom and coarse-grained trilayer LD models
composed of POPC and TO. While TO was not found to
affect the structural and dynamic properties of the POPC
monolayer, it interdigitated substantially into the POPC
monolayer. The interdigitation led to differences in lateral
pressure profiles, as well as to a decrease in deep lipid-packing
defects and an increase in shallow ones. Moreover, the lipid-
packing defects depended on the surface tension and the LD
size. For most other properties, the LD surface appeared to be
similar to that of the bilayer with the same composition, which
explains how the same protein could bind both ER or Golgi
apparatus and the LDs. On the other hand, LDs can
accommodate a broader range of surface tensions (0−20
mN/m) when compared to the bilayers (10−3−10−1 mN/m).
It is likely that LD-specific proteins sense the defects
modulated by surface tension. In addition, these properties
might play a role in LD biogenesis, whereby a decrease in the
lipid defect content due to the growing size of budding LDs
might recruit LD-specific proteins that replace the ER-specific
ones.1215
The results of Bacle et al., which suggest a role of lipid
packing defects on LD-binding of amphipathic helices,1215
were confirmed more directly by Prev́ost et al.1214 in a
combined MD and experimental study. They employed an all-
atom trilayer model of LDs, containing TO and CO in the
center and POPC, DOPE, and SAPIP in the monolayers. The
simulations suggested that the LD surface is, indeed, distinct
from the bilayer surface of the same composition. Furthermore,
the simulations showed that the LD surface exhibits more
substantial and longer-lasting packing defects. Besides, they
probed AH binding to the trilayer models directly by placing
the peptide (the AH of the LD-binding metabolic enzyme
CCTα) in a random coil conformation away from the
membrane surface. Three simulations out of four resulted in
membrane association, with large hydrophobic residues
inserting first into a packing defect. In one simulation, they
also observed the initial stages of AH folding. They further
tested other peptides with different numbers of hydrophobic
residues. The simulations collectively suggested that the large
hydrophobic residues recognize the packing defects on the LD
surface and drive the LD binding. The predictions of the
simulations were tested by in vitro experiments, which
confirmed the role of lipid packing defects and the hydro-
phobic residues in LD surface recognition and binding. In
essence, the simulations suggest that AHs containing large
hydrophobic residues bind LDs, recognizing them by the large
lipid packing defects.1214
9.1.2. Lipoproteins. High levels of low-density lipoprotein
(“bad” cholesterol) have been implicated in cardiovascular
diseases, leading to arterial plaques. On the other hand, high-
density lipoprotein particles (known as “good” cholesterol) are
critical in reverse cholesterol transport, and their low levels
have been linked to an increased risk of atherosclerosis. Here,
we review the use of all-atom and coarse-grained MD
simulations that have been used to model and explore the
structure−function relationship in LDL and HDL particles. A
review from 2016 by Pan and Segrest covers the computational
studies of plasma lipoprotein lipids.1221 We also refer the
reader to the book chapter titled “Modeling of Lipid
Membranes and Lipoproteins”1222 and to the review cited in
ref 1223, in both of which Koivuniemi and Vattulainen discuss
HDL in detail.
Low-Density Lipoprotein. LDL particles are among the
most massive cholesterol-carrying particles in the bloodstream.
Apolipoprotein B (apoB-100) is the primary apolipoprotein
found in LDLs as well as in the other three lower density
lipoproteins (chylomicrons, very low-density lipoprotein, and
intermediate-density lipoprotein).1224 Due to their large size
(21−25 nm) and the absence of known three-dimensional
Figure 65. Formation of a blister of about 17 nm diameter due to TO
aggregation captured in the simulations (A) from the side view and
(B) from the top view. Reproduced with permission from ref 1218.
Copyright 2010 Khandelia et al. (https://creativecommons.org/
licenses/by/4.0/legalcode).
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structure for apoB-100, only a single computational study of
LDLs exists to date.
Murtola et al.1225 performed coarse-grained simulations on
the first molecular-scale model for LDL consisting of COs,
trioleates (TOs), unesterified cholesterols, phospholipids
(PCs), and lysolipids (lysoPCs) with and without apoB-100,
modeled in two different conformational states (Figure 66).
Lipid−ApoB-100 interactions were shown to bring (hydro-
phobic) core lipids to the particle surface. The distribution of
the lipids within LDL was observed to be complex. The study
characterized an isotropic-like distribution of neutral (hydro-
phobic) lipids in the core of the particle, and a quite clear
surface region comprised of polar lipids and the protein, but
the interface between these regions was quite wide and not
well-defined. This model should be a good starting point for
further simulation studies of LDL particles.1225
High-Density Lipoprotein. High-density lipoproteins extract
excess cholesterol from macrophages via pathways involving
two ATP-binding cassette transporters in the reverse
cholesterol transport. HDL protects against atherosclerosis
through various mechanisms ranging from inhibiting lipid
oxidation to anti-inflammatory and antiapoptotic functions.1226
A maturation scheme suggested for HDLs involves the
following steps: (i) Lipid-free apoA-I associates with
cholesterol and lipids in the bloodstream. (ii) This process
leads to the formation of the nascent HDL (likely a discoidal
particle). (iii) Lecithin cholesterol acyltransferase facilitates
more cholesterol and lipid uptake, forming a mature spherical
HDL particle.1227 Despite extensive studies on the structure
and function of HDL particles, the specific protein and lipid
configurations involved in each step during the maturation
remain unknown, likely due to their natural diversity and
flexibility. Here, we review the recent findings based on
simulation studies on HDL models, covering lipid-free apo A-I,
nascent, and spherical HDL models, separately.
Lipid-Free ApoA-I. Apolipoprotein A1 (apoA-I) is the major
protein constituent of HDL. It stabilizes HDL particles during
their maturation by forming a scaffold around the lipids
(phospholipids, free cholesterol, CEs, TGs).1228 Moreover, the
lipid-free monomeric apoA-I is vital for HDL biogenesis.
Therefore, it is essential to characterize it structurally, which
however has been quite unsuccessful despite all the efforts with
X-ray crystallography and NMR.1229
Oda recently provided a historical overview of structural
characterization of the lipid-free apoA-I. The study also covers
potential reasons for the model diversity.1230 Various
molecular modeling efforts have been undertaken to model
lipid-free apoA-I in solution. These approaches were covered
comprehensively in a recent review by Gogonea.1228 In short,
the structural models by Silva et al.,1231 Pollard et al.,1232
Segrest et al.,1233 and Zhang et al.1234 feature several bundled
α-helices that differ in their locations. These models conform
to various sets of experimental data. On the other hand, the
model by Legerstedt et al.1235 is the only one that also features
β-strands, suggesting conformational switching from β-strands
to α-helix upon lipid binding. While all four models can explain
low-resolution experimental data to a reasonable extent, their
validity is yet to be tested against high-resolution experimental
data. Recently, a consensus time-averaged model of human
apolipoprotein A-I in its lipid-free monomeric state was
proposed by Melchior et al.1229 based on cross-link-derived
constraints, SAXS, hydrogen−deuterium exchange, and
crystallography data. Although the model was suggested by
the authors to be consistent with much of the historically
accumulated experimental data and carries implications about
the lipid binding and HDL biogenesis, it still lacks the atomic
scale resolution.1229
Among these lipid-free apoA-I models, those by Segrest et
al.1233 and Zhang et al.1234 are particularly interesting as they
capitalize on MD simulations to explore the configuration
space of the protein as a tool for molecular modeling and
refinement. Segrest et al.1233 and Zhang et al.1234 not only
assessed the stability of the previous models1231,1232 using MD,
but also employ high-temperature MD and iterative MD,
respectively, to propose presumably improved models. The
Zhang model contains a four-helix N-terminal domain.
Figure 66. Spherical LDL model by Murtola et al.1225 (A) CG lipid
models used in the simulations of LDL with glycerol moieties shown
in red. (B) The full LDL model with ApoB-100 in tan. (C) The lipid
core in the configuration in panel B is replaced with a transparent
sphere to highlight the position of apoB-100. (D) Cross section of
protein-free LDL. (E) Cross section of configuration shown in panel
B. (F) The zoomed in surface of the configuration shown in panel B.
Adapted with permission from ref 1225. Copyright 2011 the Royal
Society of Chemistry.
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Similarly, the Segrest model is formed of α-helices bundled
together with a loosely packed interior, representing a molten
globule. Segrest et al.1233 further studied the lipid binding of
this model by initiating a simulation with the coarse-grained
version of their model in the presence of dispersed POPC.
These simulations revealed the formation of a monolayer of
POPC on the surface of the monomeric apoA-I. We note that
the simulations were used as a tool for exploration of the
protein conformational space to generate test conformations
against low-resolution experimental data, that is, for molecular
modeling purposes.
MD simulations have been used for other variants of
apolipoproteins, for example, in modeling human apoA-IV,1236
in characterizing the effect of lipid concentration on apoC-
II,1237 and identifying a lipid-binding motif in apolipoprotein
B.1238
Nascent HDL Models. Nascent HDL (nHDL) particles
manifest shape and size diversity since each particle can
incorporate different numbers of apoA-I and lipids of various
types. Therefore, any working model of nHDL has to account
for and accommodate such intrinsic diversity. The majority of
the models fit into a broad category termed the discoidal
models of nHDL, which are mainly composed of a patch of a
circular bilayer wrapped around by two apoA-I chains. The
distinguishing feature of each discoidal model is the different
conformation of the apoA-I chains. A second, more recent
nHDL model was proposed based on small-angle neutron
scattering (SANS) with contrast variation: the Double
Superhelix model, in which the protein forms an open-ended
spiral around an oblate lipid phase, which, unlike that in the
discoidal models, is not exclusively a bilayer, but a lamellar−
micellar mixture. Here, we concentrate on the simulation
studies of nHDL since 2010 and refer the reader to the review
by Gogonea1228 for the historical development of the models
and a detailed account of the experimental protocols.
Discoidal HDL. Various crude models have been proposed
for the structure of nHDL molecules: the picket-fence model,
the double-belt model, the hairpin model, the looped belt
model, and the solar flare model.1228 Among these, the double-
belt discoidal model has been most extensively studied using
MD simulations. Many modeling approaches for discoidal
HDLs include an MD simulated annealing protocol, where the
system is heated up and cooled down in successive stages.
Simulated annealing allows crossing kinetic barriers resulting in
better structural optimization. Gu et al.1239 combined experi-
ments and the simulated annealing protocol to generate PL-
rich HDL models with unesterified cholesterol wrapped by
truncated apoA-I. In their model, apoA-I forms a flexible
saddle-shaped double-belt structure around a central mem-
brane. This saddle-shaped structure, by incrementally twisting,
can accommodate a variable number of lipids in the central
membrane.1239 Li et al.1240 explained the size heterogeneity of
discoidal HDL by the presence of a hinged domain formed by
a helix. Biased MD simulations were used to probe the
independent rotation of two α-helical apoA-I monomers
around the central lipid phase to assess the helix−helix
registration between the monomers. These simulations, while
supporting the existing double-helix models, also propose a
mechanism for how two well-known naturally occurring apoA-I
mutants (Paris, R151C, and Milano, R173C) can manifest
different registrations.1241 In a later study, the conformational
effects of these mutants, which contain extra disulfide bridges
between the monomers, was also tested using unbiased
MD.1242 The conformational states of the N- and C- termini
Figure 67. CG MD simulations capture how apoA-I stabilizes pleats formed on the outer leaflet due to different lipid densities between the leaflets.
The left and right panels show the same configuration from two different angles. (A) First, a wedge-like structure forms, (B) which grows in time,
(C) forming into a hemidisk. (D) ApoA-I wrapped disk connected to the bilayer with a stalk. Adapted with permission from ref 1247. Copyright
2015 Elsevier.
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of apoA-I were also modeled and studied.1243,1244 The N-
terminal domain was suggested to drive particle expansion and
the C-terminal domain, to be involved in the lipid
exchange.1244 Segrest et al.1245 compared their previous
discoidal models to the lipid-free apoA-I crystal structure and
concluded their models to be valid. The most recent models of
discoidal HDLs were generated by Pourmousa et al.1246 To
characterize the tertiary structure of apoA-I in high and low
cholesterol nHDL models, Pourmousa et al.1246 combined
multi-microsecond atomistic MD, molecular modeling, and
cross-linking experiments. The simulations captured how
apoA-I adapts to growing particle size due to the N-terminal
and C-terminal domains.1246
Segrest et al.1247 also studied the mechanism of discoidal
HDL generation by the lipid-poor apoA-I. nHDL formation
involves the ATP-binding cassette transporter A1 (ABCA1),
which uses ATP to transport phospholipids from the inner
leaflet to the outer leaflet. Surface density increase on the outer
leaflet simulated using coarse-grained MD resulted in lipid
monolayer pleating. The membrane-attached discoidal struc-
tures formed due to pleating appeared to be stabilized by
apoA-I and influenced by membrane cholesterol (see Figure 67
for the details of the mechanism).1247,1248
Several studies also concentrated on apoA-I mimetics and
their conformations. A picket-fence arrangement was suggested
for synthetic amphipathic peptides, which are indicated as
potential therapeutics for cardiovascular diseases based on the
MD simulations.1249,1250 For another apo A-I mimetic, reverse-
4F, similar discoidal structures were captured, which tend to
aggregate.1251
The Double Superhelix Model of nHDL. The double
superhelix model of nHDL has been controversial as it
substantially differs from the more widely accepted discoidal
models listed previously. Here, we discuss the two separate
studies by Gogonea et al.1252 and Jones et al.1253 that have
employed MD simulations to assess the stability and the
validity of the models. These two studies arrive at two different
conclusions, the first being in favor and the latter being against
the model.
To test the validity of the double superhelix model, Gogonea
et al.1252 performed 80 ns long MD simulations using the
united-atom force field GROMOS87 with POPC, cholesterol,
and SPC water molecules in the NVT ensemble at 300 K.
Based on root-mean-square deviation and solvent accessible
surface area calculations, the protein conformation did not
change substantially after 10 ns, while the lipid core evolved
from a prolate ellipsoid to a spheroid. This shape change was
accompanied by compression of the helix along its axis and the
formation of a void in the lipid core. The authors rationalized
this change in particle dimensions, which contradicts SANS
and electron microscopy (EM), by referring to previous MD
simulations of micelles, where such voids and shape changes
were also observed and attributed the effect to the artifacts in
the lipid force fields.1252
On the other hand, Jones et al.1253 contested the Double
Superhelix model. In contrast to the simulations of Gogonea et
Figure 68. SHDL models based on the lipid compositions of subjects with different levels of HDL and the CG simulations. (A) The CG simulation
snapshots after 8 μs equilibration. ApoA-I proteins are shown in red and green, cholesterol in yellow, and other lipids in gray. Waters are not shown
for clarity. The localization of cholesterols near apoA-I in the high HDL-C case is visible in the second panel from the left. (B) Unnormalized
number of contacts between apoA-Is and lipids. The errors bars denote the standard deviation. (C) Radial distribution function of TG molecules
around the center of mass of the HDL particle. The inset shows the average number of water contacts of TG. Reproduced with permission from ref
1254. Copyright 2010 the American Society for Biochemistry and Molecular Biology.
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al.,1252 Jones et al. performed simulations in the NPT ensemble
using the all-atom Charmm22 force field for the protein and
the lipids and the TIP3P water model. Moreover, they used a
simulated annealing protocol, in which the system was heated
up to 500 K and gradually cooled ddown to 310 K twice in a
total of 60 ns. They also performed coarse-grained simulations
of the complex using the MARTINI force field for ∼20 μs. In
addition, they obtained the simulated model from Gogonea et
al. and extended the simulations for 10 ns using the force field
and simulation parameters used for the simulated annealing
simulations. Both the coarse-grained and the simulated
annealing simulations resulted in the formation of discoidal
bilayers with the termini of the belt still separated, likely due to
the short time scales of the simulations and kinetic trapping.
Subjecting the Gogonea et al.1252 system to the same
conditions, which involve pressurizing the system in the
NPT ensemble, results in loss of voids seen in the model and
expulsion of waters from the interior within 5 ns. These studies
suggest that the original Double Superhelix model is unstable
and that the discoidal structures are more likely to represent
nHDL configurations. These simulation studies were also
supported by the negative stain and cryo-electron microscopy
tomography experiments, which showed that the reconstituted
apoA-I/HDL particles are discoidal, and by FRET experi-
ments, which showed the distances between the terminal
domain residues to be much shorter than those predicted by
the Double Superhelix model.1253
Spherical HDL Models. The reverse cholesterol transport
proceeds by the maturation of nHDL to spherical HDL
(sHDL). Lecithin cholesteryl acyltransferase, a plasma enzyme,
esterifies the free cholesterol on the nHDL surface producing
CEs, which translocates to the core of the particle. As the
particle assumes a spherical shape with the accumulation of
cholesteryl ester molecules in the lipid particle core, more
apoA-I associates with the surface of the particle, amounting to
as many as 7 apoA-I per particle.1228
In 2010, Yetukuri et al.1254 performed a lipidomics profiling
of HDL fractions from subjects with high and low HDL using
ultraperformance liquid chromatography−mass spectrometry
(UPLC/MS).1254 They determined that subjects with low
HDL have elevated triacylglycerols and diminished lysophos-
phatidylcholines and sphingomyelins. They combined these
lipidomics data with molecular modeling and coarse-grained
MD simulations to study the spatial distribution of lipids
within the HDL particles with three different compositions
corresponding to those of the subjects with low, high, and
normal HDL (referred to as low, high and normal HDL
systems, respectively, from here on) (Figure 68). The spherical
HDL models were prepared by placing the almost entirely α-
helical full-length model of apoA-I around a pre-equilibrated
lipid droplet, whose composition was later adjusted to the
desired state. In 8 μs of coarse-grained simulations, they
observed a smaller particle size for the low HDL system
(Figure 68A). In the high HDL system, cholesterols appeared
to preferentially interact with apoA-I (Figure 68A, center).
While the number of contacts between apoA-I and
sphingomyelin (SM), cholesterol, or lysophosphatidylcholine
(lysoPC) increases from low to high HDL, those of CEs, TAG,
and PC decreases (Figure 68B). TAGs accumulated near the
surface relatively more in the low HDL systems as indicated by
the tail of the radial distribution function and higher number of
contacts with water (Figure 68C). Although the simulations
did not account for the potential particle-size dependent
variation of the number of apoA-I adsorbed onto the surface of
the particles, this effect is only likely to result in even more
significant differences in the spatial distribution of lipids.1254 A
later study explored the impact of drug treatment on the
lipidomic profiles. Drug treatment increased the amount of
apoA-II and sphingomyelins and decreased the amount of
lysophosphatidylcholines. The coarse-grained MD studies
based on the experimental findings revealed that a growing
number of apoA-IIs remodels the HDL by reducing the neutral
lipids, like CEs, on the HDL surface.1255
Another study that investigated the structure and dynamics
of sHDL particles, emphasizing the importance of lipid
composition and the role of lipids, came in the same year.
Vuorela et al.1256 performed multi-microsecond coarse-grained
MD simulations of two lipid droplet models: a lipid droplet
without apoA-I and the full HDL particle including two apoA-I
molecules surrounding the lipid phase. The main finding of
this study is that the widely accepted two-layer model cannot
explain the observed conformation and dynamics of the lipids.
Instead, the study proposes a three-layer model. The models
were designed to mimic the size and lipid composition of
human serum HDL, composed of free cholesterol, CEs, TGs,
phospholipids, and lysolipids. The lipid phase appears to be
divided into three regions; the core, the surface, and the
intermediate region characterized by different dynamics,
compositions, and conformational entropy of the components.
The center is mainly composed of TGs and CEs, while POPC
and lysophosphatidylcholine headgroups form the surface
layer. Cholesterol, some CEs, and the acyl chains of
phospholipids constitute the intermediate region. While the
presence of apoA-I did not alter the shape of the particle
substantially, it affected the surface lipids, especially decreasing
the conformational order of CEs and cholesterol. The study
puts forward the conformational entropy of the lipids as a
factor in the formation of sHDL.1256
Simulations of reconstituted and circulating HDL particles
with different lipid compositions and numbers of apoA-I
suggested that apoA-I covers most of the HDL surface.
Moreover, the simulations capture that circulating and
reconstituted sHDL contain an equal amount of core lipids,
but circulating sHDL has fewer surface lipids. The differences
in lipid compositions appear to result in substantial differences
in the particle surface, and the authors concluded that the
reconstituted sHDL may not be suitable models for the
circulating sHDL.1257
Not only the lipid composition but also pH has been
suggested to affect properties of bilayers such as their thickness
and negative curvature with implications on surface properties
of LDs and lipoproteins.1258
The surface pressure and interfacial tension are essential
determinants of the shape and the protein/enzyme adsorption
onto the surface of HDL and LDL particles. Ollila et al.1213
used coarse-grained MD simulations to estimate the quantities
mentioned above for protein-free lipid droplets (using both
trilayer and spherical models) and in HDL and LDL particles
mimicking physiological conditions. While the MARTINI
model appears to underestimate the surface pressure, the
dependence of interfacial tension on the curvature of the
particle could be assessed. Presence of apoA-I on the surface
was not found to affect the interfacial tension in the HDL and
LDL models. The high interfacial tension indicates that HDL
and LDL represent kinetically stabilized metastable states.1213
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Koivuniemi et al.1259 investigated the effect of core lipid
composition and apoA-I on the interfacial tension and the
concentration of core lipids in the surface monolayer, building
upon the study by Ollila et al.1213 The simulations performed
with different lipid compositions revealed that TGs intercalate
into the monolayer and reside close to the water molecules
much more often when compared to CEs. TGs also exhibited
slower exchange between the monolayer and the core when
compared to CEs. The higher water accessibility of TGs makes
them better targets for enzymatic activity, such as trans-
portation by cholesteryl ester transfer protein (CETP).
Furthermore, CEs lowered the interfacial tension stabilizing
the droplets. In contrast, TGs helped maintain the interfacial
tension despite changes in the composition of the surface
monolayer.1259
Cholesteryl ester transfer protein facilitates the transfer of
CEs from HDL to LDL and VDL, as well as TG transfer in the
opposite direction. Although CETP deficiency is linked to high
HDL cholesterol levels,1260 it is also implicated in increased
coronary heart disease incidence.1261
Koivuniemi et al.1212 investigated the lipid exchange
mechanism of CETP using atomistic and coarse-grained
simulations. The simulations captured CETP binding to the
HDL surface with its charged and tryptophan residues. The
inherent flexibility of CETP appeared to enable its binding to
lipoproteins with varying curvatures. Moreover, a closed to
open conformational transition was proposed to be modulated
by a helix (helix X) acting as the lid for the CETP tunnel.
CETP appeared to have a flexible structure, which was
suggested to enable its binding to the curved lipoproteins. The
tryptophan residues inserted into the headgroup region and
salt bridges between the POPC and the charged residues
stabilized the binding. Coarse-grained simulations also
captured the formation of a hydrophobic patch connecting
the core to the surface. Reduction of the surface to core lipid
ratio resulted in the interactions between core CEs and the
CETP. Helix X appeared to form a mobile lid, controlling the
accessibility of the CETP tunnel.1212 In a follow-up study,
Äijan̈en et al.1262 investigated the mechanism of CETP
inhibition by the drug candidate anacetrapib. The authors
showed that the anacetrapib binding site is located in a tunnel
near the N-terminal opening inside CETP and that anacetrapib
locks CEs inside the protein preventing their translocation.1262
Cilpa-Karhu et al.1263 performed atomistic simulations to
explore the interactions of CETP with the double superhelix
model of nascent HDL as well as the spherical HDL. We note
here that the authors employed a noncanonical combination
for force fields, transferring parameters between GROMOS
and Berger. Their results suggest a different mechanism than
the curvature-matching model suggested by Koivuniemi et
al.,1212 in which CETP does not penetrate below the
headgroup region. Their model involves CETP in an upright
orientation. MD simulations captured CETP penetrating the
HDL particle surface and the opening of the N barrel domain
end of CETP. Moreover, instead of helix X proposed as a lid by
Koivuniemi et al., Cilpa-Karhu et al. suggested the N barrel
domain of CETP as a lid for lipid transfer. Based on these
results, the authors proposed a tunnel mechanism for the
transfer of CEs from HDL.1263
Combining electron microscopy with MD, Zhang et al.1264
showed that CETP binding to HDL particles involves
hydrophobic interactions and does not depend on the
individual lipid or protein components of HDL and that
CETP is only bound to one HDL at a time. The experiments
showed that CETP interaction with HDL/liposome surface
does not involve apoA-I or apoA-II and is stronger for smaller
liposomes. Coarse-grained MD simulations in this study were
used to study the dependence of surface hydrophobicity on the
liposome radius. The results confirmed that smaller liposomes
have higher hydrophobicity than the larger ones. Altogether,
instead of a shuttle mechanism, the MD and experimental
studies favor the tunnel mechanism for the transfer of CEs
from HDL to LDL particles, where CETP dissociates from the
HDL surface after getting loaded and associates with LDL.
Their results are also consistent with the results of Cilpa-Karhu
et al.1257 about the role of the N barrel domain of CETP.1264
Karilainen et al.1265 studied the effect of attaching the
fluorescent probe BODIPY to CEs in HDL particles. They
compared the structural and dynamical properties of BODIPY-
CEs to unlabeled CEs in spherical HDL models using unbiased
all-atom simulations. To characterize the partitioning of the
labeled and unlabeled CEs, they also performed replica
exchange umbrella sampling simulations (REUS) in which
they chose the distance between the center of mass of HDL
and the center of mass of the CEs or BODIPY as the reaction
coordinate. The simulations did not capture any significant
effect of BODIPY on CE partitioning between the water phase
and HDL. On the other hand, labeled CEs oriented so that the
BODIPY moiety interacted with the headgroup region. The
labeled CEs were localized closer to the surface of the particle
due to the competing effects of the hydrophilic BODIPY and
the hydrophobic ester. Moreover, the BODIPY moiety
appeared to slow down the diffusion of CEs. These results
suggest that the BODIPY probe widely used in experiments
may not be inert and may lead to qualitatively different
observations in studies of spherical HDLs.1265
Oxysterols are oxidized cholesterol derivatives. Since
oxidation impairs cholesterol uptake from the cells by HDL
and is likely to play a signaling role in cholesterol transport,
Karilainen et al.1266 investigated the effect of oxidation on
spontaneous cholesterol partitioning into the spherical HDL
using REUS all-atom simulations. Reconstructing the free
energy profiles for transfer of cholesterol and an oxysterol (7-
ketocholesterol) from the water phase into the HDL particle,
they showed that both cholesterol and the oxysterol exhibit
comparable minima and localize to the surface of the particle.
The authors proposed the surface localization of the oxysterols
as a potential mechanism for how oxysterols may be involved
in signaling.1266
9.2. Energy Storage in Electrochemical Gradients
Physiologically important ions are not in electrochemical
equilibrium across the cellular membranes. Active membrane
transport proteins embedded in cellular membranes create and
maintain this nonequilibrium condition. Without such active
maintenance, the ionic gradients would dissipate over time due
to downhill diffusion of ions across the membrane through ion
channels and, despite being slower, also through the lipid
bilayer. Dissipation of ionic gradients is, indeed, equivalent to
cell death.1267
Two types of active membrane transporters are involved in
the creation, maintenance, and modulation of ionic gradients.
Primary active membrane transport proteins, such as Na+/K+
and Ca2+/H+ ATPase pumps catalyze ATP hydrolysis and
couple the released energy to pumping ions against their
electrochemical gradients. Secondary active membrane trans-
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port proteins, such as Na+/Ca+, Cl−/HCO3
−, or Na+/H+
exchangers, on the other hand, couple the energy stored in
the established electrochemical gradient of one ion to
transporting another ion up its electrochemical gradient.1267
Secondary active transport proteins also exemplify a major
mechanism of how cells use the energy stored in electro-
chemical gradients; that is, for uptake of important molecular
species like nutrients or expulsion of deadly chemicals such as
antibiotics against their concentration gradients. We refer the
reader to the comprehensive review of the computational
studies on active membrane transporters that we presented in
section 6.
The mechanism mentioned above for generating ion
gradients as intermediate energy storage relies on energy
stored in ATP or other electrochemical gradients. All living
cells, on the other hand, have to create ATP from an external
source. Chemiosmotic theory, proposed originally for ATP
synthesis in mitochondria by the Nobel Laureate Peter D.
Mitchell in 1961, states that the proton gradients act as the
energy reservoir in the last stage of aerobic cellular respiration.
The chemiosmotic coupling is now established as a standard
mechanism for ATP production by mitochondria in eukar-
yotes, by chloroplasts in plants and algae, and by bacteria and
archaea.662
Here, we review the computational studies performed on the
characteristic components of the mitochondrial membranes.
We first describe the simulations performed on cardiolipin and
cardiolipin-containing membranes, as cardiolipin is an essential
and unique component of mitochondrial membranes. Then,
we move on to examine lipids that modulate the electron
transfer chain’s components, membrane enzymes that
intricately couple redox-reactions to generation of proton
gradient across the inner mitochondrial membrane. For in-
depth understanding of cellular respiration, we refer the reader
to reviews on the electron transport chain members.1268,1269
9.2.1. Cardiolipin and Cardiolipin-Containing Mem-
branes. Cardiolipin (CL) is a unique component of the inner
mitochondrial membrane serving various structural and
functional roles. Here, we cover the computational studies
performed on CL and CL-containing membranes. These
include quantum mechanical studies aimed at generating force
field parameters and exploring the titration states. Various
coarse-grained and atomistic studies have aimed to characterize
the mechanical properties of CL-containing membranes. The
structural and mechanical properties of the mitochondrial
inner membrane are of particular interest, as the invaginations
and buckles of the inner membrane, called cristae, serve as the
metabolic platforms for ATP production. The effects of
counterions and lipid oxidation have also been discussed
briefly in the literature. The unique titration properties and
their association with oxidative phosphorylation proteins have
suggested that CL increases the efficiency of these machines by
acting as a “proton sink” on the membrane surface.1270 Last,
we discuss how simulation studies provides insight into the
role of CL as a “proton sink”.
Many groups have undertaken efforts to parametrize CLs for
simulations. Lemmin et al.1271 parametrized CL at different
physiological protonation states, that is, with unprotonated or
singly protonated phosphate groups. The parametrization
scheme was designed to be consistent with the AMBER and
CHARMM force fields. The models reproduced the various
biophysical properties of the membranes, such as the lateral
diffusion coefficient and the area per lipid, and captured the
titration state-dependent (therefore, pH-dependent) changes
in lipid packing. This effect was discussed in the context of
membrane shape and formation of a proton sink, whose
implications about on-surface proton diffusion we have briefly
touched on above. The simulations also showed differential CL
interactions with monovalent and divalent cations.1271
Dahlberg et al.1272 explored the CL headgroup structure and
the proton exchange mechanism between the phosphate
groups using density functional theory calculations of the CL
headgroup, and its 2′-deoxy derivative, also considering the
effect of solvation. They calculated a large value gap between
the two pKa values. The proton exchange between the two
phosphate groups appeared to have a barrier of about 4−5
kcal/mol.1272 These calculations are in agreement with the
long established model of CL titration state and supports its
role as proton sink.123 We note, however, that a recent
biophysical study contested this, showing that both CL
headgroup phosphates are strong acids and remain unproto-
nated in the physiological pH range.126
Aguayo et al.1273 developed a new parameter set for two
versions of CL (tetramyristoyl and tetraoleoyl) for simulations
of CL-containing mixed-lipid membranes combining all-atom
headgroups with united atom acyl chains within the
CHARMM force field framework. The models were reported
to agree well with other simulations. The presence of CLs in
mixed bilayers results in membrane thickening and acyl chain
ordering. The new models reduced the number of atoms by
half, while still capturing important hydrogen-bonding
interactions. This is especially helpful for building sufficiently
large models to study the unique mechanical properties of
mitochondrial membranes.1273
Structure of CL-containing bilayers has been investigated in
only a few studies up to date. Earlier MD investigations of CL-
containing membranes have shown that CL increases
membrane order and reduces lipid diffusivity.1274−1276
Dahlberg and Maliniak1277 investigated the mechanical proper-
ties of CL bilayers with varying lipid compositions including
zwitterionic DOPC or DOPE, and different CL headgroup
charges. Their coarse-grained simulations showed that low CL
charge reduces the bending moduli and results in curved
microdomains.1277 Boyd et al.1278 reported that CL increases
bilayer deformability and gets enriched in highly negatively
curved regions of the membrane. These findings were based on
coarse-grained simulations, where they probed membrane
buckling by applying lateral pressure on the mitochondrial
bilayer models. These effects appeared to be unique for CL, as
they could not be reproduced by the other inverted conical
lipid in mitochondria, namely, phosphatidylethanolamine
(PE).1278
Pan et al.1279 performed atomistic MD simulations of CL
membranes constrained at different surface areas and selected
the model that best reproduces the experimental scattering
data. The chosen MD-based model also revealed important
Na+−membrane and lipid−lipid interactions.1279 An earlier
computational investigation by Pöyry et al.1274 suggested that
Na+ and Ca2+ ions do not significantly influence the structural
properties of CL-containing membranes but alter their
dynamical properties, such as rotational and lateral diffusion
of lipids.1274
Boscia et al.1280 showed that CL increases the bending
modulus of the membranes and stiffens them. They obtained
X-ray structures of pure gel and fluid tetramyristoylcardiolipin
(TMCL) and simulated pure DMPC and DMPC and TMCL
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mixed membranes to help in interpretation of the X-ray results.
Due to their bacterial ancestry, mitochondrial membranes
contain little cholesterol. The findings of Boscia et al.1280
revealed that CL indeed takes on various functional roles of
cholesterol. While TMLC appeared not to exhibit domain
formation and aggregation, it increased the thickness of the
membrane and reduced water leakage, which are established
roles of cholesterol. Besides, the phosphocholines formed an
umbrella covering the TMCL headgroup, as they do for
cholesterol.1280
CL oxidation can potentially cause various malfunctions due
to altered protein interactions and membrane properties, and
diminished capacity as a proton sink. On the other hand, CL
has to function in an environment conducive to oxidation.
Va ̈ha ̈heikkila ̈ et al.113 explored the effect of cardiolipin
oxidation on the bilayer properties. They parametrized
oxidized linoleic acids and performed atomistic simulations
of mixtures of DLPC, DLPE, and CL. Oxidation resulted in
thinning of the membrane and increase in its area. The
oxidized chains moved closer to the membrane−water
interface. Moreover, the oxidized chains appeared to influence
the chain order of unoxidized lipids.113 These results suggest
that CL oxidation may effect activation of mitochondrial
proteins that bind CL, for example, in an allosteric fashion.
Kaurola et al.1281 investigated the dynamics and distribution
of quinones and quinols and their chain length variants
(collectively referred to as Qs from here on) in a three-
component mitochondrial membrane model composed of PC,
PE, and CL with atomistic MD simulations (Figure 69A). The
simulations showed that both quinones and quinols partition
below the lipid headgroups near the acyl groups (Figure 69B).
Quinones, however, exhibit a strong peak also in the middle of
the bilayer (Figure 69B). Free energy calculations also support
these conclusions (Figure 69C). In addition, Qs mostly
interact with PC molecules instead of PE or CL likely due
to the large headgroup of PC shielding Qs from unfavorable
water interactions (the “umbrella effect”). Furthermore,
translocation of quinones through the bilayer is very fast
(10−100 ns), while that of quinols is an order of magnitude
slower. This is relevant for the efficiency of the electron
transport chain, as quinones formed on the P-side of the
membrane, which is named after the periplasmic side for
bacteria corresponding to the intermembrane space in
mitochondria, need to translocate rapidly to the N-side to be
reduced.1281
CL has long been suggested to form “a proton trap for
oxidative phosphorylation”.123 Bulk-to-bulk proton motive
force was shown to be inadequate for the experimentally
measured ATP yields. Thus, protons were suggested to
accumulate on the membrane surface, separated from the
bulk by a free energy barrier. Wolf et al.1282 applied an MD
protocol that accounts for excess proton in the Grotthuss
proton shuttling mechanism. Their findings revealed that
excess protons have a high affinity for the membrane surface,
where they interact strongly with the oxygen atoms in the
headgroup phosphate and carbonyl groups. The simulations
characterized three proton diffusion modes resulting in
anomalous diffusion: (i) binding to a lipid and diffusing with
it; (ii) hopping between water clusters associated with the lipid
headgroups; and (iii) escaping to the bulk and diffusing
through the bulk. The findings imply that on-surface diffusion
of protons can be enhanced with respect to the counter-
productive bulk diffusion in the presence of phosphatidyletha-
nolamines and CL. These lipids have smaller headgroups than
DMPC used in the study; thus, they can mediate proton
hopping between headgroup-associated water clusters more
efficiently.1282 The effect of lipid headgroup on the behavior of
excess protons was also studied using the multistate empirical
valence bond method.1283
9.2.2. Cardiolipin Interactions with Oxidative Phos-
phorylation Proteins. The role of CLs in stabilizing integral
membrane proteins including all respiratory chain complexes
responsible for generating the proton motive force is discussed
in detail in a recent review by Musatov and Sedlaḱ1270 The
Figure 69. Dynamics and distribution of quinones and quinols in the membrane. (A) The chemical structures of (left) ubiquinone (oxidized Q,
Qox) and ubiquinol (reduced and protonated Q, QH2), where n indicates the variable isoprenoid chain lengths; (right, top to bottom) cardiolipin,
DLPC, and DLPE. (B) Density profiles of (top) QH2 and (bottom) Qox for different isoprenoid chain lengths. The density of phosphorus atoms
of DLPC is shown in gray. (C) Free energy profiles for (top) QH2 and (bottom) Qox along the membrane normal for quinone with 1 and 10
isoprene monomers. The origin is set to the center of mass of the membrane. Adapted with permission from ref 1281. Copyright 2016 Elsevier.
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review concludes that CL acts both as a “glue” stabilizing the
functional assembly of subunits and as a linker allowing
communication between distant sites on the proteins.
CL not only stabilizes cytochrome bc1 complex and
cytochrome c oxidase,1285 but it is also involved in proton
transport.123,1286 The interactions of CL with these two
complexes characterized by MD put forward how CLs might
be involved in the proton transfer. Pöyry et al.1284 performed
atomistic simulations of a bacterial cytochrome bc1 dimeric
complex embedded in a three-component membrane model
composed of POPC, POPE, and CL to explore the CL
interactions with the protein. The lipid environment appeared
to influence the structure of the complex, resulting in opening
up on the P side. This conformational change is likely driven
by the positively charged residues on the P side adapting to the
negatively charged lipids. Remarkably, the simulations revealed
that the CLs move to the dimer interface and localize close to
catalytic Qi-sites, occupying similar positions captured in the
crystal structures (Figure 70A). The proximity to the active site
suggests a mechanism for CL involvement in proton transfer
via hydrogen-bonded networks (Figure 70B).1284 Coarse-
grained simulations of cytochrome bc1 from bovine and yeast
mitochondria by Arnarez et al.1287 also identified six
reproducible buried and surface CL binding sites. The surface
binding sites were located on the M-site region, supporting
CLs role as a proton sink. Arnarez et al.1287 used coarse-
grained simulations to characterize the CL binding site, also,
on the cytochrome c oxidase. They identified seven CL binding
sites, two of which were shown through PMF calculation to
have strong affinity. These two sites appeared to be in
proximity to two of the three known proton channels (D- and
H-), implicating CL in proton uptake.1287 The role of lipids in
proton uptake was also supported by Sharma et al.,1288 who
performed atomistic simulations of cytochrome c oxidase to
investigate the effect of conserved bound phospholipids on
subunit III. They captured water wire formation between the
phospholipid lipid headgroups and the proton uptake site,
enhancing its proton affinity.1288 Overall, the simulations have
not only helped characterize important CL binding sites but
also strongly support its role as a “proton sink”.
Figure 70.Mechanism of CL involvement in proton transfer in the cytochrome bc1 dimeric complex. (A, left) CL molecule (cyan) and cytochrome
bc1 (CIII) dimer (cartoon) interface captured in MD. (A, right) The small figures show the divergent interactions of CL with nearby residues
captured in different simulations. (B) Putative proton conduction pathways (magenta) mediated through waters and a lysine residue between the
CL (cyan) and the water in the quinone-binding site. The protein is not shown, and the heme is shown in black. The right-most figure shows the
same configuration as that on its left except colored based on the electrostatic potential (red, negative; blue, positive). Reprinted with permission
from ref 1284. Copyright 2013 Elsevier.
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There is a growing consensus on the formation of higher
order supercomplexes by the respiratory chain elements, also
called a respirasome. This organization is likely linked to CL in
mitochondria (or PE in bacteria).1289 Coarse-grained simu-
lations of cytochrome bc1 complex by Arnarez et al.
1290 had
earlier hinted at CL driven supercomplex formation.1290 In a
later study, Arnarez et al.1291 investigated how membrane CL
glues the respiratory supercomplexes using self-assembly
coarse-grained simulations. They embedded 9 cytochrome
bc1 dimers and 27 cytochrome c oxidase monomers in a CL-
containing bilayer to mimic the crowded environment. The
simulations captured oligomerization events that reproduced
the known interfaces as well as an alternative one. The
oligomerization interfaces featured bound CLs, and free energy
calculations showed that CLs bind stronger to the identified
binding sites than any other mitochondrial lipid.1291
CL has also been implicated in mitochondria-mediated
apoptosis functioning together with cytochrome c. A recent
study combining NMR, fluorescence spectroscopy, and coarse-
grained MD showed that CL is required for membrane binding
of cytochrome c, which leads to CL clustering initiating
apoptosis.1292
9.3. Challenges
Simulation studies have made significant advances in the last
two decades due to the increasing computational power and
better models. In this section, we reviewed how recent
simulations have contributed to our understanding of energy
storage mechanisms. Energy storage along with its production
is one of the hallmarks of living cells, and biomembranes are
involved in almost all its aspect. An organelle called a lipid
droplet is the major site of energy storage in mammalian cells
and is linked to metabolic disorders. MD simulations have
made great contributions to modeling the LD surface and
characterizing the physical properties of its membranes.
However, the mechanisms leading to lipid droplet formation
are weakly understood, if at all. Experimental evidence suggests
that there are proteins such as seipin playing key roles in lipid
droplet formation. With very recent characterization of the
structure of seipin,1293,1294 simulation studies can now
investigate the mechanism of seipin-mediated LD formation.
Similarly, simulations have been of utmost importance in
understanding lipoproteins, particularly in generating models
that conform to low resolution experimental data. Plasma
lipoproteins are integral to energy and cholesterol metabolism,
and computational research to understand lipoprotein
structure and dynamics has been quite active in this context.
On the other hand, lipoproteins remain challenging to
investigate computationally, due to their large size, their
molecular complexity, and the lack of sufficient structural
information on how their components interact. The overall
structure of LDL and that of apoB-100, the primary protein
component of the LDL, remain virtually unknown, despite
some low resolution models.1295−1297 Moreover, the inter-
actions of LDL and HDL with their receptors constitute an
essential step in their endocytosis and, thus, their metabolism.
However, these processes are still challenging for simulation
studies. We expect that with improving MD methodologies,
models capturing more complexity are likely to come. The
machinery interacting with these lipid storage particles have
various health related implications. With better models and
improving time scales, MD simulations can be used to
investigate the interactions of enzymes and other biomolecules
with these particles.
In the second part of this section, we covered how
simulations contributed to elucidating the mechanism of
ATP-generation by cells. For this, we concentrated on the
mitochondrial energy production mechanism. Due to the
availability of immense biochemical information distilled
through years, this machinery is very well characterized
structurally and functionally but does not fail to surprise us
with how much we do not know. Various levels of
computational theory have been applied to characterize the
dynamical nature of the electron transport chain components.
Here, we limited our discussion to lipids and lipid−protein
interactions. Cardiolipin appears as a fundamental functional
part of these complexes in the mitochondria, being involved in
electron transport and protein organization. However, how
CLs are directly involved in proton uptake has not been
studied directly. This requires quantum chemical studies, and it
would definitely benefit from developing MD methodologies
like the constant-pH simulations. Needless to say, the role of
the lipid environment is also established now as an active part
of energy storage in the gradients of protons and other ions, on
top of its passive role as a barrier in creating and maintaining
the electrochemical gradient reservoirs.
10. ARE BIOMEMBRANES METABOLIC PLATFORMS?
A group of transmembrane proteins, transmembrane enzymes,
are encoded by 533 genes in the human genome.232 Among
others, these include 194 transferases, 178 hydrolases, and 123
oxidoreductases. Yet, enzymatic activity is not limited to these
533 enzymes, but it is also part of the function of some
membrane receptors, such as tyrosine kinase type receptors
and active transporters. Additionally, there are many peripheral
membrane enzymes; however, their exact number is unknown.
Quite often enzymes that are well-known and established,
later turn out to be membrane associated. For example, L-
Dopa decarboxylase, the enzyme responsible for dopamine
synthesis, was shown to be associated with membranes in the
cellular environment, and this observation was made long after
its discovery.280 There are also enzymes that are not present in
humans but still abundant in nature, such as those involved in
photosynthesis, which is an entirely membrane-associated
process similar to oxidation. Further, the complexity and the
size of these enzymes can be quite large, such as in the case of
the respiratory supercomplex and photosynthetic reaction
centers and antennas.
Here, we discuss computational studies of membrane
enzymes with an emphasis on the role of membrane and
specific lipid−protein interactions on the functions of this
group of proteins. The main objective of this section is to show
that membranes should not be neglected, as has been done in
many previous studies of membrane enzymes.
10.1. Do Lipids Always Play a Role in Enzyme Activity?
Computational studies of transmembrane or peripheral
enzymes often consider those aspects of the enzyme activity
in which lipids seemingly do not play any significant role. For
example, mainly due to practical limitations, enzymatic
catalysis mechanisms studied with quantum-mechanical
calculations typically ignore the environment beyond the
catalytic pocket. The lipid environment is usually also
disregarded in the design of inhibitors that would block the
catalytic pocket of enzymes. In this respect, MD simulations
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are often used in combination with protein crystallography to
provide insight into the binding modes of substrates and
inhibitors, as well as to reveal possible effects of point
mutations (see, for example, ref 1298). However, because
membranes likely participate in substrate and inhibitor
entrance into the binding cavities of membrane enzymes,
omitting the membrane environment can be misleading. In
fact, computational studies of various substrates in a membrane
environment, such as quinones and quinols in the respiratory
and photosynthetic membrane complexes, have captured the
locations used to enter the catalytic cavities and the optimal
positions of these molecules.1281 Further examples are
discussed below.
Moving on, channels present in membrane enzymes for gas
molecules such as oxygen, hydrogen, nitric oxide, and water,
are frequently studied in MD simulations. However, most of
these studies, although performed in lipid environment, have
not considered the involvement of lipids.1269,1299−1310
Similarly, proton and electron channels studied by classical
simulations have typically disregarded lipids,1269,1311−1313
though lipids such as cardiolipin have been shown to be
potential proton donors in cytochrome bc1,
1314 and lipids
associated with cytochrome c oxidase likely play a structural
role in maintaining the oxygen patches inside the protein.1288
Considering the examples discussed in this section related to
membrane-associated enzymes where the specific role of lipids
has been recognized, it is clear that lipids may play a role in all
of the above-mentioned processes. Moreover, lipids can also
act as allosteric regulators. For example, cholesterol has been
shown to significantly reduce the conformational space
explored by β2AR.
54 For this reason, one can imagine that
the channels for gas molecules observed inside the proteins
located in single-component membranes may not exist at all in
membranes whose lipid composition is realistic. Thus, the
take-home message is that future studies should account for
the lipid involvement in the function of enzymes.
10.2. Membrane Enzymes Involved in Xenobiotic and
Small Molecule Catabolism
Cytochrome P450 (CYP) proteins constitute a family of
single-helical membrane enzymes with multiple functions in
both catabolism and anabolism.1315 In humans, there are 41
CYPs, which are involved in the synthesis of cholesterol,
steroid hormones, bile acids, vitamin D3, and second
messengers derived from polyunsaturated lipids as well as
from the degradation of naturally occurring small molecules
such as neurotransmitters, various xenobiotics, and
drugs.1316−1318 In fact, enzymes of the CYP family form a
major group responsible for drug metabolism catabolizing
approximately 50% of all approved drugs.1317−1320 Several
crystallographic structures of CYPs have been solved, but the
structures that have been determined are mostly for the water-
soluble domains of the proteins. Unfortunately, only one of the
crystallographic structures includes also the structure of the
transmembrane helix.1321 For this reason, a large number of
computational studies of CYPs have been performed without
the transmembrane domain in the absence of the membrane
(see, for example, ref 1322). Here, we concentrate on
simulation studies, in which the membrane was included.
Lonsdale et al. performed coarse-grained simulations to
identify the optimal arrangement of the transmembrane and
water-soluble domains of CYP around the membrane and then
initiated atomistic simulations from the configurations most
frequently found in the coarse-grained simulations.1323 Atom-
istic simulations showed that the flexibility of the membrane-
bound protein does not differ significantly from the protein
simulated in water. However, the tunnels used by the
substrates and the reaction products to enter and exit the
catalytic pocket were different between the membrane-bound
and the aqueous structures. In other studies, MD simulations
were used to compare the tunnels in the human and human
parasite Trypanosoma brucei CYP51s. The subtle differences
captured in the simulations may aid in optimization of drugs to
specifically and exclusively target the parasite CYP51.1324
In another study, association of CYP 12A with lipids
induced the opening of the tunnel 2A, which allows the
substrates to enter the protein from the membrane.1325 A
similar observation was made for CYP 17A1.1326 Extensive
unbiased MD simulations, randomly accelerated MD, and free
energy calculations characterized the entrance pathway and the
binding pockets of testosterone in CYP 3A4 (see Figure 71), as
well as the free energy landscape along the entry pathway.1327
Figure 71. Snapshots of two testosterone molecules (pink and
orange) in the windows prior to their docking into the catalytic
pockets. Lipids are shown as a gray surface (A). Location of
testosterone binding sites (B) and their close views (C, D) with
volumetric maps (red lines) highlighting the highest testosterone
mass-weighted density over 25 μs of a MD simulation. Representative
testosterone configurations are shown in green stick representation.
Reproduced with permission from ref 1327. Copyright 2018 the
American Society for Biochemistry and Molecular Biology.
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A few other studies have also pointed out the importance of
the membrane composition in protein stability and CYP
positioning in the membrane (Figure 72). Negatively charged
PS and PG were shown to promote the penetration of CYP
deeper into the membrane. PS and PG also promoted a more
tilted CYP orientation, when compared to simulations of CYP
in bilayers composed only of PC or PE.1328 In the presence of
cholesterol, the cholesterol molecules were observed to
accumulate in the vicinity of the protein, causing reorientation
of the water-soluble domain. This, in turn, led to tighter
interactions with the membrane and to a decrease in the
protein flexibility.1329
Due to the importance of CYPs in xenobiotic metabolism,
studies of point mutations may be of practical importance. As
various point mutations of CYP 2C19 were explored through
simulations, it was observed how they reduced the enzyme’s
affinity toward the substrate.1330 Possible mechanisms of the
reduction of the enzyme activity by the point mutations
include local deformation of the protein secondary structure,
affecting the shape and the dynamics of the catalytic pocket,
and the formation of new stable networks of hydrogen bonds,
affecting the shape of the catalytic pocket. Other studies of
CYP 1A1 showed that point mutations facilitate the
interactions of organic pollutants with the protein.1331
Like many other proteins, CYPs can form not only
homodimers but also heterodimers with other membrane
proteins. MD simulations were recently used to explore the
formation of homodimers by cytochrome P450 belonging to
the aromatase class (P450arom or CYP19) and in particular to
characterize the dimerization interface.1332 In another study on
a heterodimeric complex, Jerǎb́ek et al. elucidated the
dimerization of CYP 1A2 with cytochrome b5, predicting the
relative orientation of the proteins in the complex.1333
Monoamine oxidase (MAO) is a single transmembrane helix
enzyme playing important roles in the nervous system in
degradation of monoamine type neurotransmitters and in
xenobiotic catabolism. Therefore, inhibition of MAO has
important medical applications in the treatment of Parkinson’s
disease and major depressive disorder.1334,1335 There are two
forms of MAO: A and B. Comparison of MAO-A simulated in
water and at the membrane−water interface showed that the
membrane is necessary for opening a channel for the substrate
and the reaction products.1336 Similar observations were made
for MAO-B, for which the bilayer was shown to control the
behavior of two loops at the entrance of the active site.1337 In
the same study, interactions between the protein and various
reversible inhibitors were also considered providing drug
candidates with the optimal binding mode.1337 In recent
studies, where MAO-A and MAO-B inhibition by flavonoids
originating from medicinal plants were investigated, MD
simulations provided information about the flavonoid binding
modes.1338
Catechol O-methyl transferase (COMT) is an interesting
example of enzymes that have both water-soluble (S-COMT)
and membrane-bound (MB-COMT) forms. COMT and MAO
are primary enzymes that initialize the degradation of key
neurotransmitters. They, therefore, prevent the accumulation
of neurotransmitters in the neurons, which is potentially toxic.
MAO and COMT are particularly important, as they prevent
dopamine oxidation and thus, the formation of oxidized
dopamine, which is a toxic compound with destructive effects
in, for example, mitochondria function and vesicular trans-
port.1339 While both forms of COMT have the same catalytic
domain, MB-COMT also contains a transmembrane helix and
a short loop linking it to the catalytic domain. Extensive MD
simulations of the transmembrane helix connected to the linker
showed that the linker is highly mobile and flexible. The
simulations also identified the formation of a specific salt
bridge, which appeared to be the only structural motif in the
linker.1340 These studies allowed reconstruction of the whole
MB-COMT structure, thus rendering full MB-COMT
simulations possible.1341 In these follow-up simulations, after
binding to its cofactor S-adenosyl methionine, MB-COMT
associated with the lipid bilayer in a stable fashion such that
the entrance of the catalytic pocket faced toward the lipids.1341
Moreover, inhibitors having a high affinity for MB-COMT
were found to adopt an orientation, in which the catechol
group is exposed toward water and thus toward the entrance of
the catalytic site.1341
Membrane association of CYP, MAO, and COMT seems to
be related to their involvement in xenobiotic catabolism. The
majority of drugs that target them are amphipathic or
hydrophobic molecules that are known to position either at
the membrane−water interface or in the hydrophobic core of
the membrane, often affecting the membrane structure.
Examples of such drugs that have been studied recently
through simulations include itraconazole,1342 piroxi-
cam,1343,1344 indocyanine,1345 fluoroquinolones,1346 porphyr-
ins,1347,1348 and some others.1135,1349,1350 (For reviews, see refs
1351 and 1352) These enzymes are also involved in the
catabolism of natural compounds such as amphipathic
neurotransmitters and steroids, which also reside preferentially
Figure 72. Changes in the CYP catalytic domain orientation toward a
lipid bilayer due to an altered lipid composition: (A) Effect of
cholesterol concentration. Reproduced with permission from ref 1329.
Copyright 2015 American Chemical Society. (B) Effect of lipid
headgroup charge. Reproduced with permission from ref 1328.
Copyright 2016 American Chemical Society.
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face.1159,1162,1166,1167,1169,1353−1359
For the enzymes discussed in this section, the importance of
membrane−protein cohabitation is clear. Existing studies have
shown that the membrane lipid composition affects protein
conformation by, for example, opening the entrance to the
catalytic pocket and modifying the orientation of proteins
toward the membrane surface. On the other hand, these
enzymes are responsible for the catabolism of xenobiotic and
naturally occurring small molecules, which frequently aggregate
at the membrane interface, affecting membrane structure. For
this reason, preventing such aggregation is crucial, since
membrane properties may affect the functioning of many
transmembrane proteins. Here, CYP, MAO, and COMT may
be seen as membrane vacuum cleaners serving to maintain the
native state of a membrane.
10.3. Enzymes Involved in Lipid Metabolism
Phospholipase A2 (PLA2) is a key enzyme responsible for
phospholipid hydrolysis. This and other lipases are water-
soluble peripheral membrane proteins. An MD study of two
members of the human PLA2 family, the cytosolic group IVA
(GIVA) PLA2 (cPLA2) and calcium-independent group VIA
(GVIA) PLA2 (iPLA2), showed that the binding of these
enzymes to the membrane surface induces protein conforma-
tional changes, leading to the opening and expansion of the
binding site.1360 Thus, the membrane acts as an allosteric
regulator of the protein. Interestingly, the PLA2 enzymes seem
to have more than one allosteric site for membrane
interactions. The analysis of PAPC binding modes in the
binding cavities of cPLA2 and iPLA2 indicated that both
proteins employ the same catalytic mechanism despite the
large structural differences between them.1360 Subsequent
studies showed the same effect of the membrane on a third
enzyme in the same family: group V secreted PLA2.1361
Additionally, it was shown that the part of the binding cavity
that hosts the acyl chain in the sn-2 position, but not the part
that hosts the headgroup, determines the phospholipid
specificity of the enzyme.1361
Monoacylglycerol lipase, in turn, is a peripheral membrane
enzyme that cleaves monoacylglycerols involved in the
production of pro-inflammatory molecules. Extensive MD
simulations and free energy calculations showed that the higher
affinity of the enzyme for substrates containing arachidonic
acyl chains compared to those containing the palmitoyl chain is
related to the lid domain plasticity and its interplay with
membrane fluidity.1362 This specificity for the arachidonic acid
is important for the enzyme function, as arachidonic acid is a
precursor for pro-inflammatory molecules. These studies
allowed identifying key residues (F159 and I179) involved in
specific interactions with unsaturated chains. Interestingly,
F159 is conserved across orthologues of the enzyme across
numerous species.1362 Finally, the simulation studies provided
also a model for the key steps in the catalytic cycle of this
enzyme.1362
Another peripheral lipase, the M37 protein from Photo-
bacterium lipolyticum, is an interesting interfacial enzyme as it
preserves its activity at low temperatures and is stable in
nonaqueous solvents. The simulations by Willems et al.
showed that although M37 preferentially binds to anionic
bilayers, it is not activated upon binding to the bilayers.1363 On
the other hand, M37 also binds triglyceride surfaces, which
results in structural changes characterized by the opening of
the entrance to the catalytic site.
Glutathione peroxidase 4 is a water-soluble peripheral
membrane enzyme responsible for reduction of hydro-
peroxides in lipids. MD simulations showed that lipid chains
oxidized with hydroperoxide groups change their conformation
to expose the polar OOH-group toward the water
phase.113,117,669,1364 MD simulations also showed that the
interaction of glutathione peroxidase 4 with lipids is driven by
electrostatics, particularly between the positively charged
residues of the protein and the negatively charged phosphate
moieties of the lipids.1364 For this reason, interaction with
cardiolipin, which has two phosphate groups, was stronger
than that with PC.1364 Consideration of peroxides at the most
common positions along the acyl chains (9 and 13) indicated
that glutathione peroxidase 4 predominately reduces the
peroxide group at the chain of the bound lipid molecule
upon binding to the lipid headgroups; however, reduction of
peroxide located at other positions or neighboring lipids is still
possible, but due to steric obstacles less likely.
Vitamin K is a fat-soluble compound broadly categorized
with lipids. In a recent study, the structure of the vitamin K
epoxide reductase was predicted via homology modeling and
shown to be stable in a microsecond simulation.1365 The
structure was then used to explore vitamin K and its possible
inhibitor binding modes.
10.4. Steps of Membrane Protein Biosynthesis
Protein biosynthesis and folding are processes characterized by
large time and size scales. These are typically not accessible
with the current computational resources and methodologies.
Nevertheless, simulations can be used to explore some steps of
these processes, such as the entering of the unfolded proteins
into the translocon (for a review, see ref 1366). Early
simulation studies have considered, for example, the size of
the translocon pore,1367 the free energy of peptide
insertion,1368 and translocon’s arrangement in a bi-
layer.1369−1371
The folding of proteins begins at the exit channel of the
ribosome. Coarse-grained simulations verified that the volume
of the ribosome exit tunnel is large enough to accommodate
the initial steps of folding.1372 Extensive atomistic simulations
showed that the folding of helices in the translocon channel is
a fast process occurring in a time scale of 100−1000 ns (Figure
73). This stems from the significant reduction of conforma-
tional space due to the shape of the channel, which promotes
helix formation.1373 Meanwhile, these studies also showed that
translocation of the helix from the translocon pore to the lipid
bilayer requires time scales much longer than the microseconds
often probed in the simulations. As a matter of fact, free energy
calculations suggested that it occurs in the time scale of
seconds.1374 The mechanism and the energetics of the
translocation process have been elucidated by coarse-grained
simulations of translocon models.1375 These studies showed,
among others, that the opening of translocon due to ribosome
attachment reduces the kinetic barrier of the insertion. Thus,
the membrane insertion energy of residues does not
correspond to the free energy difference between the
translocon channel and the lipid environment.
Considering the size of the ribosome−translocon complex, it
is clear that in the near future, atomistic simulations cannot
reach the time scales taken by the processes related to protein
synthesis. For this reason, it is imperative to develop specific
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00538
Chem. Rev. XXXX, XXX, XXX−XXX
DS
coarse-grained simulation strategies. Nielsen et al. recently
used this approach, as they developed a coarse-grained model
based on experimental and extensive simulation data to study
protein translocation and integration into a lipid bilayer.1376
There is reason to encourage more research to be done in the
same spirit.
10.5. Challenges
Although membrane enzymes constitute a large group of
proteins with numerous vital functions, the current under-
standing of the role of lipids in their activity seems to be very
limited. The number of MD simulation studies in this field is
not impressive. This is particularly obvious in the light of the
literature discussed in sections 6 and 7, which highlight the
quite extensive simulation work done to understand how lipids
modulate membrane proteins. Nevertheless, a limited number
of studies have shown that membrane enzymes are not very
different from the other classes of membrane proteins and that
lipids regulate their activity, too.
Enzymatic functions usually involve specific chemical
reactions, which can only be studied using quantum-
mechanical (QM) calculations. Although classical MD cannot
provide insight into enzymatic reactions, hybrid methods
(QM/MM) aim to bring the best of the two worlds together.
QM/MM achieves this by limiting the QM calculations to a
small region of interest, while handling the rest of the system
using classical molecular mechanics. Therefore, developing
QM/MM methodologies is crucial for future studies (for the
current state of QM/MM development, see the review by
Crespo-Otero and Barbatti1377).
The fact that only a limited number of studies have explored
membrane associated enzymatic complexes is partly due to the
lack of structural data to construct atomistic models. Further,
even if the structures of individual proteins are known, it is
difficult to predict their quaternary association. Protein−
protein docking methods are not reliable for this task, and the
spontaneous assembly of the complexes occurs in time scales
far beyond those that are currently accessible to MD.
11. CONCLUDING REMARKS
In this review, we have provided a comprehensive overview of
the role of biomembranes in numerous cellular processes. We
have briefly introduced the key experimental findings related to
each of these processes, followed by an exhaustive listing and
discussion of the most relevant computational studies.
After the introduction, in section 2, we reviewed the history
of biomembrane models, ending up in the current paradigm
that sets its foundations around the raft concept. We also
briefly described the development of computer simulation
methods used to study biomembranes and concluded that the
molecular dynamics method is currently by far the most widely
used technique in the field. We also discussed the length and
time scales achievable using classical molecular dynamics
simulations.
Next, in section 3, we thoroughly described the complexity
of the biomembrane structure. Our aim here was to provide a
description of a target membrane, that is, the membrane
including all the known features that should eventually be
included in simulation models. These features include lipid
diversity, heterogeneity, and asymmetry; protein diversity,
post-translational modifications, and multiprotein assemblies;
the membrane-lining actin cytoskeleton and the glycocalyx;
and their mutual interactions, especially between lipids and
proteins. While the list seems long and even discouraging, it is
also delighting to see that simulation approaches have
numerous uncharted territories left to explore in the future.
The following six sections each focused on a different
function associated with biomembranes. In section 4, we
reviewed the studies on membrane phase behavior, discussing
both phase-separating model systems and more complex
mixtures in which the formation of nanoscopic domains is
either driven by lipid−lipid interactions or induced by
membrane proteins. We concluded that the comparison
between simulations and experiments is not straightforward
due to methodological issues, the limitations in the reached
time scales, and somewhat controversial experimental data.
Next, in section 5, we reviewed simulation studies of
membrane dynamics. We concluded that the dynamics in
protein-free systems is well described by a concept of
concerted flows, whereas in systems with dilute concentrations
of proteins the Saffman−Delbrück description succeeds, as
long as the effects of the lipid shell are accounted for. However,
in more crowded systems these models often fail, and the little
studied effects of the actin cytoskeleton and membrane
domains are likely not simply described either. In section 6,
we reviewed simulation studies on mass transport in
biomembranes, covering passive permeation and transport by
channels and carriers. Moreover, we discussed protein-
mediated lipid flip−flops and lipid transport by peripheral
proteins. All these topics are readily studied using all-atom
simulations and provide vital information to support
experimental work. In the second part, we reviewed vesicular
transport including the budding and fusion of vesicles, topics
currently within the reach of coarse-grained models. Our
examples highlight how biomembranes, being usually a barrier
for permeation, can facilitate transport through themselves
through vesiculation or by regulating the function of proteins
responsible for transbilayer diffusion. In section 7, we reviewed
the literature on how simulations have helped us understand
Figure 73. Example of peptide folding in the environment mimicking
a translocon channel. Channel thickness was 1.2 nm. (A) In the
absence of water in the channel, the peptide did not fold into a helix.
(B) In the presence of water, on the other hand, the helix formed
within 100 ns. Reproduced with permission from ref 1373. Copyright
2015, Springer Science Business Media New York.
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the role of biomembranes in signaling. We discussed
spontaneous lipid flip−flops and the regulation of protein
function by lipid−protein interactions and post-translational
modifications. Current computing resources are usually
adequate to tackle these problems efficiently using all-atom
models, especially with the aid of biased simulations. In section
8, we discussed how membrane lipids can regulate protein
function. We considered their effects on protein aggregation,
signaling, and sorting. Moreover, we reviewed drug−mem-
brane interactions, binding of peripheral proteins on
membrane lipids, and the allosteric modulation of membrane
proteins by their neighboring lipids. While all-atom simulations
readily probe the favorable interactions, studies on conforma-
tional changes of proteins are still not entirely feasible.
Moreover, studies on protein aggregation and partition rely on
coarse-grained models. In section 9, we discussed energy
storage in terms of lipid droplets and lipoproteins, as well as
ion gradients across membranes. For the large droplets, as for
all nonplanar membrane systems, coarse-grained models are
currently required. Finally, in section 10, we reviewed the
rather limited number of molecular dynamics studies that have
characterized the role of membranes in enzymatic activity
related to lipid metabolism and catabolism of small molecules
and xenobiotics. Here, the role of lipids in regulating the access
of the substrate and inhibitor molecules to the catalytic pockets
is of crucial pharmacological interest.
The vast number of topics and studies we have covered in
this review proves that computer simulations have rapidly
evolved into an indispensable tool to support experiments and
theoretical work, and to lead the development of selected
topics. It is fairly impressive considering that the first
membrane simulations were performed only 25 years ago
and covered time scales with little relevance for biological
functions. How did we get so far so fast? First, the
development of computing power has been rapid over the
last decades. Apart from the rapid increase in single-chip
performance, improved parallelization schemes, the use of
graphics processing units, and the integration to hardware
development via the use of advanced instruction sets have
contributed greatly to the push from the simulations spanning
a few picoseconds to the microsecond or even millisecond
regime. That is 8 orders of magnitude, arguably the most rapid
development in any field in the history of modern science.
Not all computing capacity has been exploited to push up
the time and size scales. The simulation engines have also
implemented new and improved algorithms that increase the
accuracy of the simulations. Improved models for proteins and
lipids constantly appear in the literature, and parametrizations
of new molecule types such as sugars are also popping up
regularly. These developments are driven by improved
experimental input as well as more accurate quantum-
mechanical calculations used in parametrization. In addition
to pushing the size and length scales further, enhanced
sampling methods are also constantly under development,
providing faster convergence and hence more trustworthy data
with the same amount of resources. It is also worth mentioning
that the multiscale methods also bridge the more detailed
models with more efficient ones to utilize the computing
capacity optimally. Such multiscale methods include combina-
tions of atomistic and coarse-grained models, as well as
combining quantum-mechanical calculations with classical
molecular mechanics in QM/MM. Finally, we are starting to
see the impact of machine learning methods on the field. Tools
for parametrizing molecules, finding reaction coordinates for
free energy calculations, evaluating protein−protein interac-
tions, and predicting the effect of mutations have recently
surfaced, and we expect to see many more applications in the
near future. These developments will hopefully aid us in
improving the extremely vast and complex force fields that are
soon becoming impossible to maintain by manual efforts only,
and to determine proper reaction coordinates to study protein
activation−a task that currently resembles looking for a needle
in a haystack. Still, despite the rapid developments of the
classical molecular dynamics method, other techniques such as
physics-based phase field models and techniques that
incorporate hydrodynamics such as the lattice-Boltzmann
methods are likely required on the way to a cell-level
description.
Another factor that has driven the simulation field forward is
the rapid development of experimental methods. Improved
crystallization techniques and cryo-EM supply protein
structures at record rates, and these structures are often
resolved with some bound lipid molecules. Moreover, new
lipidomics techniques provide information on the lipid
composition of different tissues, and especially on how these
compositions are affected by disease. Together, they allow for
straightforward computational studies of lipid−protein inter-
actions. What is more, current super-resolution microscopy
methods can probe the plasma membranes of living cells at a
resolution that already overlaps with the size scales of current
simulations, providing means for seamless comparison of
simulation and experiment. While benefiting from the
experimental input, simulations can also pay back by
characterizing the effects of probes and other required
nonidealities and therefore help improve the experimental
methodology. Fortunately, many laboratory experiments are
becoming less intrusive, further benefiting the interplay with
simulations.
We would also like to specially thank the raft concept.
Despite its historical shortcomings, it has reached an odd status
in the scientific community. While the discussion on the
existence of rafts seems to continue, rafts still dominate the
way we consider biomembranes today, and the concept has
sparked an enormous amount of studies. Importantly, the
research built around rafts has brought up many interesting
findings on biomembranes, fostered the rapid development of
super-resolution applications, and, most notably, elevated the
lipid membrane from merely an embedding matrix into the
limelight as a functionally relevant counterpart of proteins.
This development has also given a massive boost to the
biomembrane simulation field, rendering it a central tool in
many related fields.
Perhaps everyone thinking of rafts should instead consider
what has been observed through biomembrane experiments
and simulations. It is established that biomembranes are
heterogeneous and rich in proteins. For many membrane
proteins, there is compelling evidence that they have allosteric
binding pockets for specific lipids. The proteins also favor
certain lipids and fatty acids in their immediate vicinity, and
together, these proteins and lipids form dynamic complexes
that partition to membrane environments that foster the
protein’s activation and function. Further, quite often it is not
just a single protein doing the job, but the proteins form
oligomers that together with selected lipids form the functional
unit. The size of the dynamical protein−lipid complex depends
on the protein oligomer and the lipid−protein interactions, but
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roughly speaking it ranges from about 5 to 20 nm, being
possibly larger if the number of proteins in the oligomers is
very large. It is a matter of taste what these dynamical,
transient, and functional protein−lipid nanocomplexes are
called, but there is quite a bit of evidence supporting the view
that they exist.
Unfortunately, bridging simulation and experiment is not
always a walk in a park. While we struggle to understand even
the behavior of simple model membranes, we are still heading
full speed toward more and more complex membrane systems,
trying to capture the in vivo behavior probed by many
experiments nowadays. This is understandable since complex-
ity seems to sell papers better than reliability and the most
interesting phenomena take place in extremely complicated
membranes. Sadly, the model is always only as good as its
weakest part, and the current hastiness can become costly in
case the models are not constantly improved. In case we lose
the hard-earned status as a reliable tool to back up
experiments, it will be incredibly difficult to reclaim it.
So let us review for what the current models and the
available scales are good. Considering the topics covered in
this review and listed in the beginning of this section, it is safe
to say that all-atom simulations can nowadays be used to study
the dynamics of fairly simple membranes, the passive
interaction of drugs and proteins with membranes, and the
interaction of membrane proteins and lipids. With the use of
enhanced sampling techniques, all-atom models can be
extended to studies of protein conformational changes,
permeation of molecules through membranes either in the
absence or in the presence of proteins, and lipid flip−flops.
Moving on to coarse-grained models, dynamics and phase
behavior of more complex membranes can be studied along
with membrane fusion, membrane protein oligomerization,
and sorting.
The listing above suggests that further developments in
computing power and model quality need to be made before
certain topics can be reliably studied using simulations. Such
problematic cases include monolayers at water−air interphases
where surface tension is not well reproduced by the used
models. Similarly, the interactions between membranes and
peripheral proteins are likely affected by the poor description
of the headgroup structure and especially their response to
ionic environments. The coarse-grained MARTINI model used
to study the aggregation of membrane proteins and water-
soluble proteins suffers from excessive protein−protein
interactions undermining such studies. Similarly, studies on
phase behavior with the same model seem to be haunted by
occasionally poor agreement with experimentally observed
behavior. While biased simulation techniques can be used to
study protein conformational changes, finding the right
reaction coordinates is often hard. Hence, it would be
desirable to see spontaneous conformational changes in
unbiased simulations. Unfortunately, this might not be only a
time scale issue, since the membrane proteins seem to be
overstabilized in many force fields. The proper sampling of
time scales is also important in studies of membrane dynamics,
where only averages over a substantial amount of long
trajectories are useful. The importance of sampling becomes
crucial in crowded environments, where membrane compo-
nents can be in an extremely immobile state. Similar issues also
arise when considering crystalline structures such as the waxes
in tear film lipid layer or the ceramide-based models of stratum
corneum. Large scales are also required to see the proper
mixing and hence domain formation in complex biomem-
branes, as well as in studies involving large vesicles.
Special attention must also be paid to the fact that the
equilibrium state modeled by most simulation studies is fairly
irrelevant for most processes. Instead and except for diffusion,
most mass transport takes place via nonequilibrium processes,
such as endo- and exocytosis and the function of carrier
proteins such as lipoproteins. Moreover, the components in
lipid bilayers are constantly recycled meaning that the
membranes are in a steady state instead of being in
equilibrium. The largest challenge in modeling such non-
equilibrium processes is likely sampling as statistically
significant results can only be extracted from a large number
of samples, which requires simulating the process numerous
times. Sometimes the nonequilibrium conditions at the
nanoscale are apparent even in the macroscale: Due to our
breathing and blinking, the lipid structures at the interfaces in
the eye and the lungs undergo repeated cycles of spreading to
and buckling away from the interface. Fortunately, the current
simulation scales are reaching a point in which these
phenomena can be modeled at realistic speeds.
How about the features that our models currently lack? Most
biomembrane simulations are still performed with simple and
symmetric lipid compositions, whereas cellular membranes
have long been known to be compositionally complex and
asymmetric. Implementing the former means that simulations
have to be extended to allow for a proper mixing of lipid
molecules, while the latter feature can be readily incorporated
as soon as experiments can provide us with trustworthy data on
asymmetry, especially with regard to the distribution of
cholesterol. Moreover, the roles of the actin cytoskeleton and
the glycocalyx, lining the membrane at both sides, are very
rarely considered in simulations, partly due to their large sizes
and in part due to the lack of structures of proteins building
these networks. Perhaps the easiest things to implement are
post-translational modifications in proteins. While these
modifications do not call for a large increase in the required
computing resources, their importance for protein function can
be significant. Fortunately, databases for these modifications
are readily available, and the tools for incorporating them in
simulation models are also rapidly improving.
Finally, we want to point out that exceptional scientists are
required to overcome all these limitations. Fortunately,
research groups engaging in software, tool, and model
development are filled with bright minds that work to benefit
everyone in the field. Technical aspects aside, we also need the
people that are able to ask the right scientific questions. Here,
the persistent efforts of computational scientists have raised
molecular dynamics simulations to a level where they can be
considered as equal counterparts to experimental work. This
interplay leads to an exchange of interesting ideas and hence to
better science. Furthermore, the ongoing attempts to make
simulation software and tools more accessible to people
without programming skills has lured numerous talented
scientists to the field, leading to a rapid increase in the size of
the community. All in all, we believe that the near future will
turn out to be an extremely prosperous era for the field as more
and more complex systems are explored at ever larger and
longer scales by more accurate models and by an ever growing
number of bright scientists.
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Carrasco, M. P. Alkylphospholipids: An Update on Molecular
Mechanisms and Clinical Relevance. Biochim. Biophys. Acta,
Biomembr. 2017, 1859, 1657−1667.
(70) Mobarak, E.; Javanainen, M.; Kulig, W.; Honigmann, A.;
Sezgin, E.; Aho, N.; Eggeling, C.; Rog, T.; Vattulainen, I. How to
Minimize Dye-Induced Perturbations While Studying Biomembrane
Structure and Dynamics: PEG Linkers as a Rational Alternative.
Biochim. Biophys. Acta, Biomembr. 2018, 1860, 2436−2445.
(71) Rissanen, S.; Grzybek, M.; Orłowski, A.; Roǵ, T.; Cramariuc,
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(134) Manna, M.; Roǵ, T.; Vattulainen, I. The Challenges of
Understanding Glycolipid Functions: An Open Outlook Based on
Molecular Simulations. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids
2014, 1841, 1130−1145.
(135) Slotte, J. P. Molecular Properties of Various Structurally
Defined Sphingomyelins − Correlation of Structure with Function.
Prog. Lipid Res. 2013, 52, 206−219.
(136) Gulshan, K.; Smith, J. D. Sphingomyelin Regulation of Plasma
Membrane Asymmetry, Efflux and Reverse Cholesterol Transport.
Clin. Lipidol. 2014, 9, 383−393.
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00538
Chem. Rev. XXXX, XXX, XXX−XXX
DZ
(137) Müller, C. P.; Reichel, M.; Mühle, C.; Rhein, C.; Gulbins, E.;
Kornhuber, J. Brain Membrane Lipids in Major Depression and
Anxiety Disorders. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2015,
1851, 1052−1065.
(138) Karunakaran, I.; van Echten-Deckert, G. Sphingosine 1-
Phosphate − A Double Edged Sword in the Brain. Biochim. Biophys.
Acta, Biomembr. 2017, 1859, 1573−1582.
(139) Li, L. K.; So, L.; Spector, A. Membrane Cholesterol and
Phospholipid in Consecutive Concentric Sections of Human Lenses.
J. Lipid Res. 1985, 26, 600−609.
(140) Subczynski, W. K.; Raguz, M.; Widomska, J.; Mainali, L.;
Konovalov, A. Functions of Cholesterol and the Cholesterol Bilayer
Domain Specific to the Fiber-Cell Plasma Membrane of the Eye Lens.
J. Membr. Biol. 2012, 245, 51−68.
(141) Jain, M.; Ngoy, S.; Sheth, S. A.; Swanson, R. A.; Rhee, E. P.;
Liao, R.; Clish, C. B.; Mootha, V. K.; Nilsson, R. A Systematic Survey
of Lipids across Mouse Tissues. Am. J. Physiol.-Endocrinol. Metab.
2014, 306, E854−E868.
(142) Iwai, I.; Han, H.; Hollander, L. d.; Svensson, S.; Öfverstedt, L.-
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Javanainen, M.; Manna, M.; Rog, T.; Hof, M.; Vattulainen, I.;
Jungwirth, P. Experimental Determination and Computational
Interpretation of Biophysical Properties of Lipid Bilayers Enriched
by Cholesteryl Hemisuccinate. Biochim. Biophys. Acta, Biomembr.
2015, 1848, 422−432.
(164) Kulig, W.; Mikkolainen, H.; Olzẏnśka, A.; Jurkiewicz, P.;
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Berglund, L. Prediction of the Human Membrane Proteome.
Proteomics 2010, 10, 1141−1149.
(226) Scherer, W. F.; Syverton, J. T.; Gey, G. O. Studies on the
Propagation in Vitro of Poliomyelitis Viruses. IV. Viral Multiplication
in a Stable Strain of Human Malignant Epithelial Cells (Strain HeLa)
Derived from an Epidermoid Carcinoma of the Cervix. J. Exp. Med.
1953, 97, 695−710.
(227) Nagaraj, N.; Wisniewski, J. R.; Geiger, T.; Cox, J.; Kircher, M.;
Kelso, J.; Paabo, S.; Mann, M. Deep Proteome and Transcriptome
Mapping of a Human Cancer Cell Line. Mol. Syst. Biol. 2011, 7, 548−
548.
(228) Liu, J.; Rost, B. Comparing Function and Structure between
Entire Proteomes. Protein Sci. 2001, 10, 1970−1979.
(229) Vit, O.; Petrak, J. Integral Membrane Proteins in Proteomics.
How to Break Open the Black Box? J. Proteomics 2017, 153, 8−20.
(230) Garrow, A. G.; Agnew, A.; Westhead, D. R. TMB-Hunt: An
Amino Acid Composition Based Method to Screen Proteomes for
Beta-Barrel Transmembrane Proteins. BMC Bioinf. 2005, 6, 56.
(231) Chaturvedi, D.; Mahalakshmi, R. Transmembrane β-Barrels:
Evolution, Folding and Energetics. Biochim. Biophys. Acta, Biomembr.
2017, 1859, 2467−2482.
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Mapping the Human Membrane Proteome: A Majority of the Human
Membrane Proteins Can Be Classified According to Function and
Evolutionary Origin. BMC Biol. 2009, 7, 50.
(233) Yin, H.; Flynn, A. D. Drugging Membrane Protein
Interactions. Annu. Rev. Biomed. Eng. 2016, 18, 51−76.
(234) Yıldırım, M. A.; Goh, K.-I.; Cusick, M. E.; Barabaśi, A.-L.;
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Visualization of Ligand-Induced Transmembrane Signaling in the
Full-Length Human Insulin Receptor. J. Cell Biol. 2018, 217, 1643−
1649.
(255) Manna, M.; Kulig, W.; Javanainen, M.; Tynkkynen, J.;
Hensen, U.; Müller, D. J.; Rog, T.; Vattulainen, I. How To Minimize
Artifacts in Atomistic Simulations of Membrane Proteins, Whose
Crystal Structure Is Heavily Engineered: β2-Adrenergic Receptor in
the Spotlight. J. Chem. Theory Comput. 2015, 11, 3432−3445.
(256) Hanson, M. A.; Cherezov, V.; Griffith, M. T.; Roth, C. B.;
Jaakola, V.-P.; Chien, E. Y. T.; Velasquez, J.; Kuhn, P.; Stevens, R. C.
A Specific Cholesterol Binding Site Is Established by the 2.8 Å
Structure of the Human β2-Adrenergic Receptor. Structure 2008, 16,
897−905.
(257) Radoicic, J.; Lu, G. J.; Opella, S. J. NMR Structures of
Membrane Proteins in Phospholipid Bilayers. Q. Rev. Biophys. 2014,
47, 249−283.
(258) Park, S. H.; Das, B. B.; Casagrande, F.; Tian, Y.; Nothnagel, H.
J.; Chu, M.; Kiefer, H.; Maier, K.; De Angelis, A. A.; Marassi, F. M.;
et al. Structure of the Chemokine Receptor CXCR1 in Phospholipid
Bilayers. Nature 2012, 491, 779−783.
(259) Bordignon, E.; Bleicken, S. New Limits of Sensitivity of Site-
Directed Spin Labeling Electron Paramagnetic Resonance for
Membrane Proteins. Biochim. Biophys. Acta, Biomembr. 2018, 1860,
841−853.
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00538
Chem. Rev. XXXX, XXX, XXX−XXX
EC
(260) Bai, X.; McMullan, G.; Scheres, S. H. How Cryo-EM Is
Revolutionizing Structural Biology. Trends Biochem. Sci. 2015, 40,
49−57.
(261) Murata, K.; Wolf, M. Cryo-Electron Microscopy for Structural
Analysis of Dynamic Biological Macromolecules. Biochim. Biophys.
Acta, Gen. Subj. 2018, 1862, 324−334.
(262) Mio, K.; Sato, C. Lipid Environment of Membrane Proteins in
Cryo-EM Based Structural Analysis. Biophys. Rev. 2018, 10, 307−316.
(263) Vinothkumar, K. R. Membrane Protein Structures without
Crystals, by Single Particle Electron Cryomicroscopy. Curr. Opin.
Struct. Biol. 2015, 33, 103−114.
(264) Lee, S. C.; Khalid, S.; Pollock, N. L.; Knowles, T. J.; Edler, K.;
Rothnie, A. J.; Thomas, O. R. T.; Dafforn, T. R. Encapsulated
Membrane Proteins: A Simplified System for Molecular Simulation.
Biochim. Biophys. Acta, Biomembr. 2016, 1858, 2549−2557.
(265) Lee, S. C.; Knowles, T. J.; Postis, V. L. G.; Jamshad, M.;
Parslow, R. A.; Lin, Y.; Goldman, A.; Sridhar, P.; Overduin, M.;
Muench, S. P.; et al. A Method for Detergent-Free Isolation of
Membrane Proteins in Their Local Lipid Environment. Nat. Protoc.
2016, 11, 1149−1162.
(266) Nasr, M. L.; Baptista, D.; Strauss, M.; Sun, Z.-Y. J.; Grigoriu,
S.; Huser, S.; Plückthun, A.; Hagn, F.; Walz, T.; Hogle, J. M.; et al.
Covalently Circularized Nanodiscs for Studying Membrane Proteins
and Viral Entry. Nat. Methods 2017, 14, 49−52.
(267) Autzen, H. E.; Myasnikov, A. G.; Campbell, M. G.; Asarnow,
D.; Julius, D.; Cheng, Y. Structure of the Human TRPM4 Ion
Channel in a Lipid Nanodisc. Science 2018, 359, 228−232.
(268) White, S. Membrane Proteins of Known 3D Structure. http://
blanco.biomol.uci.edu/mpstruc/ (accessed Aug 5, 2018).
(269) Almeida, J. G.; Preto, A. J.; Koukos, P. I.; Bonvin, A. M. J. J.;
Moreira, I. S. Membrane Proteins Structures: A Review on
Computational Modeling Tools. Biochim. Biophys. Acta, Biomembr.
2017, 1859, 2021−2039.
(270) Grigorieff, N.; Ceska, T. A.; Downing, K. H.; Baldwin, J. M.;
Henderson, R. Electron-Crystallographic Refinement of the Structure
of Bacteriorhodopsin. J. Mol. Biol. 1996, 259, 393−421.
(271) Laganowsky, A.; Reading, E.; Allison, T. M.; Ulmschneider,
M. B.; Degiacomi, M. T.; Baldwin, A. J.; Robinson, C. V. Membrane
Proteins Bind Lipids Selectively to Modulate Their Structure and
Function. Nature 2014, 510, 172−175.
(272) Poveda, J. A.; Marcela Giudici, A.; Lourdes Renart, M.;
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(570) Carpenter, T. S.; Loṕez, C. A.; Neale, C.; Montour, C.;
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Lohstroh, W.; Böckmann, R. A.; Unruh, T. Dynamic Processes in
Biological Membrane Mimics Revealed by Quasielastic Neutron
Scattering. Chem. Phys. Lipids 2017, 206, 28−42.
(620) Armstrong, C. L.; Trapp, M.; Peters, J.; Seydel, T.;
Rheinstad̈ter, M. C. Short Range Ballistic Motion in Fluid Lipid
Bilayers Studied by Quasi-Elastic Neutron Scattering. Soft Matter
2011, 7, 8358−8362.
(621) Chavent, M.; Reddy, T.; Goose, J.; Dahl, A. C. E.; Stone, J. E.;
Jobard, B.; Sansom, M. S. P. Methodologies for the Analysis of
Instantaneous Lipid Diffusion in MD Simulations of Large Membrane
Systems. Faraday Discuss. 2014, 169, 455−475.
(622) Starr, F. W.; Hartmann, B.; Douglas, J. F. Dynamical
Clustering and a Mechanism for Raft-like Structures in a Model
Lipid Membrane. Soft Matter 2014, 10, 3036−3047.
(623) Jacobson, K.; Mouritsen, O. G.; Anderson, R. G. W. Lipid
Rafts: At a Crossroad between Cell Biology and Physics. Nat. Cell
Biol. 2007, 9, 7−14.
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00538
Chem. Rev. XXXX, XXX, XXX−XXX
EL
(624) Aponte-Santamaria, C.; Briones, R.; Schenk, A. D.; Walz, T.;
de Groot, B. L. Molecular Driving Forces Defining Lipid Positions
around Aquaporin-0. Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 9887−
9892.
(625) Cohen, M. H.; Turnbull, D. Molecular Transport in Liquids
and Glasses. J. Chem. Phys. 1959, 31, 1164−1169.
(626) Almeida, P. F. F.; Vaz, W. L. C.; Thompson, T. E. Lateral
Diffusion in the Liquid Phases of Dimyristoylphosphatidylcholine/
Cholesterol Lipid Bilayers: A Free Volume Analysis. Biochemistry
1992, 31, 6739−6747.
(627) Galla, H. J.; Hartmann, W.; Theilen, U.; Sackmann, E. On
Two-Dimensional Passive Random Walk in Lipid Bilayers and Fluid
Pathways in Biomembranes. J. Membr. Biol. 1979, 48, 215−236.
(628) MacCarthy, J. E.; Kozak, J. J. Lateral Diffusion in Fluid
Systems. J. Chem. Phys. 1982, 77, 2214−2216.
(629) O’Leary, T. J. Lateral Diffusion of Lipids in Complex
Biological Membranes. Proc. Natl. Acad. Sci. U. S. A. 1987, 84, 429−
433.
(630) Vaz, W. L. C.; Clegg, R. M.; Hallmann, D. Translational
Diffusion of Lipids in Liquid Crystalline Phase Phosphatidylcholine
Multibilayers. A Comparison of Experiment with Theory. Biochemistry
1985, 24, 781−786.
(631) Macedo, P. B.; Litovitz, T. A. On the Relative Roles of Free
Volume and Activation Energy in the Viscosity of Liquids. J. Chem.
Phys. 1965, 42, 245−256.
(632) Javanainen, M.; Monticelli, L.; de la Serna, J. B.; Vattulainen, I.
Free Volume Theory Applied to Lateral Diffusion in Langmuir
Monolayers: Atomistic Simulations for a Protein-Free Model of Lung
Surfactant. Langmuir 2010, 26, 15436−15444.
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L.; Verrey, F.; Diederichs, K.; Faraldo-Goḿez, J. D.; Pos, K. M.
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F.; Latorre, R. Molecular Determinants of Phosphatidylinositol 4,5-
Bisphosphate (PI(4,5)P2) Binding to Transient Receptor Potential V1
(TRPV1) Channels. J. Biol. Chem. 2015, 290, 2086−2098.
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00538
Chem. Rev. XXXX, XXX, XXX−XXX
EW
(1055) Antollini, S. S.; Barrantes, F. J. Fatty Acid Regulation of
Voltage- and Ligand-Gated Ion Channel Function. Front. Physiol.
2016, 7, 573.
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Vattulainen, I.; Hytönen, V. P.; Roǵ, T. PIP2 and Talin Join Forces to
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(1147) Fab́iań, B.; Sega, M.; Voloshin, V. P.; Medvedev, N. N.;
Jedlovszky, P. Lateral Pressure Profile and Free Volume Properties in
Phospholipid Membranes Containing Anesthetics. J. Phys. Chem. B
2017, 121, 2814−2824.
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E.; Neutze, R. Lipidic Cubic Phase Crystal Structure of the
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00538
Chem. Rev. XXXX, XXX, XXX−XXX
FF
Photosynthetic Reaction Centre from Rhodobacter Sphaeroides at
2.35 Å Resolution. J. Mol. Biol. 2003, 331, 681−692.
(1386) Stowell, M. H. Light-Induced Structural Changes in
Photosynthetic Reaction Center: Implications for Mechanism of
Electron-Proton Transfer. Science 1997, 276, 812−816.
(1387) Chirino, A. J.; Lous, E. J.; Huber, M.; Allen, J. P.; Schenck, C.
C.; Paddock, M. L.; Feher, G.; Rees, D. C. Crystallographic Analyses
of Site-Directed Mutants of the Photosynthetic Reaction Center from
Rhodobacter Sphaeroides. Biochemistry 1994, 33, 4584−4593.
(1388) Chang, C. H.; El-Kabbani, O.; Tiede, D.; Norris, J.; Schiffer,
M. Structure of the Membrane-Bound Protein Photosynthetic
Reaction Center from Rhodobacter Sphaeroides. Biochemistry 1991,
30, 5352−5360.
(1389) Johansson, L. C.; Arnlund, D.; Katona, G.; White, T. A.;
Barty, A.; DePonte, D. P.; Shoeman, R. L.; Wickstrand, C.; Sharma,
A.; Williams, G. J.; et al. Structure of a Photosynthetic Reaction
Centre Determined by Serial Femtosecond Crystallography. Nat.
Commun. 2013, 4, 2911.
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